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ABSTRACT 
Adult Polycystic Kidney Disease (APKD) is a genetic disease transmitted in an 
autosomal dominant fashion. There is no cure. Treatment is of the symptoms as they 
appear usually in adulthood. Patients affected by APKD may receive genetic counselling 
from renal physicians. 
The aims of genetic counselling can be described through paradigms which reflect 
the current understanding of genetics and knowledge of the illnesses. The availability of 
new diagnostic techniques creates a new paradigm concerned with the ethical issues of 
genetic testing and counselling. 
An investigation into patients' knowledge, perceptions and understanding of 
genetic counselling was undertaken at the Renal Unit of Glasgow Royal Infirmary, prior 
to the establishment of a screening and counselling service for those at risk for APKD. 
The main findings of the study were: the majority of patients had received some 
genetic counselling from renal physicians; the majority of patients had relatively good 
knowledge of the symptoms of and treatments for APKD; nevertheless patients believed 
that the two most important items to be included in genetic counselling were information 
about the symptoms and the treatment of APKD; patients did not fully understand the 
genetic inheritance of APKD; they described the risk of transmission of APKD (50-50) 
as a medium risk; almost all patients recommended that their at risk relatives and their 
children be tested for APKD; prior to the availability of prenatal diagnosis, patients 
thought that their children should be tested between the ages of 16 and 20. 
A secondary study, including spouses of those with APKD and also haemophiliacs 
and their spouses, found that respondents favoured prenatal testing without termination 
of pregnancy and that both diseases were rated as being of medium severity. 
These findings raise ethical issues for those giving genetic counselling, and have 
implications for the content of genetic counselling. 
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CHAPTER 1. INTRODUCTION AND OUTLINE OF THESIS 
1.1 INTRODUcnON 
Throughout the 1970s there was an increasing interest in genetic diseases and in 
ge~etic counselling. According to a WHO Report (1972 pS) this interest in disease of 
genetic origins stemmed from: 
"the absolute and relative decline in morbidity and mortality attributable to 
infection, parasitic infection and malnutrition; the relative increase in 
morbidity and mortality attributable to genetic factors and the development 
of promising approaches to the diagnosis, treatment and prevention of 
genetic diseases ... " • 
Genetic diseases were also becoming a subject of discussion in more popular 
literature with the availability of clearly written books such as Milunsky's Know your own 
Genes (1977), and Etzioni's Genetic Fix (1973), which discusses moral and ethical issues 
raised by the ability to identify genetic diseases. There also appeared books such as 
Phillips Living with Huntington's Disease (1982) which discussed the physical and social 
problems of Huntington's Disease (or Chorea) as well as problems created by the fact that 
the disorder is genetic. 
By 1982, according to a report of the Clinical Genetics Society, genetic counselling 
was being offered by clinical geneticists from genetic clinics and was available in most 
health authority areas in the United Kingdom. 
Adult Polycystic Kidney Disease (APKD) is an inherited disease of variable age 
of onset. There is no cure; the treatment is the treatment of the symptoms as they appear 
and these symptoms may necessitate renal dialysis and transplantation. It is possible to 
&'l.gnose the condition in adults by non-invasive ultrasound. Furthermore, the genetic 
transmission is clearly understood. Once diagnosed, patients with APKD attend a hospital 
renal clinic on a regular basis. 
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In 1982, a new service to offer genetic counselling and presymptomatic testing for 
APKD at the Tenovus Kidney Unit of Glasgow Royal Infirmary was under consideration 
and the research worker had been employed to ascertain the feasibility of establishing such 
a service which would be offered by the staff of the renal unit rather than having patients 
attend a genetic clinic run by geneticists. 
At this time, genetic counselling was becoming a subject of interest both to doctors 
as well as to other non-medical researchers, with interest focused on the defmitions of 
genetic counselling, the aim of genetic counselling and the outcome measures used in the 
studies (Shaw 1977). The criteria most consistently used by genetic counsellors to evaluate 
the success of their work were patient knowledge, patient reproductive intentions andlor 
reproductive behaviour after counselling, with the assessment of patient knowledge mainly 
focused on the patients' understanding of the risk of recurrence or occurrence of the 
particular disease. 
However some studies into genetic counselling had suggested that the attitudes of 
many families coming to genetic counselling were determined more by the sense of the 
burden of the illness (Leonard et al1972) than by knowledge of the precise genetic risks. 
Such a fmding may reflect the different concepts of illness and health held by the patients 
on one hand and the doctors on the other hand. It could have implications for the content 
of genetic counselling in terms of giving information about the problems that may be 
associated with particular diseases. Therefore, it seemed important from the point of view 
of the content of genetic counselling to consider how patients perceived the burden of the 
particular illness. For example a study of haemophilia (Markova and Forbes 1984) 
highlighted C'!'! importance to those with haemophilia of social problems such as 
employment. 
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Apart from giving information about the genetic risks, very little was known from 
the available research about what other information was given to patients in genetic 
counselling. It was not known whether information about such topics as contraception or 
about adoption and fostering was routinely given. Moreover it was not known what sort 
of information patients therr.selves would consider important to be included in genetic 
counselling. 
At the time of the beginning of this study, it was likely that most genetic 
counselling was retrospective, ie it was given after the diagnosis of the illness in the 
individual or after the birth of a child affected by a particular disorder. With regard to 
APKD, it was assumed that genetic counselling, if given, would have been given after the 
diagnosis of the illness in the patient. 
Prospective genetic counselling involves the identification of the at risk relative 
who can then be offered counselling and diagnosis. As the success of the identification of 
the at risk relatives depends on the cooperation of a source patient, it is important to 
ascertain the views of patients about informing at risk relatives of their risk as well as 
about the presymptomatic testing of those at risk. 
In view of the likely expansion of genetic knowledge and of genetic counselling, 
the importance of the patients' views of the content of genetic counselling, the perceived 
burden of the illness and attitudes to presymptomatic testing of a genetic disease seemed 
serious and worthwhile subjects of an investigation. 
The specific focus of this thesis was to assess the knowledge, perceptions and 
understanding of patients with APKD to their illness as well as to ascertain topics that 
could be included in a gene~c counselling service. A secondary focus of the study was to 
ascertain the views of patients with APKD and their families to prenatal diagnosis for 
APKD and termination of pregnancy of an affected fetus. In order to provide a 
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comparison with a 'control population', the views of male patients with haemophilia, 
haemophilia carrier women and their famllies to prenatal diagnosis for haemophilia and 
termination of pregnancy of an affected fetus was also sought. 
The research, therefore, had the following objectives in relation to those with 
APKD: 
1. To ascertain the patients' experience of genetic counselling. 
2. To ascertain the patients' knowledge of the symptoms of APKD and 
the treatments available. 
3. To ascertain the patients' knowledge of the genetic inheritance and 
transmission of APKD. 
4. To ascertain the attitude of patients to family limitation. 
5. To ascertain the influence of genetic counselling on the patients. 
6. To assess the attitudes of patients to testing their at risk children 
and asymptomatic relatives for APKD. 
7. To identify topics that patients perceived to be problems of APKD. 
8. To identify topics that patients thought should be included in 
genetic counselling. 
9. To ascert~n the views of patients and their families to prenatal 
diagnosis for APKD and termination of an affected fetus. 
10. To offer recommendations on the content of genetic counselling 
based on the findings of the study. 
The research for this thesis took place with the following timetable: 
1982: Registered for higher degree with Department of Psychology, 
University of Stirling. 
June 1982: Appointed Research Fellow, Department of Psychology, 
University of Stirling and Department of Medicine, Glasgow Royal 
Infirmary, based in the Renal Unit, Glasgow Royal Infrrmary. 
July 1982 - September 1982: Initial accrual of patients and pilot study. 
October 1982 - May 1983: First interviews carried out and accrual of 
patients completed. 
May 1983 - November 1983: Second interviews carried out and completed. 
November 1983 - April 1984: Third interviews carried out and completed. 
November 1984: Also appointed Research Fellow/HIV counsellor at the 
Haemophilia Unit, Glasgow Royal Infrrmary. 
1985: Announcement of discovery of gene marker for APKD on short arm 
of chromosome 16. 
January 1986 - October 1987: Collecting of data for APKD gene marker 
investigation with Dr Keith Simpson and in conjunction with 
Department of Medical Genetics, Yorkhill Hospital Glasgow. 
January 1986 - March 1987: Secondary study on prenatal diagnosis in 
APKD and haemophilia carried out and completed. 
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1986 - 1987: Data from all questionnaires coded and analysed using SPSS 
at Stirling University. 
February 1988: Moved to South East England. 
September 1988 - October 1990: Leave of absence from thesis for domestic 
reasons. 
1991: Commenced writing up of thesis. 
1991: All data recoded and analysed using SPSS PC. 
August 1992: Thesis title lodged with University of Stirling. 
September 1992 - November 1992: Data reanalysed using GLIM computer 
package and analysis using ridits carried out. 
December 1992: Thesis submitted to University of Stirling. 
1.2 OUIUNE OF THEsIs 
The content of the thesis is outlined below. 
In Chapter 2 key themes in the development of genetic counselling from the 
historical beginnings in the Eugenic movement are described with reference to the 
literature. The influence of preventive medicine in genetic counselling is discussed as well 
as the implications of the emphasis on prevention in genetic counselling. The relationship 
between the availability and type of diagnostic tests and the psychological and ethical 
implications of these tests for genetic counselling are explored. 
In Chapter 3 the development of medical knowledge of APKD from the earliest 
description to date are examined. The physiology of the illness and the major medical 
problems are described. A description of the most common treatments available is given. 
In Chapter 4 specific issues in genetic counselling in relation to APKD are 
examined. In particular the availability of accurate diagnosis, presymptomatic diagnosis 
and gene markers are discussed and the influence that these factors may have on genetic 
counselling. 
Chapter 5 explores lay concepts of health and illness. 
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In Chapter 6 the methodology of the data collection and the type of interview used 
are described. 
Chapter 7 describes the populations involves in the study. While 83 patients were 
initially accrued to the investigation, only 71 completed the frrst interview, and smaller 
numbers attended subsequent interviews. The reasons for this are given. 
Chapter 8 presents an overview of the subsequent analysis. 
Chapter 9 examines the demographic and medical explanatory variables. This 
includes the analysis by age, sex, number of children, education, occupation, housing and 
religion as well as severity of disease and family history. 
In Chapters 10 to 15 the analysis of the main responses is examined. In Chapter 
10 the patients' experience of genetic counselling is discussed. Chapters 11 and 12 are 
concerned with the analysis of the data on the patients' knowledge of the symptoms and 
treatment of APKD and their knowledge of the inheritance of the illness. In Chapter 13 
the respondents' perceptions of the burden of certain problems that could be caused by 
APKD are examined. In Chapter 14 the results of the analysis of the patients' attitudes to 
having children, attitudes to screening and testing of at-risk relatives, attitudes to testing 
of children, the outcomes of genetic counselling, and their views about who should give 
genetic counselling are discussed. The patients' perceptions of elements that could be 
included in genetic counselling are analysed in Chapter 15. 
In Chapter 16 a secondary study on prenatal diagnosis and termination of 
pregnancy is described, and in Chapter 17 the results of that study are discussed. 
The conclusions of the study are put forward in Chapter 18. 
Details and selected tabulations of the basic results and "Iupplementary results 
appear in the Appendices in Volume 2. 
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CHAPfER 2: GENETIC COUNSELLING 
2.1 INTRODUcnON 
The term 'genetic counselling' can be first traced to Sheldon Reed, an American 
doctor who reputedly coined the phrase in 1947 (porter 1977). Reed was concerned that 
the prevailing phrases of 'genetic advice' and 'genetic hygiene' were too eugenic or too 
socially oriented. In their place he suggested the term 'genetic counselling' to emphasise 
more the individual one-to-one relationship that he felt should exist between a counsellor 
and a patient. 
The activity that we now call genetic counselling has evolved in the 20th century. 
The state of knowledge of genetics and genetic diseases has increased during this century 
due to a greater understanding of the application of the principles of Mendelian 
inheritance. There has been an increase in the knowledge and availability of diagnostic 
tests for genetic diseases including both prenatal and presymptomatic diagnosis. There has 
also been the development of computer technology and the widespread use of computers. 
In this chapter the association between the state of knowledge of genetics and genetic 
diseases and the development of four paradigms in genetic counselling is discussed. 
2.2 TIm USE OF PARADIGMS IN THE ANALYSIS OF GENE11C COUNSELLING 
Kessler (1980) fust suggested that the history of genetic counselling could be 
organised around three different paradigms, relating to eugenics, preventive medicine and 
psychological medicine, each paradigm being based on a different set of beliefs and 
assumptions regarding the goals, principles and practices of genetic counselling. The 
sequence of Kessler's paradigms can be summarised: (1) genetic counselling had its 
origins in the eugenic movement and in the biological sciences of the early 20th century; 
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(2) by the 1950s it had become established as a medical activity; (3) during the 1970s a 
new paradigm emphasising communication and attention to psychosocial issues as an 
integral part of genetic counselling had emerged. 
The adoption of the concept of a paradigm is a useful starting point from which 
to analyse genetic counselling. These paradigms are based on different sets of ideologies 
and beliefs reflecting societal attitudes in' different historical periods and also reflecting 
the current knowledge of genetics, the prevailing medical attitudes to genetic disease, the 
awareness of the psychological needs of patients in genetic counselling, and the awareness 
of ethical problems created by new technologies. 
I suggest that a new fourth paradigm is now emerging in which the emphasis is on 
the ethics of how genetic information should be used. The widespread use of computers 
and computer linkage has enabled geneticists to store information easily as well as to 
transfer information about individuals and families from one genetic centre to another. As 
evidenced by the Report of the Working Party of the Clinical Genetics Society on Genetic 
Registers (1978) computerised genetic registers have been developed and used for clinical 
purposes for some time. These registers are intended to make it easier to recall individual 
patients for therapeutic purposes or to inform them of advances in treatment or diagnosis. 
Such registers may also be used to store information about at-risk relatives who may be 
contacted and offered genetic counselling (Emery and Miller 1976). The use of such 
registers raises important ethical considerations concerning confidentiality. It is necessary 
to protect the confidentiality of those about whom information is stored in the register; 
information about any family member must be confidential to that person alone. 
The increase in availability of easy diagnostic tests both for particular genetic 
diseases and for the identification of carrier status increases the opportunity of conflict for 
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the genetic counsellor wishing to protect the confidentiality of the patient but at the same 
time knowing that the information acquired could prevent harm to at-risk relatives. 
Presymptomatic screening for genetic disease raises the ethical dilemma of the need 
to protect the privacy of patients from institutional third parties such as employers and 
insurance companies. The increasing use of prenatal diagnosis raises the question of the 
need to respect parental choice which would include the decision either to terminate the 
fetus or to carry to term a fetus known to have some genetic defect. 
The four paradigms, Kessler's three and this fourth paradigm, which I am now 
proposing, do not form discrete entities. Rather there is an evolutionary development from 
one to the next, with each paradigm retaining some of the features of its predecessor. For 
example, a principle of negative eugenics, to prevent or reduce genetic disease, can be 
found reflected in the writings of many authors and does not belong solely to the first 
paradigm. In her examination of published studies of genetic counselling Shaw (1977) 
found that the most frequently stated objective of genetic counselling was to 'prevent' or 
'reduce' genetic disease. Rainer (1969) in discussing counselling of single gene disorders 
says " ••• weight must also be given not only to the genetic risk but also to the mental 
health and social responsibility of the prospective parents .•• ~wering the incidence or 
prevention of severe handicap is good for the community ... " (P225). And Lynch (1969) 
in his suggestion that "genetic counselling is ideally suited to programs of prevention" 
(P279) is supporting the same philosophy. Similar views are found in the writings of 
Leonard et al (1972), and the authors of the Report on the Provision of Regional Genetic 
Services in the United Kingdom (1982 pI) state: "There is increasing evidence that a 
national network of comprehensive genetic services would provide a real opportunity for 
disease prevention". 
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2.3 PARADIGM 1: EUGENICS 
The concept and the philosophy of genetic counselling can be traced back to the 
beginning of the 20th century and the eugenics movement. It is necessary to discuss the 
historical background first to demonstrate that it is the availability of knowledge of 
genetics that initially determined the focus of genetic counselling. 
2.3.1 Historical background: knowledge of heredity 
An understanding of heredity and the practical application of genetics by humans 
can be traced back to early civilisations. The process of domestication of animals and 
plants required an understanding of heredity. In early civilisations, individual animals and 
plants with desirable traits were selected, and by inbreeding them offspring with more of 
the same trait were produced. The success of domestication indicates that early human 
cultures understood a simple, but important rule of heredity, that 'like breeds like'. 
Early writings provide evidence that early societies had some understanding of 
heredity. According to Pierce (1990) Hindu sacred books attribute the characteristics of 
children primarily to the father, but differences between a son and his father were thought 
to result from the influence of the mother. Early writings also provide rules for choosing 
a spouse, suggesting that women from families with undesirable traits should be avoided. 
The ancient Greeks showed a knowledge of human heredity in their poetry and 
literature, and also in their medical writings. Euripides in Electra (413 BC) drew attention 
to the physical similarities between relatives, and also to psychological differences. The 
poet Theognis (6th century BC) described how practical considerations overcame eugenic 
ideals: 
·we seek well bred rams and sheep and horses and one wishes to 
breed from those. Yet a good man is willing to marry an evil wife, if she 
brings him wealth; nor does a woman refuse to marry an evil husband who 
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is rich. For men reverence money, and the good marry the evil, and the 
evil the good. Wealth has confounded the race.-
The fact that pattern baldness (alopecia) is sex limited was noted by Hippocrates 
(ca 400 Be) in his statement that eunuchs neither get gout nor grow bald and by Aristotle 
(384-322 Be) in his comment that no boy ever gets bald, no woman and no castrated 
man. One of the followers of Hippocrate~, in the 4th century Be, describes conception 
and the growth of the fetus and observes that wthe child must inevitably resemble each 
parent in some respect- , though he attributes the degree of resemblance to the strength and 
quantity of 'sperm' contributed by each parent (Lloyd 1978). 
In early Talmudic writings there is reference to an understanding of the hereditary 
nature of haemophilia. According to Rabbi Judah, if two children of the same mother died 
as a result of circumcision or, according to Rabbi Simeon ben Gamliel, if three children 
died as a result of circumcision, then circumcision of a third or fourth child respectively 
should not be performed. The same applied to the situation of three sisters. If one son of 
each sister had died as a result of circumcision then the son of the fourth sister may not 
be circumcised. This is in accord with Talmudic comment that in regard to circumcision 
there are families where the blood is loose and others in which the blood is held fast 
(Kami!, easily congealed, Yebamoth 64b, Rosner 1983 p245). 
Historically views about inheritance were often confused with popular superstition. 
In the 19th century, some believed in telegony, the idea that a person's heredity is affected 
not only by his father but also by other males who had had intercourse with his mother. 
This belief in telegony was taken to extreme in old British law which held that a man who 
seduced the wet nurse of the heir to the throne was guilty of polluting the blood of the 
Royal Family (McKie 1988 plO). 
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The problem of heredity in the 19th century was studied by scientists such as 
Mendel, Galton and Weissmann in different ways. Gregor Mendel (1822-1884) discovered 
the mathematical law governing dominant and recessive characteristics in hybrids. But the 
application of this discovery belonged to the 20th century. Mendel fertilised tall plants 
with pollen from short plants. He noted that a uniformly tall generation of plants was 
produced. When a second generation was 'grown from these plants some of the shortness 
characteristic of the fust generation returned in the ratio of three tall plants to one short. 
Mendel concluded that each of these characteristics 'must be determined by two distinct 
factors which acted as physical particles transmitted from one generation to another. One 
of these factors was inherited from the male, the other from the female. Further, Mendel 
concluded that one of these factors dominated the other. For the first time an explanation 
for heredity had been found (Mendel 1959). 
However for 35 years Mendel's work remained obscure. In 1900 the botanists 
Hugo de Vries (1848-1935), Carl Correns (1864-1933) and Erich von Tschermak-
Seysenegg (1871-1962) independently rediscovered Mendel's work and recognised its 
importance. In 1908 Ottenburg and Epstein demonstrated that blood groups were inherited 
in mendelian fashion and in 1911 Wilson made the first gene assignment in humans by 
assigning the gene for colour blindness to the X chromosome (Connor and Ferguson-Smith 
1988 p4). 
Francis Galton (1822-1911) began to investigate heredity experimentally in 1871. 
His observations on the inheritance of transfused blood in rabbits, of tricoloured spots in 
the coats of basset hounds, and of stature in humans led him to reject the Lamarckian 
theory of inheritance. The French biologist Jean-Baptiste Lamarck (1744-1829) had 
suggested that characteristics acquired by an individual during his lifetime could be passed 
on to the next generation. Lamarckism was popular in revolutionary France where the 
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emphasis on an individual's power to impose his or her influence on future generations 
was popular (Mckie 1988,pl0). The theory had flaws which were demonstrated by 
scientists who amputated the tails of mice who continued to produce offspring with tails. 
In Natural Inheritance (1889) Galton described the law of filial regression which 
asserts that the offspring of tall parents regress to the mean. Galton had approached the 
problems of inheritance through the then infant science of statistics. In the mid 19th 
century the practice of statistics consisted mainly of the accumulation of socially useful 
numerical data, with neither theoretical underpinning nor mathematical analysis. By the 
late 1860s Galton had come upon a quite different approach to statistics, the formulation 
now called the normal or Gaussian distribution. In 1877 in Typical Laws of Heredity, 
based on sweet pea data, it was clear that Galton realised that the laws governing heredity 
could be treated mathematically in terms of units of statistical deviation. Galton's work 
in statistics constituted a sharp and irreversible departure from the mere data gathering 
that had characterised the science of the mid 19th century (Kevles 1986 pl7) and insisted 
that statistics had to incorporate the theory and methods of mathematical probability. 
Galton's biographer Karl Pearson wrote in 1930: wThousands of correlation coefficients 
are now calculated annually, the memoirs and textbooks on psychology abound in them; 
they form •.• the basis of investigations in medical statistics, in sociology and 
anthropology •.• w. The method Galton invented to express the degree of resemblance 
between parents and children was the 'regression diagram' (pearson 1914). 
Augustus Weissmann (1834-1914) was a biologist who maintained that variation 
is produced by sexual selection and that acquired characters are not directly transmitted. 
Garrison (1921) suggested tha~ if Weissmann's theory were true and accepted it would 
have far reaching social significance as it would seem probable that Wmoral qualities 
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cannot be transmitted to children but have to be acquired in each case by intensive early 
training- (P554). 
Weissmann also suggested that the hereditary endowment of the animal, which he 
called genn plasm, was separate from and protected against influences from the 
environment. The insulation of the genn plasm from environmental influences called the 
Weissmann barrier is a fundamental principle of modern evolutionary theory. 
Charles Darwin (1809-1882) in The Origin of Species (1859) suggested that 
animals best suited to an environment survive longer and produce more offspring. In his 
review of the 1867 edition of The Origin of Species Fleeming Jenkin, Professor of 
Engineering at University College London, clarified the problem that Darwin had still to 
explain. Jenkin pointed out that an individual with a useful trait, which mated with a 
normal partner, would pass on only 50% of the trait to its offspring, 25% to its grand 
children 121/1 % to its great grand children and so on until the trait disappeared. Darwin 
died in 1882 without realising that a solution to that problem had been found 15 years 
earlier by Mendel. 
2.3.2 The eugenic movement: application of genetic knowledge 
The word 'eugenics' was coined by Galton in 1883 and first introduced in his book 
on Inquiries into Human Faculty (1883). He had, however, f1l'st published his eugenic 
ideas in 1865 in a two part article for Macmillans Magazine entitled Hereditary Talent and 
Characters. According to Schuster (1912), Galton was stimulated by the publication of 
Darwin's The Origin of Species in 1859. He was also impressed by the many cases of 
what he referred to as heredity among the men who were graduates of Cambridge 
university. In his investigations he drew a sample population of distinguished statesmen, 
military men, artists, jurists and musicians and found that a disproportionately large 
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number were related to one another. This observation led Galton to the conclusion that 
families of reputation were much more likely than ordinary families to produce offspring 
of ability. Galton believed that superior hereditary lines tended to be diluted by crossing 
with inferior lines, that human offspring tended to be more like the average between their 
parental strains than like either parent. He further believed that inferior genetic types, 
judged mainly by intelligence, tended to reproduce more rapidly than superior ones 
(Galton Hereditary Genius 1869) Galton's ideas indicated that unless strong measures were 
taken, the human evolutionary course could only be' downhill. He argued that the effect 
of ancestry caused the progeny of one generation to revert towards the centre population 
and he called that tendency the 'coefficient of reversion' • 
The concept of eugenics embodied in Human Faculty (1883) was the study of 
agencies that might improve or impair the racial qualities of future generations either 
physically or mentally. 
The practical measures by which eugenic principles could be applied were often 
divided into positive and negative eugenics (Haller 1963). The aim of positive eugenics 
was to secure the multiplication of those individuals above average in physical, mental and 
moral qualities. Negative eugenics focused on preventing an increase in the stock from 
which persons inferior in these respects may be expected to be derived (Schuster 1912 
p23S). 
In the preface to the 1892 edition of Hereditary Genius Galton acknowledged that 
"the great problem of the future betterment of the human race is ••• at the present time, 
hardly advanced beyond the state of academic interest •.. " • He continued: "The processes 
of evolution are in constant and spontaneous activity, some towards the bad, some towards 
the good. Our part is to watch for the opportunities to intervene by checking the former 
and giving free play to the latter" (Kevles 1986 p30S). 
15 
CHAPTER 2: GENETIC COUNSELLING 
Galton's eugenic ideas gradually won some degree of commendation from the 
scientific community in Britain and in the United States as well as among intellectuals 
such as George Bernard Shaw, Havelock Ellis and Sidney and Beatrice Webb. 
In 1904 Galton founded a Research Fellowship at the University of London, the 
aim of which was research and not for the spread of eugenic ideals. Galton expected the 
first Eugenics Fellow, Edward Schuster, to establish a register of able families so as to 
ascertain the hereditary ingredients of ability. Galton, disappointed by the lack of progress 
made by Schuster, terminated the Fellowship and founded instead the Galton Laboratory 
for National Eugenics, providing further in his will that the majority of his estate should 
go to University College London for the support of studies in eugenics. 
2.3.3 The Eugenics Society 
The Eugenics Society was founded in 1907 as the Eugenics Education Society (the 
name was changed in 1926) with Galton as Honorary President. The initial aims of the 
society were: 
"I. Persistently to set forth the national importance of Eugenics in order 
to modify public opinion and create a sense of responsibility, in the 
respect of bringing all matters pertaining to human parenthood 
under the domination of eugenic ideals. 
2. To spread a knowledge of the laws of heredity so far as they are 
known, and so far as that knowledge might effect improvement of 
race. 
3. To further eugenic teaching at home, in the schools and elsewhere." 
(quoted in Schenk and Parkes 1967 plS0). 
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These aims were modified and expanded over the years so that by 1944 the Aims 
and Objectives of the Society took up a 12 page leaflet (Hall 1990) and according to Hall, 
even in its peak years of 1911 and 1932/33, the membership never exceeded 800. 
The influence of the Society, however, went further than its small membership, 
which included members of distinction and influence and also members represented on 
government committees. The Society held regular meetings, endowed lectures and 
published The Eugenics Review. However, it is difficult to assess the impact of the 
Eugenics Society in bringing about eugenic awareness. According to Hall (1990 p328), 
from evidence in letters and documents sent to the Eugenics Society there did appear to 
be "pervasive but vague notions about good and bad breeding to be found in nearly all 
levels of British society". From the beginning of the Society there also appears to have 
been a tension in the aims between positive eugenics, encouraging those perceived as 
'suitable' to have more children, and negative eugenics, discouraging or preventing those 
perceived as 'unfit' from breeding. 
2.3.4 Sterilisation 
The Society also received requests for information about sterilisation and from 
evidence held in the Society archives it appears that there was often considerable support 
for legislative measures such as sterilisation from organisations not necessarily perceived 
as particularly in sympathy with the Eugenics Society. In 1926 the Society printed 20,000 
copies of a leaflet explaining the advantages of sterilisation. Although there was no law 
against it, British doctors were generally reluctant to perform sterilisation, even on 
volunteers who wished the operation let alone on those who were unable to decide to have 
the operation voluntarily (Kevles 1986 pl1S). 
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In 1934 the Brock committee reported on sterilisation and stated wthat there is no 
sound scientific basis for sterilisation on account of immorality of character defect. Human 
conduct and character are matters of too complex a nature, too interwoven with social 
conditions ••• to permit any defmite conclusions to be drawn concerning the part that 
heredity plays in their genesisw. The Brock Report declared that there was no case for 
compulsory sterilisation for eugenic reasons or any other reasons. The Report suggested 
that sterilisation may be warranted for a few genetic disorders but such sterilisation should 
be voluntary (Kevles 1986 pI67). 
2.3.5 Widening horizons 
In the years 1910-1914 eugenics took up subjects that had previously been outside 
the bounds of respectable discussion. For example, many eugenicists considered it 
important to teach adolescents about the physiology of sex to prevent venereal disease and 
to give information about sex, heredity and marriage. The scope of genetics adopted by 
the Society evolved as more knowledge of genetics became available to the scientific 
community. Until the early 1930s the hereditary nature of many traits now known to be 
infectious diseases was accepted. In addition good and less desirable moral qualities as 
well as scientific and artistic ability were treated as if they had simple patterns of 
inheritance and transmission. In the mid 1930s the Society had begun to appreciate the 
complexity of inheritance and had adopted the concepts of dominant and recessive 
transmission. By this time the Society was also distancing itself from the eugenic ideas 
adopted by Nazi Germany. As Hitler became more anti-semitic, Nazi racial and eugenic 
policies merged and the extremely barbaric Nazi policies eventually provoked a powerful 
anti-eugenic feeling. 
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Organisations to further eugenic ideas were also established at an early date in 
other countries. In Holland a committee was formed to urge the need for medical research 
before marriage and to convince mankind that one is morally bound to ask for medical 
advice before marriage, which ought to be done both in the interests of the enquirers and 
of the offspring (Schuster 1912 p55). 
2.3.6 Genetic advice and genetic hygiene: forerunners of genetic counselling 
Until the end of the Second World War, 'genetic hygiene' and 'genetic advice' 
were the terms used to describe what is now called 'genetic counselling'. The information 
was given by a variety of professionals, including doctors in public health, sociologists 
and biologists. Many of these people were zealous social reformers and social 
philanthropists. Genetic information was aimed at groups in society, e.g. the mentally ill 
and the feeble minded, through lectures and the dissemination of pamphlets and literature 
(Huxley 1936, Kevles 1986), rather than directed at individuals. 
The principal aims were to prevent the breeding of poor stock and therefore to 
reduce the social and economic burden to society. There is some evidence in the records 
of the Eugenics Society (Hall 1990) that information was also given to individuals, but the 
content of information given to individual people and by doctors to individual patients 
during this period is not well documented. As the aim was to reduce further harm to 
society, it is not unreasonable to assume that the personal needs of the individual patient 
were not necessarily considered (Twiss 1979). 
In the period prior to 1945, while individual doctors had an understanding and 
knowledge of the growing information about the influence of genetics on disease, the main 
thrust of information, research and interest in genetics came from organisations such as 
the Eugenics Society and the scientific community. Although members of the Eugenics 
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Society, the scientific community and social reformers wrote and distributed pamphlets 
and gave lectures on the implication of heredity and genetic diseases, they did not have 
the infrastructure to organise genetic counselling service for individual patients. The 
application of the knowledge of heredity to disease had still to be accepted by the medical 
profession, who would then provide genetic information and the infrastructure necessary 
for the further development of genetic counselling. 
Thus the period of the first paradigm is characterised by the discovery of 
Mendelian inheritance and the activities of the Eugenics Society. Their broad aims were 
to encourage the weaker stock to have fewer children and the more talented to have more, 
but neither of these groups of people was in the habit of consulting their doctor about how 
many children they should have. The genetic inheritance of individual diseases was not 
yet widely understood in the medical profession, and individual patients were hardly 
affected by the activities of the eugenics movement. 
2.4 PARADIGM 2: PREVENTIVE MEDICINE 
After the Second World War and with the realisation of the extent of Nazi 
atrocities, eugenics became a word to be hedged with caveats (Kevles 1986 p251) and 
many scientists withdrew their support from the eugenic movement (Kessler 1980). 
Since 1950 there had also been a decline in infant mortality and childhood 
morbidity due to the availability of antibiotics and better control of infectious diseases. In 
addition improved medical and nursing care resulted in the survival of many infants who 
previously would have died shortly after birth (Connor and Ferguson-Smith 1987). 
The reduction in mortality from infectious diseases produced an increase in the 
proportion of deaths attributed to congenital abnormalities among infants and an increase 
in the proportion of cases in both childhood and adult morbidity (Emery and Pullen 1984). 
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Different authors have attempted to estimate the extent of fetal abnormality present at birth 
and attributable to genetic abnormality. For example, according to Pembrey (1987) at least 
1 % of all live births have a disorder inherited in a simple Mendelian fashion that is 
manifest at birth, or will develop later. Pembrey suggests that if the multifactorial 
conditions where there are substantial genetic influences are included the figure rises to 
2-5%. 
Furthermore, researchers such as Stickle (1965) have estimated that birth defects, 
because of their relative early onset, account for a heavier loss or reduction in productive 
future years than other more widely recognised public health problems such as 
cardiovascular disease, cancer and stroke. Others such as Wilkie (1980) and Roberts 
(1991) have pointed to the appreciable contribution made by genetic diseases to the 
morbidity and mortality load of the community. 
After the Second World War the medical profession in Britain was beginning to 
take an interest in genetic counselling. In 1946 a genetic clinic was established at the 
Hospital for Sick Children, Great Ormond Street, London (Roberts and Pembrey 1985 
p324). It is not surprising that the first genetic counselling centre was in a children's 
hospital since people tended to seek or were sent for genetic information because they had 
had a child affected by what either the parents or their doctor suspected was a genetic 
disorder. This situation is often referred to as 'retrospective counselling'. 
Furthermore, by this time the philosophical basis of medicine had broadened to 
include the concept of prevention (porter 1977). The application of genetic principles to 
medical illnesses harmonized well with this extension of the role of medicine. The 
prevailing ethos in this second paradigm of genetic counselling is one of preventive 
medicine, but in this period genetic counselling became fumly embodied in the medical 
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setting in hospitals and carried out within the doctor-patient relationship. In this paradigm 
the focus is, therefore, on the doctor and the individual patient. 
Another feature of this paradigm is that most genetic counselling was still 
retrospective. Patients were referred for genetic counselling following the birth of a child 
with a genetic handicap or following the diagnosis of a genetic disease in themselves. 
2.4.1 Content or genetic counselling in paradigm 2 
The focus in the content of genetic counselling in the second paradigm is on giving 
information about the diagnosis and the risk of occurrence or recurrence and this reflects 
the tools and knowledge of the genetic counsellors. Fraser (1968 p928) in his description 
of what the genetic counsellor does states: •••• the genetic counsellor confrrms and 
establishes the diagnosis; takes a family history; performs and arranges for appropriate 
tests; uses this information to make an estimate of the probability of recurrence; conveys 
the significance of the probability to the counselleew• However the information that could 
be offered in genetic counselling at this time was limited to information about the 
diagnosis and the significance of the risk or probability of occurrence or recurrence of the 
particular disease. The particular expertise of the medical geneticist was in calculating the 
risk of transmission. This limitation of knowledge is commented upon by Fraser (1958) 
• •.• much new information is needed ••• new means of detecting genetic 'carriers' of 
disease will greatly increase the precision of the counsellor's predictions in many cases. 
In the meantime the paediatrician consulted about the possibility of family occurrence of 
a disease must make best use of what information is available •.• and exercise proper 
caution in applying average risk rates to individual situations •••• (p488). 
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2.4.2 Aim of genetic counsellin: In paradigm 2 
As already noted, by 1940, the philosophical basis of medicine had broadened to 
include the concepts of prevention (porter 1977). With their knowledge of heredity doctors 
were now able to offer genetic counselling to parents affected by a genetic disorder and 
thereby: •••• prevent the unwitting passage of a disease to subsequent generations· (porter 
1977 p23). 
While it is unlikely that many doctors offering genetic counselling in this period 
would have considered themselves eugenicists, the objective of their counselling clearly 
was to prevent. For example Dice (1952) believed that voluntary abstention from 
reproduction by those people who carry hereditary defects was consequently the only 
practical method for eliminating any considerable number of harmful genes from the 
population of a democracy and he says: ·From my experience in giving advice about 
heredity to families in all walks of life I can affirm that every parent desires his children 
to be free from serious handicap •.. and if there is a known high probability of 
transmitting a serious defect, it would be an abnormal person indeed who would not 
refrain from having children.· (P2). 
The same author considered that there were only two practical ways available for 
the elimination of harmful genes: ·Either those who carry the defective defects may be 
segregated or sterilised by the state or they may voluntarily refrain from reproduction·. 
The author does not recommend that any pressure be put on prospective parents but that 
·sterilisation of those persons who carry obvious hereditary defects should continue to be 
carried out on a voluntary basis· (P2). 
In this example there is an assumption that patients would be motivated by societal 
goals, a feature also of the frrst paradigm. There is also an underlying expectation that the 
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patient will be compliant with the authority and recommendations of the doctor within the 
traditional doctor-patient relationship. 
2.4.3 Measurement of effectiveness of genetic counselling 
Studies examining the effectiveness of genetic counselling (Shaw 1977, Evers 
Kiebooms and Van Den Berghe 1979) demonstrate that the criteria most consistently used 
by genetic counsellors to evaluate the success of their work was patient knowledge and 
patient reproductive intentions andlor behaviour after counselling. 
The assessment of patient knowledge mainly focused on the patient's understanding 
of the risk of recurrence or occurrence of the particular disease. The results show wide 
variability in the knowledge of patients about the risk after counselling. Pearn and Wilson 
(1973} found that only 26% of their sample knew the genetic risks after counselling. 
Sibinga and Friedman (1971) found that there was no correlation between the education 
level of parents and their understanding of the genetics of the disorder phenylketonuria 
with fewer than 20% of parents having an adequate understanding. However, authors such 
as Emery et al (1972) and Carter et al (1971) reported what they described as effective 
understanding of risks. According to Leonard et al (1972), 44% of their sample 
misunderstood, denied, distorted or incorrectly interpreted the genetic information. In spite 
of the lenient interpretation of their test results, these authors found that only one half of 
the sample had sufficient information to make informed and rational choices. 
It is not surprising that the quantification of the risk was seen as the essential 
information as this was to a great extent the major expertise that the medical geneticist had 
to offer patients at this particular point in time. The understanding of the nature of risk 
is, however, complex. Tversky and Kahneman (1981) suggested that all theories of 
decision making under risk contain two basic components: (a) the desirability of the 
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outcomes to the individual or individuals concerned, and (b) the perceived likelihood of 
the desired result eventuating. 
Pearn (1973) in discussing patients' subjective interpretation of risks offered in 
genetic counselling, suggested that in the genetic context the former of these two factors -
the desire for children and in particular healthy children - represents a basic attitude 
determined before the specific genetic status of the individual is known. Pearn suggested 
that whether or not at-risk parents following genetic counselling satisfied this universal 
desire to have children depended very largely on the subjective interpretation of odds 
given to them. 
For example, in a study by Carter et al (1971) two thirds of couples who were at 
high risk, i.e. greater than 1 in 10, of having a child with a particular genetic disease 
were deterred from having further children following genetic counselling. Similar results 
were found by Ives et al (1973). However, in the work of Hsia and Silverberg (1973) as 
many as 75 % of those considered at high risk of having a child with a particular genetic 
disorder either decided to have more children or remained undecided. 
The interpretation by patients of the risk figures given to them may also be 
influenced by the manner in which risk is explained to them. An explanation that there is 
a 1 in 4 risk of having a child with an abnormality may be interpreted very differently 
from the explanation that there is a 3 to 1 chance of having a child without the particular 
problem. Similarly the explanation that there is a SO-50 chance of developing a disease 
(in the case of variable age of onset autosomal dominant disorders) may be interpreted 
very differently from the explanation that there is a 50-50 chance that the patient will not 
develop the disease. Counsellors may consciously or unconsciously choose to emphasise 
one fraction or another depending upon how they wish the situation to be interpreted by 
the patient. Pearn (1973) believed that • ••• at the core of the subject lies the individuals 
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ability to appreciate the mathematical symbolism of exact risks, or at least the ability to 
appreciate relative orders of risk •.• -. This argument was also supported by Howell and 
Burnett (1978) who suggested that the formulation of a realistic interpretation of odds is 
dependent on how well subjects are available to reflect their actual perception of 
probabilistic events or degrees of certainty. 
It is important to appreciate that these studies which have just been discussed fail 
to point out that while the concepts of risk and probability are useful in aggregate for 
large numbers of cases, they may cease to be useful in single, individual situations such 
as in genetic counselling, where other considerations such as the burden of the disorder 
and other medical, social and economic factors may influence the decision more than the 
mathematical odds (Wilkie and Sinclair 1977). Rational decision making may be more 
difficult when only one or a few gambles are to be taken, rather than a large enough 
number for the 'law of averages' (strictly the law of large numbers) to apply, and 
decisions then may be quite unrelated to probabilities. 
A further problem in the interpretation of these studies is that they do not say 
precisely what information was given to the patient and how that information was phrased 
since this may also influence the decision making process. 
The measurement of reproductive behaviour after counselling was carried out by 
several authors (Emery et al1972, McCrae et al1973, Carter et alI971). Carter's study 
showed that an increased genetic risk tended to deter families from having further children 
and in this study -no high risk couple in the study had planned a further child with a 
serious long term handicap·. However these couples were not deterred from having 
further children if the affected child was expected to die young, if treatment was available 
or if the condition was mild. In a study by McCrae et al (1973) one third of the parents 
26 
CHAPTER 2: GENETIC COUNSELLING 
of cystic fibrotic children reported that they had not received any family planning 
information. 
It is clear from these studies that information about the risk of transmission of a 
genetic disorder was not the sole factor in influencing subsequent reproductive behaviour. 
In addition work by Sorenson (1974) suggested that many patients do not remember or 
understand the genetic information that they have been given. Kessler (1980) argues that 
those offering genetic counselling were becoming aware of the large discrepancies between 
their goals as genetic educators and the realities actUally achieved. 
A direct consequence of the understanding of the limitations of the approach to 
genetic counselling which emphasised prevention, was a movement away from the 
medically led genetic counselling based on information and advice, to genetic counselling 
in which there was a greater awareness of the psychological needs of the patient and 
which was focused on the needs of the patient. This leads on to the third paradigm. 
2.5 PARADIGM 3: PSYCBOWGICAL MEDICINE 
Writing in 1980 Kessler suggested that genetic counsellors were becoming more 
aware of the dilemmas posed by a model of genetic counselling that emphasised 
prevention. In particular there was increasing evidence that the goal of prevention of 
genetic disease was not a realistic one, with authors such as Epstein (1977) suggesting that 
persons at risk for genetic disorders were sometimes reluctant or resistant to using 
available prevention technology. There was often a gap between what the counsellors 
hoped would be the results of genetic counselling and the actual results. For example, in 
a follow-up of 200 couples seen in a genetic counselling clinic, Emery et a1 (1979) found 
that over one third of those couples who had been told that they were at high risk (greater 
than 1 in 10) of having a child with a serious genetic disorder were undeterred and 
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planned further pregnancies. Writing five years later the same author said: -in the past 
such behaviour was often regarded as 'irresponsible', a failure on the part of the 
counsellor and an indictment of counselling in general. But when the couples were 
carefully questioned their reasons for planning further children were often very 
understandable. - (Emery and Pullen 1984 p4). 
It is arguable that in a model of genetic counselling that emphasises prevention, 
the counsellor is protecting the social good, possibly at the expense of the individual 
patient. Most counselling is carried out by doctors and in the relationship between a 
patient and the doctor, it is frequently assumed that the interests of the patient always 
come first. The British Medical Association in their Handbook of Medical Ethics (1984) 
states that for the individual doctor -the health of my patient will remain my first 
consideration- (Pp70-72), although acknowledgement is given to the principle of service 
to humanity endorsed in the statement that it is -the mission of the medical doctor to 
safeguard the health of the people - (Pp43-46). 
In the period of the third paradigm genetic counsellors were beginning to consider 
the autonomy of the patient by favouring the rights of individual patients to choose their 
own reproductive destiny. Counsellors were also appreciating the psychological needs of 
the individual patient. 
The paradigm shift to a more psychologically oriented genetic counselling as 
suggested by Kessler became evident in the United States some years before such a change 
was evident in the United Kingdom. This can be explained by the fact that in the United 
Kingdom, genetic counselling had been given generally by medically qualified staff mainly 
based in departments of human genetics. By contrast in the United States other 
professionals, such as psychologists, sociologists and specially trained genetic counsellors 
or genetic associates in addition to doctors, had already become involved in both the 
28 
CHAPTER 2: GENETIC COUNSELLING 
process and the evaluation of genetic counselling. It is arguable that these professionals 
brought different skills and different perspectives and raised awareness of the 
psychological and social components in genetic counselling including the way in which 
patients acquire information and reach decisions and the coping strategies used by patients 
in dealing with a difficult medical diagnosis. 
The extension of the role of genetic counselling to nurses, health visitors and 
psychologists in the United Kingdom has been a recent phenomenon. For example the fll'st 
course in genetic counselling for community nurses 'started in London in 1991 (Anionwu 
1992) although a course for specialist genetic nurses in post had already started in Cardiff. 
An acceptance of a wider view of genetic counselling embracing the psychological 
needs of the patient is reflected in the following widely used defInition of genetic 
counselling written by the Ad Hoc Committee on Human Genetics (1974) and reported 
in Fraser (1974). Genetic counselling is a "communication process which deals with the 
human problems associated with the occurrence, or risk of occurrence, of a genetic 
disorder in the family. This process (Fraser 1974) involves an attempt by one or more 
appropriately trained persons to help the individual or family to: 
(1) comprehend the medical facts, including the diagnosis, the probable 
course of the disorder, and the available management; 
(2) appreciate the way heredity contributes to the disorder, and the risk 
of recurrence in specified relatives; 
(3) understand the options for dealing with the risk of recurrence; 
(4) choose the course of action which seems appropriate to them in 
view of their risks and their family goals and act in accordance with 
that decision and 
29 
CHAPTER 2: GENETIC COUNSEUlNO 
(5) make the best possible adjustment to the disorder in an affected 
family member and/or to the risk of recurrence of that disorder.· 
This defmition is broad. Counselling is aimed both at those who have already been 
faced with a genetic disorder as well as those concerned with their risk. Many skills 
including the ability to communicate genetic knowledge and counselling skills are 
required. In addition, in order for (3) and (4) to be accomplished counsellors would need 
to have a detailed knowledge and understanding of the patient including their aspirations 
and their values. This definition points to the complexity of the process of genetic 
counselling, and implies what could be the content of genetic counselling as well as what 
skills are needed by the counsellor. 
Furthermore, during the 1970s attention was being paid to the impact that genetic 
information could have on the lives of patients and their families, and there was an 
awareness that an understanding of these factors could lead to improved effectiveness in 
genetic counselling (Reynolds et al 1974). 
This impact of genetic counselling on the individual patient began to be discussed 
in articles in the popular press. For example Tysoe (1983) comments on the difficulties 
involved in Wgrappling with the psychological and ethical dilemmas raised in genetic 
counsellingW and goes on to suggest that while theoretically all genetic counselling is non-
directive it is Wvery hard for doctors to do, as their whole training is geared towards 
giving advice and preventing diseasew (P276). Issues such as the cost of treating and not 
treating genetic disorders and the difficulties in decision making following genetic 
counselling were debated by the Council of Science and Society in Life and Death before 
Birth (1978). 
Authors such as Gaylin (1972 and 1976) and Wilkie (1980) questioned the ethics 
of genetic screening which gave people information about genetic traits or defects which 
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cannot be remedied and which may cause anxiety and a feeling of stigmatization, and 
Shore (1975) emphasised the need for psychological support in genetic counselling by 
highlighting such adverse reactions of genetic counselling as depression, family disruption 
and desertion (p 170). 
By the early 1980s several academic textbooks addressing the psychological 
dimensions in genetic counselling by Am'erican authors, e.g. Kessler (1979), Sorenson 
et al (1981), Applebaum and Firestein (1983) and also by Emery and Pullen from the 
United Kingdom (1984) had been published. 
This realisation that genetic counselling is not just a matter of giving information 
including probabilities, to the patient, but that the psychological needs of the patient 
should also be taken into account leads into the ethical issues that are the heart of the 
fourth paradigm. 
2.6 PARADIGM 4: E'IlUCS 
During the 1980s another conceptual shift took place in which genetic counselling 
came under greater scrutiny. This forms my fourth paradigm. In this fourth paradigm 
there is a movement away from what was essentially retrospective genetic counselling 
(although there will always be a need for retrospective genetic counselling) to a more 
proactive form of genetic counselling. Proactive or prospective genetic counselling can be 
defined as an activity in which individual prospective patients are sought out and offered 
genetic counselling. These may be the relatives of an index patient, i.e. an already 
identified patient. This is conceptually different from the situation where the patient has 
sought help and has been referred to a genetic counsellor. 
The shift towards proactive genetic counselling has raised a number of ethical 
issues that were not previously relevant to genetic counselling. Proactive genetic 
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counselling has been made possible by a number of developments, each of which raises 
different ethical problems. The availability of computers and the use of record linkage 
(Benjamin 1977) raises questions about the confidentiality of information and the right of 
doctors to approach patients who have not consulted them. The availability of prenatal 
diagnosis for a number of genetic diseases raises questions about the role of termination 
of pregnancy. The availability of presymptOmatic diagnosis raises questions about whether 
those affected ought to know, and who owns the information. The development of 
population screening programmes for certain single gene recessive disorders raises similar 
problems, in respect of those with carrier status. Each of these is discussed in the ensuing 
sections. Presymptomatic testing raises problems in a specific field, that of life assurance. 
Finally, the question of the possibility of neutral genetic counselling is discussed. 
2.6.1 Genetic registers and record linkage 
According to Harper (1983), genetic registers can be established with diverse aims. 
The main categories of genetic register are: preventive, therapeutic, epidemiological, 
reference and research. It is preventive registers that are of interest here. The principle 
aim of preventive registers is to help the avoidance of births of children with a genetic 
disorder by "recording those families and individuals who are affected or who have a high 
risk of transmitting the disorder in question" (Harper 1983 p 118). 
One example of a preventive genetic register was the genetic register system 
RAPID (Register for the Ascertainment and Prevention of Inherited Disease) (Smith et al 
1971). This system involved the ascertainment of individuals in the population who might 
have been at risk of having a child with a serious genetic disorder, the determination of 
their risks, the follow-up and provision of genetic counselling and antenatal diagnosis 
(where applicable) for those found to be at high risk (defined as greater than 1 in 10) of 
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a serious genetic disorder. It was believed that RAPID was a feasible and relatively 
inexpensive method of ascertaining and preventing cases of serious genetic disorders 
(Emery et al 1974). 
Another example of a preventive genetic register is the South Wales Huntington's 
Chorea Register, which as well as providing information on individuals to be seen 
clinically, has made it easier to monitor the incidence of the illness (Harper 1983). 
The use of these registers has enabled doctors to offer proactive genetic counselling 
systematically, because accurate information is recorded about the index patient as well 
as about his or her at-risk relatives. In proactive genetic counselling the relatives at risk 
for a particular disorder are contacted and offered genetic counselling. While such a 
system could operate without the use of computers, their use has made it very much 
easier. 
The introduction of systematic proactive genetic counselling raises some very 
serious concerns about the risk of psychological disturbance in those who learn early of 
their risk of contracting an illness for which there is no effective treatment. Such early 
knowledge may also affect applications for insurance and even employment opportunities 
and in this context the question of confidentiality is raised. The power of modem 
computers means that much information can be easily stored and easily accessed 
necessitating the need for strict security for genetic registers. 
It is also arguable that such genetic counselling should be restricted to those who 
seek it and who are referred by their doctor and should not include those relatives who 
have not requested such counselling. 
Wilkie and Sinclair (1977) in their study on the acceptability of genetic registers 
point out that it is not always clear, particularly in prospective or proactive counselling, 
who is to be the beneficiary of the genetic counselling. Is it the at-risk person or patient 
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who has been identified, the as-yet-unborn child or the society of the future? Nor is it 
known whether at-risk individuals wish to know of their own risk or involvement with the 
particular genetic disorder. It is also not clear whether the advantages to society of telling 
individuals of their involvement outweigh the possible disadvantages. These authors 
suggested that the advantages can be seen at both a personal and at a societal level. By 
telling such individuals of their situation~ geneticists hope that individuals will behave 
'responsibly', i.e. they will not have children. As a result the burden and the 
responsibility of having a possibly affected child may be removed, presumably to the 
advantage of the individual and their partner and to society. The personal disadvantages 
seem to lie mainly in the anxiety and suffering that may be caused by telling such an 
individual of their risk and the difficult decision making that is often called for (Wilkie 
1980). 
2.6.2 Prenatal diagnosis for genetic diseases 
There have been very considerable advances in the techniques now available to 
diagnose genetic diseases prenatally. These techniques and the risks associated with them 
are discussed in Section 2.7. Prenatal diagnosis for genetic disease followed by 
termination of an affected fetus, should this be what the parents want, is a choice that is 
now available to an increasing number of parents. 
According to Laurence (1991) terminations for genetic reasons account for 
approximately 2% of all terminations in the United Kingdom (P79). However, there is 
already evidence that some women are permitted prenatal diagnosis only if they agree in 
advance to an abortion should the fetus be abnormal (Farrant 1985 pI13). In these 
circumstances the mother is hardly being offered her own choice. Similarly, according to 
Rothman (1988), the choice to avoid having a child with a handicap also becomes a forced 
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choice; she states; "in gaining the choice to control the quality of our children, we may 
rapidly lose the choice not to control the quality, the choice of simply accepting them as 
they are " (P191). 
It is arguable that prenatal diagnosis both reflects the values of society and also 
puts pressure on parents to conform to these values. As McIntyre (1987) argues, the 
language in which prenatal diagnosis is offered to women, "to ensure that the baby is all 
right", implies that all possible abnormalities will be detected, whereas in reality only 
certain abnormalities can be identified and not all of these are investigated in anyone 
case. The dilemma for parents is that it is not considered acceptable to allow a newborn 
handicapped baby to die but it is considered highly desirable to terminate a pregnancy 
where the baby is known to be affected (Green 1990). A major concern is that parents 
who decline prenatal diagnosis and parents who reject termination of pregnancy may be 
seen as having brought the situation on themselves. Such a concern may be more acute 
in times of economic stringencies and high costs for health services. 
Markova (1990) argues that while it is to the advantage of a society that its 
members be healthy, advances in genetics have put the burden for improving the health 
status of the country on individuals at risk or affected by genetic disorders and she 
suggests that these advances raise profound ethical dilemmas. 
It is necessary to question what the underlying problem is for which prenatal 
diagnosis and termination of pregnancy is the solution, and to consider that the views of 
the parents and the professionals may not be the same. 
2.6.3 Presymptomatic diagnosis of eenetic diseases 
The availability of DNA analysis can now be used to determine the presence or 
absence of a particular gene in a person postnatally as well as prenatally. These techniques 
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have, for the first time, allowed a very high degree of accuracy in diagnosis in genetics. 
It is now possible to use DNA analysis to diagnose such disorders as haemophilia, cystic 
fibrosis, Huntington's Chorea and adult polycystic kidney disease (APKD). 
Both haemophilia and cystic fibrosis affect children and while not all prospective 
parents may wish prenatal diagnosis followed by termination of pregnancy, prompt and 
accurate diagnosis postnatally so that treatment can begin is uncontroversial. 
The situation with Huntington's Chorea and APKD is very different. They are both 
diseases of variable age of onset, the symptoms not appearing until middle years. For 
Huntington's Chorea there is really no effective treatment. The treatment for APKD is of 
the symptoms as they appear, as described in Section 3.8. 
While there are clearly advantages for an at-risk individual to learn that they do 
not carry the gene for a particular disease, one has to question what the advantages are 
to the individual of knowing that they are affected before the symptoms begin if it is by 
a disease for which there is no treatment. The technology is available, but do people wish 
to use it? 
Rosenfield (1984) has argued that the central issue created by these new 
technologies concerns the question of disclosure of genetic knowledge. Rosenfield was 
concerned with the amount of pressure that may be put on a person who was, for 
example, at risk for Huntington's Chorea to be tested. The partner of such a person may 
want to know what the future holds. Offspring may want to know in order to establish 
their own genetic status. A decision to disclose genetic knowledge raise a number of 
further ethical questions including when the information should be disclosed, how it 
should be disclosed, who should be told and by whom (Harper 1992). 
In this respect, and in relation to Huntington's Chorea, it has been suggested that 
predictive testing for minor children as well as for couples who seek prenatal diagnosis 
36 
CHAPTER 2: GENETIC COUNSEUlNG 
but hesitate about terminating a high risk pregnancy, should be unavailable (Bloch and 
Hayden 1990). According to Pelias (1991) parents of minor children would therefore be 
classified as third parties whose interests in their own minor children would be equated 
with the interests of ·adoption agencies, educational institutions, insurance companies and 
other third parties· (pelias 1991 p349). According to Pelias the reason for limiting the 
interests of parents by classifying them as third parties is to protect the privacy and 
autonomy of the minor child. As parents are usually considered the sole decision makers 
for their children's health, this suggestion raises the question of paternalism in genetic 
counselling as well as challenging the principles of parental autonomy. 
The debate about the right to information also applies to the adult. Protocols for 
molecular genetics predictive tests in Huntington's Chorea have been developed (Went 
1990) and they could be used as guidelines in the presymptomatic testing of other late 
onset genetic diseases for which there is no effective treatment. Such protocols point to 
the need for pre-test counselling, a period of consideration before taking the test and the 
availability also of post-test counselling. 
2.6.4 Population screening for genetic disease 
Prospective counselling of large groups in society involves identifying people with 
incipient disease so that prompt treatment may avert harm (Beck et alI974). Population 
screening can also be used to identify otherwise healthy persons who may be heterozygous 
carriers of certain genetic diseases and to explain to them their risk of having affected 
children if they mate with another heterozygous carrier of the same gene (WHO 1972). 
This approach has become used widely in populations where the frequency and severity 
of a particular disease is high. For example there are programmes directed against sickle 
cell disease in populations of Afro-Caribbean descent (Massarik and Kaback 1981), against 
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Tay-Sachs disease amongst Jews of Ashkenazi descent (Kaback 1977), and against G6PD 
deficiency and thalassaemia in populations of Mediterranean descent (Bundey 1991). 
Individuals identified as carriers of recessive genes are told that they may have a child 
with a particular disease if they mate with another carrier. 
What are the implications for the individual of being confmned as a (heterozygous) 
carrier of a genetic disorder? To be a carrier of a genetic disorder does not mean illness 
or disability. With very few exceptions carrier status does not carry with it any observable 
indices of being different, unlike having the disease itself. But it is possible that to be 
identified as a carrier may cause the development of psychological disabilities. These 
disabilities would result not from being a carrier but from the personal and social 
meanings which may become attached to carrier status. It is, therefore, the carrier's 
perception of the carrier status that is important. 
The time in a person's life when they are identified as a carrier may significantly 
affect the psychological and social meaning of carrier status. For example, if screening 
is carried out before marriage the knowledge that the person is a carrier may affect whom 
that person marries and whether he or she has children. Further, the scientific label of 
carrier status could acquire a psychological interpretation for the person, threatening their 
sense of personal worth and integrity (Sorenson 1974). For some, carrier status may be 
perceived as stigmatising, as described by Goffman (1968). This perception of stigma is 
similar to the stigma perceived by the asymptomatic HIV carrier (Anderson 1992) or by 
the person with epilepsy (Edwards et a11986). Furthermore, once a person knows of their 
carrier status they are no longer able to deny this information. Prior to learning of their 
carrier status the person was able to say that there was a possibility that they were a 
carrier and there was equally a possibility that they were not a carrier. 
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In establishing population screening programmes consideration has to be given to 
the factors that would motivate an asymptomatic individual to comply with a screening 
test. There is increasing awareness that such factors as the person's perception of the 
susceptibility to and their perception of the seriousness of the inherited condition could 
influence their decision to agree to a screening test (lvker et al1974). 
2.6.5 Genetic testing and liCe assurance 
The increased understanding of genetic iriheritance and the availability of 
pre symptomatic testing has a significant effect on life assurance. Before there was any 
understanding of genetic inheritance a presymptomatic individual who had no other 
impairment could obtain life assurance at the ordinary premium rates. The same still 
applied after genetic inheritance became understood, if the applicant had no knowledge 
of the family history that might cause him or her to be at risk, if the life assurance 
proposal form did not elicit this information in its questions, or if the life underwriter was 
insufficiently knowledgable or alert to the significance of the information that had been 
elicited. 
However, once life assurance underwriters came to understand the principles of 
genetic inheritance, if applicants gave sufficient information for them to be identified as 
being at risk of developing a particular disease, for example by stating that one parent had 
died of APKD or Huntington's Chorea, they became uninsurable. They had a one half 
chance of developing the disease, but even though they also had a one half chance of not 
developing the disease neither the applicant nor the underwriter knew which chance would 
fall out. 
Now that presymptomatic testing is available for certain diseases further 
considerations arise. If the applicant is tested, he (or she) may discover that he is not 
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affected with the relevant gene, and he becomes insurable at ordinary premium rates, 
provided he has no other impairment. But if it is discovered that he is affected, then he 
becomes certainly uninsurable, quite apart from any other problems that may ensue from 
this knowledge. 
There are similarities with my testing, though there are also differences. Inability 
to get life assurance and hence (in many'cases) a loan for house purchase is frequently 
stated to be a serious disadvantage for an individual who is found to be HIV antibody 
positive and it is particularly problematic for the' asymptomatic HIV positive patient 
(Wilkie 1987). It has become widely believed that an insurance company is likely to 
decline to insure anyone who has had an HIY test, whatever the result, even though the 
insurance companies themselves deny that a negative test by itself would prove adverse. 
What they really mean is that a negative test for an applicant who is gay and who was 
tested because he was worried would be treated adversely, whereas a negative test for an 
applicant who required one for travel to some particular country would not be; but it 
would be insensitive of the insurance companies to say this explicitly. 
The situation for those who have had a genetic test for a disease of later age of 
onset may appear to be not dissimilar. lust as there was evidence that people were 
deterred from being tested for my because of their fear that they would subsequently be 
unable to get life assurance regardless of the results of the test, there is now some 
evidence of the same concern, however illogical, regarding genetic testing. For example 
the Health Council of the Netherlands (1989), quoted in Harper (1991), stated: "If it is 
felt that the suspicion that fear of insurance problems may deter some individuals from 
genetic testing is well founded in an atmosphere of growing uncertainty, genetic testing 
could be perceived as threatening" (P7). 
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2.6.6 Neutrality of counselling 
Emery and Pullen (1984) refer to the neutrality of genetic counselling when they 
say: "we are moving away from entirely factually oriented counselling to person oriented 
counselling ..•. It is only in this way that counselling is likely to be really meaningful and 
couples helped to make decisions which are the right ones for themselves. There is no 
place for directive counselling" (p vii). . 
There is an assumption here that it is possible to have non-directive, neutral, 
genetic counselling. Counselling is seldom neutral.· The counsellor comes with genetic 
knowledge. That knowledge is not necessarily neutral. For example, Anderson (1992) has 
pointed out in relation to AIDS that the "facts about HIV and AIDS do not represent some 
unquestionable reality, but are the products of complex processes of social construction" • 
Similarly, in genetic counselling it is extremely difficult for counsellors to avoid 
communicating their own values and beliefs, if not by what they say, then by their body 
language, tone of voice or choice of words. 
For example the patient may be told that prenatal diagnosis and termination of an 
affected fetus is available. The counsellor may think that the information was delivered 
in a neutral fashion for the patient to reach their own decision. But unless the patient was 
also given sufficient information about the treatment and facilities for a child who may be 
affected by the particular disease should she (or he) decide not to have prenatal diagnosis 
followed by termination of an affected fetus, the patient is unable to make an informed 
choice. Furthermore she may perceive that she is expected to have prenatal diagnosis 
because she was not given any other'information. 
Giving the patient information in a way that respects the patient's own ability to 
reach a decision empowers the patient. The concept of patient empowerment has been 
highlighted particularly by those involved in HIV counselling (Anderson 1992). 
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The process and content of genetic counselling is now under wider scrutiny. For 
example, in 1987 the King's Fund ran a forum on screening for fetal and genetic 
abnormality and published a consensus document (King's Fund 1987). Consumer 
organisations such as GIG (Genetic Interest Group) have recently been invited to discuss 
the organisation of genetic counselling services with the Royal College of Physicians, 
London (Hunt 1992). 
2.6.7 Characteristics or paradigm 4 
The new knowledge (of testing) and the new equipment (computers) have caused 
genetic counselling to move into another phase, in which it can be seriously questioned 
whether the application of the new technology is in fact beneficial to those affected with, 
or who are at risk of being affected with, a particular disease. 
Counselling patients who come for advice is one thing; seeking out patients to 
counsel is another. Obtaining information from a patient about those who are not yet 
patients is questionable. Offering prenatal testing with the threat of termination of an 
affected fetus may not be the way to give choice to parents. Those who are 
presymptomatic but affected and for whom no treatment is available may prefer to remain 
in ignorance until treatment becomes necessary. Those who are carriers of a recessive 
disorder might pass their whole lives without ever discovering this fact; do they need to 
be told? And is it possible to provide wholly neutral, non-directive counselling of any 
kind, genetic or other? All these issues are now under discussion and the answers are not 
yet resolved. 
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2.7 TEcnNIQUES USED IN PRENATAL DIAGNOSIS 
In the fmal section of this chapter the procedures now available for the detection 
of prenatal abnormality are described. There are four of them: amniocentesis, ultrasound, 
fetoscopy and fetal blood sampling, and chorion villus sampling. Two of these procedures, 
amniocentesis and ultrasound, have been available for some time. Ultrasound is the only 
procedure that is non-invasive and as far as is known carries negligible risk to the fetus. 
2.7.1 Amniocentesis 
Amniocentesis was first introduced some 20 years ago and is the most widely used 
invasive prenatal diagnostic technique (Rodeck 1987). The procedure is usually carried 
out at 16 weeks gestation. Under ultrasound guidance, a needle is passed through the 
abdominal wall to draw off amniotic fluid from the amniotic sac that surrounds the fetus 
in the uterus. Amniotic fluid contains fetal cells which can then be sent for examination. 
The investigations that can be performed include chromosome analysis, biochemical and 
DNA studies and alphafetoprotein and acetylcholinsterase estimation. Cytogenetic reports 
are available in approximately three weeks. The most common reason for amniocentesis 
is fetal chromosomal analysis in mothers at increased risk of having a child with Down's 
syndrome. All the numerical and many of the structural chromosomal abnormalities such 
as Down's syndrome (Trisomy 21) can be detected by culture of cells obtained by 
amniocentesis. 
The main complication of amniocentesis is miscarriage. However amniocentesis 
at 16-17 weeks gestation is considered quite a safe procedure with the risk of causing a 
miscarriage that would not have otherwise occurred being of the order of 1 in 150, with 
the risk increasing if repeat amniocenteses are required (Roberts and Pembrey 8th edition 
1985). According to these authors, studies have failed to demonstrate any risk to the 
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mother's health, or any evidence of a significant risk of damaging the fetus with the 
needle, provided that amniocentesis is carried out under proper conditions and under 
ultrasound control. 
Prenatal diagnosis of the major neural tube defects, anencephaly and open spina 
bifida can be diagnosed by a raised level of alphafetoprotein in amniotic fluid at 17 weeks 
gestation. 
2.7.2 Ultrasound 
Ultrasound examination plays a critical role in prenatal diagnosis allowing the 
detection of structural abnormalities and the detection of abnormal growth by regular 
ultrasound examinations. Ultrasound can reveal the internal anatomy of the fetus, whether 
the fetus is alive, and how many fetuses there are and it can confirm gestational age. 
Ultrasonography is used for the guidance of all invasive investigative procedures. There 
is no evidence that diagnostic ultrasound is harmful. 
2.7.3 Fetoscopy and fetal blood sampling 
Fetoscopy is used for direct observation of the fetus. The procedure involves the 
insertion of a fetoscope through the abdominal wall into the amniotic sac. The fetoscope 
has a channel for withdrawing fluid or blood in addition to the fibreoptic and lighting 
system. Fetoscopic examination can be used to confirm a diagnosis by ultrasound as well 
as being the primary means of prenatal diagnosis for example to diagnosis such 
abnormalities as small or absent ears. 
Fetal blood obtained by fetoscopy is used in the prenatal diagnosis of beta-
thalassaemia and it has also been successfully used in the prenatal diagnosis of Von 
Willebrand's disease and various red cell enzyme defects. 
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Fetal blood sampling cannot be carried out until 18 weeks gestation and analysis 
takes about one week. Fetal blood sampling is associated with a fetal mortality of between 
2 and 5 per cent and an increased maternal morbidity due to infection and haemorrhage 
(Weatherall 1991 p257). 
2.7.4 Chorionic villus sampling 
Chorionic villus sampling (CVS) is a method of obtaining a small sample of tissue 
from the region of the chorion frondosum where the'villi persist and eventually form the 
placenta. The procedure was introduced in 1982 and is carried out in the frrst trimester 
of pregnancy, usually at about 10 weeks gestation, by a suction tube inserted 
transcervically or transabdominally. The range of possible investigations is similar to 
amniocentesis and includes chromosomal, biochemical and DNA analysis. 
Alphafetoprotein for neural tube defects cannot be measured from chorion villus. The 
precise risks of chorion villus sampling are not known but fetal loss is probably increased 
by 2% (Rodeck 1987). 
Chorion villus sampling has greatly advanced the ability to diagnose certain genetic 
disorders prenatally by DNA analysis. DNA samples can be obtained from chorion villus 
and results can be available in 48 hours. 
There are several ways to analyse fetal DNA for single gene disorders like APKD. 
Currently prenatal diagnosis using restriction fragment length polymorphisms (RFLPs) is 
being used successfully in the diagnosis of diseases such as APKD, Huntington's chorea 
and neurofibromatosis (Weatherall 1991). The limitations of this approach are the 
complexity of the investigation and hence the expense. Furthermore this technique can 
only be offered to women where linkage has previously been established in appropriate 
family members (Gabow et al 1992). 
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A major problem associated with amniocentesis, fetoscopy and fetal blood sampling 
is that these procedures cannot be carried out until the second trimester of pregnancy as 
many of the conditions for which prenatal diagnosis is required necessitate the growth of 
amniotic cells in culture for several weeks. Parents, therefore, not only have to consider 
the risks of the individual procedures but also the implications for termination when the 
diagnosis is made late in the second trimester. By the end of the second trimester the 
mother will have experienced fetal movement and may have already bonded with this 
baby. In addition her pregnancy will have become ·obvious, which may ~xacerbate her 
difficulties should she decide to terminate. Psychological trauma following a late second 
term termination may not be inconsiderable (Green 1990). 
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3.1 INTRODUCI10N 
This chapter is divided into three main parts. After a short section (Section 3.2) 
in which Adult Polycystic Kidney Disease (APKD) is described, the first main part 
(Section 3.3) describes the development of the knowledge and understanding of APKD 
from the 19th Century to date in terms of symptoms, diagnosis, clinical history and 
understanding of genetics as applied to APKD. The second part (Sections 3.4 and 3.S) 
describes the functions of the normal kidney as well as some common renal function tests. 
The third part (sections 3.6 to 3.9) describes the diagnosis and symptoms of APKD, the 
treatment for end stage renal failure (ESRF) and the prognosis for APKD. 
3.2 DESCRIPI10N OF APKD 
3.2.1 APKD: the illness 
Adult Polycystic Kidney Disease (APKD) is the most common inherited renal 
disease leading to end stage renal failure (ESRF) and the need for renal replacement 
therapy. It is estimated that APKD is responsible for 6-9 % of cases of ESRF in Europe 
(Robinson and Hawkins 1981). Prior to the need for dialysis there is likely to be a period 
of some years of declining health which can present major problems for the affected 
persons and their families in terms of reduced quality· of life, reduced working life, 
reduction in earnings, and chronic ill health in middle age (Wilkie et alI98S). The age 
of onset of symptoms of APKD including hypertension, urinary tract infection (UTI), loin 
pain and chronic renal failure is variable with most authors agreeing that there is a long 
asymptomatic period. It is estimated that approximately 14 % of deaths amongst patients 
with APKD are attributed to subarachnoid or intracerebral haemorrhage (Zeier 1988). 
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3.2.2 APKD: genetics 
APKD is transmitted in an autosomal dominant fashion, which means that each 
child of an affected parent has a SO-SO chance (one half chance) that he or she has 
inherited the defective gene. Diagnosis of APKD is the confrrmation by ultrasound of the 
presence of bilateral renal cysts in individuals in families with a positive family history. 
In 1985 a gene marker for APKD was locaUzed to the short arm of chromosome 16 
assisting in the presymptomatic diagnosis in families where there is sufficient family 
linkage information. 
3.2.3 APKD: terminology 
Historically many terms have been used to describe polycystic kidney disease 
including: congeneries of renal cysts, cystic degeneration of the kidneys, conglomerate 
cysts of the kidney, cystic metamorphism of the kidney, polycystic disease of the kidney, 
bilateral polycystic kidney. According to Davis (1925) all the above terms have been used 
to describe congenital, bilateral cystic degeneration of the kidneys. The most common 
terminology now used is adult polycystic kidney disease, usually abbreviated to APKD, 
although some authors (forres et al1988, Parfrey et all990) refer to APKD as autosomal 
dominant polycystic kidney disease (ADPKD). APKD is not to be confused with infantile 
polycystic kidney disease (IPCD) which is transmitted in an autosomal recessive fashion 
(Mandell et alI983). 
3.3 IIIsToRICAL BACKGROUND 
3.3.1 Development of knowledge of APKD In 19th and 20th centuries 
According to Lejars (1888 p7) a polycystic kidney was first described by Hufeland 
and then by Rollet after an autopsy had been carried out on a woman, not known to suffer 
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from other illnesses, who had been found dead in the street. Bilateral polycystic kidneys, 
however, were first described by Rayer. In the middle of the 19th century with the 
expansion of scientific pathology, investigators such as Virchow (1856) were beginning 
to describe polycystic kidneys as a specific condition. In the second half of the 19th 
Century, authors focused on a description of the kidneys as they appeared in autopsy. In 
the advanced stage of the condition, the kidneys take on a very characteristic appearance 
(see Figure 3.1), which seldom failed to arouse great interest when discovered and 
frequently a very graphic description. For example, Dickinson (1885) described the 
appearance of polycystic kidneys in the following way: "The kidneys are transformed into 
collections of cysts so completely that it is difficult to discern with the naked eye any 
remnants of the proper tissue which may be destroyed by extension and distortion. The 
increase in bulk is usually great and renal shape is more or less preserved as if the 
addition of substance were distributed with some uniformity. The cysts protrude from the 
surface as circular bosses raising the capsule, which, together with the cyst wall is so 
transparent that the variously coloured contents can be seen from without. The external 
appearance roughly resembles that of a water worn mass of conglomerate or pudding 
stone, the prominent pebbles resembling the cysts, which appear to be lined with a 
smooth, translucent membrane. The contents of the cysts are various in colour and kind: 
they are generally pale or deep yellow and highly albuminous often viscoid, treacly or 
even colloid; they are sometimes purplish, variously blood tinged, purulent or caseous. " 
(P844). 
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Figure 3.1 . A normal kidney (above) and an APKD kidney (below). 
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3.3.2 Causes or APKD 
By the mid 19th century explanations were also being offered as to the cause of 
the cysts. Virchow (1856) fust suggested that tubular casts or insoluble calcium salts 
might be sufficient to obstruct the urinary flow and so lead to cystic dilation. Later, in 
1892, Virchow attributed the formation of cysts to fibrous tissue occlusion of the 
excretory tubules which he thought resulted from prenatal inflammation. 
3.3.3 Polycystic kidneys in adults and in children 
Polycystic kidneys appeared in both infants and adults. In infants the condition 
usually leads to death at birth or shortly afterwards (Kaplan et alI989). In the case of the 
newborn, it was easy to see that the majority of the cysts were distended nephrons or 
enlarged portions of nephrons which were separated from the excretory tubules (Beckmann 
1856). Lambert (1947) suggested that in the case of the adult technical difficulties 
encountered in the reconstruction of the nephrons in the past had made it difficult for a 
thorough investigation of the topography of the distorted structure to be carried out. In the 
infant with polycystic kidneys other forms of known congenital abnormality such as 
polydactyl, anencephaly, meningocele and congenital defects of the urinary tract were 
often observed (Wigand 1899). Cystic condition of the kidneys in infants was the first to 
be described as congenital. 
Throughout the second half of the 19th century, there were references to cystic 
kidneys in infants having been observed in several members of one family (Virchow 
1856). Attempts were also made in the second half of the 19th century to differentiate 
between the adult cystic kidney and that found in the infant. Dickinson (1885) described 
adult cystic kidney as an acquired chronic disease somewhat resembling in its incidence 
the granular kidney and congenital kidney fatal about or before birth. A few years earlier 
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Virchow (1869) had traced the history of the congenital cystic kidney of the infant 
and attributed the degenerative cystic kidney of the adult to a persistence of the infant 
disorder at least in a number of cases. In 1876, Laveran stated that the degenerative cystic 
kidney of the adult must be treated as a -maladie speciale qui doit ~tre distinguk de la 
d6generesce kystique des nouveau-nes. - (quoted by Lejars 1888 p8). 
3.3.4 Clinical bistory or APKD in 19th century 
Towards the end of the 19th Century several scholarly articles detailing the clinical 
history of adult polycystic kidneys appeared. 
Dickinson (1885) reviewed 33 cases and described the condition as frequently 
latent until an advanced age is reached and often not revealed until post mortem. This 
author suggested that the symptoms included marked loin pain, haematuria, palpable 
kidneys and in the advanced stage all the symptoms of uraemia. Dickinson found it 
difficult to estimate the duration of the disorder because of the -indefInite beginning". He 
assumed that it must be considerable. Treatment was the treatment suitable for uraemia. 
Lejars (1888) stated that for a definitive diagnosis of APKD both kidneys must be 
affected, ie the condition was always bilateral, and the condition was compatible with a 
long period of general good health. During this period, the cystic kidney was seen as an 
isolated occurrence. 
In the latter part of the 19th century the association between polycystic kidneys and 
cerebral haemorrhage was highlighted (Lejars 1888). The association was described as 
sudden death of a young patient with no previous history of illness. 
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3.3.5 Clinical history of APKD in 20th century 
In 1933 Braasch and Schacht described data from 193 patients attending the Mayo 
Clinic. They observed that symptoms did not usually appear until the third decade of life, 
and that the clinical picture varied considerably depending upon the stage which the 
disease had reached. Their description of the symptoms was very clear: -As the cystic 
disease progresses, symptoms caused by renal insufficiency will appear, such as weakness, 
periods of malaise, headache and gastric distress. Occasionally, cerebral haemorrhage 
occurs in cases where there was hypertension which had previously caused no distressing 
symptoms. Complications from intercurrent disease may appear as a result of decreased 
vitality and lowered values for haemoglobin, and may add rapidly to the patient's decline. 
With increased vascular disturbance there may be symptoms caused by hypertension with 
cardiac failure, which usually appears late, there may be oedema and dyspnoea. Patients 
may be unaware of the gradual progressive enlargement of the kidneys. After a varying 
period the kidneys become insufficient, the cardiovascular system is impaired and death 
will follow as a result of uraemia or vascular accident. - (p469). These authors concluded 
that -the hereditary nature of the disease should discourage the having of progeny and 
sterilization should be considered - (p4 74). 
3.3.6 Development of knowledge of genetics of APKD 
It has already been stated that Virchow as early as 1856 had pointed to the familial 
nature of polycystic kidney disease in infants. Lejars (1888 pS5) referred to both 
'acquired' and 'congenital' polycystic kidneys. Mohne (1896, quoted in Bunting 1906 
p273) reported on the removal at operation of a cystic kidney from a 20 year old girl 
whose mother had had bilateral cystic kidneys and cysts in liver and ovaries. However, 
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according to Dalgaard (1957), Steiner (1899) was the first to conclude that an 
outstandingly hereditary character was the cause of polycystic kidney disease. 
David and Iacobsohn (1900) and Beck (1901) both reported that heredity was the 
cause of polycystic kidney disease. Bunting (1906) reviewed the state of knowledge about 
congenital cystic kidney and liver and in a much quoted sentence stated that -the attempts 
to explain the pathogenesis of the congenitaI cystic kidney have been so numerous and so 
varied that one is inclined to question whether pathologists have been dealing throughout 
with a single pathological process- (P276). He concluded that -from the marked hereditary 
and family tendency shown in the disease, one is led to search for the etiological factor 
in the parents and that where the condition has appeared in two generations it has 
generally been transmitted from father to son and mother to daughter. - (p287). 
In 1925 Cairns concluded that APKD was a hereditary disease. In 1925 Davis, 
supported by Fuller (1929), suggested from the evidence from his study that polycystic 
kidney disease was caused by defective protoplasm which may be inherited or congenital 
in obedience with the same biological laws governing the recessive characteristics 
illustrated in phylo-genetic changes and in other congenital deformities. In 1933 Braasch 
and Schacht pointed to the hereditary nature of polycystic kidney disease. However, it was 
Bell (1935) who expressed the opinion that polycystic kidneys were inherited in Mendelian 
dominant fashion. Oppenheimer (1934) suggested that the hereditary predisposition of 
APKD appears to be equally transmitted by either sex and this suggestion was supported 
by Ferguson (1949) who investigated the incidence of polycystic kidneys in hospital 
practice and demonstrated an equal distribution of the disease between the sexes. Ferguson 
also attempted to isolate some distinguishing factors e.g blood group, saliva, hair and eye 
colour. Fifty relatives of affected persons were investigated but no other genetic factor 
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was isolated. Ferguson concluded his investigations with the hope that a genetic linkage 
would ultimately be found. 
Dalgaard (1957) in his study of polycystic kidney disease in Denmark demonstrated 
that polycystic kidney disease in adults was transmitted in an autosomal dominant fashion 
and that penetrance could reach 100% should the individual reach 80 years. 
In Dalgaard's study only 60% of patients with APKD had a positive family history 
of the illness. As a result, Dalgaard assumed that spontaneous mutations occurred 
frequently. According to Gabow (1990) a negative family history more commonly reflects 
failure to diagnose APKD in the parent rather than absence of the disease and this was 
substantiated by the work of Iglesias et al (1983) who found that half the cases of APKD 
in their study population had been diagnosed on autopsy. 
3.3.7 Discovery of a gene marker for APKD 
A major breakthrough in the genetics of APKD came with the work of Reeders et 
al (1985) who used gene linkage techniques and localized a gene for APKD on the short 
arm of chromosome 16. In gene linkage the gene itself is not discovered but DNA 
markers near the gene are identified. For each family, it is necessary to identify the form 
of the marker linked with the gene. In order to identify which form of the marker is 
linked with the APKD gene in the particular family, the affected and unaffected parents 
must have different markers. Furthermore, in the particular family there must also be at 
least two affected people whose gene status has still to be established. When these 
criterion can be met, the gene marker can be applied and can demonstrate the status of 
gene carrier to a 99 to 1 chance. Without gene marker technology the risk status for 
offspring of an affected parent is 50-50 (Gabow 1990). 
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In 1988 Kimberling et al were the first to identify a family whose gene for APKD 
was not found on chromosome 16 and since then other families have been identified 
(Romeo et alI988). The gene located on chromosome 16 has now been called APKDl 
and the other gene on the as yet unidentified chromosome has been called APKD2 or non-
APKDl. 
3.4 'fBE NORMAL JaDNEY 
The kidney is one of a pair of organs which lie towards the back of the body. The 
upper part of the kidney lies under the ribs which offer some protection for them. The 
kidneys are bean shaped organs measuring approximately 12cm by 7cm by 3cm with some 
variation from individual to individual and weigh 150-170g (60zs) each in the average 
male and a little less in the female. The length of the kidney is equivalent to 3th vertebrae 
and on respiration the kidney moves up and down the length of one vertebrae. The 
kidneys receives their blood supply from a branch of the aorta, the renal artery from 
which blood is passed to the outer parts of the kidney in blood vessels which form a fan 
shape (Fig 3.2). The blood is passed back into the main vein, vena cava, by the renal 
vein. The whole kidney is covered by a thin fibrous capsule which is joined to the renal 
vein, renal artery and pelvis at the hilum. Urine is passed from the kidneys through the 
ureter into the bladder. 
A kidney is made up of approximately 1 million nephrons. A nephron consists of 
two parts: the glomerulus which is the fllter of the kidney and the tubule. The glomeruli 
lie in the cortex or outer part of the kidney and are composed of tufts of capillaries with 
very thin walls which allow the glomerulus to function as a fllter. The tubules drain the 
glomerulus into the calyces which join to form the pelvis. The inner part of the kidney, 
the medulla, contains only tubules and no glomeruli. 
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Figure 3.2. Details of a normal kidney. 
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The nephrons function in the following way. The glomerulus takes in blood and 
filters off about one fifth of the water and its dissolved substances. The volume of this 
filtrate is approximately 200 litres every 24 hours. Most of this filtrate is then reabsorbed 
by the tubules, reduced in volume and the waste transformed into urine. In normal 
circumstances, llh to 21h litres, or 3 to S pints of urine is passed daily. Through this 
process the kidneys carry out the function' of disposing in the urine the waste products of 
metabolism, the chemicals urea, uric acid and creatinine, as well as regulating and 
retaining substances vital to the body water content; 
Urine contains several water soluble body constituents. By regulating the rate at 
which these substances are excreted, the lddneys keep the amounts retained in the body 
within normal limits. Clearly the kidneys have to make frequent adjustments to allow for 
variations in dietary and fluid intake. As well as regulating the composition of body fluid, 
the kidneys also maintain the volume of body fluid and in particular preserve the volume 
and composition of the extracellular fluid content. 
The last major function of the kidneys is the secretion of some important 
hormones. The first is the active form of vitamin D which promotes the absorbtion of 
calcium from the intestine and is essential in the maintenance of healthy bones. Before 
vitamin D can act on calcium absorbtion or on bone development, it must first be 
transformed to its active form by the liver and then by the kidneys. Failure of the kidneys 
to do this may result in bone disease. 
Erythropoietin which promotes the formation of red blood cells by the bone 
marrow is produced by the kidney. Failure of the kidneys to produce sufficient 
erythropoietin may result in anaemia. 
The kidneys also produce renin which stimulates the production of angiotensin and 
aldosterone which are important in the regulation of blood volume and blood pressure. 
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Finally the kidneys are responsible for the production of several prostaglandins some of 
which also regulate blood flow and blood pressure. 
3.5 RENAL FAILVRE 
Renal failure describes the situation when the kidneys are no longer able to carry 
out their function. Renal failure can be acute or chronic. Chronic renal failure is almost 
always caused by an irreversible impairment of renal function, such as APKD. For 
patients with progressive chronic renal failure the ou'tcome is death unless treatment such 
as dialysis or transplant is given. 
As the function of the kidneys fail, high levels of waste products accumulate in the blood 
, 
causing uraemia. 
Various tests are used to investigate kidney disease and to assess the degree of 
renal impairment; these are described below. 
3.S.1 Glomerular r.Itration rate 
The glomerular filtration rate (GFR) is a measurement of the amount of water 
being flltered at the glomeruli and is the single most important functional test in renal 
medicine. GFR is measured by a clearance study. The renal clearance of any substance 
represents the theoretical volume of plasma which is completely cleared of that substance 
in a given period of time. A clearance is usually expressed in mlImin and is calculated 
from the formula UV where U=urine concentration, V=volume of urine and P=plasma 
concentrate. The most frequently used clearance substance is creatine an end product of 
muscle metabolism, which accumulates in kidney failure and is filtered at the glomerulus. 
A 24 hour urine collection ie all urine passed over a specific 24 hour period and a blood 
S9 
CHAPTER 3: ADULT POLYCYSTIC KIDNEY DISEASE 
sample are needed for this test. The degree of renal failure according to creatinine 
clearance can be described as; 
mild 
moderate 
severe 
ESRF 
3.5.2 Serum creatine 
100-60 
60-40 
40-20 
20 and less 
Another method of measuring renal function is to calculate the amount of serum 
creatine in the urine. This is a simpler test than creatine clearance and a less accurate 
assessment of renal function. The degree of renal failure according to serum creatine can 
be described as; 
mild 0-200 
moderate 200-400 
severe 400 and over 
ESRF 
3.5.3 Volume of urine 
Urine: the volume of urine passed by an adult with healthy kidneys is 
approximately 2.25 titres per day (4-5 pints). Passing urine at night (nocturia) may be an 
indication that the usual fall in volume during the night is not taking place. This is a 
symptom of renal failure when the volume of urine to be passed has increased and the 
concentrating power of the kidney is impaired. Passing urine frequently pan:cularly if 
accompanied by pain burning or smarting is frequently due to a urinary tract infection 
(UTI). In APKD this may be caused by rupture of the cysts. 
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Frequent blood tests are carried out on renal patients to assess the degree of urea, 
creatine, uric acid and phosphates in the blood as well as the level of blood electrolytes 
such as sodium, bicarbonate and potassium. 
3.6 DIAGNOSIS OF APKD 
3.6.1 Autopsy 
In 1888 Lejars wrote that the signs of a certain diagnosis of polycystic kidneys 
were loin pain, haematuria, palpable kidneys combined with a detailed analysis of 
antecedents but that certainty of diagnosis remained on autopsy. 
3.6.2 Intravenous pyelogram 
By 1927 Braasch and Hager were using urogram as a method of confmning a 
diagnosis and by 1933 Braasch and Schacht were recommending intravenous urography 
as the "ideal means of diagnosis in many cases" (p473). De Bono and Evans (1977) 
suggested that the most common diagnostic technique for APKD was excretion urography . 
• 
However, there was evidence that this technique gave equivocal or misleading results and 
Fischer and Doust (1972) showed that there was a small but realistic risk of a major 
reaction to the contrast material used in excretory urography. 
3.6.3 Ultrasound 
It was not until 1983 that ultrasound was recommended by Sahney et al as the 
optimum diagnostic method for presymptomatic polycystic kidney disease. These authors 
suggested that if ultrasonography showed multiple cysts bilaterally in a person with a 
family history of APKD no further investigations were necessary. There is a problem of 
ascertaining the diagnosis in a patient in whom ultrasonography has raised the possibility 
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of some abnormality but no defInitive evidence of cysts were seen. In these circumstances, 
Sahney et at (1983) suggest that intravenous pyelogram with nephrotomography could be 
considered while Watson et at (1990) recommend that such patients return for 
ultrasonography on a yearly basis. 
Ultrasound has several advantages over other invasive investigative procedures. It 
is easily and quickly performed without the use of needles and the patient is caused little 
or no discomfort. There is no radiation as there is with excretory urography. It is safe and 
cheap and the results of ultrasound examinations can 'very quickly be given to the patient. 
As it has become possible to diagnose APKD more accurately by ultrasound so it 
has become easier to offer early diagnosis to the asymptomatic members of families who 
are at risk of inherited polycystic kidney disease. 
3.6.4 Computed axial tomography 
Computed axial tomography (cr scan) can also be used to diagnose APKD. CT 
scan may be more sensitive than ultrasound in the detection of small renal cysts. (Levine 
and Grantham 1981) but it is more expensive than ultrasound and exposes the patient to 
radiation. 
3.6.5 Gene marker 
The discovery of a gene marker by Reeders et al (1985) on the short arm of 
chromosome 16 enables, if sufficient family data can be obtained (Bear et al 1992), a 
more accurate diagnosis to be given to asymptomatic patients prior to the identification 
of cysts by ultrasonography. The gene marker can also be used for prenatal diagnosis. 
However the use of gene marker technology is still expensive and moreover requires the 
involvement of other family members in order to establish the diagnosis. 
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3.6.6 Family history/family pediuee 
The taking and development of a detailed family history is important in the 
diagnosis of APKD. A positive family history by itself cannot diagnose APKD in the 
asymptomatic. But when a patient is suffering from some of the symptoms often 
associated with APKD, the presence of a positive family history can facilitate an accurate 
~IY diagnosis. 
3.7 SYMPTOMS OF APKD 
3.7.1 Symptoms of APKD 
The . most recent clinical studies of polycystic kidney disease have not added 
substantially to knowledge of the symptoms of the disease as documented by 19th century 
authors Lejars (1888) and Dickinson (1885). The major symptoms, when they appear, are 
urinary tract infection, haematuria, hypertension, loin pain, gastrointestinal complications 
and eventually end-stage renal failure (Wilkie 1992). It is now generally agreed that in 
patients with a positive diagnosis of bilateral polycystic Jddneys there is a symptom free 
period with the studies of Higgins (1952), Simon and Thompson (1955), Dalgaard (1957), 
and Mitcheson et al (1977) all suggesting that for the majority of people with APKD, 
symptoms develop in their 305 and 40s with authors agreeing that there is likely to be a 
long asymptomatic period prior to the onset of symptoms. 
3.7.2 Urinary tract infection 
Urinary tract infection (lITI) is a common symptom and recurrent urinary infection 
(more than three infections in one year) were found to be more common in female patients 
(De Bono and Evans 1977). 
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Most workers suggest that as many as 75 % of patients develop urinary tract 
infection during the course of their illness (Dalgaard 1957, Simon and Thompson 1955). 
De Bono and Evans (1977) and Milutinovic et at (1984) found the frequency of UTI 
significantly higher in females than in males. Urinary tract infections does not appear to 
be related to kidney size. 
3.7.3 lIaeDlaturia 
Frank, painless haematuria is a presenting symptom in as many as one third to one 
quarter of patients studied (De Bono and Evans 1977 and Funck-Brentano et at 1964). 
Haematuria may be microscopic, macroscopic, intermittent or virtually continuous. 
Danovitch (1976) suggested that haematuria was frequently precipitated by trauma and 
physical exertion. 
There does not seem to be consensus amongst authors whether haematuria affects 
the sexes equally. 
Milutinovic at al (1984) showed that haematuria was related to kidney size in 
patients of either sex. In this study one or more episode of haematurla occurred in 14% 
of the 22 patients with radiographically measured longitudinal kidney sizes of 15cm or less 
in contrast to 43% of the 100 patients with kidney sizes larger than 15cm (p=O.OOI). 
Most workers suggest macroscopic haematuria seldom lasts more than 2 days. The 
average duration is 2 days and haematuria is seldom sufficiently severe to require blood 
transfusion. 
3.7.4 Hypertension 
Hypertension occurs in approximately 60% of patients with APKD prior to the 
development of renal impairment (Milutinovic et al 1984, Valvo et al 1985). Gabow 
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(1990) suggests that since APKD is a systemic disease, the pathogenesis of early 
hypertension could be attributed to renal factors, extrarenal factors or both. 
Hypertension is very frequently associated with renal disease as is left ventricular 
failure (L VB) and pericarditis. 
Blood pressure depends upon the relationship between the level of output of blood 
from the left ventricle of the heart and the resistance in the peripheral blood vessels. Two 
blood pressures are measured. The systolic pressure which corresponds to the peak 
pressure as blood is pumped from the heart and the diastolic pressure which is the low 
point between contractions of the heart. The convention is to record systolic over diastolic 
in mmHg. The units are millimetres of mercury from the height of the column of the 
sphygmomanometer. At birth blood pressure is about 80/40 and rises with age to reach 
120170 at age 20 approximately 140/80 at age 40 and continues to rise with increasing 
age. A persistent rise in blood pressure, hypertension, if left untreated, is known to be a 
cause of increased mortality and morbidity. 
In his study of impaired lives Leighton (1987) demonstrated that there is extra 
mortality for moderate hypertension but a marked increase in risk for high blood pressure 
readings whether systolic or diastolic or both and in particular as soon as the systolic 
pressure exceeds 170 or the diastolic pressure exceeds 95 (Table 3.1). Persons with 
untreated hypertension are at high risk of dying of myocardial infarction, cerebral 
haemorrhage, heart failure or renal failure. 
Almost all patients with APKD will develop hypertension (De Bono and Evans 
1977) if the disease runs its course (Dalgaard 1957, Danovitch 1976, Rall and Ode11949, 
Hatfield and Pfister 1972) with blood pressure higher than 140/90 in 70%-75% of all 
cases. Some authors suggest that hypertension in polycystic kidney disease is relatively 
mild and in most patients susceptible to treatment (Hamburger et alI968). 
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Table 3.1 
Excess mortality from hypertension 
% excess mortality 
S.A.P. D.A.P. 1974-83 1964-73 
155-170 
155-170 
155-170 
over 170 
over 170 
over 170 
under 95 
95-105 
over 105 
under 95 
95-105 
over 105 
+38% 
+53% 
+53% 
+89% 
+91% 
+161% 
+26% 
+60% 
+103% 
+106% 
+136% 
+193% 
Excess mortality among lives insured by Prudential Assurance Company, entering at 
ages 40-59, not overweight, policies in force for more than two years, as compared 
with policyholders accepted at normal premium rates. 
Source: Leighton (1987) 
The cause of hypertension in APKD is unclear. It cannot be explained merely on 
the basis of chronic renal disease since it occurs much more commonly in the presence 
of polycystic kidneys than in chronic pyelonephritis with equivalent functional impairment 
(Schacht 1931, Calabrese et al 1982). 
The relationship between hypertension and renal disease is twofold. Untreated 
hypertension causes renal impairment and renal disease such as APKD causes 
hypertension. The result of hypertension if left untreated is steadily rising hypertension 
and progressive renal damage. 
Hypertension is frequently the symptom which brings patients to the attention of 
the renal physician (Dalgaard 1957 and De Bono and Evans 1977) and as a presenting 
symptom is frequently related to age. In women, it may first be recorded in pregnancy 
(De Bono and Evans 1977). 
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Hypertension is known as an early symptom in three quarters of patients with 
polycystic kidney disease when kidney function measured by serum creatinine is still 
normal (Hansson et a11974). 
The relationship between serum creatine and hypertension in patients with APKD 
was studied by Hansson et al (1974). In patients with normal serum creatine the incidence 
of hypertension which was defined as a'resting recumbent blood pressure of 160/100 
mmHg was 75 % indicating that an increased blood pressure normally precedes impairment 
of renal function. A lower incidence of hypertenSion had previously been found by 
Dalgaard (1957) who regarded hypertension as a late phenomenon in the progression of 
polycystic kidney disease occurring concomitantly with an advancing impairment in renal 
function. 
It is also known that hypertension, untreated, causes renal damage. To date there 
has been no comprehensive screening and treatment of early hypertension in patients with 
APKD. Therefore, the effect of early treatment of hypertension on otherwise 
asymptomatic patients with APKD and on morbidity and mortality is unknown. However, 
the effect of early treatment of hypertension in other fields is well documented. 
3.7.5 Pain 
In many studies pain represents the most frequent complaint of patients with APKD 
(Dalgaard 1957, Danovitch 1976, De Bono and Evans 1977). The pain is frequently 
described as a nagging, dull, aching pain in the lumbar or lateral abdominal area. The 
pain is frequently unilateral and may radiate to the back. It is frequently very acute. 
Danovitch (1976) suggests that the relationship to exertion and other variables is 
inconsistent as is the success of the measures of pain. Pain mayor may not be 
accompanied by haematuria or urinary tract infection. A variety of theories for the 
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aetiology of pain in the presence of JXllycystic Jddneys has been suggested. For example 
the cysts have swollen producing pressure or stretch of the renal parenchyma or capsule. 
Braasch and Schacht (1933) suggest that pain is caused by the excessive weight of the 
enlarged Jddney while Dalgaard (1957) and Simon and Thomson (1955) suggest that the 
enlarged kidney puts pressure on adjacent organs and traction on the renal pedicle and that 
it is this that causes pain. 
3.7.6 (;astro-UntestUnalsyste~ 
Common symptoms are nausea, loss of appetite, weight loss, sickness and peptic 
ulceration. Many patients complain of an unpleasant taste in the mouth which may be 
due to urea in the saliva and gastric juices. 
3.7.7 Bone disease 
In addition to the above symptoms, bone disease may appear due to the disturbance 
in the production of vitamin D and parathyroid hormone. This can be particularly 
problematic in younger patients. Joints may become inflamed and painful due to deJXlsits 
of calcium and phosphate. 
3.7.8 ~naeDDia 
Anaemia is one of the early symptoms of renal failure due to failure of the kidneys 
to produce erythropoietin which stimulates the bone marrow to manufacture red blood 
cells. 
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3.7.9 Skin 
In renal failure the skin becomes dry and flaky as a result of the failure of the skin 
to form normal secretions. Frequently the skin becomes very itchy. The cause of the 
itchiness is still unknown. People with chronic renal failure often appear pale due to 
anaemia. In end stage renal failure the skin often takes on a muddy brown colour due to 
the presence of pigments which normally 'colour urine being present in the .blood. 
3.7.10 Other lesions or symptoms associated with APKD 
The finding of cysts in other organs of the body in patients with APKD is not 
uncommon. Hatfield and Pfister (1972) question the diagnosis of APKD in the absence 
of cysts in other organs. Cysts in patients with APKD have been found in the liver, 
pancreas, lungs, spleen, ovaries, testes, epididymis, thyroid, uterus, broad ligament, and 
bladder (Danovitch 1976). Of these hepatic cysts appear to be the most common 
(Milutinovic et al 1980). Gardner (1976) suggest that polycystic disease of the liver is 
present in 33% of patients with APKD. These figures vary according to the different 
series of autopsies carried out (Melnick 1955) and to the range of investigations at 
diagnosis. Hepatic cysts are seldom symptomatic although nausea, vomiting and 
discomfort in a sitting position may develop after some years (Rettiri 1969). Cysts in 
organs other than the liver occur in approximately 2% of patients (Danovitch 1976). It has 
not yet been shown conclusively whether the occurrence of cysts in organs other than the 
liver in patients with APKD is a chance finding or not. 
Patients with APKD have an increased risk of intracranial aneurysm or 
subarachnoid haemorrhage (O'Crowley and Martland 1939). 
The discovery of the existence of intracranial aneurysm in the region of the circle 
of Willis was reported by Lejars (1888) and Borelius (1901) and has since been described 
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in studies by Dalgaard (1957), Brown (1951), Bigelow (1953), Ditlefsen and Tonjum 
(1960). Bigelow and Dalgaard also reported an increased incidence of subarachnoid 
haemorrhage without aneurysm. However the relationship between subarachnoid 
haemorrhage, Berry aneurysm and APKD has not been clearly defmed. 
3.8 END STAGE RENAL FAILURE AND ITS TREATMENT 
A major symptom of APKD is end stage renal failure (ESRF). In the study by 
Dalgaard (1957) 50% of patients developed ESRF by age 50 while Churchill et al (1984) 
found that 70% of patients in their study had not developed ESRF by age SO and SO% had 
not developed ESRF by age 73. 
When the kidneys are damaged to a degree that renal function is described as 
ESRF, the patient will die unless some form of renal replacement therapy (RRT) is 
introduced to carry out the function of the kidneys. Haemodialysis, Continuous 
Ambulatory Peritoneal Dialysis (CAPD) , Intermittent Peritoneal Dialysis (lPD) and 
successful renal transplantation all perform this task. In many hospitals IPD is used mainly 
as a holding measure until a more permanent form of RRT is found and is therefore not 
discussed any further. 
In haemodialysis, the dialyser is the mechanism by which waste products are 
removed from the patients blood. The dialyser consists of two separate compartments 
separated by a semi-permeable membrane. Blood from the patient goes into one 
compartment and the waste products from the blood pass through the membrane into the 
fluid of the dialysis machine and are pumped out of the body. Blood cells are too large 
to pass across the membrane. The purified blood is then pumped back into the body. This 
system requires a mechanism by which blood from the patients body is passed to the 
dialysis machine and back again into the body. The usual method of vascular access is the 
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fistula which is a direct connection between an artery and a vein. This connection is made 
under the skin by attaching a vein in the forearm to the digital artery which runs down 
towards the base of the thumb. The vein eventually grows large as some of the blood that 
previously went to the hand passes through it. To dialyse, blood is taken from the patient 
by passing one needle, the arterial, into the fistula. This blood goes to the dialysis 
machine and is passed back into the body 'through a second needle, the venous needle in 
a different part of the fistula. The process of inserting the needles, often referred to as 
needling, is carried out every time the patient dialyses. 
The principle of haemodialysis is that waste and water products that the kidney is 
no longer able to dispose of cross a synthetic semipermeable membrane and are pumped 
out of the body. In peritoneal dialysis water and waste products cross from the blood 
stream through the peritoneum which is a natural semipermeable membrane and into the 
dialysate which has been inserted into the abdominal cavity. Access for peritoneal dialysis 
is by a Tenckhoff catheter, often made of silicone rubber, which is inserted into the 
abdominal cavity with about two inches of catheter left outside the body. To dialyse a 
sterile tube is attached to the Tenckhoff catheter and warmed dialysate is passed into the 
abdominal cavity where it is left for a short period to allow the transfer of waste products. 
The fluid is then allowed to drain out by gravity and the catheter capped off until the next 
time. 
Each form of dialysis has its adherents within the medical profession and there may 
be medical reasons why one form of dialysis is preferred for an individual patient. 
Haemodialysis has been tried for longer. The longest surviving time for a patient to be 
on haemodialysis in Scotland is 25 years (Henderson 1988). Haemodialysis can be done 
at home where it is cheaper or in hospital. Approximately 12-15 hours of dialysis per 
week are needed and this will vary from patient to patient. 
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Some of the psychological disadvantages of haemodialysis include the loss of 
independence during dialysis, concern about the cosmetic effects of the shunt and 
problems relating to the restrictions on the amount of fluid that the patient can take. 
Peritoneal dialysis has been developed during the last 20 years. CAPD is normally 
carried out 4 times per day every day and takes about three quarters of an hour to do. 
From the patients points of view the amount of time spent on either system per week is 
approximately the same. A major difference is that in peritoneal dialysis the patients are 
entirely responsible for their own care ie they could live alone and dialyse themselves. 
This is in contrast to haemodialysis where the patient requires the assistance of another. 
Patients on CAPD are prone to peritonitis and some patients put on weight. Some patients 
would argue that the need to dialyse daily in CAPD is more intrusive on their time than 
the 3 times per week sessions required for haemodialysis. However patients on CAPD can 
have a relatively 'normal' dietary and fluid intake and dialysing on CAPD can be more 
flexible than haemodialysis for the patient. 
Dialysis treatment is a way of life for the patient and his family in that the patient 
has to fit their life around the regular need to dialyse and the time that it takes. For some 
patients the psychological problems of adjusting to the restrictions that dialysis imposes 
may be considerable (Hardiker et al 1986). 
3.9 PROGNOSIS OF APKD 
In the studies of Dalgaard (1957), RaIl and Odel (1949) and Braasch and Schacht 
(1933) the mean life expectancy following clinical presentation ranged from 4 to 13 years 
with the time being considerably shorter for patients older than 50 years at the time of 
presentation to medical attention. Mitcheson et al (1977) estimated that 70% of patients 
with APKD would develop end stage renal failure (ESRF) if they survived to age 6S. On 
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the other hand Hatfield and Pfister (1972) suggested that many persons with APKD remain 
asymptomatic and have a normal life span. Churchill et al (1984) studied 17 APKD 
kindreds to calculate the prognosis for affected members. Their results indicated that the 
person with ultrasonographically detectable APKD may be told that their chances of 
developing ESRF before the age of 40 years are about 2 % rising to 23 % by the age of 
50 years and to 48 % by the age of 73 years. These authors conclude that the prognosis 
for patients with APKD is therefore much better than previous reports have suggested. In 
their study of the epidemiology of APKD in Olmsted County, Minnesota, Iglesias et al 
(1983) found that approximately only half of patients with APKD were diagnosed during 
their lifetime. They attributed this finding to the completeness of the authors case 
ascertainment, to the use of advanced diagnostic techniques and to the high proportion of 
deaths that came to autopsy in the population of Olmsted County (p638). These authors 
also discovered that there was a significant improvement in kidney survival in patients 
diagnosed after 1956 compared with those whose disease was diagnosed between 1935-
1955. These authors conclude that these improvements may be attributed to the more 
effective antihypertensive therapy and that early diagnosis of APKD combined with good 
medical attention may wimprove patient survivalw (p638). 
It has already been stated that patients with APKD have also an increased risk of 
intracranial aneurysm. Levey at al (1983) estimated the risk in APKD of rupture of 
intracranial aneurysm at 2% a year. Once rupture of intracranial aneurysm has occurred 
both the short and long term prognosis is poor (Nishioka et al 1984). It has also been 
suggested that patients with APKD and a family history of intracranial aneurysm or 
subarachnoid haemorrhage have a greater risk of having an aneurysm themselves than 
those without such a family history (Saifuddin and Dathan 1987). 
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4.1 INTRODUCllON 
There are rather few studies concerned with genetic counselling and adult 
polycystic kidney disease (APKD). This may be because patients with APKD in the 
United Kingdom are cared for by renal physicians and may not be referred to genetic 
departments from where most research about genetic counselling in the United Kingdom 
comes. Furthermore renal physicians may not be familiar with some of the problems 
inherent in genetic counselling nor with the literature referred to in Chapter 2. 
4.2 BACKGROUND 
From studies of APKD such as Danovitch (1976) and Chester and Argy (1979) it 
is evident that the management of APKD has four facets: management of complications 
between diagnosis and the onset of end stage renal failure; dealing with end stage renal 
failure; selection and preparation of patients for kidney transplantation; and the screening 
and counselling of relatives. De Bono and Evans writing in 19n point out that APKD 
whas persisted because its effects are often not manifested until after the peak reproductive 
period in lifew (P363). These authors usually told patients that they had a hereditary 
disease which -may on average affect one in two of their sibs or children- (P363). 
Normally relatives were not screened unless there were clinical grounds for suspecting a 
diagnosis when treatment could begin or if the relative requested screening. These authors 
were not offering proactive counselling as described in Chapter 2, but reacting to requests 
from at-risk relatives. 
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4.3 SnmIES OF GENE'IlC COUNSElUNG IN APKD 
By the early 1980s the majority of studies of APKD were particularly concerned 
with the reliability of non-invasive ultrasound in the diagnosis of APKD in both the 
symptomatic and presymptomatic patient as compared with the longer established but 
invasive method of diagnosis, intravenous pyelogram (IVP) (Milutinovic et al 1980, 
Hogewind et al 1980, Sahney et al 1983, Rosenfield et alI980). 
One of the early problems in genetic counselling in APKD and described by 
workers such as Hogewind et al (1980) was the lack of availability of age specific 
detection curves for APKD for any of the four possible diagnostic procedures, IVP, 
nephrotomography, sonography, arteriography. 
Hogewind et al (1980) set out to assess the reliability and sensitivity of ultrasound 
for the detection of APKD in the asymptomatic offspring of patients with known APKD. 
They suggested that ultrasound appeared to be at least as sensitive as IVP for identifying 
carriers of the APKD gene and recommended that this be the diagnostic procedure for 
asymptomatic carriers of APKD. These fmdings were supported by Sahney et al (1983) 
who recommended that ultrasound of the kidney and the liver be the initial screening 
procedure for APKD. They further recommended that if there was evidence on ultrasound 
of multiple bilateral cysts and there was also a family history of APKD no further 
investigations were required. They also suggested that if the patient was under 20 and the 
ultrasound was normal a further ultrasound could be carried out in a few years time. The 
authors thought that this approach would reduce the need for unnecessary IVP in many 
at-risk individuals but would still identify the asymptomatic individuals with APKD so that 
they could receive genetic counselling sufficiently early to be of value in planning their 
family. These authors did not discuss what should be included in genetic counselling. Nor 
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did they comment on any psychological problems that could occur by informing the 
asymptomatic at-risk individual of their risk status. 
As it became evident from these studies that ultrasound appeared to be just as 
reliable in diagnosing APKD, particularly in the presymptomatic patient, some authors 
began to consider the implications of early diagnosis of an illness in which the symptoms 
may not appear for some years. For example Milutinovic et al (1980) suggested that early 
testing of relatives at risk for APKD has the following potential benefits: 
1. early detection of gene carriers should theoretically lead to better 
therapeutic management of complications; 
2. subjects over the age of 20 who know that they are at risk for 
APKD and who are found to be unaffected can be reassured that 
they will not develop the condition and that they cannot transmit 
APKD to their offspring. 
However, these authors did point to the possibility of problems as a result of 
establishing a diagnosis in some asymptomatic people many years before they would 
otherwise have known. They suggested that physicians and genetic counsellors would need 
to balance these factors when deciding whether to recommend unsolicited early testing of 
persons at risk for APKD. 
In 1982 Sahney et al published a study which had set out to 
a) assess knowledge of the hereditary nature of APKD in 22 patients 
with end stage renal failure due to APKD and 
b) to determine whether these patients had received adequate genetic 
counselling. 
Their findings showed that patients were neither sufficiently informed of the 
familial nature of the disease nor had they received adequate genetic counselling. This 
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study, like many of the studies described in Chapter"2, assessed knowledge of the disease 
by measuring both. the patients' knowledge of the genetics of APKD and the symptoms 
of the illness. The emphasis was on whether the patient was aware of the presence of 
kidney disease in the family and whether the illness was passed from generation to 
generation. The investigation did not focus on the understanding of risk and probability 
as frequently happened in studies described in Chapter 2 and falling into paradigms 2 and 
3. Indeed the authors stated that • ••• effective counselling should not only emphasise the 
risk of recurrence of a genetic disease but should help the family cope with the genetic 
burden· (Sahney et al 1982 p466). Although the authors did not describe what they 
thought should constitute genetic counselling they made several references to the 
psychological component in genetic counselling. The authors referred specifically to the 
possible psychological impact of learning of the genetic nature of APKD and in this 
respect this study fits into the third paradigm described in Chapter 2. 
4.4 IsSUES IN PRESYMPTOMATIC AND PRENATAL DIAGNOSIS 
By the mid 1980s ultrasonography had become the recommended method of 
diagnosing APKD presymptomatically. 
The announcement in 1985 of the discovery of two genetic markers closely linked 
to APKD on chromosome 16 (Reeders et al1985) greatly increased the potential for early 
presymptomatic diagnosis of APKD. Later in 1986 Reeders et'al carried out prenatal 
diagnosis of APKD in a fetus by chorion villus sampling. 
o 
These authors point out that the inclusion of presymptomatic diagnosis of APKD 
has not yet been established in the management of patients with APKD. This is not 
surprising when one considers the short time scale between the establishment of non-
invasive ultrasonography as an accurate method of presymptomatic diagnosis of APKD 
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and the discovery of gene markers that can also be used prenatally. Reeders et al pointed 
to the need to define the place of both prenatal and presymptomatic detection of APKD 
in genetic counselling. 
In 1990 Hodgkinson et al described a study into knowledge, experience and 
attitudes to prenatal diagnosis amongst patients with APKD. The work was carried out in 
Manchester between 1987 and 1988. The authors contacted 352 subjects aged between 18 
and 45 who were on a confidential genetic register held by the North Western Regional 
Genetic Centre. Their subjects included patients affeCted by APKD, those at high risk, ie 
50%, of developing APKD, those classified at low risk, which was defmed as one or 
more negative presymptomatic tests by a consultant radiologist, and spouses of any of the 
above. The take-up rate for the whole population was 54% but only 19% for those at high 
risk. 
Respondents were asked whether they themselves would be interested in a prenatal 
test for APKD. 29% of the whole population said that they would, compared with 25% 
of those affected, 13% of those at high risk and 47% of those at low risk, for whom the 
question was more hypothetical. The high non-response rate for those at high risk should 
be noted as it is this group whose perceptions of the implications of presymptomatic and 
prenatal diagnosis are particularly important. 
The relationship between the respondents perception of the severity of APKD and 
interest in a prenatal test was examined. 65 % of those who said that they were interested 
in a prenatal test and who were also at high risk of inheriting APKD considered that 
APKD was "extremely serious" compared with 34% of those respondents who were 
affected by APKD but who were not interested in a prenatal test. However the authors do 
not discuss how the perception of seriousness was ascertained. While a majority of the 
respondents in this study felt that the development of a prenatal test was acceptable, only 
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a minority of the sample would personally be interested in using it. The authors also found 
that a higher proportion of those at low genetic risk for APKD said that they would have 
had a prenatal test for APKD if they had been at high risk which led the authors to 
suggest that prenatal diagnosis for APKD may be more appealing in the abstract. 
The authors concluded that • ••• even for persons with a realistic perception of the 
disease and a good recall of the recurrenCe risk, the demand for prenatal diagnosis will 
be low· (p557). 
Another study into attitudes of at-risk and affected individuals regarding 
presymptomatic testing for APKD using gene linkage analysis was carried out in the USA 
and also reported in 1990 (Sujansky et al 1990). This study involved 141 affected 
respondents and 137 at-risk respondents. Ninety seven per cent of the at-risk group stated 
that they would want to know their own gene status if gene linkage were available, and 
the majority of respondents said that they would like to confmn the genetic status of a 
child postnatally with regard to APKD. While 65% of the affected and 50% of those at 
risk would consider using prenatal diagnosis, only 4 % of affected respondents and 8 % of 
those at risk would terminate a fetus with APKD. The authors explored respondents' 
attitudes to termination and found that the participants' attitudes to termination of 
pregnancy for APKD was different from their view of termination of pregnancy for ·a 
very serious medical problem· in the fetus. They found that significantly more 
respondents, including both those at risk and those affected, would be definitely willing 
or would consider termination of a pregnancy for ·a very serious medical problem· than 
would consider termination of pregnancy for APKD. The authors concluded that many of 
their respondents did not perceive APKD as a serious medical problem. The authors were 
also surprised that the severity of the disorder in the family did not appear to influence 
the desire of the respondent for prenatal diagnosis and termination of pregnancy. 
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These authors do point to the apparent inconsistencies in their results in the desire 
for fetal genetic knowledge on the one hand but the reported lack of take-up of 
termination of an affected fetus on the other hand. They state that their data did not 
indicate that this was caused by lack of medical or genetic understanding of APKD and 
assume that the late onset of APKD influenced judgements of respondents about prenatal 
diagnosis. The authors conclude that from their data earlier presymptomatic diagnosis will 
have little effect on the frequency of the disorder as it will only occasionally alter 
reproductive plans. This study highlights the great complexity of attitudes that should be 
considered by clinicians before offering presymptomatic diagnosis or prenatal diagnosis 
for those at risk for APKD. 
4.5 AWARENESS OF ETHICAL AND PSYCHOLOGICAL PROBLEMS 
CREATED BY PRESYMPTOMAnC DIAGNOSIS 
The three studies discussed above all point to possible difficulties that may be 
caused by presymptomatic diagnosis of APKD. Sahney et al (1982) clarify some of the 
problems when they state: -If young people who are at risk of developing end stage renal 
disease are identified early, the psychological problems created in them and their parents 
during the long asymptomatic period will have to be carefully weighed against the benefits 
of early diagnosis. - (p467). These authors see the potential benefits of presymptomatic 
diagnosis as rational reproductive decision making and the remote possibility of delaying 
renal failure by monitoring and controlling urinary tract infections and hypertension. 
However, in their study of the attitudes of those affected by or at risk for APKD 
to presymptomatic testing for APKD, Sujansky et al (1990) found that only 40% of those 
affected and 30 % of those at risk would consider altering their plans to have children 
because of APKD. The authors assumed that these respondents did not consider APKD 
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to be a serious condition and they concluded that presymptomatic testing for APKD would 
not substantially modify the incidence of APKD since it ·may only occasionally alter 
reproductive plans· (PS10). 
Hodgkinson et al (1990) suggest that the diagnosis of an adult onset condition many 
years before the onset of symptoms could have adverse consequences, including the 
possibility of discrimination in employment and difficulties in acquiring life assurance, as 
well as psychological problems. 
4.6 1'mRD PARTIES, ETHICAL IMPUCAnONS AND INFORMED CONSENT 
There is an ethical issue raised by the practice of acquiring information about other 
family members from the index ie the affected patient. In order to develop a family tree 
or pedigree it is customary to start with the patient and to ask them whether their parents 
are alive and if not what was the cause of their death. The same questions are then applied 
to siblings, having first established how many there are and their sex, as well as to uncles, 
aunts and cousins. What is the obligation on the patient to give information about other 
family members when that information is not necessary for the diagnosis of the illness in 
the patient? The cooperation of the patient in the task of developing a family tree may 
depend on a variety of factors including their comprehension of the problem, their actual 
knowledge of other family members, their relationship with these other family members, 
the presumed benefit of the investigation and their desire to protect these family members 
from investigation. In tum their willingness to give information could depend upon the 
point in time that the patient was given the diagnosis. 
In APKD the diagnosis has frequently been given to the patient when symptoms 
first appear or when the patient is unwell. In these circumstances the patient has firstly 
to absorb information about what is to happen to himself or herself and, as Sahney et al 
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(1982) point out, the patient may then be unable to assimilate all the information that is 
given. These authors raise the ethical question of collecting information about the extended 
family when they state: W ••• because the patient may deny the reality of the disease, the 
counsellor must persist in order to identify and trace family members at risk and have 
them evaluated. W (p467). 
There are two important ethical issues raised implicitly in the study by Sahney et 
al. The first is embodied in the statement quoted above W ••• the counsellor must persist 
in order to identify and trace family members at risk •.• w. In these circumstances is the 
patient giving information voluntarily and has informed consent been sought'] It is 
appreciated that some patients may fmd it very difficult to remember biographical details 
of their family. 
The second problem concerns what is done with the information about other family 
members and whether the doctor should diwlge information to a third party, the relative. 
This situation also raises the question of medical confidentiality. The norms of medical 
confidentiality require that doctors do not diwlge information given to them by their 
patients and which these patients wish to keep secret (Gillon 1988). Both the GMC (1987) 
and the BMA (1984) describe the few exceptions to the situations where a doctor may 
diwlge information given to them by a patient. These include situations such as when it 
is medically undesirable to seek the patient's consent, when disclosure to a third person 
not a relative is in the best interests of the patient, certain court requirements to disclose 
and when it is in the interest of the public to disclose. Gillon (1988) argues that at present 
it seems likely that definitions of medical confidentiality as described by the BMA and the 
GMC do not permit the giving of medical confidences to third parties unless there is what 
is described as wharm equivalent to a grave or very serious crimew (P172). Neither the 
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BMA nor the GMC recommendations specifically mention whether genetic disorders 
would fall into this category but it is unlikely that they would. 
It becomes important, therefore, that information given to doctors by patients about 
their relatives and partners so that appropriate relatives can be informed of their genetic 
risk must be based upon informed consent. And this importance of informed consent is 
emphasised by Pelias (1991) when she states: -The geneticist should have the consent of 
both his client and the participating collateral relative before revealing any information to 
the relative. Any fortuitous information about non-participating relatives should ideally be 
kept in confidence until an ilUJuiry is initiated by t1uJt relative himselj (my italics). Pelias 
suggests that the geneticist is in a position to encourage communication among family 
members, but the geneticist is obliged to respect the privacy, autonomy and confidentiality 
of those with whom he has direct contact (P350). 
The importance of informed consent in screening for fetal and genetic abnormality 
was also emphasised by the King's Fund Forum Consensus Statement (1987). 
The use of DNA markers in the testing of genetic diseases such as APKD requires 
blood samples not only from the patients but also from several relatives. Relatives who 
do not wish to -be involved- or to receive any genetic information about themselves, can, 
at least theoretically, not participate by not giving a sample of blood. However it is not 
known to what extent pressures may be put on these relatives to participate. Nolan and 
Swenson (l988) suggest that family pressures on even distant relatives to participate in 
genetic diagnosis can result in harm to individuals and to family relationships. 
The problems of genetic counselling for APKD fall fully into those described in 
Chapter 2 as part of the fourth paradigm. 
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S.1 INTROnucnON 
In the studies into genetic counselling and APKD discussed in Chapter 4, there is 
reference to the 'genetic burden' of APKD (Sahney et alI982), and also to patients who 
have 'realistic perceptions' of APKD and to patients who did not 'perceive APKD as a 
serious medical problem' (Hodgkinson et all990). APKD is a chronic illness for which 
there is no cure. The development of symptoms is normally gradual but the symptoms of 
chronic renal failure can be distressing and the treatment of end stage renal failure is 
complicated and creates restrictions for the patient. 
In the these studies there is the assumption that those at risk for APKD would wish 
to take advantage of pre symptomatic diagnosis 'so that appropriate reproductive decisions 
can be made' and that pregnant women with APKD would take advantage of prenatal 
diagnosis followed by termination of an affected fetus. The assumption here is that 
patients with APKD and those at risk of APKD perceive APKD as a sufficiently serious 
illness that they would wish to prevent. And yet the conclusion of Hodgkinson et al (1990) 
is that earlier presymptomatic diagnosis will be unlikely to have an effect on reproductive 
decisions. 
There are two problems inherent in this assumption. The rrrst concerns the 
interpretation that patients perceive APKD in the same way as the doctors looking after 
them. Doctors and many others undoubtedly perceive APKD as a serious illness that 
people would wish to prevent. In the present climate of increasing health costs, doctors 
also may be concerned about the cost of treating the illness and this may influence their 
perception of the illness. The second problem is that patients with APKD cover a broad 
spectrum of symptoms from the asymptomatic person to patients in end stage renal failure 
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and that the symptoms and the available treatment for these symptoms may influence 
patients' perception of the illness. Furthermore, although APKD is a genetic or family 
condition, some patients may not have been in contact with a relative with more advanced 
symptoms of the illness. In this chapter specific aspects of lay perceptions that may be 
relevant to APKD are explored. 
S.2 LAy AND BIOMEDICAL CONCEFI'S OF ILLNESS 
In western society, the medical definition' of ill health is largely based on 
objectively demonstrated physical changes in the structure or function of the body and 
these changes can be quantified by reference to some standard of physiological 
measurement. This medical perspective assumes that diseases are universal and will be the 
same in whichever country or society they appear. However, as Helman (1986) points out, 
this perspective does not include the social and psychological dimensions of health and 
illness which determine the meaning of the disease for the patient and his family. 
Authors such as Engel (1980) have suggested that the dominant model of disease 
is biomedical, with molecular biology its basic scientific discipline. This model assumes 
disease to be fully accounted for by deviations from the norm of measurable (somatic) 
variables. It leaves no room within its framework for the social, psychological and 
behaviourial dimensions of illness (P196). 
Helman (1986) reminds his readers that not only do medical models change over 
time as new discoveries are made and new technology becomes available but also that 
medical models are neither homogeneous nor consistent. Anyone doctor may use a 
number of different perspectives when making a diagnosis, including lay health beliefs. 
For example, according to Stacey (1988), GPs may collude with the lay model when they 
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negotiate with their patients on the basis of a lay model and for example agree that 'there 
is a bug going around'. As Stacey (1988) comments, this is not a scientific explanation. 
However, this is not to say that patients and professionals will hold quite different 
beliefs about illness. For example, there is evidence that lay ideas about the causation of 
illness, if not paralleling scientific theories (Calnan 1987), are influenced by them 
(Helman 1986). According to Helman art increasing number of people use the germ 
theory, where the cause of illness is external to the body, as an explanation for their 
illness. Helman has observed that such explanations are particularly common amongst his 
younger patients and he links the spread of the germ theory in lay models of illness 
causation with the introduction of antibiotics and the establishment of the National Health 
Service. 
There is also evidence that to some extent biomedical concepts are used by 
patients. For example Blaxter (1983) demonstrated that the respondents in her study 
adopted biomedical concepts and ideas although their logical framework followed a 
different model. Similar findings were also described by Cornwell (1984) 
5.3 LAy CONCEPTS OF BEALm AND W..NESS 
For some time, social psychologists and sociologists have examined the ways in 
which patients explain, perceive or try to make sense of, their illness. 
In an analysis of why people with APKD do or do not take certain actions and take 
particular views about the illness, it may be helpful to examine studies of lay concepts of 
both health and illness. The diagnosis of APKD in a presymptomatic person does not 
necessarily make that person ill. The pathology has been identified but the person may not 
have experienced any symptoms or changes in him or her body nor defmed him- or her-
self as ill. For example Cassell (1978) describes illness as the problem the patient has 
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when he goes to the doctor: disease is what the patient has when he leaves the doctor. 
Disease is something attributed to an organ or part of the body, while illness is the 
subjective response of the patient to being unwell. 
Blaxter (1990) examined perceived links between health and lifestyle. The majority 
of her respondents expressed multiple concepts of health. The types of defInitions offered 
varied mainly by stage in the life cycle and also by sex. For example younger people 
spoke in terms of physical fItness or vitality while in middle age ideas became more 
complex with a greater emphasis on total mental and physical wellbeing. In old age there 
was a greater emphasis on function, on being able to manage for oneself. There were also 
social class differences in the self- assessments of health, with the most disadvantaged and 
the poorest respondents most likely to say that their health was poor. 
Locker (1983) examined how people construct defInitions of illness. He suggested 
that illness is one explanation of patterns of action described as 'illness relevant 
behaviours', which were used in the construction of the defmitions of illness and in 
prescriptions for action, such as going to bed, calling the doctor, not going to work. 
These actions characterise people who are ill; those who follow these actions will be 
described as being ill, and those who say that they are ill can be expected to behave in this 
way. Locker also suggested that illness has a moral component in that those who are 
labelled as ill are usually absolved of responsibility for their actions because the major 
cause of illness is believed to be outside the control of the individual. lllness, therefore, 
involves judgements about the extent to which a person has control over his actions. 
BIaxter (1983) in her study of attitudes of Scottish women to health and disease, 
found that the most commonly cited cause of illness was family susceptibility and heredity 
including ideas about family similarity and inherited weaknesses. Blaxter argued that this 
focus enabled the women to deny that could in any way be responsible for their own 
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illness and this is similar to Locker's explanation that the cause of illness was outside the 
control of the individual. BIaxter found that the women distinguished between illness and 
disease. illness for these women was weakness, 'lying down to it', being functionally unfit 
and giving in to disease. The women also offered explanations from the environment such 
as bad working conditions, poor housing and poor climate. Blaxter suggested that it was 
more acceptable for her respondents to fuid a cause or explanation for their illness in the 
environment rather than to locate the responsibility in their own body. 
Blaxter also widened the scope of investigations into chronic illness by examining 
both the way in which the individual perceives his or her place in society and the 
relationship between this self-perception and the structures that surround and constrain the 
individual. For example, Blaxter (1983) described the administrative structure, which, she 
suggested, forces doctors" ••. to choose between 'sick' or 'well' for a certificate, to 
adjudicate whether a man is 'fit' to work and not whether he wants to work or whether 
it would be best for him to work" (P240). "By convention, the actions of doctors are 
given arbitrary meanings: a patient has to wait for the final review of his condition before 
he has recovered." (P239). This administrative structure also imposes a timetable on the 
patient. For example an individual can be 'off sick' from work for up to S days before 
having to supply a medical certificate and be recognised as officially sick, while short 
term sickness lasts for three months. 
Pill and Stott in a series of studies between 1981 and 1987 examined beliefs about 
health and illness amongst Welsh working class mothers with specific focus on the 
distinctions construed between inferences of internal causality (ie individual responsibility) 
and of external attributions (fate and the influence of powerful others). They developed 
a salience of lifestyle index which they used to distinguish between people whom they 
described as 'lifestylists', those who saw health as under their own control, and others 
88 
CHAPTER S: LAY PERCEmONS OF HEALTH AND ILLNESS 
whom they called 'fatalists' who felt that they had little control over their health, seldom 
reported trying to improve it and were likely to rely on the expertise of the doctor. 
Lifestylists reported taking regular exercise and seeking to reduce stress. They were 
knowledgeable about the causes of such illnesses as heart disease and cancer but they 
commented on the need to evaluate medical advice. These authors were careful to point 
out that their respondents were neither totally fatalists nor did they believe that leading a 
healthy lifestyle would grant them immunity from illness. While the respondents in these 
studies had no doubt that there is a link between behaviour and lifestyle and health and 
illness, health was not seen as a matter of personal responsibility. These respondents 
argued that if people lived in circumstances which reduced choices of courses of action, 
individuals could not accept blame for their illness. Pill and Stott have suggested that 
while this interpretation may be seen as 'fatalism' from one perspective, from another it 
may be seen as a realistic appraisal of the complex variables involved in the aetiology of 
illness. 
A question raised by the work of Pill and Stott concerns the extent to which those 
respondents described as lifestylists acquire the more positive self-perceptions as a 
consequence of overcoming adversity or whether they overcome difficulties because of the 
attitudes to life that they adopt. Similarly do those who were described as fatalists believe 
that life has been hard, or is life hard for them because their attitude does not encourage 
them to help themselves? An alternative approach is to accept that these two different 
explanations are themselves explanations of health and illness. 
Amongst the respondents in the Pill and Stott study the notion of heredity was 
stated as an explanation of the cause of illness. Blaxter (1983), who had similar fmdings, 
commented that there appears to be a greater readiness to involve genetic causation in lay 
culture than in medical science. She suggests that patterns of shared illness in families can 
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offer a powerful source of ideas of inheritance. However, it is not known how widespread 
this interpretation is, nor whether it is an interpretation that would be accepted by 
individuals from families where there is a known inherited illness. 
Dingwall (1976) accepted that illness was a socially determined state and that 
people from all social groups engage in the active construction and interpretation of reality 
for themselves. He suggested that people try to make sense of health and illness through 
what he calls the concept of 'ordinariness'. To be ordinary is to do usual, expected, 
normal things at usual times in usual places mtd this requires familiarity with 
commonsense knowledge. Therefore, according to Dingwall, our understanding of illness 
is dependent upon our conception of ordinariness. 
5.4 CONCEPTS OF W.NESS AS SOOAL REPRESENTATIONS 
When we label people as 'ill' what is happening is a process of social definition 
in human terms. Illness is only meaningful as an illness when it has particular implications 
for the person. lllness is, therefore, a product of a particular social reality. Berger and 
Luclemann (1967) suggest that knowledge in any culture is distributed within socially 
segregated sub-universes of meaning (PI03) which are developed within specialized 
groups. According to Berger and Luclemann such sub-universes of meaning compete 
within society for dominance and that in advanced industrial societies "pluralistic 
competition between sub-universes of meaning becomes the normal state of affairs". The 
authors argue that as these sub-universes become more complex they become sealed off 
from one another. They illustrate this with the following example (P105): 
"It is not enough to set up an esoteric sub-universe of medicine. The lay 
public must be convinced that this is right and beneficial and that the 
medical fraternity must be held to the standards of the sub-fraternity. Thus 
the general population is intimidated by images of the physical doom that 
follows 'going against the doctor's advice'; it is persuaded not to do so by 
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the pragmatic benefits of compliance, and by its own horror of illness and 
death. To underline its authority the medical profession shrouds itself in the 
age-old symbols of power and mystery, from outlandish costume to 
incomprehensible language, all of which, of course, are legitimated to the 
public and to itself in pragmatic terms. Meanwhile the fully accredited 
inhabitants of the medical world are kept from 'quackery' (that is, from 
stepping outside the medical sub-universe in thought or action) not only by 
the powerful external controls available to the profession, but by a whole 
body of professional knowledge that offers 'scientific proor of the folly 
and even wickedness of such deviance. In other words, an entire 
legitimating machinery is at work So that laymen will remain laymen, and 
doctors doctors, and (if at all possible) that both will do so happily.· 
Berger and Luc1emann argue that it is possible to distinguish between four different 
levels of legitimation. The first is built into the language, the second is the impact of 
everyday explanations, the third are explicit theories of a particular collection of 
knowledge, and fourthly there are symbolic sub-universes themselves. These are whole 
bodies of knowledge which integrate different provinces of meaning into coherent wholes. 
By legitimation, the sub-universe of biomedical knowledge becomes the property of 
individuals. 
Herzlich (1973), in her study mainly of Parisians with some country people from 
Normandy, set out to examine the way in which people made sense of the concepts of 
health and illness. Herzlich, who was influenced by the work of Moscovici (1961) on 
social representations, analyzed the content of respondents' accounts of health and illness. 
Herzlich argued that health and illness are experienced and thought of by the individual 
in reference to society. She found that illness was conceived of as being produced by a 
mainly urban way of life, whereas health came from within the individual. runess was 
conceived of as something external to the individual and in terms of pathological agents 
such as germs, which were perceived as products of modem life. Certain illnesses such 
as cancer and mental disorders were also conceived as products of the way of life. 
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Herzlich identified three kinds of perception of illness: 
1. illness as destructive; 
2. illness as a liberator and 
3. illness as an 'occupation', 
and suggested that "in terms of these the individual expressed his relation to illness or to 
health as this relation is established in soCiety, and his relation to society as this relation 
is established through health or illness" (PlOS). 
The concept of illness as destructive, according to Herzlich, appeared characteristic 
of active people for whom the essential part of illness was perceived as inactivity, as 
exclusion from their social group, changed professional and family and fmancial problems. 
Herzlich identified two possible responses to destructive illness, denial and passivity. 
Denial can be seen as representing victory over the illness. To reject illness behaviour is 
to get better and to maintain one's life through social integration. The maintenance of 
activity as long as possible is important. The refusal to take special care or to go to the 
doctor was seen as a desire to deny illness as was the refusal to 'know' or fmd out about 
one's condition. As one of the respondents in Herzlich's study said " ... there's nothing 
like telling people that they are ill to make them feel even iller •.• When you know, that's 
it, you have got your illness and I think that makes it worse ••• ". Denial does not need 
to be complete but any adoption of illness behaviour has to remain hidden or discreet. If 
the illness becomes established the patient may become powerless to deny and this, 
according to Herzlich, is when passivity often takes precedence over denial. 
For some people illness appeared as a kind of liberation where it was possible to 
relinquish certain social constraints and responsibilities thus 'freeing' oneself to think and 
to be alone. 
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Illness was also seen as an occupation where the patient is occupied in fighting the 
illness with the aim of getting better. 
Cure is the nonnal outcome of illness. In contrast health was conceived as 
something internal to the individual and the major factors determining health were 
temperament and heredity. Herzlich identified three categories of health which she called: 
health in a vacuum, reserve of health and eqUilibrium. 
Health in a vacuum simply means the absence of illness. Reserve of health was 
seen as something the individual had and childhood was seen as a good opportunity to 
develop a reserve of health. Equilibrium was sometimes referred to as real health when 
'the body functions like a well oiled machine'. Equilibrium means physical and 
psychological well being and absence of fatigue. 
Herzlich's respondents also referred to heredity. Some referred to the inheritance 
of weak or strong points, of fragility or robustness requiring certain precautions. Other 
respondents tended to restrict the role of heredity" •.. we don't really know why some 
people have abnormal children ..• there is heredity •.• but there are parents who are 
drunkards and others whose parents aren't drunkards, who are still abnormal." (P25). 
There were also respondents for whom hereditary diseases were much rarer than those 
diseases due to the way of life: "There's heredity if you like, but it doesn't count for all 
that much ..• in the cities you come across so many queer folk in the street you don't 
really notice them." (P25). Herzlich suggests that while this respondent did consider 
heredity as an explanation for some illness he abandoned it for the view shared by many 
other respondents that the way of life was the cause of much illness. 
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5.5 CONCEPTS OF CHRONIC ILLNESS 
APKD is a chronic illness. Authors such as Channaz (1983) have suggested that 
the onset of chronic illness represents an assault on both the person's physical self as well 
as on the sense of identity held by the person and calls into doubt the person's self-worth. 
Chronic illness by defmition is a long-term and possibly permanent event in a 
person's life. Bury (1991) suggests that the 'meaning' of chronic illness is to be found 
both in the consequences for the individual in, for example, the effects of the onset of 
symptoms on everyday life at home and at work as well as in the significance of the 
chronic illness. Significance of a chronic illness according to Bury means that different 
illnesses carry with them different connotations and different imagery, and that these 
differences may have a profound effect on how individuals regard themselves and on how 
they think that others perceive them. This is evocatively described by the author, Susan 
Sontag, in her work on the metaphors used to describe tuberculosis and cancer (1983) and 
more recently AIDS (1989) 
The meanings surrounding illness often change as they interact with different stages 
of life. Changes in symptoms over time may affect social responses, and these in tum will 
influence experience. Bury (1991) suggests that chronic illness creates what he describes 
as 'meanings at risk' by which he means that in responding to chronic illness, individuals 
-test the meanings attached to their altered situation against the reality of everyday 
experience- (p454). This is a situation of risk, as individuals cannot be certain that their 
own developing perception and defmition of the situation will be shared by others. For 
example, Shelley (1985) in his description of his life with haemophilia learned that -as 
long as people were ignorant of my condition I was welcomed anywhere, but as soon as 
they became aware of the truth I was an alien who made them feel uncomfortable ... I 
must invent plausible excuses that the normal person could relate to, such as having a 
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bleed. I had to remember never to tell them that I had had a bleed- (P115). A similar 
situation is described by Iphofen (1990 p462) in his study of petit mal where some patients 
alternate between concealing their situation and revealing it, depending upon their 
situation. 
Uncertainty is another feature of chronic illness and this may be particularly 
disruptive at the time of diagnosis. This is particularly true in conditions like Huntington's 
Chorea where at the beginning of the illness symptoms of the illness overlap with a range 
of what could be considered normal symptoms and' behaviour (Phillips 1982). A raised 
sense of uncertainty also features in chronic illness when people consider employment 
(Markova et al 1980). In patients with renal failure this raised sense of uncertainty was 
evident when considering social and holiday arrangements and kidney transplantation 
(Morgan 1988). 
The term 'legitimation' is described by Bury (1991) as the process whereby the 
individual attempts to establish an acceptable place for the chronic illness in their life. The 
diagnosis of Huntington's Chorea can be seen to represent official validation of a series 
of problems that have faced the patient. Similarly Robinson (1988), in his study of 
multiple sclerosis, suggested that people might use the diagnosis of multiple sclerosis to 
overcome the feelings of being regarded as mentally ill. 
In APKD there are now not only better forms of diagnosis but also more treatment. 
Gerhardt (1990) suggests that the new and more effective forms of treatment that are now 
available for many chronic conditions have extended the role of medicine to affect the 
quality of life as well as the clinical outcomes. She suggests that expectations of medicine 
have been raised in an area where previously the use of medicine had been limited. This 
raised expectation of what medicine may have to offer can lead patients into searching for 
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more and more information that makes sense to them. This situation is described very 
clearly by Iobling (1977), who has psoriasis himself, in his study of that disease. 
5.6 CONCEPTS OF SERIOUSNESS OF w..NESS 
What does 'serious' mean? Herzlich (1973) found amongst her sample that 
seriousness of illness was most frequently associated with the danger of dying. But 
seriousness was also associated with the duration of the illness and with its irreversibility. 
Herzlich suggests that the seriousness of the illness is'not something specific but -indicates 
an accentuation of one of the features of a disorder- and that this will vary from disease 
to disease, for example incurability in the case of cancer but duration in the case of 
tuberculosis, frequently considered as curable by respondents in Herzlich' s study. Herzlich 
argues that the attributes used by her respondents to define the seriousness of the illness 
differed from medical classifications of seriousness. They are not related to the aetiology 
of the illness nor for example, is there a distinction made between diseases of the digestive 
system and diseases of the circulatory system. Herzlich suggested that the attributes have 
all the function of indicating the implications of the illness for the present or future life 
of the individual and rendering them meaningful by defining their relationship to the 
individual. 
In their study of HIV and AIDS in people with haemophilia, Markova et al (1990) 
showed that people with haemophilia who were HIV antibody positive did not consider 
HIV such a serious condition as did people with haemophilia who were mv antibody 
negative. The authors offero different explanations for this rmding. Denial of the 
seriousness of HIV could be a coping strategy on the part of those affected which would 
also give them some feeling of control over their illness. Alternatively those who were 
HIV antibody positive were also those more severely affected by haemophilia and because 
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of the severity of their illness were likely to have overcome life-threatening episodes of 
illness. For these patients, therefore, HIV infection could be perceived as of relatively 
smaller importance when compared with other patients with haemophilia less severely 
affected. 
This is similar to Stainton Rogers' (1991) idea of 'the body as a machine'. She 
suggests that within this system illness is regarded as naturally occurring and modem 
biomedicine is seen as the only valid source of effective treatment for any kind of serious 
illness. In this model the medical profession are seen to have the expertise to cure all 
problems. This image is also reflected by the media both in newspapers and in television 
in programmes like Tomorrow's World (Murrell 1987). Furthermore it is an image 
adopted by such disease-related voluntary organisations as the Haemophilia Society 
(Madhok et al 1991) and the Kidney Patients Association (see Outlook 1984) in their 
bulletins to members as well as for use in fund raising. 
Murrell (1987) argued that programmes such as Tomorrow's World are not neutral 
windows through which science can be viewed but that they impose approving glosses on 
explanations which constructs an image of -an autonomous science which naturalises the 
'impartiality' and, in a material sense, the inevitability of the consequences of 'scientific 
progress'- (Pl00). 
Moscovici and Hewstone (1983) suggested that this message that proclaims how 
wonderful science is gives people second hand knowledge which fulflls a psychological 
need. These authors suggest that biomedical theorization which promises effective cure 
and turns illness into disease gives a sense of safety as well a fulfllling the desire to know 
of the cause and the suitable treatment advised for a particular illness. 
Stainton Rogers (1991) suggests that an implication of this interpretation is that it 
can increase dependency and an unwillingness to assume responsibility, since from this 
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perspective -medicine is seen as able to patch people back together after they become ill, 
making preventive actions unnecessary- (p 21O). 
Another consequence of this view of modem medicine is that the expectations of 
the public are likely to be raised, with the resulting increase in demand for more 
expensive treatments. This in tum puts very considerable financial pressure on health 
services. Currently policy makers in the United Kingdom and in other western countries 
have been forced to develop principles for prudent health care allocation. For example the 
Oregon Experiment (Lansdown 1992) has attempted to develop a system, based on the 
views of the public of which health services should be available, and, therefore, to 
prioritise resources for medical care by rational rationing. This idea has created very great 
interest and controversy. In the United Kingdom there have been recent changes in the 
organisation of health services with the introduction of general practitioner (GP) Fund 
Holding Budgets and the adoption of trust status by certain hospitals. There has been 
considerable focus on the cost of the service. A result is that some patients are seen as 
being expensive and because of this may not be accepted as patients by GP practices 
(patients Association 1992). 
It is not known whether such financial restraints will alter the common expectation 
of patients that something can be done for them and that they can be cured, thus negating 
the need for the patient to take responsibility for his health and to take appropriate 
preventive action. This point was emphasised by Ehrenreich and Ehrenreich (1978) in 
their comment that these unrealistic expectations of what the medical profession can do 
has led to the inability of (North) American medicine to deal adequately with problems 
that require the patient's willed participation in the cure. 
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5.7 CONCEPTS OF RLNESS AS S11GMA11SING 
Chronic illness can also be stigmatising. Goffman (1968) describes some of the 
consequences of the stigma (Pp5-6): 
-The individual who might have been received easily into ordinary social 
intercourse possesses a trait that can obtrude itself upon attention and turn 
those of us whom he meets away from him, breaking the claim that his 
other attributes have on us. He possesses a stigma, an undesired 
differentness from what we anticipated - we believe the person with a 
stigma is not quite human. On this assumption we exercise varieties of 
discrimination, through which we effectively, if often unthinkingly, reduce 
his life chances. We construct a stigma theory, an ideology to explain his 
inferiority ••• We tend to impute a wide range of imperfections on the basis 
of the original one •.• Further, we may perceive his defensive response to 
his situation as a direct expression of his defect.-
The visibility of symptoms has long been noted as important in this context. For 
example MacGregor (1951) describes the problem in the following way (Pp629-630): 
-Except when the disfigurement is accompanied by a functional impairment 
such as harelip with cleft palate, these facially deformed individuals do not 
necessarily suffer from organic or functional inability to perform the 
normal activities of daily living. Nevertheless they are handicapped because 
of the way they look. The twisted mouth, the conspicuous port wine stain 
or the peculiarly shaped nose may well be a barrier to the privileges and 
opportunities available to the non handicapped. Such an affliction, 
therefore, is more of a social handicap than a physical one for the suffering 
of the individual results from the visibility of the defect and what it means 
to others as well as to himself. -
In her study of rectal cancer, MacDonald (1988) found that there was a high 
degree of perceived stigma in patients who had been treated for rectal cancer by 
colostomy. However patients with rectal cancer who did not have a colostomy also felt 
stigmatized and this Macdonald attributed to the stigma of cancer. 
The stigmatising effect of illness has implications not only for the affected person 
but also for others close to them. Burton (1975) describes the implications for parents and 
non-affected siblings of having a child in the family with cystic fibrosis. And Voysey 
(1975), in a perceptive analysis of parents' responses to having a disabled child, showed 
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how parents attempt to make normal, and in doing so to compensate for, the stigma 
associated with disability. 
5.8 GENE11C IDEN'I1TY AND DISEASE 
A strongly held belief in modem medicine is that the earliest diagnosis of a 
condition is the most desirable so that appropriate treatment can begin. Early diagnosis 
of a disease such as APKD, where symptoms develop later, raises questions about how 
this asymptomatic person is perceived. Will this asymptomatic person be 'classified' as 
having a disease even though they have no symptoms and will they have to face early 
medica1isation of daily life. 
Nelldn and Tancredi (1989) describe early diagnosis of a presymptomatic illness 
as 'diagnostic labelling' (P169), and suggest that once a person is labelled as having a 
specific condition, even though they show no symptoms, the way is open to 
discrimination, stigmatisation and vulnerability. This suggests that the situation for the 
asymptomatic carrier would be similar to the situation where someone is already showing 
symptoms of the illness. The problem for asymptomatic persons is that it may be several 
years before they develop symptoms of the particular illness and, according to Natowicz 
et a1 (1992), such patients are prone to what they call 'genetic discrimination', in 
particular by insurance companies and by employers (p465). 
Authors such as Mennie et a1 (1990) and Wexler et a1 (1985), writing about the 
predictive test for Huntington's Disease (Chorea) prior to the use of the test, commented 
on the benefits for those who would receive results which reduced their risk of 
Huntington's Disease. Huggins et al (1992) describing the Canadian experience in the use 
of the predictive test in Huntington's Disease found that 10% of the patients who learned 
that they had a decreased risk experienced great difficulties in coping with this altered risk 
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statuS. Genetic counsellors had assumed that patients would be relieved to receive a risk 
reduced, in this study, from SO % to 11 %. The perception of the patients was different. 
An explanation offered by Chapman (1992) was that the patients described by Huggins 
used their risk status as a 'crutch' on which to place or blame some problems they were 
facing. 
In this chapter different lay percePtions of health and illness have been explored, 
including perceptions of chronic illness, seriousness of illness and of genetic identity. Not 
all of the studies referred to may appear relevant to the study of genetic counselling in 
APKD. But together they form an appropriate framework which may help to explain 
patients' attitudes to APKD. Specific studies are referred to throughout the thesis. 
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6.1 BACKGROUND TO mE S1UDY 
In Iune 1982 a study of patients with APKD began in the Renal Unit of Glasgow 
Royal Infirmary (GRI). Professor Arthur Kennedy head of the Renal Unit and Muirhead 
Professor of Medicine, University of GlaSgow, had had a long-standing interest in APKD 
and supported the establishment of the study which was initially funded by a grant from 
the National Kidney Research Foundation. 
The objectives of this study were to assess the medical and psychological problems 
of the population, to determine the total number of patients with APKD attending GRI, 
and to determine the extent of the at risk population with a view to planning a genetic 
counselling service for patients with APKD and a screening and counselling service for 
those at risk of developing APKD. 
Approval for this study was given by the Ethical Committee of GR!. 
A secondary purpose of the study was to collect data for this doctoral thesis which 
would investigate the patient's knowledge, perceptions and understanding of genetic 
counselling in APKD. 
6.2 WHERE mE S1UDY WAS CARRIED our 
6.2.1 The Renal Unit 
The study was carried out at the Tenovus Kidney Unit, also referred to as the 
Renal Unit, GRI. The Renal Unit was spread over three sites and consisted of an eight 
bedded 'admission' and diagnostic ward which was closed at the weekends, laboratory, 
secretarial facilities, consulting rooms and seminar room on one site. The haemodialysis 
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ward with ten dialysis units and the CAPD unit were on another site. And there was an 
acute six bedded renal ward in another part of the hospital. 
The Renal Unit at GR! is a major renal referral centre and patients came to the 
hospital from all areas of the city of Glasgow as well as from other parts of the West, 
South West and Central Scotland. The Renal Unit at GR! offered diagnosis and treatment 
for patients with APKD including hospital haemodialysis and Continuous Ambulatory 
Peritoneal Dialysis (CAPD). Patients were transferred to the Western InflI1l1ary for a 
kidney transplant and to Stobhill Hospital for home ·haemodialysis. 
6.2.2 Starr 
At the beginning of the study, there were three full time consultants, Dr Marjorie 
Allison, Dr Michael Boulton-lones and Dr lim Dobie (who left during the study), one 
senior registrar, Dr lain Henderson, and two registrars who also changed during the 
study. In addition Professor Arthur Kennedy took a ward round once a week and retained 
a special interest in certain patients. There were two junior doctors attached to the Renal 
Unit and these changed every six months. 
There were five nursing sisters who rotated round the different sections of the 
Renal Unit. These senior nursing staff were assisted by staff nurses, state-enrolled nurses 
and some student nurses. 
Other relevant staff included a senior research scientist, Mrs Mary Smith, and a 
technician in the laboratory, a senior renal dietician, Miss Patricia Campbell, and two 
secretaries. A senior social worker in the hospital, Mr Bob Paisley, spent a part of his 
time servicing the Renal Unit. 
At the commencement of the study a senior house officer, Dr lohn Gribbon, was 
asked by Professor Kennedy to assist with the study. Dr Gribbon left during the first year 
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of the study and his place was taken by a registrar, Dr Keith Simpson, who remained with 
the study until the end. 
6.2.3 Location 
Glasgow Royal Infumary is situated at the east end of the centre of Glasgow in an 
area in which there has been considerable'demolition of inner city housing and rehousing 
of the population in peripheral housing estates. It is still considered a 'local' hospital by 
those who live nearby and it evokes considerable loyalty and affection. It has 976 beds 
and it is one of the two major teaching hospitals in Glasgow, the other being the Western 
Infirmary. Although some early parts of the hospital were built in the 18th century, the 
major part of it was built around 1900. A new section containing all the out-patient 
departments and some wards was opened in 1986. 
6.3 WHO WAS INCLUDED IN THE snJDV 
6.3.1 APKD patients at GRI 
At the beginning of this study there was no systematic system in GR! by which 
patients with Adult Polycystic Kidney Disease could be identified. There was neither a 
system where manual records of patients with a diagnosis of APKD could be easily 
identified nor was there yet in existence a hospital computerised system which could 
identify patients with APKD. Before the commencement of the study different members 
of the medical staff of the Renal Unit could identify at least 40 patients with a diagnosis 
of APKD; it was expected that more could be found. 
Professor Kennedy had, over the years, encouraged junior medical colleagues to 
collect data about APKD. However, there had been no consistent attempt to ascertain the 
numbers of patients with this illness. 
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6.3.2 Identification of the study population 
The first task was to identify patients with APKD. The three consultants in the 
Renal Unit were approached and their cooperation gained to carry out a study of patients 
with APKD. Permission was sought from the renal unit at the Western Infmnary and the 
home dialysis unit at Stobhill Hospital to contact former patients of GRl. 
Two methods of identifying patients for the study were used. The rust method 
identified patients retrospectively from the medical notes. A systematic search of medical 
notes of all patients attending renal clinics at GRl was made to identify those patients with 
a diagnosis of APKD. Case notes were examined both by the researcher and by the 
physician attached to the project. 
The criterion used to identify patients was a stated diagnosis of adult polycystic 
kidney disease confirmed by either intravenous pyelogram or ultrasonography. The criteria 
recommended for the confirmation of the diagnosis of APKD is the establishment of 
bilateral renal cysts either by IVP or by ultrasound and the presence of a positive family 
history. As on only a very few occasions was there evidence in the notes of attempts 
having been made to take a family history, it was necessary to rely on diagnostic 
evidence. 
The second method used to identify patients involved the cooperation of doctors 
to inform APKD patients of the study and to pass on the names of these patients when 
such patients with APKD came to the attention of doctors at an out-patient clinic or when 
they were admitted to hospital as in-patients. Iunior doctors were also informed of the 
study and their cooperation sought. 
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6.3.3 Location of patients' Dotes 
Prior to the beginning of this study patients' medical notes had been kept in the 
Renal Unit. At the beginning of the study a system to centralise patients' medical notes 
in the Medical Records Department began, making it difficult to identify renal patients, 
since medical records were classified by patient number and not by clinic or department 
attended or by disease. The process of keeping track of notes was extremely time-
consuming as notes moved between the Renal Unit, clinics and wards, medical records, 
central typing pool, Renal Unit secretaries and individual doctors. Furthermore, where 
renal patient notes were kept depended upon which clinic the patient had attended. It was 
therefore decided that the notes of patients with APKD should continue to be retained in 
the Renal Unit regardless of which clinic they had attended. The cooperation of Renal 
Unit secretarial staff, medical records clerical staff and doctors was sought. 
6.3.4 ProCessional collaboration 
Informal talks were given at departmental staff meetings in the Renal Unit which 
were attended by many Renal Unit staff including doctors, nurses, dietician, laboratory 
and social work staff. An objective of these talks was to inform Renal Unit staff of the 
aims of the study and to gain their interest and support. All the consultants gave the names 
of patients with APKD as did both the senior laboratory scientist and the renal dietician. 
As the study developed, the opportunity was taken to inform Renal Unit staff of the 
progress of the study as well as to tell new staff about the study and its aims. Draft 
questionnaires were shown to staff for comment. In addition as the study developed 
invitations to talk to staff of other departments including radiography and urology were 
accepted, with the intention of increasing knowledge of the study and possible future 
referral to the Renal Unit of patients with APKD. 
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The researcher attended the major renal out-patient clinic every week and spent 
time explaining the study to out-patient nursing staff. Lectures were given to nursing staff 
in the School of Nursing, on issues surrounding the early detection of genetic disease and 
the social and psychological problems associated with chronic illness. 
In addition the opportunity was taken to talk to members of the local Kidney 
Patients' Association about the study and 'its progress. 
6.3.5 Study population 
As it was not known how many patients with APKD there were, it was decided 
to invite all patients with a diagnosis of APKD who were attending the Tenovus Kidney 
Unit GR! to assist with a project to determine the total number of affected patients and 
the extent of the at risk population, with a view to developing a genetic counselling 
service and a screening programme for at risk relatives. Patients were approached by 
letter and offered an appointment to attend a special clinic established at the Tenovus 
Kidney Unit. For the duration of the study patients would attend this special clinic and 
those current patients of GR! would cease to attend the renal out-patient clinics for the 
duration of the study. In order to reduce travelling time and expense for the patient, 
appointments were offered when the patient would be due to attend an out-patient clinic. 
It had been intended at the outset of the investigation that a specific time would be 
set aside when the designated physician would be seeing patients. This proved to be 
impractical. Both the doctors allocated to assist with the study were junior and were not 
allocated nor able to negotiate specific time to service this clinic. Furthermore the time 
for the medical consultation was relatively short in comparison with the time required to 
conduct the study interviews for which one to one and a half hours was required. 
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Following discussions with Professor Kennedy and all consultants in the Renal 
Unit, it was decided that it was desirable that study patients should attend a special clinic 
at the Renal Unit and that patients would be seen by the doctor allocated to the study or 
by another renal physician. It was the responsibility of the researcher to make 
arrangements for the medical consultation. 
Patients with the following criteria were included in the study: 
(1) patients with a stated diagnosis of APKD in their notes who were 
currently attending the Renal Unit at OR!; 
(2) patients with a stated diagnosis of APKD who had formerly 
attended the Renal Unit at GR! and who had been transferred to the 
Western Infirmary for kidney transplant; 
(3) patients with a stated diagnosis of APKD who had formerly 
attended the Renal Unit at GR! and who had been transferred to 
Stobhill Hospital for home haemodialysis treatment. 
The reasons for including patients in this way were to have patients at each stage 
of APKD including asymptomatic patients, those with mild symptoms, those in end stage 
renal failure, those being treated with hospital haemodialysis, home haemodialysis, CAPO 
and those who had had a transplant, as well as to determine the extent of the at risk 
population. 
Patients were excluded from the study if they were in the terminal stages of illness 
or if it was known that there was some major problem which made attending the hospital 
difficult. These proved also to be reasons why patients dropped out during the course of 
the study. 
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Each patient was assigned a study number and added to a master list in alphabetical 
order. Records were kept in a locked filing cabinet in a consulting room, which was 
primarily used for the study, in the Renal Unit. 
As it was not known how many patients with APKD there were and as it was 
anticipated that numbers might drop through illness or death, the initial target was to 
accrue all patients until 100 people with APKD had been included. In the event fewer than 
this were identified in the time allocated to the study. 
6.4 METHODS OF DATA COLLEC1l0N 
6.4.1 Interviews and questionnaires 
The nature of the subject under investigation, a genetic disease, genetic counselling 
and the patient's understanding and perception of these topics, required an extremely 
sensitive approach to data collecting. There is some evidence that respondents may answer 
questions of a personal or potentially embarrassing nature more willingly and accurately 
when not face to face with an interviewer whom they do not know well (Cannell and 
Fowler 1963). This would indicate the use in certain circumstances of self-administered 
questionnaires rather than interviews. This did not seem appropriate for the major data 
collection of this study. 
There were several reasons why the use of interviews rather than of self-
administered questionnaires was preferred. It was important to ensure confidentiality and 
to establish that the patient's name and address were accurate. Patients move house and 
one cannot rely on the accuracy of hospital records. In any family the same forename may 
be used by more than one family member. Furthermore in a study about a genetic disease 
it is likely that there will be patients with the same surname (and even the same 
forename), thus necessitating the need for great accuracy in diagnosis and record keeping. 
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6.4.2 Family history or pedigree 
Patients in whose notes the diagnosis of APKD was recorded and where this 
diagnosis had been confirmed by intravenous pyelogram (IVP) or ultrasonography were 
approached. According to Sahney et al (1983), an accurate diagnosis of APKD is 
confirmation by IVP or ultrasound of bilateral renal cysts and a positive family history. 
An examination of a few sets of notes showed that a family history was seldom taken or 
at least that there was no record of this having 'happened and this observation was 
confirmed by medical staff. Doctors who had worked in the Renal Unit for some time 
may have known several affected patients from one family. Comments such as 'Mrs 
Brown's sister' might appear in the notes, but a detailed pedigree was seldom included. 
It was essential, therefore, to interview patients to develop a pedigree both to 
confirm the accuracy of the diagnosis and to assess the numbers of relatives at risk of 
developing APKD. In addition, the accuracy of the diagnosis had to be determined before 
asking detailed questions about the patient's understanding of the genetic implications of 
APKD and questions about genetic counselling. 
Furthermore, it was felt that the process of developing a family pedigree could be 
distressing for some patients as they realised the number of people in their family who had 
APKD or who had possibly died as a result of APKD. It seemed therefore, important that 
this information was collected in the presence of the patient. 
The development of a pedigree was started in the rust interview. All patients were 
willing to cooperate. As some patients knew very little about their ancestors and their 
cause of death, the family pedigree could take some time to complete. Many patients 
became extremely interested in tracing their family history and presented large family 
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trees in some cases going back as far as the 17th century. In these cases, however, the 
cause of death was usually not known. 
A strong family history where there are sibs, cousins and offspring affected by 
APKD could have an effect on the way in which patients answered certain questions and 
on the way they perceived APKD. A grading was given to the pedigrees so that the family 
history could be used as a variable in the analysis of the data. How this grading was 
constructed is described in Section 9.12. 
6.4.3 Type of interview 
A major advantage of interviews is their flexibility. It is possible to probe for more 
specific answers and questions can be repeated when the response indicates that the 
respondent has not understood the question. In the interview it is possible to control the 
order in which questions are answered and to ensure that all questions are answered, or, 
if appropriate, omitted. The interviewer can observe body language and respond 
appropriately (Bailey 1987). In the interview it is possible to use language that is 
understandable to and part of the frame of reference of the person being interviewed 
(patton 1980). 
It was probable that some patients would find talking about APKD and about 
relatives who had already died from APKD distressing. A formal or structured interview 
with the need to ask each question as it is worded (Judd, Smith and Kidder 1991) was 
therefore considered inappropriate. 
A less structured interview, similar to the personal history interview described by 
Selltiz (1976) was chosen. Each interview would have a theme and a questionnaire would 
be designed to reflect that subject. The importance of this type of interview is that the 
questions do not need to be asked in the order that they appear in the questionnaire. There 
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is flexibility in that the interviewer can probe. The chief function of a probe is to lead the 
respondent to answer more fully or more accurately. Another function of a probe is to 
enable the interviewer to ensure that all relevant topics have been covered, or not, as 
appropriate, as well as to structure the answers. There are a variety of ways of probing 
including repeating the question, repeating the answer, indicating interest and 
understanding and pausing (University of'Michigan 1969). 
This type of interview provides a framework within which respondents can express 
their own understandings in their own terms (patton 1980 p20S). Genetics is a complex 
subject which some patients may have difficulty in comprehending. Questions which use 
the respondent's own language are the questions which are most likely to be clear to the 
respondent. The type of interview model adopted needed to allow a degree of flexibility 
for the investigator in order to maximise comprehension by the respondent. The flexibility 
of these semi-structured interviews allows for a full exploration of unanticipated factors. 
This may mean that different questions are asked of different patients and may cause 
problems when comparing data. It is arguable that this type of interviewing may introduce 
more bias than for example a highly structured interview. Gorden (1969) suggested that 
it may be necessary to return to a topic on several occasions within one interview to 
enable respondents to remember. Gorden is referring to respondents who may have 
memory failure. Memory failure may also be a problem for some people with uraemia. 
However it is possible that the subject matter of this study may be distressing. In these 
circumstances respondents who felt hurried by a highly structured interview may be unable 
to remember accurately. It is arguable that the unstructured interview is less stressful for 
respondents than the highly structured interview where respondents may feel the urgency 
to move on to the next question. 
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6.4.4 Procedure for inteniewing 
All interviews were to be carried out by the one researcher, myself. From previous 
experience of interviewing patients with serious genetic diseases in the Genetic Register 
System Acceptability Study (subsequently referred to as the Acceptability Study, Wilkie 
and Sinclair 1977), I appreciated the sensitivity of the subject matter for the patient. I also 
anticipated that the study interview might be the first occasion or the first formal occasion 
when the patient had an opportunity to talk about APKD in detail as well as its genetic 
transmission. I believed that having sufficient time and a quiet place to carry out the 
interview were important considerations for the success of the study. One and a half hours 
was allocated for each interview although it was calculated that the actual interview would 
take less than that time. A quiet consulting room through a double door off the main 
corridor of the Renal Unit was acquired for interviewing. The room was warm (some 
patients attended for interview when they were in-patients) and easy chairs were arranged 
in a comfortable manner. Occasionally the interview was interrupted when medical staff 
felt that the room was needed by them to see a patient. 
I had learned from the Acceptability Study that patients may disclose information 
that they did not wish discussed with anyone else. Patients were therefore reassured at the 
beginning of the study that any information that they gave was confidential to the study 
and that any publication that resulted from the study would not be able to identify 
individual patients. Patients were also reassured that any information gained during an 
interview would not be discussed with Renal Unit staff unless with the express permission 
of the patient. I realised that difficulties could arise with staff, in particular medical staff, 
who might wish information about particular patients and who believed that either the 
researcher had information or that the researcher could get particular information. 
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Nevertheless, I believed that it was crucial to maintain the confidentiality of patients and 
their trust. 
I was aware of the importance of developing a rapport with the patient of the 
manner in which the study was introduced to the patients and of creating a non-judgmental 
atmosphere in which the patient felt secure. 
As a trained counsellor, I was' familiar with the need to promote a good 
relationship and to show empathy, openness and acceptance. Within the interview, the 
skills of probing, reflection, clarification and summarising (Nelson-lones 1982) were used. 
6.4.5 Tape recordin2 of interview 
The form of interviewing adopted for this study requires very considerable 
concentration on the part of the interviewer. The social process of the interview is 
important, particularly the way in which the interviewer interacts with the patient. It was 
also felt that to give full attention to the person being interviewed was important and this 
militates against constant note talcing. It seemed appropriate to consider tape recording all 
interviews so that recording and transcription of data could be done at a later date. It was 
explained to the patient prior to the beginning of the interview that tape recording enabled 
the interviewer to concentrate on what was being said and to fill in the questionnaire 
accurately. The permission of the patients to record the interview was sought. In addition 
patients were reassured that the tape would only be used for this purpose and would be 
erased when data had been transcribed. 
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6.5 DATA VERmCAnON AND PROCESSING 
6.5.1 Reliability and validity 
Reliability is defmed as the ability of the data gathering instrument to obtain 
consistent results (Oppenheimer 1972). One measure of reliability used was to compare 
information collected from different sources, for example the demographic information 
collected in the first interview and the information in the medical notes. It is recognised 
that hospital records are not always accurate. When there were inconsistencies between 
the study interview and the patient's medical records, the patient was asked again at the 
next interview. 
Within each questionnaire there was an internal check on consistency by repeating 
certain questions in a slightly different form. For example in Questionnaire 1, Section S, 
questions 4 and 8 asked for the same information in a different way. 
Questions were also repeated over time. For example section 8 in questionnaire 1 
on problems associated with APKD was repeated in questionnaire 3. Similarly the section 
on factors considered important in genetic counselling, section 3, questionnaire 2, was 
repeated in questionnaire 3. 
Validity is concerned with the extent to which the instrument actually measures 
what it sets out to measure. Content validity was assessed in a number of ways. Previous 
experience on the Acceptability Study, knowledge of work in genetic counselling in 
Haemophilia, knowledge gained from a literature review and my experience of working 
in a voluntary capacity with families with Huntington's Chorea identified the major areas 
of investigation. Prior to the beginning of the study, a small pilot study was carried out 
to ascertain the validity for renal patients of the social and medical questions. Content 
validity was exposed to peer and interdisciplinary review. Draft and fmal questionnaires 
were circulated to Renal Unit colleagues for comment. 
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6.5.2 Interviewer bias 
All the interviews were carried out by the one researcher. Skill was used in asking 
questions and listening objectively. Listening included observing and sensing generally and 
was not limited to the aural modality. Care was taken to hear the exact words used by the 
patient as it was appreciated that terminology could reflect an important orientation (Yin 
1984). The researcher was assisted by being able to listen again to the interview on tape. 
It is understood that, however skilful the interviewer is, there will always be the 
possibility of some interview bias. 
6.5.3 Data processing 
All the interview schedules were coded. Some of the coding was done by two 
research assistants from Stirling University. All coding was then checked by the 
researcher. Analysis of the data was initially carried out using SPSS, and later by using 
ad hoc programmes specially written for this an~ysis; some of the statistical calculations 
were carried out using GLIM. 
6.6 THE INI'ERVIEWS: CONTENT AND QUESTIONNAIRES 
The study involved three separate interviews with each patient. Each interview 
lasted approximately 1-llh hours and was for the majority of the study carried out in a 
quiet consulting room dedicated to the study. At the beginning of the study no room had 
been allocated for this work and some early interviews were conducted wherever a quiet 
comer could be found. This was very unsatisfactory for both the patient and the 
interviewer. 
On a very few occasions when the patient was an in-patient and immobile, the 
interview was carried out behind screens at the bedside. 
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The data used for this thesis is taken from each of these questionnaires. Not all the 
questions asked were central to the subject of the thesis and were therefore not used in the 
analysis. 
Each of the three interviews was structured around a written questionnaire which 
was later f11led in by the researcher with the aid of the tape recordings. The content of the 
three questionnaires is now described. Copies of the forms appear in Appendix A. 
6.6.1 Interview 1 and questionnaire 1 
During the fll'st interview, the first task was to establish accurate demographic 
information to identify the patient. This included current and previous surnames and in 
the case of married women their maiden name. 
The patients age, sex and marital status were recorded and also the number of both 
live and deceased children and adopted children. This information was necessary to 
develop a family pedigree. An accurate family pedigree is essential to confirm the 
diagnosis in genetic disorders. 
In Section 2 questions were asked about age on leaving school, qualifications 
obtained at school and since leaving school and the educational qualifications of father and 
spouse. This information along with some information from section 3 would be used to 
identify the educational level of the patient and their parent. Educational level might be 
an important independent variable in the analysis of the data. Furthermore there is some 
evidence (paterson and Inglis 1975) that the presence of chronic illness in the family may 
result in downward social mobility. The employment of father was asked as a guide for 
comparison. 
In Section 3 the focus was on occupation and employment. There is evidence 
(fownsend 1979) of higher unemployment amongst those with chronic illness. A person's 
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employment history, their difficulties in getting work and the degree of unemployment 
may influence that person's attitude to the particular illness. Respondents were asked the 
name of their current employment and to describe what they did. Details of previous 
employment history, length of time in the post and reason for leaving were asked. Those 
unemployed were asked the length of time since last employment and the reason for 
unemployment; those in employment were asked whether their employer knew about their 
condition. 
Section 4 was concerned with housing. Questions were asked about the type of 
accommodation, whether it was privately owned or rented and whether the accommodation 
was a house or a flat. These questions were asked as it is known that housing is a good 
indicator of income and it was felt that the type of housing occupied by the patient added 
to the qualitative description of the population. 
In Section 5 questions about the patient's knowledge of the inheritance and 
transmission of APKD were asked. Respondents were asked to describe how they got the 
condition and whether it ran in the family. They were asked whether the condition was 
inherited and whether it could be passed on to children. 
This was the first set of questions to ascertain the respondent's knowledge of the 
genetic nature of APKD. 
Section 6 focused on knowledge of the disorder and treatment available. 
Respondents were asked when they were first diagnosed as having APKD, and what 
treatment, if any, they were currently having. Respondents were also asked if they knew 
what forms of treatment were available. 
There were ten questions in Sections S and 6 relating to the patients's knowledge 
of APKD. The answers to these knowledge questions have been grouped together and the 
results scored in terms of accuracy of knowledge. 
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Respondents were asked when they fmt learned about APKD and what they were 
told about the condition. Patient case notes were examined for reference to the information 
given to the patient. 
Section 7 was concerned with social and statutory support. Patients were asked 
about the main source of their income, whether they got help with rent and rates and 
whether they received any form of disability allowance. Respondents were asked what sort 
of transport they normally used, whether they received a mobility allowance and how they 
got to hospital. In this section there were also questions about contact with general 
practitioners and other members of the community health team and questions about life 
insurance. 
The questions in this section were asked in order to be able to describe the effect 
of APKD on the study population. 
Although section 7 may appear to be logically out of sequence it was desirable to 
move back to factual questions to take the patient's mind away from the genetic questions 
in section 6. 
Section 8 was concerned with problems that could be associated with kidney 
disease. It was designed to be self-administered, i.e. completed by the patient, but often 
the researcher assisted the patient in completing it. Respondents were asked to identify on 
a six-point scale how problematic certain issues were for the person affected by APKD. 
The questions covered areas such as physical problems often associated with severe kidney 
disease, the genetic nature of the disease, fmancial issues associated with chronic illness, 
any restrictions on physical and social activity that may be attributed to chronic illness and 
whether APKD has an effect on family life and sexual relationships. It was hoped that 
answers to these questions would give some indication as to the focus or content of future 
genetic counselling. 
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6.6.2 Interview 2 and questIonnaire 2 
Section 1 of the second interview and questionnaire was concerned with the 
respondent's experience of genetic counselling. Genetic counselling was defmed as a 
discussion about the inheritance of APKD, the effect on the patient and their children and 
about what they can do about it. 
Questions were asked about whether the patient had received counselling and if so 
how had this been arranged. As a test of consistency the patients' experience of 
counselling was compared with what they reported they had been told in questionnaire 1. 
Patients were asked to identify which topics from a list of topics that could be included 
in genetic counselling had been discussed with them. The topics chosen were those seen 
as important in other studies of genetic counselling. Respondents were also asked how 
often they had discussions about the inheritance of APKD and its effect on them and their 
family, whether other members of the family were involved and whether they had taken 
any decisions as a result of genetic counselling. 
Section 2 was concerned with attitudes to genetic counselling. Questions were 
asked about whether knowledge of APKD had affected the number of children they had 
or wanted to have. Respondents were asked whether at risk relatives should be told of 
their risk and whether they thought that at risk relatives should be tested for APKD. They 
were asked whether their children should be screened and at what age people should be 
screened for APKD. Respondents were asked how helpful genetic counselling was in 
relieving stress and anxiety, in giving information about the risk of inheritance, in helping 
to decide whether to have a family, in giving information about the symptoms of APKD 
and in giving information about the available treatment. Patients were also asked what sort 
of person, OP, social worker, nurse, doctor in renal unit or specialist genetic counsellor 
should give genetic counselling. 
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In Section 3 respondents were asked to rank on a six-point scale how important 
were topics that could be included in a genetic counselling consultation about APKD, its 
inheritance and its effect on the patient and their family. These topics included the risk 
of transmission of APKD, the advantages and the disadvantages of testing for APKD, how 
to tell those at risk, possibility of adoption, fostering, voluntary childlessness, deciding 
to have no more children, available family planning methods, sterilisation, vasectomy, 
Artificial Insemination by Donor (A.I.D.), the prevention of APKD and telling partners 
and in-laws that there was an inherited disorder in the family, and information about the 
symptoms and the treatment available. 
6.6.3 Interview 3 and questionnaire 3 
The third questionnaire began in Section 1 with further rather general questions 
about the patients' knowledge of APKD, including the problems of it, how it is acquired 
and discovered and how it can be prevented. 
In Section 2 respondents were asked questions about how many children they had 
and how many they would like, about whether they would like grandchildren, and about 
whether APKD had affected their ideas about children. 
Section 3 contained questions to elicit the patients' opinions of presymptomatic 
screening and testing at risk relatives and the children of those affected, the advantages 
and disadvantages of testing, and their views on the ownership of genetic. Section 4 went 
on to the consequences of APKD on the patients, and the effect it had had on their lives. 
Section 5 contained detailed questions about the inheritance and transmission of 
APKD and the risks involved, in a precise 'multiple choice' form. Section 6 covered 
detailed knowledge of the symptoms and treatment of APKD. 
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In Section 7 respondents were asked to complete again a section on problems 
associated with kidney disease previously asked during the fIrst interview. This was done 
because the condition of many of the patients had deteriorated quite considerably over the 
course of the study as well as to test for consistency. 
In Section 8 respondents were asked to complete again the section previously 
completed in the second interview on topics that could be included in any genetic 
counselling consultation. 
6.7 DATA FROM MEDICAL RECORDS 
6.7.1 Medical data 
There was no systematic collection of medical data about patients with APKD in 
GRI. There had been two major studies of APKD, Dalgaard in 1957 and De Bono and 
Evans in 1977. There was no reason to believe that there would be any signifIcant 
differences in this population. It is possible that the degree of severity of a genetic illness 
could influence patients' attitudes to screening and prevention of that illness (Ekwo et al 
1987). It was decided to collect medical information in order also to assess the severity 
of illness in the patient. Medical information was collected about the date of fust 
diagnosis, family history, stage of illness and treatment. This information was taken from 
medical notes in order to establish a detailed proflle of the patient and to confIrm 
consistency of data. 
Medical information about each respondent was collected from the medical notes. 
Information was collected about symptoms, treatment including drugs, the method and 
date of diagnosis of diagnosis and genetic information. 
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6.7.2 Symptoms 
Information was collected about loin pain, haematuria, urinary tract infection, 
hiatus hernia, duodenal ulcer, subarachnoid haemorrhage. Blood pressure and creatinine 
clearance levels were recorded from the time of diagnosis to date. 
6.7.3 1rreatnnent 
The information recorded about treatment included diet, whether the patient was 
on diet and or fluid restriction, whether they were'receiving dialysis and what type of 
dialysis, and whether they had had a transplant. The type of drug treatment was recorded 
under the headings of antihypertensive therapy and pain killers. The date when diagnosis 
was first confirmed and the diagnostic method for confmnation of diagnosis were 
recorded. 
6.7.4 Genetic infonnation 
Genetic information is part of the medical information about APKD and evidence 
of a positive family history was sought from the records including the sex of the affected 
parent, age of parent when parent started dialysis and age of parent's death. The number 
of affected and at risk children was recorded. When available, information about affected 
sibs was recorded as well as deaths in the family attributed to APKD. Early in the study 
it became clear that the availability in the medical notes of this genetic information was 
very erratic. Frequently there was no genetic information recorded for individual patients. 
Furthermore when information was recorded, it appeared to be inconsistent with 
information given by the patients in the research interview. It was therefore decided to use 
the information from the family trees made during the research interviews, to develop a 
family history grade, as described in Sections 6.7.4 and 9.12. 
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7.1 INTRODUcnON 
In this short chapter, the numbers of patients who were interviewed at each stage 
of the study are identified, so that the 'populations' considered in the later analyses are 
made clear. 
7.2 PATIENTS CONSIDERED FOR 1BE S11JDY 
During the period from July 1982 to May 1983 all patients with a diagnosis of 
APKD who were registered or came to be registered at the renal clinic of Glasgow Royal 
Infirmary were initially included in the study. Although the original intention had been to 
accrue 100 patients to the study, only 83 patients (50 female and 33 male) with a 
diagnosis of APKD could be identified from the medical notes or came fresh to the clinic. 
Of these 83: 
7 (2 females, 5 males) were found to have died before being 
interviewed, 
1 (female) had emigrated before the beginning of the study, and 
4 (3 females, 1 male) declined to cooperate in the study, 
leaving 71 patients. Of the 4 patients who declined to cooperate the male replied that he 
had multiple social problems and did not wish to cooperate in the immediate future, two 
females replied that they were infmn and housebound, and the third female gave no 
explanation. 
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7.3 THE nRST POPULATION 
A total of71 patients (44 females and 27 males) were interviewed at the first stage 
of the inquiry and these are described as 'the first population', included in the analysis of 
QuestioMaire 1. These interviews were carried out at a special clinic established at the 
Tenovus Kidney Unit, Glasgow Royal Infmnary between the summer of 1982 and the 
spring of 1983. 
7.4 THE SECOND POPULATION 
A second interview for each of these 71 patients was arranged at the end of the 
frrst interview and was made around a time when the medical profession would wish to 
see the patient again, approximately 3 months after the first interview. Only 65 (40 
females and 25 males) of the original 71 were included in this interview, at which 
Questionnaire 2 was completed. The six who dropped out included: 
3 (2 females, 1 male) who had died, 
1 (female) who was now too ill to be interviewed, 
1 (female) who was found not to be affected with APKD, and 
1 (male) who had moved to another district. 
Those included in the second interview are described as 'the second population', 
and are included in the analysis of Questionnaire 2. These interviews were carried out 
between March 1983 and November 1983. 
7.5 THE THIRD POPULATION 
A third interview for each of these 65 patients was arranged approximately six 
months after the second interview. As with the second interview, patients were asked to 
return for the third interview around the time when the medical profession would wish 
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to see them again. Only 47 (32 females and 15 males) of the 65 in the second population 
were included in this 'third population'. The 18 who dropped out included: 
5 (3 females, 2 males) who had died, 
2 (1 female, 1 male) who were now too ill to be interviewed, 
2 (males) for whom the journey to the interview was now too far, 
1 (female) who was pregnant and lived some distance away, 
5 (2 females, 3 males) who were found not to be affected with 
APKD, and 
3 (1 female, 2 males) who had moved to another district. 
These interviews were carried out between October 1983 and Apri11984. 
7 .6 HOSPITAL RECORDS 
The hospital medical records for each of the patients in the study were inspected, 
and details were extracted relating to their medical history and to their family history in 
relation to APKD. These hospital records were not always available or complete (see 
Section 6.7) and in respect of family history they did not always agree with the 
information obtained from the patients during the interviews. In particular the hospital 
records were not available for: 
12 who were not included in the rust population, 
6 (3 females, 3 males) who were found to be not affected by 
APKD, 
1 (female) who died before the second interview. 
Reasonably complete hospital records were therefore available for: 
64 (40 females, 24 males) out of 71 in the rust population, 
61 (38 females, 23 males) out of 6S in the second population, 
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all 47 (32 females, IS males) in the third population. 
From these records a grade of severity of illness for each patient was defmed, as 
described in Section 9.11. 
7.7 FAMILY TREES OR PEDIGREES 
During the series of interviews described above a family tree or pedigree for each 
patient was drawn up by the researcher. In some cases these interlocked with the family 
trees for other patients in the study. Partly as a result of this work certain patients were 
found to be not affected with APKD, there being no family history and no conclusive 
symptoms of the disease. From these family trees additional information about the extent 
of family history of the disease was derived, as described in Section 9.12. 
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RESPONSE AND EXPLANATORY VARIABLES 
8.1 INTRODUCI10N 
In attempting to understand what are the perceptions of patients with APKD to 
genetic counselling it is necessary to differentiate between two sets of variables which 
have been investigated and used in the analysis of the data, which is discussed in 
subsequent chapters. In accordance with statistical terminology, these can be describoo as 
'response variables' and 'explanatory variables'. Response variables contain the material 
which is of inherent interest for the study; explanatory variables consist of those which, 
not being of relevance in themselves, may help to explain variations in the response 
variables. 
The response variables in this study concern the following main areas of interest: 
experience of genetic counselling; 
knowledge of symptoms and treatment of APKD; 
knowledge of the inheritance of APKD; 
perceptions of problems that may be associated with APKD; 
screening and testing of at risk relatives; 
testing of at risk children; 
attitudes to having children; 
decisions taken as a result of genetic counselling; 
patients' perceptions of the importance of elements that could be included 
in genetic counselling. 
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These response variables are discussed in more detail below, followed by 
discussion of the second set of variables, the explanatory variables, which are mainly 
medical and demographic. 
8.2 EXPERIENCE OF GENE'IlC COUNSELLING 
One objective of this study was to ascertain the patients' experience of genetic 
counselling. The experience of genetic counselling covered questions not only about the 
content of the counselling that the patient had received but also questions concerned with 
the 'environment' of the genetic counselling. These questions focused on such areas as 
whether a special time had been set aside for the genetic counselling or whether genetic 
counselling had been given during a routine clinic visit, the number of occasions that the 
patient had received genetic counselling and whether the patient was alone or was 
accompanied by his or her partner, other relative or friend. 
The respondents in this study were very likely to have received their genetic 
counselling in the renal unit from renal physicians. It takes time to cover the important 
factual elements of genetic counselling as well as to have a discussion of any 
psychological issues that may be relevant. A national study of genetic counselling services 
by Sorenson et al (1981) in the United States found that the average length of time of a 
counselling session to be 45-60 minutes which, according to Griffin et al (1977), may not 
be sufficient. The timing of genetic counselling is also important. Evidence from studies 
such as Leonard et al (1972) suggested that if counselling was given too soon after the 
emotional shock of receiving a diagnosis, then respondents tended not to recall the 
information that had been given to them. 
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8.3 KNOWLEDGE OF SYMPTOMS AND TREATMENT OF APKD 
AND KNOWLEDGE OF 11IE GENE11C INIlERITANCE OF APKD 
Many studies into genetic counselling have assessed the patient's knowledge or the 
symptoms and the treatment for the disease being studied as well as the patient's 
knowledge and understanding or the genetics of the disease (Chapter 2). The success 
of genetic counselling was often measured by the amount of information about the disease 
and its transmission that the patient had retained post counselling (Chapter 2). However 
an understanding or the knowled2e of the disorder that the patient suffers from could 
be an important factor in how the patient perceives problems that may be caused by the 
illness and hence the patient's attitude to genetic counselling. In this study questions about 
the knowledge of inheritance and transmission were asked in questionnaire 1, section S, 
and in questionnaire 3, section S. In the analysis of the data, these questions were grouped 
together and subsequently referred to as knowledge of genetic inheritance. 
There are difficulties in assessing the knowledge of the symptoms of the disease. 
APKD is a disease of variable age of onset and has several symptoms. Not all patients 
experience all the symptoms. Questions about the knowledge of symptoms of APKD and 
the treatment available were asked in questionnaires 1 and 3. A knowledge score was 
developed and the degree of consistency of knowledge was assessed by comparing the 
results of the knowledge questions in questionnaires 1 and 3. 
8.4 PERCEPTION OF PROBLEMS ASSOCIAlm WITH APKD 
The perceived burden or the disease is often used to explain attitudes of patients 
to genetic counselling and to the decisions that they may take as a result of genetic 
counselling. However it is not clear what the factors are that influence patients in coming 
to a decision about whether or not the disease is a burden. It is not known how important 
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the genetic nature of the disease is in the patient's perception of the burden of the disease 
nor what is the importance of the physical symptoms or social implications of the illness. 
It is also possible that the patient's perceptions of the burden of APKD may not be the 
same as the perception of the burden as defined by medical or health care professionals. 
In order to assess the respondents' perceptions of the burden attributed to APKD, 
patients were asked to rank on a six point scale how problematic they perceived particular 
items to be. These items included certain medical problems associated with APKD, items 
concerned with income maintenance, items about the genetic implications of APKD and 
items about the effect that APKD may have on both social and sexual life. This section 
on the problems of APKD, which were asked twice in the study, gives some indication 
as to what patients perceive as problematic about APKD. 
8.5 SCREENING AND TESTING OF AT RISK RELA11VES 
Genetic diseases run in families but not all family members know of their risk. 
Contacting the at risk relatives through the source patient or consultand to offer them 
screening and genetic counselling is carried out by many departments of human genetics. 
It seems, therefore, relevant and important to assess the views of existing patients as to 
whether they think that their relatives should be tested for APKD. It is likely that when 
an illness can be effectively treated, patients would be happy to give the names of their 
relatives so that they could be offered the relevant screening test. However, in the case 
of APKD the treatment is only of the symptoms as they appear and it has not yet been 
conclusively demonstrated even that early treatment of hypertension in the otherwise 
asymptomatic patient with APKD will improve the overall morbidity of patients with 
APKD (Bear et al 1992). 
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There are many factors which could influence patients' views on testing those at 
risk. The severity of disorder as perceived by the individual, the stigma associated with 
the illness and the degree of knowledge of the illness in the extended family (the degree 
of family history) may all be relevant factors. On one hand the more severely affected 
the patient, the more important the patient may think it is for their relatives to know. On 
the other hand the patient may wish to protect the relative and may not wish to be the 
source of potentially unpleasant information. Knowledge and educational levels could also 
influence patients' views, since more knowledge and possibly higher educational levels 
could make people more aware of the disadvantages as well as the advantages of testing 
and hence make their decision more difficult. 
8.6 TESTING OF AT RISK CHILDREN 
It may be acceptable for patients to suggest that their at risk relatives, which would 
include sibs and cousins, should be tested for APKD. However it may be less acceptable 
for patients to recommend that their own children be tested as this could remind the 
patients that they may have transmitted APKD to their child and kindle or rekindle 
feelings of guilt. Since there is as yet no effective treatment for APKD it seemed 
important to ascertain at what age parents thought it appropriate for their offspring to be 
tested. 
8.7 ATITIUDES TO HAVING CHILDREN 
It was important to assess whether knowledge of APKD would influence 
respondents' attitudes to having children. For example, in a study by Sahney et at (1982) 
56 % of those asked said that they would not have had children had they known that they 
had APKD. This is similar to the fmdings of Zerres and Stephan (1986), who found that 
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46 % of a group of at risk and affected individuals would not have had children had they 
been aware of their status. The Sahney study was published before the commencement of 
the work for this thesis and the Zerres and Stephan study was published towards the end 
of the data collection for this investigation. In contrast to these two studies the more 
recent study of Sujansky et al (1990) found that only 18 % of their sample would not have 
had children had they been aware of their status, although 57 % of these patients 
considered the 50% risk of passing on the gene to be a high risk. Respondents in the 
present study were asked whether they had planned their children and whether APKD had 
affected their plans, and also how many children they would like to have and whether 
their knowledge of APKD had affected their view. 
8.8 DECISIONS TAKEN AS A RESULT OF GENE'IlC COUNSELLING 
Studies of genetic counselling often examine the decisions taken as a result of 
genetic counselling. It was known at the outset of this study that, while there had been 
no comprehensive genetic counselling system for patients with APKD, some patients had 
received some genetic counselling. Questions were asked about the reproductive decisions 
that patients had made as a result of genetic counselling. 
8.9 DEMOGRAPmC AND MEDICAL EXPLANATORY VAlUABLES 
Studies by social scientists and geneticists into the knowledge, perceptions and 
understanding of genetic diseases in general and APKD in particular have sought factors 
that may help explain how patients perceive the illness (Zerres and Stephan 1986, Harris 
1987) (See Chapter S). Factors that may affect patients' perceptions of APKD may include 
the demographic and medical variables collected in this study: sex, age, marital status, 
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number of children, education, occupation, housing, religion, severity of disease and 
family history. 
8.9.1 Sex 
Sex could be an important explanatory variable, particularly when examining 
patients' views of genetic counselling. It is not known whether the same information in 
genetic counselling is given to males and females. It is possible that counsellors may give 
more information about the prevention of an illness to female patients than to male 
patients because it is the female who has the children. On the other hand males and 
females may take different messages from the same information. It is also not known 
whether there is any difference in the information that males and females want from 
genetic counselling. 
8.9.2 Age 
The age of the patient may have an influence on their perceptions both of the 
disease and of genetic counselling. Younger patients are more likely to be asymptomatic 
themselves and because of their age may be less aware or less concerned about APKD 
related illness in older members of the family. Younger patients may show more 
knowledge of medical problems generally in keeping with their generation. In APKD older 
patients are more likely to be symptomatic as well as being more aware of any APKD 
related illness in the family. Older patients may also have a child who has already been 
diagnosed as having APKD or whom the parent fears may be affected or who has still to 
be tested. 
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8.9.3 Marital status and number of chlldren 
It is possible that marital status combined with whether the patient has had 
children and the number of children they have had may have an influence on attitudes 
to having children. The views of older single patients who have never had children may 
be different from those who have a family and do not intend to have more children and 
from younger patients who have not yet had children or completed their family. In 
addition the number of children that the patient has may be an important influence. 
8.9.4 Education 
The education of the patient could be an important influence on the amount of 
information and the knowledge of APKD that the patient has. Studies in other chronic 
illnesses such as haemophilia have pointed to the importance of good education which may 
lead to enhanced occupational opportunities and jobs that are more flexible and less 
physically demanding (Markova et al1980). Questions were asked about the age at leaving 
school, qualifications gained at school, and qualifications gained since leaving school. For 
the purpose of analysis each patient was classified into a particular 'educational level' . 
8.9.5 Occupation 
It is likely that the education of the patient would be related to their occupation. 
Each patient was asked questions about their current occupation, and also about their 
former occupations. Occupations were classified using an adaptation of the extended 
classification of occupations of the Registrar General for Scotland since this system gives 
a wide range of occupations as well as including the categories of unemployed, student, 
housewife and retired. This was considered a more sensitive tool for the classification of 
occupation in a chronic illness as compared with the more restrictive Registrar General's 
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Social class I-V. Also the interest was in the occupation that the respondent did rather than 
any social class classification. 
8.9.6 'Housing 
Data had been collected about housing tenure. It was decided to use this data as 
an explanatory variable as it is known that housing tenure can be a sensitive indicator. 
8.9.7 Religion 
The religion of the patients may influence attitudes to genetic counselling. Some 
studies have suggested that the religion of the patient may influence their attitude to 
genetic counselling. For example Forbes and Markova (1979) found that religion did not 
influence the attitudes of female carriers of haemophilia to genetic counselling. 
Mastromaura et al (1987) found that religious affiliation strongly dictated the use of 
prenatal diagnosis in their study of attitudes towards prenatal diagnosis in Huntington's 
disease. Sujansky et al (1990) found that religious affiliation did not appear to influence 
the views of patients and at risk relatives. Our sample contained catholics, protestants and 
those who said that they had no religion. 
8.9.8 Severity of lllness 
Some studies have indicated that the burden or severity of the illness as perceived 
by the patient may have a considerable influence on the patient's perception of the illness 
as well as their understanding of the illness and its wider implications. Little is known 
about the factors that may influence the patients' perception of the burden of the illness. 
For example Sujansky et all990 were surprised that the knowledge of the severity of the 
disorder in the family did not appear to influence the patients' desire for prenatal diagnosis 
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and termination of pregnancy. It is possible that the degree of illness or severity of illness 
in the individual patient may be an influencing factor. The severity of illness grading used 
in this analysis was based on the assessment of severity which reflected medical 
information taken from the patient's notes. 
8.9.9 Family history 
In a genetic disorder an influencing factor in the patient's perception of the burden 
of the disease may be the breadth or extent of the family history of APKD. In some cases 
the patient is a member of a family where there are several relatives with APKD as well 
as some whose death was attributed to APKD. It is possible that to be a member of a such 
family could be an important influence on the patient's perception of their illness or 
attitudes to other responses. 
137 
CHAPTER 9: DEMOGRAPmC AND MEDICAL EXPLANATORY VARIABLES 
9.1 DEMOGRAPmC INFORMA1l0N 
Demographic, social, education and occupational information for each patient was 
gathered during the rust interview. This information helped to establish the background 
of the population. Certain items from this information were selected as possible 
explanatory variables for the subsequent analysis of the answers to the questions of interest 
(the response variables). Details of the demographic items are described in this chapter, 
for each of the three populations as described in Chapter 7, i.e those who attended each 
of the three interviews. An analysis of the other demographic questions asked appears in 
Appendix B. 
Medical information was gathered from the hospital records for 64 out of the 71 
in the rust population. On the basis of this information an assessment of the current 
severity of the disease for each patient was made; this is described in Section 9.11. The 
medical information is described in detail in Appendix C. 
As each patient was interviewed a pedigree or family tree was drawn up. On the 
basis of this pedigree an assessment of the level of the family's experience of the disease, 
or family history was made; this is described in Section 9.12. 
9.2 SEX 
The numbers of males and females in each population are shown in Table 9.1. 
Nearly two thirds of the total were females (44 out of 71 in the rust population or 62 %) 
and about one third were males. 
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Table 9.1. 
Distribution of each population by sex. 
Population 1 Population 2 Population 3 
Sex Number % Number % Number % 
Females 44 62 40 62 32 68 
Males 27 38 25 38 15 32 
Total 71 65 47 
9.3 :MARrrAL STArns 
The marital status of all patients was identified and the numbers in each population 
of each marital status are shown in Table 9.2. 
Table 9.2. 
Distribution of each population by marital status. 
Population 1 Population 2 Population 3 
Marital status Number % Number % Number % 
Single 15 21 15 23 13 28 
Married 51 72, 46 71 31 66 
Widowed 3 4 2 3 2 4 
Divorced 1 1 1 2 1 2 
Separated 1 1 1 2 
Total 71 65 47 
The distribution of the first population by sex and by marital status is shown in 
Table 9.3. Almost all the males were married (23 out of 27 or 85 %), there being only one 
single, one divorced, one widowed and one separated. By contrast, almost one third of 
the females (14 out of 44 or 32%) were single, with two widowed and the rest (28) 
married. 
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Table 9.3. 
Distribution of first population by sex and by marital status. 
Marital status Female Male Total 
Single 
Married 
Widowed 
Divorced 
Separated 
Total 
14 
28 
2 
44 
1 
23 
1 
1 
1 
27 
15 
51 
3 
1 
1 
71 
The large groups are single females (14), married females (28) and married males 
(23). For subsequent analyses by sex and marital status it was found convenient to group 
all respondents into one of these three groups, including the two widows with the married 
females, and the four not married males (one of each status) with the married males. 
These groups are described as 'single females', 'married females' and 'males' in 
subsequent analyses. The numbers in each population are shown in Table 9.4. 
Table 9.4. 
Distribution of each population by sex and marital status. 
Population 1 Population 2 Population 3 
Sex and marital status Number % Number % Number % 
Single females 14 20 14 22 12 26 
Married females 30 42 26 40 20 43 
All males 27 38 25 38 15 32 
Total 71 65 47 
9.4 AGE 
The age of each patient at the time of the rrrst interview was recorded. The 
numbers in each population in each age group are shown in Table 9.5. 
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Table 9.S. 
Distribution of each population by age group. 
Population 1 Population 2 Population 3 
Age group Number % Number % Number % 
Up to 19 3 4 3 S 3 6 
20-24 4 6 4 6 4 9 
2S-29 7 .10 7 11 7 IS 
30-34 9 13 9 14 7 15 
3S-39 9 13 9 14 6 13 
40-44 10 14 9 14 6 13 
4S-49 8 11 7 11 3 6 
SO-S4 9 13 7 11 7 15 
S5-S9 3 4 3 5 1 2 
60-64 6 8 5 8 2 4 
65-69 1 1 1 2 
70 and over 2 3 1 2 1 2 
Total 71 65 47 
The distribution of the first population by age group and by sex and marital status 
is shown in Table 9.6 and in Figure 9.1. 
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Table 9.6. 
Distribution of rust population by age group and by sex and marital status. 
Single Married 
Age group females females Males Total 
Up to 19 3 3 
20-24 4 4 
25-29 1 6 7 
30-34 3 5 1 9 
35-39 4 5 9 
40-44 1 S 4 10 
45-49 3 S 8 
50-54 1 'I 7 9 
55-59 2 1 3 
60-64 1 2 3 6 
65-69 1 1 
70 and over 2 2 
Total 14 30 27 71 
Figure 9.1. 
First population: distribution by sex and marital status and by age group. 
Age group Single females Married females Males 
Up to 19 SSS 
20-24 SSSS 
25-29 S MMMMMM 
30-34 SSS MMMMM M 
35-39 MMMM MMMMA 
40-44 S MMMMM MMMS 
45-49 MMM MMMMW 
50-54 S M MMMMMMD 
55-59 MM M 
60-64 S MW MMM 
65-69 M 
70 and over MW 
Note: S = Single M = Married W=Widowed D=Divorced A = Separated 
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The ages of the females in the population ranged from 17 to 72 (single females 
from 17 to 62, married females from 25 to 72), whereas for males it was 34 to 68. The 
average age of all females was 35.6 (standard deviation 14.2) and of males was 48.1 
(standard deviation 9.1). The average age of single females was 30.0 (standard deviation 
12.8) and of married females was 42.7 (standard deviation 12.9). The majority of patients 
of both sexes were in the age range 30 to' 54 (see also Figure 9.1). 
There was only one male aged less than 35 (who was 34), whereas there were 22 
females below this age, 11 single and 11 married. These young females, of whom half 
were single, formed a separate group with a number of different characteristics from the 
others in the population; for example, they had many fewer symptoms of the disease (see 
Appendix C). 
APKD is an autosomal dominant disorder which is governed by the principle that 
males and females are equally affected. The sample was collected from symptomatic 
patients who had been referred to the renal unit and in whom a diagnosis of APKD had 
subsequently been made. The larger number of females in the sample might be explained 
by the fact that, unlike men, women go to the doctor for contraceptive advice, prescription 
and antenatal care and on such a visit an abnormality such as hypertension may be 
discovered (Wilkie et al 1985). The larger number of younger females in the present 
sample is consistent with this hypothesis. 
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9.5 NUMBERS OF CHILDREN 
The numbers of living children for those in each population are shown in 
Table 9.7. 
Table 9.7. 
Distribution of each population by number of living children. 
Population 1 Population 2 Population 3 
Number of children Number '% Number % Number % 
None 19 27 18 28 15 32 
One 16 23 16 25 13 28 
Two 18 25 ' 16 25 8 17 
Three 9 13 7 11 6 13 
Four 8 11 7 11 4 9 
Five or more 1 1 1 2 1 2 
Total 71 65 47 
Three females had each had a child who had died but the cause of death of these 
children was not known. As APKD normally only affects adults, it is unlikely that the 
cause of death of these children could be attributed to APKD. Table 9.8 shows the same 
analysis as Table 9.7, but including the three children who had died. 
Table 9.8 
Distribution of each population by number of children, living or dead. 
Population 1 Population 2 Population 3 
Number of children Number % Number % Number % 
None 19 27 18 28 15 32 
One 15 21 15 23 12 26 
Two 18 25 16 25 8 17 
Three 10 14 8 12 7 15 
Four 8 11 7 11 4 9 
Five or more 1 1 1 2 1 2 
Total 71 65 47 
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The distribution of the fIrst population by numbers of children, living or dead, is 
shown in Table 9.9 by sex and marital status, and in Figure 9.2 by sex and age group. 
Table 9.9. 
First population: numbers of children, living or dead, by sex and marital status. 
Single Married 
Number of children females females Males 
None 
One 
Two 
Three 
Four 
Five or more 
Total 
13 3 3 
1 10 4 
8 10 
S 5 
3 5 
1 0 
14 30 27 
Figure 9.2. 
First population: numbers of children, living or dead, 
by sex and marital status and by age group. 
Age group Single females Married females Males 
000 
1000 
0 221111 
000 32210 2 
3211 22210 
0 33211 4420 
444 43210 
Total 
19 
15 
18 
10 
8 
1 
71 
Up to 19 
20-24 
25-29 
30-34 
35-39 
40-44 
45-49 
50-54 
55-59 
60-64 
65-69 
0 5 4333211 
21 2 
0 32 432 
2 
70 and over 00 
Note: the digit (0 to 5) represents the number of children, living or dead 
145 
CHAPTER 9: DEMOORAPIDC AND MEDICAL EXPLANATORY VAlUABLES 
Ever-married females had had on average 2.0 children (1.9 living and 0.1 dead) 
compared with 2.3 (all living) amongst ever-married males. However, the younger 
married females and the young single females might have further children in the future. 
It was found during the subsequent analysis that the combination of age and 
number of children (including both living and dead children) was useful in explaining 
some of the results. These two factors were combined into one, splitting by age into those 
up to age 44 and those aged 45 and over, and splitting by number of children into those 
with up to two children and those with three or more. 
The numbers in each category of age and number of children in each population 
are shown in Table 9.10, and the distribution of the fIrst population by age and number 
of children is shown in Table 9.11 by sex and marital status. 
Table 9.10 
Distribution of each population by age and number of children combined. 
Age and Population 1 Population 2 Population 3 
number of children Number % Number % Number % 
S44,s2 36 SI 3S S4 28 60 
S44,~3 6 8 6 9 5 11 
~45,S2 16 23 14 22 7 15 
~45,~3 13 18 10 15 7 15 
Total 71 65 47 
It can be seen that a higher proportion of those in the fIrst group (age S 44 and 
children S 2) than of those in the other three groups persist up to the third interview (28 
out of 36 or 78% as compared with 19 out of 35 or S4%). Fisher's exact test (see Everitt 
1992) shows that the probability of the fIrst number being 36 or more is 0.0323, so the 
result is significant at a 5 %, but not at a 1 % probability level. 
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Table 9.11. 
First population: age and number of children, by sex and marital status. 
Age and number of Single Married 
children females females Males Total 
S44,s2 
S44, C!:3 
~45,S2 
C!:45, C!:3 
Total 
12 
2 
14 
16 
4 
S 
S 
30 
9.6 PoSSIBLE FUIURE cmLDREN 
8 
2 
9 
8 
27 
36 
6 
16 
13 
71 
It seemed possible that the attitudes of respondents might be affected, not by the 
number of children that they had or had had, but by whether they might expect to have 
more in the future. Patients were not asked explicitly how many more children they 
intended to have, but an assessment was made, on a rather arbitrary basis, as follows. 
Those aged 40 and over and all widows: none. 
Those aged 30 to 39: 
Single: none. 
Two or more children already: none. 
Others: one. 
Those aged less than 30: 
Two or more children already: none. 
One child already: one. 
No children so far: two. 
The number of possible future children for those in each population are shown in 
Table 9.12. 
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Table 9.12 
Distribution of each population by number of possible future children. 
Number of possible Population 1 Population 2 Population 3 
future children Number % Number % Number % 
None 
One 
Two 
Total 
53 
11 
7 
71 
75 
15 
, 10 
47 
11 
7 
65 
72 
17 
11 
31 
9 
7 
47 
66 
19 
IS 
The distribution of the fIrst population by numbers of possible future children is 
shown in Table 9.13 subdivided by sex and marital status, and in Figure 9.3 by sex and 
marital status and by age group. 
Table 9.13 
First population: numbers of possible future children, by sex and marital status. 
Number of possible Single Married 
future children females females Males Total 
None 
One 
Two 
Total 
6 
1 
7 
14 
148 
22 
8 
30 
25 
2 
27 
53 
11 
7 
71 
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Figure 9.3 
First population: numbers of possible future children, 
by sex and marital status and by age group. 
Age group Single females Married females Males 
Up to 19 
20-24 
25-29 
30-34 
35-39 
40-44 
45-49 
SO-54 
55-59 
60-64 
65-69 
222 
2221 
2 
000 
0 
0 
0 
111100 
11000 
1100 
00000 
000 
0 
00 
00 
70 and over 00 
0 
11000 
0000 
00000 
0000000 
0 
000 
0 
Note: the digit (0 to 2) represents the number of possible future children 
9.7 EDUCATIONAL QUALUlCATIONS 
Studies in other chronic illnesses such as haemophilia have pointed to the 
importance of good education which may lead to enhanced occupational opportunities and 
jobs that are more flexible and less physically demanding (Markova et al 1980). 
Questions were asked about the age at leaving school, qualifications gained at 
school, and qualifications gained since leaving school. The results for the rll'st population 
are summarised in Table 9.14, subdivided by sex and marital status. 42 out of the 71 
(59 %) had left school without any qualifications and gained none since. 8 (11 %) had only 
school certificates, either Ordinary grade or Higher grade. A further 8 (11 %) had left 
school with no qualifications but had gained later qualifications (typically City and Guild 
certificates but including 3 nurses). 6 (8%) had added later qualifications to school 
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certificates, and 7 (10%) had obtained degree level qualifications (4 with university 
degrees and 3 with Higher National Certificates). 
Table 9.14 
First population: educational qualifications, by sex and marital status. 
Age at leaving school and Single Married 
qualifications females females Males Total 
Age 14 no qualifications '2 4 8 14 
Age IS no qualifications 10 10 20 
Age 16 no qualifications 4 3 1 8 
Ages 14, IS or 16 2 1 2 S 
with school certificates 
Ages 17 or 18 2 1 3 
with school certificates 
Ages 14, IS or 16 with no 1 S 2 8 
school certificates but with later 
qualifications 
Ages IS or 16 with school and 2 4 6 
also later qualifications 
Ages IS or 16 with degree level 1 2 3 
qualifications 
Ages 17 or 18 with degree level 3 1 4 
qualifications 
Total 14 30 27 71 
The age at leaving school was associated with the age of the respondent, almost 
necessarily so, since until 1947 the normal school leaving age in Scotland was 14; this 
was increased to IS in 1947 and to 16 in 1976. 
Those who are younger not only left school at a later age but also have gained 
more qualifications; this partially explains the greater number of females with more 
qualifications. Apart from the group of younger women, many with qualifications, there 
is little difference between the sexes in terms of educational level. 
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For the purpose of later analyses each patient was classified in a particular 
'educational level' as follows: 
I those leaving school at ages 14, IS or 16 and with no qualifications 
(42); 
2 those leaving school with school certificates but with no later 
qualifications (8); 
3 those with later qualifications not of degree level (14); 
4 those with later qualifications of degree level (7). 
Figure 9.4 shows the educational level for the frrst population subdivided by sex 
and marital status and by age group. 
Figure 9.4 
First population: educational level by sex and marital status and by age group. 
Age group Single females Married females Males 
Up to 19 122 
20-24 1124 
25-29 1 123334 
30-34 233 13334 2 
35-39 1113 11114 
40-44 3 11113 1111 
45-49 111 11144 
50-54 1 1 1111233 
55-59 11 1 
60-64 1 14 112 
65-69 1 
70 and over 13 
Note: the digit (0 to 4) represents the educational level 
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Table 9.15 shows the numbers in each educational level for each population. 
Table 9.15. 
Distribution of each population by educational level. 
Population 1 Population 2 Population 3 
Number % Number % Number % 
Levell 42 59 38 58 27 57 
Level 2 8 '11 7 11 5 11 
Level 3 14 20 14 22 11 23 
Level 4 7 10 6 9 4 9 
Total 71 65 47 
9.8 OCCUPAnoN 
Each patient was asked questions about their current occupation, and also about 
their former occupations. Many were retired or were housewives and ,for these an 
occupation, styled their 'permanent' occupation, was derived from their occupation in 
their last period of employment. For those currently employed the 'permanent' occupation 
was taken as their current one. 
Occupations were classified using an adaptation of the extended classification of 
occupations into socio-economic groups as used by the Registrar General for Scotland. 
This system gives a wide range of occupations as well as including the categories of 
unemployed, student, housewife and retired and it was considered a more sensitive tool 
for the classification of occupation in a chronic illness as compared with the more 
restrictive Registrar General's Social Classes I-V. In addition it was the occupation that 
the respondent did which was of interest rather than any social class classification. 
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The 'permanent occupation' of patients in the rust population is shown in Table 
9.16, subdivided by sex and marital status. The large numbers of females in clerical jobs 
is conspicuous and not unexpected, reflecting a pattern in the general population. 
Table 9.16. 
First population: permanent occupation, by sex and marital status 
Occupation Single Married 
females females Males Total 
Managerial 1 1 1 3 
Professional 2 2 
Lesser professions 1 S 3 9 
Clerical 6 12 4 22 
Service jobs 1 3 1 5 
Skilled manual 5 S 
Semi-skilled manual 2 3 7 12 
Unskilled manual 1 4 1 6 
Farmers 1 2 3 
Agricultural workers 1 1 
None 1 2 3 
Total 14 30 27 71 
The extent to which the occupation of respondents reflects their educational 
attainment is shown, for the rrrst population, in Table 9.17. There is a clear tendency for 
those' with higher educational qualifications to have corresponding occupations, in 
particular those in the professions, lesser professions and clerical jobs. There are, 
however, exceptions to this rule in both directions. 
The tendency just noted can be tested by performing Fisher's exact test on a 2 by 
2 table formed by grouping education Levell versus Levels 2, 3 and 4, and grouping 
managerial, professional, lesser professions and clerical jobs versus service, skilled, semi-
skilled and unskilled manual, farmers and agricultural workers, omitting the 3 with no 
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occupation. The resulting table is shown in Table 9.18. Fisher's test shows that, if there 
were no connection between educational level and occupational group, the probability of 
obtaining by chance a value in the lower right comer of the table of 5 or less is as low 
as 0.00005, an extremely significant result. 
Table 9.17. 
First population: permanent· occupation by educational level 
Occupation Levell Level 2 Level 3 Level 4 Total 
Managerial 1 1 1 3 
Professional 1 1 2 
Lesser professions 1 1 3 4 9 
Clerical 10 4 7 1 22 
Service jobs 4 1 5 
Skilled manual 3 1 1 5 
Semi-skilled manual 12 12 
Unskilled manual 5 1 6 
Fanners 2 1 3 
Agricultural workers 1 1 
None 2 1 3 
Total 42 8 14 7 71 
Table 9.18. 
First population: permanent occupation by educational level, grouped 
Occupation Level 1 Levels 2-4 Total 
Managerial, professional, lesser 
professions and clerical 
Service jobs, skilled, semi-skilled and 
unskilled manual, fanners and 
agricultural workers 
Total 
13 
27 
40 
p(* ~ 5) = 0.00005 
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Table 9.19 shows the numbers in each occupational category for each population. 
Table 9.19. 
Distribution of each population by permanent occupation. 
Population 1 Population 2 Population 3 
Occupation Number % Number % Number % 
Managerial 3 4 2 3 1 2 
Professional 2 3 2 3 1 2 
Lesser professions 9 13 7 11 5 11 
Clerical 22 31 22 34 18 38 
Service jobs 5 7 5 8 5 11 
Skilled manual 5 7 5 8 3 6 
Semi-skilled manual 12 17 10 15 7 15 
Unskilled manual 6 8 6 9 4 9 
Farmers 3 4 2 3 1 2 
Agricultural workers 1 I I 2 
None 3 4 3 5 2 4 
Total 71 65 47 
9.9 HOUSING AND TYPE OF ACCOMMODATION 
All patients were asked questions about their housing: for this purpose the only one 
of relevance is how the house was owned (owner-occupied, rented from local authority, 
.•. ). The results for the frrst population are shown in Table 9.20, subdivided by sex and 
marital status. 
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Table 9.20. 
First population: ownership of house, by sex and marital status. 
Single Married 
females females Males Total 
Owner occupied 
Local authority rented 
Other 
Total 
5 
9 
14 
12 
17 
1 
30 
10 
16 
1 
27 
27 
42 
2 
71 
Table 9.21 shows the numbers in each category of house ownership for each 
population. 
Table 9.21. 
Distribution of each popUlation by house ownership. 
Owner occupier 
Local authority rented 
Other 
Total 
Population 1 Population 2 Population 3 
Number % Number % Number % 
27 
42 
2 
71 
38 
59 
3 
24 
39 
2 
65 
37 
60 
3 
17 
28 
2 
47 
36 
60 
4 
In the West of Scotland there is a high incidence of local authority housing. The 
majority of patients in the first population rented from a local authority (42 out of the 71 
or 59%). A smaller proportion were in owner-occupied houses (27 out of the 71 or 38%). 
Only two were in other forms of accommodation, both renting from private landlords. 
These numbers can be compared with the results from the 1981 Census of Scotland 
(Registrar General for Scotland 1982). The percentages of persons living in private 
households in Glasgow City and in Strathc1yde Region, subdivided by the type of housing 
tenancy, are shown in Table 9.22, along with the numbers and percentages from the first 
study population. There was a slightly higher proportion in owner-occupied housing in the 
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study population than in either Glasgow or Strathclyde, and a lower proportion in 'other' 
tenancies. The difference between the study population and Strathclyde Region is not 
significant, but the difference between it and Glasgow City is significant at a 2 % 
probability level. 
Table 9.22. 
Distribution first population' and of persons in Glasgow City 
and in Strathclyde Region (Census 1981) by house ownership. 
Population 1 Glasgow City Strathclyde Region 
Number % % % 
Owner occupier 27 38 26 32 
Local authority rented 42 59 64 62 
Other 2 3 10 6 
Total 71 100 100 
9.10 RELIGIOUS AFFILIAnON 
In this study questions were to be asked about prevention of APKD. Some patients 
might have had strong religious beliefs which would not have allowed them to consider 
the use of contraception or termination of pregnancy, although evidence from work in 
haemophilia suggests that religious affiliation did not playa significant part in the attitudes 
of patients to prevention of haemophilia. 
The religious affiliation of those in the first population, subdivided by sex and 
marital status, is shown in Table 9.23. Fewer than half (31 out of 71 or 44%) had no 
religious affiliation; these included a majority of the males (16 out of 27 or 59%). Among 
those belonging to a church a rather greater proportion of female than male patients 
belonged to the Catholic church, though this difference is not significant. Such a 
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distinction could be of importance if women take the sole decision of whether or not to 
become pregnant. 
Table 9.23. 
First population: religious affiliation, by sex and marital status. 
Protestant 
Catholic 
No church 
Total 
Single Married 
females females Males Total 
4 12 
4 9 
6 9 
14 30 
7 
4 
16 
27 
23 
17 
31 
71 
Table 9.24 shows the numbers in each religious affiliation for each population. 
Table 9.24 
Distribution of each population by religious affiliation. 
Population 1 Population 2 Population 3 
Church Number % Number % Number % 
Protestant 23 32 22 34 15 32 
Catholic 17 24 15 23 10 21 
No church 31 44 28 43 22 47 
Total 71 65 47 
9.11 SEVERITY OF DISEASE 
Each patient was classified as to the 'degree of severity' of his or her disease. This 
was done in the following way. The six who were found to be unaffected were given a 
severity grade of O. The other patients were given severity grades of 1, 2 or 3 in 
increasing order of severity. The severity grade was assigned as follows. 
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Severity grade 3 (severe) was assigned to 30 patients: 
10 who had received a successful transplant; 
11 who were on dialysis; 
5 who had had a cerebral haemorrhage; 
4 whose creatinine level was 500 or more. 
Severity grade 2 (moderate) was assigned to 21 patients: 
12 whose loin pain had been classified as moderate, severe or very 
severe; 
7 whose headaches had been classified as moderate, severe or very 
severe; 
1 who had moderately severe gastra-intestinal trouble; 
1 who had moderately severe chest pain. 
Those assigned in this way to severity grade 2 included all those whose creatine 
level was 300 or more, which would also have been used as a criterion for level 2 
severity. 
Severity grade 1 (little affected) was assigned to the remaining 13 patients for 
whom medical records were available, and also to the one (a female in her 70s) who died 
between the first and second interviews for whom no medical records were available. Two 
of the 13 had mild loin pain; one had a creatinine level of ISS; none had any other 
symptoms. All 13 were females under age 35. 
The numbers of patients in each severity grade in the first population, subdivided 
by sex and marital status, are shown in Table 9.25 and by sex and marital status and by 
age group in Figure 9.5. 
All but one of the 14 (20%) patients in grade 1 severity of disease were females 
under age 35.21 out of71 (29%) were in grade 2 severity and 30 out of71 (42%) were 
in grade 3 severity. For the two higher levels there was little differences between the 
sexes and age groups. 
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Table 9.25 
First population: severity of disease, by sex and marital status. 
Single Married 
Severity grade females females Males Total 
o (unaffected) 3 3 6 
1 (little affected) 7 7 14 
2 (moderate) 3 7 11 21 
3 (severe) 4 13 13 30 
Total 14 30 27 71 
Figure 9.5 
First population: severity of disease, by sex and marital status and by age group. 
Age group Single females Married females Males 
Up to 19 123 
20-24 1123 
25-29 1 111122 
30-34 111 11223 3 
35-39 0233 22233 
40-44 3 00233 2333 
45-49 333 02233 
50-54 2 3 2233333 
55-59 33 2 
60-64 3 33 022 
65-69 0 
70 and over X2 
Note: the digit (0-3) shows the severity grade of the disease; 
X=no medical records, treated as 1. 
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Table 9.26 shows the numbers in each severity grade for each population. 
Table 9.26 
Distribution of each population by severity of disease. 
Population 1 Population 2 Population 3 
Severity grade Number 
" 
Number 
" 
Number % 
Grade 0 6 8 5 8 
Grade 1 14 . 20 13 20 12 26 
Grade 2 21 30 20 31 15 32 
Grade 3 30 42 27 42 20 43 
Total 71 6S 47 
9.12 FAMILY IDSTORY 
It is explained in Section MM.4.2 how family trees or pedigrees were drawn up 
during the interviews with the patients. The degree of involvement with APKD was 
assessed for each patient and a grading was assigned on the following criteria, so that the 
family history could be used as a variable in the analysis of the data. 
Grade 0, no family history, where the patient was not affected by APKD. 
Grade 1, weak family history, where the patient was the sole affected 
person or did not know of affected ancestors or other affected 
relatives. 
Grade 2, moderate family history, where apart from the patient there were 
only two or three known affected relatives. 
Grade 3, strong family history, where apart from the patient there were 
also affected sibs, cousins or uncles and aunts and offspring. 
The numbers of patients in each family history grade in the first population, 
subdivided by sex and marital status, are shown in Table 9.27 and by sex and marital 
status and by age group in Figure 9.6. 
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Table 9.27 
First population: family history grade, by sex and marital status. 
Family history grade Single Married 
females females Males Total 
o (unaffected) 4 3 7 
1 (weak) 2 5 4 11 
2 (moderate) 4 13 12 29 
3 (strong) 8 8 8 24 
Total 14 30 27 71 
Figure 9.6 
First population: family history grade, by sex and marital status and by age group. 
Age group Smgle females Married females Males 
Up to 19 233 
20-24 1123 
25-29 3 222333 
30-34 333 22233 2 
35-39 0222 12333 
40-44 2 00123 2223 
45-49 123 01223 
50-54 2 2 2222233 
55-59 12 3 
60-64 3 13 011 
65-69 0 
70 and over 01 
Note: the digit (0-3) shows the family history grade. 
Table 9.28 shows the numbers in each family history grade for each population. 
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Table 9.28 
Distribution of each population by family history grade 
Population 1 Population 2 Population 3 
Family history grade Number % Number % Number % 
0 7 10 S 8 
1 11 15 10 15 S 11 
2 29 ·41 28 43 25 53 
3 24 34 22 34 17 36 
Total 71 6S 47 
Note that none of those who were unaffected (grade 0) were asked back for the 
third interview. 
Specimens of two family trees are shown in Figures 9.7 and 9.8. Figure 9.7 shows 
a simple family history, graded as 1, with a single male 'index' patient, an affected male, 
whose father and aunt were both affected and are both dead, and who has two children, 
one daughter affected and one son at risk but not yet tested. His father's grandparents are 
both dead; presumably one of them was affected, but which one is not known. 
Figure 9.8 shows a much more complicated family tree. The male in the first 
generation was presumably affected, since children from both his marriages are affected. 
The surviving son from the second marriage has two affected daughters; all three are 
index patients, included in the study. From the frrst marriage there are two affected 
granddaughters, one of whom had seven children by three different men; two of these 
children are affected; all three affected are index patients. The status of many of the 
younger members of the family and of members of the lateral branches is not known. All 
six patients in the study were classified as having a strong family history, grade 3. 
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? 
D Male o Female 
Affected 
[JJ At risk, untested 
~Dead ~ Index patient 
Figure 9.7. A specimen of a simple family history. 
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f-------1 0-. 
i-----i C'- . 
.--------i C'-. 
~-----i C'-. 
Figure 9.8. A specimen of a complicated family history. 
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9.13 USE OF EXPLANATORY VARIABLES IN SUBSEQUENT ANALYSES 
In order to assist the analysis of areas of investigation - the 'response variables' 
described in Chapter 8 - the answers to certain groups of questions were turned into 
composite scores, which could be analysed numerically. Each score was used as the 
response variable in an analysis using the GUM computer package (Aitkin et al 1987). 
This package is suitable for identifying complex interactions in the effects of possible 
! 
explanatory variables. As it turned out, however, the analysis of the response variables 
in the present study showed that no very complex interactions needed to be included, and 
the results in subsequent chapters are therefore usually presented in a simple form as the 
mean scores for the appropriate explanatory variables. 
All the possible explanatory variables were treated as categorical variables, rather 
than as numeric variables. The explanatory variables described above were grouped into 
slightly fewer categories, in order to avoid categories with too few observations, and they 
are listed, with the number of categories used in each, in Table 9.29. 
Certain of the explanatory variables were grouped also in ways other than that 
shown in Table 9.29; for example age was grouped into a smaller number of categories; 
sex and marital status were combined into the three groups: single females, married 
females, males; age and number of children were combined into the four groups: 
S44, S2; S44, C!:3; C!:45, S2; C!:45, C!:3. 
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Table 9.29 
Explanatory variables and number of categories used for each. 
Explanatory variable Categories 
Sex 2 
Age (in 10 year groups) 6 
Marital status 3 
Number of children 5 
Number of possible future children 3 
Housing 2 
Occupation (in socia-economic groups) 11 
Education 4 
Church 3 
Severity of disease 4 
Family history 4 
Each response variable was fitted to each possible explanatory variable in tum, and 
the amount of explanation, measured by the reduction in the residual sum of squares, was 
observed. The significance of the explanation was measured by testing the F-statistic. In 
general only explanatory variables whose effect was significant at a 1 % probability level 
were accepted. It is appropriate to use a more stringent level such as 1 % when a range 
of different explanatory variables is being considered. Where appropriate more than one 
explanatory variable was admitted, and in some cases, noted below, explanatory variables 
were admitted at a 5 % probability level. 
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10.1 INTRODUCIlON: THE SECOND INTERVIEW 
The patients' experience of genetic counselling was explored during the second 
interview. In this chapter the patients' responses are analysed. Detailed results are 
presented in Appendix D. 
As part of an investigation of patients' knowledge of genetic counselling, it was 
necessary to establish whether respondents had received any genetic counselling, who had 
given them genetic counselling and whether they had been counselled on their own, as 
well as what sort of information or content of genetic counselling the patient had received. 
The questions asked were divided into two sections: the first section was concerned 
with the 'environment' of genetic counselling, i.e. whether the respondent had received 
genetic counselling, from whom they had received genetic counselling and where the 
counselling had taken place; the second section was concerned with the content of the 
counselling. The answers to some of the questions were used to construct scores, which 
were then used in the further analysis. 
For this chapter each individual response and each constructed score was analysed 
by each of the demographic and medical variables described in Section 9.13. These are: 
sex, age, marital status, number of children, educational level, occupation, housing, 
religious affiliation, severity of disease and family history. 
Before discussing the results of the analysis of the data, it is appropriate to 
comment on the factors that could have influenced the respondents' experience of genetic 
counselling. Severity of illness could influence experience in different ways. There is 
more opportunity to offer genetic counselling to patients who are more ill since these 
patients are seen by doctors frequently, and it may be thought important to ensure that the 
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more severely affected patients have been given genetic counselling so that they can 
inform their relatives while they are still able. On the other hand doctors may be 
concentrating on the medical management of those patients who are more ill rather than 
on giving them genetic information. 
The sex of the respondent could influence the experience of genetic counselling, 
since much of it concerns whether or not to have children, and this may be seen as the 
woman's responsibility. However it was not known whether both the experience and the 
content of genetic counselling was the same for both sexes. 
In the second section of the chapter the content of genetic counselling is discussed. 
Once again sex of respondent could be an important variable. Family history may also be 
important in this analysis. Those with a strong family history may be more familiar with 
the problems associated with APKD and, therefore, may remember more about the content 
of genetic counselling. 
10.2 THE ENVIRONMENT OF GENE11C COUNSEUJNG 
The first set of questions related to the environment within which patients had had 
genetic counselling, and the circumstances of it. The first point to establish was whether 
patients had had any genetic counselling at all. Respondents were therefore asked whether 
they had had any genetic counselling, which was described as 'a discussion about the 
inheritance of polycystic Iddney disease, the effect on the patient and their children and 
what they could do about it'. The majority of respondents (49 out of 65 or 75 %) had 
received information about the inheritance of APKD, but almost one quarter reported that 
they had not. 
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Patients were asked from whom they had received information about the 
inheritance of APKD. The majority of patients (40 out of 65 or 62 %) had received it from 
doctors in the renal unit at Glasgow Royal Infumary. 
Respondents were also asked whether they had had any information about other 
problems associated with APKD. Only six of them (9 %) said that they had. 
Patients were asked how they had come to have genetic counselling. The most 
common route was that patients received genetic counselling during a routine medical 
consultation. Six patients were referred by their GP. or by another specialist and five at 
the instigation of their spouse or another member of their family. Three patients said that 
it was their own idea to seek counselling. 
Respondents were asked whether anyone else was present when the patient received 
genetic counselling, and, if so, whom. The spouse or partner was present when the patient 
received genetic counselling in 9 cases (14%). Other family members were present in 19 
cases (29%) and these included sibs (12), children (4 - including one with the spouse), 
and other family members (2 - one mother and one nephew). This leaves 23 patients who 
received genetic counselling on their own (47% of the 49 who did receive it), including 
11 out of the 17 males. 
Respondents were asked whether they would have liked their spouse or partner to 
have been present. Just over half the respondents who did not have their spouse or partner 
present would have liked them to have been present (29 out of 56 or 52 %); this preference 
was strong for married women (16 out of 26), half and half for men (11 out of 22) and, 
not surprisingly, weak for the single women (2 out of 12). 
Most patients who had received information about the inheritance of APKD had 
received it on only one occasion (41 out of 49 or 84%), with 7 patients reporting that they 
had received information on two occasions and 1 patient on several occasions. 
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10.3 SCORE FOR ENVIRONMENT OF GENE11C COUNSELLING 
A numeric score was constructed, denoted EGCS 1, in order to measure the 
patients' experience of genetic counselling, based on the answers to some of these 
questions. The construction of this score is described in Appendix D. The maximum score 
was 7 points, and the average was 2.S points. IS respondents got no points, 13 got two 
points and IS got three. 
The score so constructed was then analysed using the GUM system, as described 
in Section 9.13, in respect of all the possible explanatory variables described in Chapter 
9. Analysis showed that severity of disease was the best explanatory variable, the only one 
significant at a 1 % probability level. However, this only accounted for 21.3% of the 
original variance of the score (R2 = 0.213), which is not a particularly high proportion. 
(The statistic R2 in a GLIM analysis has the same meaning as in a multiple regression 
analysis; if it were a simple linear regression the value of 0.213 would correspond to a 
correlation coefficient of 0.46.) 
The mean scores, subdivided by severity of disease, are shown in Table 10.1. 
Table 10.1 
Second population: mean scores for environment of genetic counselling (EGCSI), 
classified by severity of disease. 
Severity of disease Mean score 
Grade 0 2.00 
Grade 1 4.08 
Grade 2 1.75 
Grade 3 2.33 
The scores fall into an irregular pattern. Those with severity Grade 1 (mildly 
affected) had the best experience of genetic counselling (average 4.08 points). The other 
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three Grades were not very different from one another, with mean scores ranging from 
1. 75 to 2.33. 
10.4 INFoRMATION GIVEN IN GENE11C COUNSElLING 
Respondents were asked whether they had received information about 19 different 
topics that might have been included in a genetic counselling session. The results, 
subdivided by family history, are shown in Table 10.2. 
The majority of respondents (45 out of 65 or 69%) had received information about 
the risk to children, 20 out of 65 (31 %) had received information about the risk of 
inheritance. Fewer than one quarter of respondents had received information about having 
no more children (16 out of 65), sterilisation (14 out of 65), screening of the at risk (13 
out of 65) and prevention of APKD (10 out of 65). Only a few respondents had received 
information about any other topic in the list. 
Among the men, the only topic remembered by more than a few patients was the 
risk to children (14 out of 25 or 56%). For many of the topics none of the men had 
received information. The married women had in general had more information. The 
single women were in general no better informed than the men, except for two women 
(the same two, who were both in severity Grade 1 and family history Grade 2) who had 
received information about every topic on the list; they had received counselling from a 
specialist genetic counsellor. 
The number of topics that each patient had had discussion about were counted. 
Apart from the two patients who had received information about every topic, no patient 
remembered receiving information about more than six topics, and the most common 
numbers were one (10 cases), two (10 cases) and four (13 cases). 
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Table 10.2 
Second population: 'was discussion about the specified topic included in your 
genetic counselling?', subdivided by family history; 
the number resJXlnding 'yes' is shown. 
Grade 0 Grade 1 Grade 2 Grade 3 Total 
Maximum number 5 10 28 22 6.5 
1 Risk of inheriting 3 1 8 8 20 
2 Risk to children 3 4 23 IS 45 
3 Advantages of testing 1 5 2 8 
4 Disadvantages of testing 3 3 
5 How to tell 2 2 
6 Screening of at risk 1 9 3 13 
7 Adoption 3 3 
8 Fostering 2 2 
9 Voluntary childlessness 2 3 5 
10 Having no more children 2 13 1 16 
11 Family planning 3 3 
12 Sterilisation 1 10 3 14 
13 Vasectomy 2 3 5 
14 A. I. D. 2 2 
1.5 Prevention of APKD 1 1 5 3 10 
16 Telling boy/girlfriend 2 2 
17 Telling in-laws 2 2 
18 Symptoms of APKD 4 4 
19 Treatment available 1 3 1 5 
10.5 SCORE FOR CONTENT OF GENE11C COUNSEU.ING 
A numeric score was constructed, denoted EGCS2, based on the answers to the 
questions relating to the content in genetic counselling. The construction of this score is 
described in Appendix D. The maximum score was 10 points, and the average was 3.0 
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points. The most common scores were none (16 cases), three (11 cases) and five (11 
cases). 
Analysis using the GLIM system showed that of all the possible explanatory 
variables listed in Chapter 9, family history was the most useful factor, though significant 
only at a 5 % probability level and not at a 1 % level; the factor combining age and number 
of children was second, also significant at a 5" probability level. There was no significant 
interaction term. Family history by itself accounted for 15.1 % of the original variance and 
the combined factor for age and number of children explained a further 13.4%, making 
28~5 % in all (R2 = 0.285). The components for the two explanatory variables, relative 
to the mean score of 3.03, are shown in Table 10.3, and the expected scores for the two 
variables are shown in Table 10.4. 
Table 10.3 
Second population: components of mean scores 
for experience of genetic counselling (EGCS2). 
Element Component 
Overall mean 3.03 
Family history: 
Grade 0 +0.77 
Grade 1 -1.47 
Grade 2 +0.94 
Grade 3 -0.70 
Age and number of children: 
S44, s2 +0.78 
S44, ~3 -0.35 
:i!:45, s2 -1.52 
~45, ~3 -0.38 
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Table 10.4 
Second population: mean scores for experience of genetic counselling (EGCS2), 
classified by family history and by age and number of children. 
Family history 
Grade 0 
Grade 1 
Grade 2 
Grade 3 
:S44, s2 
4.58 
2.33 
4.74 
3.11 
Age and number of children 
s44, ~3 ~45, s2 
3.45· 2.28 
1.20 0.03 
3.61 2.44 
1.98 0.81 
~45, ~3 
3.43· 
1.18 
3.59 
1.96 
There were no observations in the cells marked • and the mean scores are those 
implied by the model. 
The mean scores again form an irregular pattern, those with Grades 0 (unaffected) 
and 2 (medium family history) being high, and those with Grade 1 (low family history) 
being low. There seem no obvious reasons for this. Those aged less than 45 and with 
fewer than three children scored more highly than those who were older or had more 
children. 
The correlation coefficient between the two scores, EGCS 1 and EGCS2, was 
calculated; its value is 0.73, very significantly different from zero. 
10.6 DISCUSSION 
This was a retrospective study. There had been no particular policy in the Renal 
Unit at GR! for routine genetic counselling to be given to patients with APKD. Yet 75 % 
of respondents reported that they had received some genetic counselling. It was not easy 
to check from the medical records whether the patient had received information and if so 
what information had been given, as it was very seldom recorded in the patient's medical 
notes that the patient had received such information. In some cases it was possible to 
confirm with a particular consultant that information had been given to a patient, but 
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precise details of the content of the information were unknown. It is possible that some 
patients had in fact been given more information than they could remember. 
It is good practice to record what information was discussed with the patient. This 
could be recorded in a letter sent both to the patient to refer to in the future and to remind 
them of what was discussed and also to the patient's GP (Hughes 1992). 
Of the 25 % of patients who reported that they had not received genetic 
counselling, the great majority were moderately or severely affected. It is possible that 
if they were uraemic they may not have remembered what they had been told. Another 
possible explanation is that, because they were more severely affected, the emphasis in 
the consultation would have been on the medical management of their symptoms. Since 
the great majority of respondents had received their genetic counselling from renal 
physicians it is possible that for many patients genetic counselling was simply not given. 
Most counselling was given during a routine medical consultation and the majority 
of patients reported that they received information on one occasion only. This means that 
most patients received their genetic counselling along with any other information about 
the medical management of their condition. 
More than half the patients had received their genetic counselling on their own. 
This is in keeping with the finding that most counselling had been given during a routine 
medical consultation. The very nature of a genetic disease such as APKD has implications 
not only for the affected person but also for their partner. And yet in this investigation in 
only nine cases was the partner or spouse present. Given a choice, the majority of 
respondents would have liked their partner to have been present. 
The analysis of the first score relating to the environment of genetic counselling 
showed that severity of disease was the most significant explanatory variable. The mean 
scores for this variable, classified by severity of disease, are shown in Table 10.1. It can 
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be seen that there is little difference in the mean scores for severity of disease Grades 0, 
2 and 3, but those in Grade 1 had a much higher mean score. Patients who are more 
severely affected may find it more difficult to assimilate the information that may be 
discussed in genetic counselling simply because they are more ill. In these circumstances 
the presence of a partner or other family member may assist in the transmission of 
information to the family unit. 
Respondents in severity of disease Grade 1 who are only mildly affected may have 
had fewer immediate medical problems and this may explain their higher scores. 
It can be seen from the analysis of the content of counselling that 69% of 
respondents had received information about the risk to children, and amongst the male 
respondents this was the only topic remembered by more than a few patients. Male 
patients reported receiving very little information in comparison with married women. A 
possible explanation is that less information was given to male patients. Alternatively male 
patients were given the information but they did not remember it as they did not think that 
such information was relevant to them. 
It can be seen from Table 10.2 that some information was given about having no 
more children, and about sterilisation and vasectomy; but the majority of patients who 
received such information were married women (See Table 0.21). 
The analysis of the score for the content of genetic counselling showed that family 
history was the most useful explanatory variable, along with age and number of children. 
However, it can be seen from the contributions to the mean scores in Table 10.3 that the 
four grades of family history have very different scores which do not appear to follow an 
obvious pattern. It could be argued that those with little family history might have scored 
higher in this section. Since they do not have a family knowledge of the illness, they 
might have received more content in the genetic counselling. In this analysis those with 
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no family history, Grade 0, score highly while those with a low family history score very 
low. The respondents in Grade 0 had originally been diagnosed as having APKD and had 
been treated for symptoms similar to those of APKD as if they were caused by APKD for 
some time but, as a result of this study, had been found not to have APKD. I do not know 
whether the lack of family history in their case had influenced the amount of information 
given. It is possible that there was more concern about the diagnosis because of the 
absence of family history, so more information was given to them. 
The effect for the combined factor for age and number of children is that those 
aged less than 4S and with fewer than three children were told more, or remembered 
more, of the possible topics than those who were older or had more children. This factor 
attains greater prominence when the results of questionnaire 3 are considered, and it will 
be discussed further there (Chapters 11 and 12). 
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KNOWLEDGE OF SYMPfOMS AND TREATMENT OF APKD 
11.1 INTRODUcnON 
Patients' knowledge of the symptoms of the illness as well as the risk of 
inheritance is frequently used as a measure of the effectiveness of genetic counselling as 
well as a means of trying to understand why patients followed certain courses of action 
following genetic counselling. It is appreciated that the patients' knowledge of the illness 
is needed as part of the evaluation of any genetic counselling service. However Beveridge 
(1989 p97), in her study of mv and AIDS in Scottish Prisons, points to the importance 
of obtaining systematic baseline information about levels of knowledge, knowledge gaps 
and misconceptions about HIV and AIDS for the initial development and subsequent 
assessment of prison educational programmes. It seemed essential that, prior to 
establishing a genetic counselling service for APKD, a detailed investigation into the 
patient's knowledge of APKD, how the disease is transmitted and the treatments available 
was undertaken. 
In this chapter the patients' knowledge of the disease and its treatments is 
discussed. Analysis of the basic results is presented in Appendix E. The patients' 
knowledge and understanding of the genetic inheritance and transmission of APKD are 
discussed in the next chapter. 
The patients' knowledge of the symptoms and treatment of APKD was elucidated 
by questions in the r1l'st and the third interviews. Their responses are discussed below. 
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11.2 ANALYSIS OF RESPONSES 
For this chapter each individual response and each constructed score was analysed by each 
of the demographic and medical variables described in Chapter 9. These are; sex, marital 
status, age, number of children, educational level, occupation, housing, religious 
affiliation, severity of disease, family history, and the combined factor for age and number 
of children. In addition each response and each score was analysed according to the two 
scores for the experience of genetic counselling described in Chapter 10 (EGCSI and 
EGCS2); however, this could not be done for all the respondents in the first population, 
since the questions on the experience of genetic counselling came into the second 
interview. 
It was anticipated that severity of illness, family history, educational level and 
possibly age of respondent could influence the respondent's knowledge of the symptoms 
of and treatments available for APKD. The subsequent GUM analysis of the constructed 
scores showed that severity of illness and educational level were significant in explaining 
some of the variability of the score for knowledge of treatment in the first questionnaire. 
11.3 KNOWLEDGE OF DISORDER AND TREATMENT: QUES110NNAIRE 1, SECIlON 6 
11.3.1 Questions on knowledge of treatment 
Respondents were asked in an open ended question in the fust interview what they 
had been told about APKD. Respondents reported that they had been given information 
about the following topics: prognosis of APKD, inheritance of APKD, the risks to 
children and the association of cysts with APKD. 
A majority of respondents (47 out of the 71 respondents or 66%) reported that they 
had been told about the presence of cysts. A minority of 12 respondents (17%) had been 
told about the inheritance of APKD and about the prognosis of APKD with the majority 
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of these respondents belonging to severity groups 2 and 3. Three respondents were told 
about the risk to children and one respondent reported that he had been told 'not to 
worry' • 
The majority of patients (54 out of 71 or 70%) said that they were having some 
sort of treatment at the time of this interview, and these included almost all the patients 
in severity grades 2 and 3. 
lust over half of patients were receiving antihypertensive drugs (39 out of 71 or 
55%). The next most common treatment was dialysis (8 out of 71 or 11 %). 
Those who were having no treatment or 'other' treatment were asked whether they 
knew about what treatments were available. About half of those who were not having 
treatment (10 out of 21) knew about at least some forms of treatment. 
All patients were asked what forms of treatment they knew about. The forms 
included: anti-hypertensive treatment, transplant, haemodialysis, CAPD and diet. 
A majority of patients knew about each of the first three treatments (37, 38 and 
39 out of 71 respectively), but fewer than half knew about CAPD (19 out of 71 or 27%) 
and diet (27 out of 71 or 38%). Those with the highest grades of severity of illness were 
much better informed than those with lower grades. 
11.3.2 Score for knowledge of treatment in questionnaire 1 
The answers to the questions in questionnaire 1 about the treatment of APKD were 
scored and a composite score of knowledge of treatment, denoted KDS 1, was formed as 
described in Appendix E. The maximum score was 7. The distribution is distinctly 
bimodal, with 23 respondents getting only 1 point and 17 getting the full 7 points. 
Analysis with GUM using the replies from the respondents in the first population 
and the demographic and medical explanatory variables showed that both severity of 
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disease and education level were significant explanatory variables, both at a 1 % level, and 
that the interaction between them was also significant at a 1 % level. 
Analysis of the responses for the second population using the scores for experience 
of genetic counselling as explanatory variables showed that there was no significant effect 
of these variables on this knowledge score. 
The mean scores for each combination of severity grade and education level are 
shown in Table 11.1. The important point is best brought out by grouping the severity 
grades into 0-2 and 3, and the education levels into. 1 and 2-4, and the mean scores are 
shown again in Table 11.2 with this grouping. 
The percentages of the original variance explained by the different variables are 
shown in Table 11.3. It can be seen that the full 4 by 4 table explains 63.1 % of the 
original variance, with the interaction term explaining more than education by itself; when 
the 2 by 2 table is used, the percentage of the original variance explained by the model 
falls to 43.9%. 
Table 11.1 
First popUlation: mean scores for knowledge of treatment of APKD (KDSI), 
classified by severity of disease and education level. 
Education level 
Severity of disease 1 2 3 4 
Grade 0 1.75 2.00 1.00 • 
Grade 1 0.50 3.33 5.50 1.00 
Grade 2 1.54 2.50 4.33 3.00 
Grade 3 5.76 6.50 5.75 1.33 
Note: there were no observations in the cell marked •. 
182 
CHAPTER 11: ANALYSIS: KNOWLEDGE OF SYMPTOMS AND TREATMENT OF APKD 
Table 11.2 
First population: mean scores for knowledge of treatment of APKD (KOSI), 
classified by severity of disease and education level. 
Severity of disease 
Grade 0-2 
Grade 3 
Table 11.3 
Education level 
1 
1.38 
5.76 
2-4 
3.70 
4.44 
First population: percentages of original variance of score for knowledge of 
treatment of APKD (KOSI) explained by successive factors. 
Table: 4 by 4 2 by 2 
% % 
Original variance 100.0 100.0 
Severity of disease 32.9 29.9 
Education level 12.9 3.1 
Interaction 17.3 10.9 
Total explained 63.1 43.9 
Residual 36.9 56.1 
There is a significant contrast among those in education level 1 (low education) 
between those with high severity of disease (grade 3), whose average points are 5.76, and 
those with lower severities (0-2), whose average points are 1.38. In education level 1 
respondents more severely affected by APKD have much better knowledge of the 
treatment for APKD than those less severely affected. On the other hand, among those 
with more educational qualifications (levels 2-4), there is much less difference in their 
knowledge of symptoms and treatment between those with greater severity of disease 
(grade 3), whose average points are 4.44, and those with lesser severity (grades 0-2), 
whose average points are 3.70. 
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11.4 KNOWLEDGE OF SYMPrOMS OF APKD: QUES1l0NNAIRE 3, SECIlON 6 
11.4.1 Questions for knowledge of symptoms of APKD 
In section 6 of questionnaire 3, respondents were asked to state which, if any, of 
a given list of symptoms might be associated with APKD. The results for all respondents 
in the third population are shown in Table 11.4. The total in each row is 47. A few 
respondents did not reply to any of this section, and others omitted certain items. 
Table 11.4 
Third population: 'are the symptoms listed associated with APKD1'. 
Don't know 
Symptom Yes No Sometimes or no reply 
Obesity 7 30 10 
Headache 21 16 10 
Kidney stones 11 2.5 11 
Infection in urine 33 .5 9 
High blood pressure 37 2 11 
Heartburn 15 22 10 
Cloudy urine 32 6 9 
Tiredness 33 4 10 
Digestive problems 19 19 9 
Pain 33 5 1 9 
Itchy skin 23 14 10 
Swollen ankles 23 13 11 
Obesity and kidney stones are not symptoms normally associated with APKD, and 
a majority of respondents knew this. All the other symptoms can be associated with 
APKD, and for eight out of ten of these symptoms the majority of those who expressed 
a view knew this. But Heartburn was thought to be not a symptom by a majority (22 'no' 
against 15 'yes'), and the respondents were divided equally about Digestive problems (19 
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each). It is possible that respondents replied in respect of their own experience, rather 
than about what they knew in general, but there is no way of establishing whether this is 
the case. 
11.4.2 Score for knowledge of symptoms of APKD 
A composite score for each respondent's knowledge of the symptoms of APKD 
was fonned, denoted KDS2, as described in Appendix E. The maximum score was 12 
points. Although there were peaks in the distribution at 0 points and 10 points, the 
bimodality was less marked than the score for knowledge of treatment in questionnaire 1, 
KDSI. 
Analysis using the GLIM system, and including all the explanatory variables 
described in Chapter 9 and also the scores for experience of genetic counselling, EGCS 1 
and EGCS2, showed that the most useful explanatory variable was the combined factor 
for age and number of children, which was significant at a 1 % probability level. It 
explained 26.7% of the original variance. 
The mean scores for each combination of age group and number of children group 
are shown in Table 11.5. The mean scores for those aged 45 and over are lower than 
those for younger ages, and the mean scores for those with 3 or more children are lower 
than the scores of those with fewer children. 
Table 11.5 
Third population: mean scores for knowledge of symptoms of APKD (KDS2), 
classified by age group and number of children. 
Age group 
up to 44 
45 and over 
185 
Number of children 
0-2 
8.32 
4.43 
3 or more 
7.00 
3.57 
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11.5 KNOWLEDGE OF TREATMENT OF APKD: QUES110NNAIRE 3, SECIlON 6 
11.5.1 Questions for knowled2e of treatment of APKD 
In the same section 6 of questioMaire 3, respondents were also asked to state 
which, if any, of a given list of treatments might be used to treat APKD. The answers, 
for all respondents in the third population, are shown in Table 11.6. The total in each row 
is 47. A few respondents did not reply to any of this section, and others omitted certain 
items. 
Table 11.6 . 
Third population: 'are the treatments listed used for treating APKD1'. 
Don't know 
Treatment Yes No Sometimes or no reply 
Water tablets 26 10 11 
Blood pressure tablets 35 1 11 
Kidney machine 35 3 9 
Exercise 18 16 1 12 
Diet 34 4 9 
Kidney transplant 35 2 10 
Rest 25 6 1 15 
A large majority of respondents correctly said that Blood pressure tablets (anti-
hypertensive drugs), Kidney machines (dialysis), Kidney transplants and Diet could be 
used to treat APKD. A smaller majority thought correctly that Water tablets could be so 
used, but about as many thought that Rest would be appropriate, when in fact doctors do 
not usually make any recommendation about this. Respondents were undecided about the 
benefits of Exercise, roughly half each of those who gave a reply saying 'yes' and 'no' 
(18 to 16). Again, doctors do not usually make any specific recommendations about this. 
It is again possible that respondents replied in respect of their own experience, rather than 
about what they knew in general. 
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11.5.2 Score for knowledge or treatment of APKD 
A composite score for each respondent's knowledge of the treatments for APKD 
was formed, denoted KDS3, as described in Appendix E. The maximum score was 5. 
This score too showed some evidence of bimodality, with 9 respondents getting 0 points, 
and the rest getting 3 or more, with the largest number (20) getting the full 5 points. 
Analysis using the GUM systeni, and including all the explanatory variables 
described in Chapter 9 and also the scores for experience of genetic counselling, EGCSI 
and EGCS2, again showed that the most useful explanatory variable was the combined age 
and number of children, which was again significant at a 1 % probability level. This time 
it explained 29.2% of the original variance. 
The mean scores for each combination of age group and number of children group 
are shown in Table 11.7. Again, the mean scores for those aged 45 and over are lower 
than those for younger ages, and the mean scores for those with 3 or more children are 
lower than the scores of those with fewer children. 
Table 11.7 
Third population: mean scores for knowledge of treatment of APKD (KDS3), 
classified by age group and number of children. 
Age group 
up to 44 
45 and over 
Number of children 
0-2 
4.32 
2.43 
3 or more 
2.60 
2.00 
11.6 TOTAL SCORES FOR KNOWLEDGE OF SYMPTOMS AND TREATMENT OF APKD 
Two further scores were formed as totals: the rust was formed as the total score 
in questionnaire 3, the sum of the number of points for knowledge of symptoms and 
knowledge of treatments, i.e. KDS2 plus KDS3, denoted KDS4. The maximum score was 
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17 points. The second totals score was formed as the total score for knowledge of the 
symptoms and treatment for APKD in the two questionnaires combined, i.e. KDS 1 plus 
KDS4, denoted KDS5. The maximum score was 24 points. Both of these scores are 
available only for the third population. 
The fast totals score, KDS4, like its component parts, showed evidence of 
bimodality, with a small peak at 0 points·(7 respondents) and the rest of the distribution 
peaking at 15 points, though the peak is very flat. 
This score is the sum of two scores which· were highly correlated (correlation 
coefficient 0.82), and for both of which the variable combining age and number of 
children was the most useful explanatory one. It is not surprising that this variable 
provided the best explanation for this score, again significant at a 1 % probability level, 
and explaining again 29.2% of the original variance. 
The mean scores for each combination of age group and number of children group 
are shown in Table 11.8; they are simply the sum of the mean scores for the component 
parts, KDS2 and KDS3. The scores conform to the same pattern as before. 
Table 11.8 
Third population: mean scores for total score for knowledge of symptoms and 
treatment of APKD (KDS4), classified by age group and number of children. 
Age group 
up to 44 
45 and over 
Number of children 
0-2 3 or more 
12.64 
6.86 
9.60 
5.57 
The final score in this section, KDS5, is the grand total of the scores for 
knowledge of the symptoms and treatment of APKD, both in questionnaire 1 and 
questionnaire 3. The distribution has rather little evidence of bimodality, but is fairly flat. 
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This component parts of this score, KOSI and KOS4, are not closely correlated 
(correlation coefficient 0.01), and these two scores were best explained by different 
variables, severity of disease and education for KDS 1 and age and number of children for 
KOS4. In fact this latter variable explained more of the variance in this case, this time 
significant at a 5% but not at a 1 % probability level, and explaining only 21.9% of the 
original variance. 
The mean scores for each combination of age group and number of children group 
are shown in Table 11.9. The scores conform to the same pattern as before. 
Table 11.9 
Third population: mean scores for grand total score for knowledge of symptoms 
and treatment of APKD (KDS5), classified by age group and number of children. 
Age group 
up to 44 
45 and over 
Number of children 
0-2 
16.11 
11.29 
3 or more 
14.40 
8.86 
11.7 CORRELATIONS BETWEEN SCORES 
Correlation coefficients between the various scores for knowledge of the symptoms 
and treatment of APKD and between them and the scores for experience of genetic 
counselling described in Chapter 10 (EGCSI and EGCS2) were calculated. The scores for 
knowledge of symptoms and of treatment in questionnaire 3 (KDS2 and KDS3) were 
closely correlated, the correlation coefficient being 0.82. The correlation coefficients of 
both these scores with the score for knowledge of treatment in questionnaire 1 (KDS 1) 
were close to zero. 
Five out of six of the correlation coefficients between the scores for knowledge of 
APKD (KDS 1, KDS2 and KOS3) and the scores for experience of genetic counselling in 
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questionnaire 2 (EGCSI and EGCS2) were in the range 0.21 to 0.31, significant at a (one-
sided) S % probability level, but not at a 1 % level. The exception, the correlation 
coefficient between KDS 1 and EGCS2, was close to zero. 
11.8 FuRTHER QUES110NS ON KNOWLEDGE OF APKD: QUES110NNAIRE 3, SECIlON 1 
Respondents to questionnaire 3 were asked what could be done to help someone 
suffering from APKD. 36 out of 47 offered a variety of answers including monitoring, 
control of blood pressure, drugs, dialysis and transplantation. 11 patients said that nothing 
could be done or they did not know of anything. 
These patients were spread through the severity categories almost evenly. The 
majority of patients (8 out of 11) who suggested dialysis were in severity category 3, the 
group who would have most knowledge of dialysis. More patients in severity category 1 
than 3 suggested monitoring. Patients in category 3 need treatment. 
Patients were asked 'what are the medical problems associated with APKD,] , . A 
variety of answers was given, the most common being 'raised blood pressure' (23 
responses) and 'kidneys don't work' (10 responses), as shown in Table 11.10, though a 
number of single features or combinations of features were also given, such as renal 
failure (1 response). One patient (in severity category 3) did not know what the medical 
problems were and two married females (both in severity category 2) thought that there 
were no medical problems. 
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Table 11.10 
Third population: 'what are the medical problems of APKD7', 
subdivided by sex and marital status. 
Single Married 
females females Males Total 
Blood pressure 5 10 8 23 
Kidneys don't work 4 2 4 10 
Other suggestions 1· 2 3 
Combinations of suggestions 2 4 2 8 
Don't know or nothing 2 1 3 
Total 12 20 15 47 
Patients were asked whether they knew of other problems that might be associated 
with APKD. The list of problems given is shown in Table 11.11. Six patients, 2 from 
severity category 2 and 4 from severity category 3, explained that they were 'not whole 
people'. Eleven patients, spread evenly through the severity categories, reported that there 
were no problems. 
Table 11.11 
Third population: 'what other problems of APKD are there7', 
subdivided by sex and marital status. 
Single Married 
females females Males Total 
Pain 2 2 3 7 
'Not a whole person' 2 4 6 
Restricts children 1 3 4 
Blood pressure 1 1 1 3 
Infection 1 1 1 3 
Assorted others 1 3 2 6 
Don't know or none 6 8 4 18 
Total 12 20 IS 47 
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Respondents were asked whether APKD could be described as serious. 23 out of 
the 47 (49%) said that APKD is a serious illness and 13 of these 23 patients were in 
severity category 3 compared with four in severity category 1 and six in severity category 
2. 12 out of the 47 patients said that it could be serious or was moderately serious but 
only 2 of these patients belonged to severity category 3. 
These rather diverse questions were not consolidated into a single score. 
11.9 DISCUSSION 
APKD is not only an illness of variable age of onset, it is also an illness of several 
symptoms, and it may be that the absence of one major symptom could make it difficult 
for patients to have a totally accurate knowledge of the symptoms. 66 % of the respondents 
had been told about the presence of cysts in APKD. The majority of patients knew about 
the availability of anti-hypertensive therapy, transplant and haemodialysis as possible 
treatments for APKD and in the fust interview it was not surprising to flOd that those with 
the highest degree of severity of illness were much better informed. 
Analysis of the results of knowledge of symptoms and treatment in the third 
interview showed that patients were really very well informed about symptoms and 
treatment of APKD with 26 out of 47 (55 %) knowing about at least 8 out of the 12 
symptoms, and more than half knowing about each individual symptom correctly. In 
addition 31 out of 47 (66%) knew about at least 4 of the S treatments and the majority of 
patients knew about each individual treatment. 
From the results of the third questionnaire (Table 11.4) it can be seen that many 
patients were aware that hypertension, urinary tract infection and pain might all be 
associated with APKD. While half the patients said that blood pressure was a medical 
problem of APKD, fewer than half suggested diet as a possible means of controlling blood 
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pressure. This may reflect the lack of professional acceptance of the efficacy of the early 
introduction of diet to control hypertension in APKD, rather than simply lack of 
knowledge on the part of the patients. If diet is shown to be effective in the control of 
hypertension in APKD, then the use of diet may be helpful to the patient by giving them 
a feeling of some control over their Ulness. For this reason the relationship between diet 
and hypertension should be more widely understood by patients. 
Diet is an important part of the treatment of patients in renal failure and for 
patients on haemodialysis (Gardner 1981). It is also a part of treatment that many patients 
in this study found difficult and restrictive. 
Fewer than half the patients knew about CAPO. It is not surprising that CAPD as 
a method of dialysis, and often described by patients as the 'bag', is not so well known. 
It is a relatively new form of dialysis. Furthermore pictures of patients on dialysis usually 
show patients on haemodialysis and in this study patients tended to refer to 'going on the 
machine' when describing the principle of dialysis as a method of treatment for APKD. 
It would seem important for patients that wider publicity be given to all the different 
forms of dialysis. 
Open ended questions about the medical problems associated with APKD and what 
can be done to help were asked of patients in the third questionnaire. It is interesting to 
note that there were as many respondents who said that nothing could be done as there 
were who suggested monitoring, dialysis and control of blood pressure. If this fmding is 
a true reflection of what patients believe, it could affect whether patients were prepared 
to have presymptomatic diagnosis. 
The respondents' knowledge of APKD was ascertained by examining their 
knowledge both of the symptoms of APKD and of the treatments that are available. 
Questions about this knowledge were asked in both interviews 1 and 3. The questions in 
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the two interviews were not, however, identical. In questionnaire 1 the questions were 
necessarily of a more exploratory nature in order to find out what the patient knew about 
the illness without raising anxiety whereas it was possible by the time of the third 
questionnaire to ask more detailed and specific questions. 
The analysis of the knowledge of treatment in questionnaire 1 shows that severity 
of illness was a significant explanatory variable. This is not a surprising fmding. It has 
already been stated that there had not been a special programme at the Renal Unit at GR! 
for genetic counselling for patients with APKD. Therefore the knowledge of patients is 
likely to have depended on their own experience. It might also have depended on the 
strength of their family history but the GUM analysis did not show this to be a significant 
variable. Level of education was a statistically significant variable; but the important 
observation here was the interaction between the level of education and severity of illness. 
For those respondents with a low educational level, severity of illness was an important 
factor in their knowledge, whilst for respondents with a higher educational level severity 
of illness was a less important factor. 
It would not have been unreasonable to have assumed that these same two variables 
would have been equally significant in the analysis of the patients' knowledge of the 
symptoms and treatment of APKD in questionnaire 3. However, this was not the case. In 
this second analysis of knowledge of symptoms and treatment two other variables were 
influential, expressed in the combined factor for age and number of children. It is not 
altogether obvious why these different factors should become important in the second part 
of this analysis. It is possible that by the time of the third interview the research project 
itself was having an influence on information given to patients. Medical, nursing and other 
ancillary staff were interested in the project, and the research worker had control only of 
information that she herself gave to patients. In the third population those who were 
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younger were more knowledgeable about the symptoms and treatment of APKD. This 
higher knowledge amongst younger people may reflect the possibility that they had been 
given information more recently, although there is no direct evidence of this; it may also 
be the case that younger people now have a greater general knowledge of biology; there 
may also be a general trend for greater knowledge in health matters amongst younger 
people. 
Those who had fewer children were also more knowledgeable about the symptoms 
and treatments of APKD analysed in the third questionnaire. It is difficult to suggest 
reasons why this should be so. 
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KNOWLEDGE OF GENETIC INHERITANCE AND TRANSMISSION OF APKD 
12.1 INTRODUcnON 
The patients' understanding and knowledge of the genetic inheritance and 
transmission of APKD was elucidated by' questions in the first and the third interviews. 
Their responses are reported in Appendix F and are discussed in this chapter. 
12.2 KNOWLEDGE OF INHERITANCE IN FIRST QUFSI10NNAIRE 
12.2.1 Questions and basic results 
Section 5 of the first questionnaire was concerned with what the patients knew 
about the inheritance and transmission of APKD. Ten questions were asked, but some of 
these questions were not relevant for some respondents. 
Respondents were first asked whether they could describe how they got the 
condition. The word 'got' was used in order to allow respondents describe how they 
thought the illness was acquired, whether genetically or otherwise. More than half (38 out 
of 71 or 54 %) knew correctly how they had got the condition. A higher proportion of 
females than of males (27 out of 44 or 61 % as opposed to 11 out of 27 or 41 %) knew 
correctly how they got the condition. Among the women were six who were aged under 
35 and who had been screened for APKD, and two who had been diagnosed when they 
were pregnant. It is possible that these women were given information about APKD in the 
screening process. It is also possible that more information is given to women because 
they are the ones who have the children and that because women are the child bearers they 
are more interested in seeking information about problems that they or their child may 
have. 
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Respondents were next asked whether the disorder 'ran in the family' • 48 patients 
(68%,32 females and 16 males) knew that the disorder ran in the family, compared with 
12 (17%, 8 females and 4 males) who said that it did not run in the family. There were, 
however, 8 patients (4 females and 4 males) who said that the disorder 'did not seem to 
run in the family', 1 male who recorded that he did not know and 2 males who were not 
sure. 
The fact that 48 patients (67%) knew that the disorder ran in the family compared 
with 38 who knew how they got the condition might be explained by a misunderstanding 
of the question by the respondents. It is also possible that patients knew that the disorder 
ran in the family but did not "express their answer to 'how did you get the condition'?' as 
an inherited or familial condition. 
Every one of the 24 with a strong family history (Grade 3) said that APKD did run 
in the family, as did most of those (21 out of 29) in family history Grade 2. 
The respondents were next asked whether APKD was inherited. 51 out of the 71 
(72 %) (33 females and 18 males) knew that APKD was inherited. In addition 8 patients 
(7 males and 1 female) answered that it seemed to be; 6 of these had no affected relatives, 
including 4 who had not been sure about whether APKD ran in the family; the other 2, 
however, had affected relatives and said that it ran in the family, so their answers were 
inconsistent. 
All the 6 who said that it was not inherited also said that it did not run in the 
family and had no affected relatives. The S who did not know whether APKD was 
inherited included 1 who had no affected relatives, 1 who had affected sibs, but believed 
it not to run in the family, and 3 who had affected relatives and said that it did run in the 
family. 
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The patients were then asked how the condition was inherited. 29 out of the 71 
(41 %) (13 females and 16 males) did not know how APKD was inherited, and a further 
22 (31 %) (15 females and 7 males) were unsure. Only 6 (8%) (2 females and 4 males) 
got the answer almost correct. 2 patients thought that APKD skipped generations and 5 
patients that it only affected members of the same sex. 
Patients were then asked whether APKD could be passed on. 57 out of the 71 
(80%) (34 females and 23 males) knew that APKD could be passed on, but 11 (15%) (7 
females and 4 males) did not know; included in these 11 were 9 who had given uncertain 
answers to some of the previous questions. None asserted that it could not be passed on. 
21 out of 24 in family history grade 3 and all the 29 in family history grade 2 said that 
it could be passed on. 
Patients were then asked how APKD was passed on. Only 10 out of the total of 
71 answered correctly (8 females and 2 males); 22 (9 females and 13 males) did not know 
how it was passed on; and 25 (17 females and 8 males) were unsure. 2 females stated that 
it was passed from mother to daughter (only one of these thought it was inherited in the 
same way), 1 female and 1 male thought that it skipped generations (neither of whom 
thought that it was inherited the same way), and 1 male reported that it was transmitted 
by a germ. This last was not a misunderstanding. The patient was quite emphatic that the 
condition was caused and passed on by a germ. It is clear from the results of this question 
that the great majority of patients did not understand the autosomal dominant transmission 
of APKD. 
Different words including inherited, genetic and familial have been used to 
describe genetic disorders such as APKD. The next question for respondents was: 'is 
APKD a genetic disorder?'. 42 out of 71 (59%) (30 females and 11 males) knew that 
APKD is a genetic disorder compared with 24 (34%) (10 females and 14 males) who did 
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not. 3 patients (2 females and 1 male) were unsure. The one who believed that it was not 
genetic was quite consistent in her views: it did not run in her family, it was not inherited, 
it was not genetic; she was herself affected (severity grade 2), and the medical records 
showed that her father had died of APKD, though she claimed to have no affected 
relatives. 
The question about whether the patient knew his or her own risk of inheriting 
APKD was not asked of 56 out of the 71 patients (79 %) at this stage, since it was clear 
to the researcher that the method of transmission was problematic and potentially 
distressing to these patients. 
For the same reasons 18 patients were not asked about whether they knew the risk 
to their children. Of the 53 patients who were asked about their knowledge of this, 36 
(68%) (24 females and 12 males) did not know the risk compared with 17 (32%) (10 
females and 7 males) who did know. Many more knew the risk for their (or any) children 
to inherit than knew the risk for themselves. 
12.2.2 Score for knowledge or inheritance in questionnaire 1 
Certain of the questions in questionnaire 1 about the genetic inheritance of APKD 
were used to form a composite score for the respondents' knowledge of genetics, denoted 
KIS I and described in Appendix F. The maximum score was 5 points. A score of 4 or 
5 represents good knowledge of the inheritable nature of APKD, even if the precise details 
were not known; a lower score indicates some uncertainty at least about the terminology 
used. The average score was 3.5 and 31 out of the 71 (44%) got the full 5 points, with 
a further 9 (13 %) getting 4 points. 
Analysis using the GLIM system of the score for knowledge of inheritance, KIS 1, 
using all the possible explanatory variables described in Section 9.13 and including the 
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first population showed that the only factors to produce effects significant at a 1 % 
probability level were family history and housing. Family history accounted for 41.7% 
of the original variance, and housing an extra 7.4%, making 49.1 % in all, quite a 
substantial reduction in the original variance. 
Further analysis using also the scores for experience of genetic counselling 
(EGCS 1 and EGCS2) and including the" second population showed that again family 
history and housing were significant at a 1 % level, explaining 48.3% of the original 
variance, but score EGCSI explained a further 4.5%, significant at a 5%, though not at 
a 1 %, probability level. The correlation coefficient between scores KIS 1 and EGCS 1 was 
0.44, so by itself it would explain 19.1 % of the variance, but this is reduced when this 
factor is brought in after other and more powerful factors. 
The components of the mean score for the two populations are shown in Table 
12.1, and the mean scores for those with each combination of family history and housing, 
using the results from the fll'st population, are shown in Table 12.2. Those with higher 
grades of family history (2 and 3) have better knowledge of the genetic inheritance of 
APKD than those with lower grades, to the extent of about 2.S points more, and those 
who are owner occupiers have better knowledge than tenants to the extent of about one 
point. 
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Table 12.1 
First and second popUlations: components of mean scores 
for knowledge of inheritance in questionnaire 1 (KIS1). 
Element 
Overall mean 
Family history: 
Grade 0 
Grade 1 
Grade 2 
Grade 3 
Housing: 
Owner-occupier 
Tenant 
Per unit of EGCS 1 
Population 
First Second 
3.46 
-1.80 
-1.90 
+0.60 
+0.67 
+0.60 
-0.37 
Table 12.2 
3.SS 
-1.28 
-1.78 
+0.S4 
0.41 
+0.62 
-0.36 
+0.21 
First population: mean scores for knowledge of inheritance in questionnaire 1 
(KIS1), classified by family history and housing. 
Owner 
Family history occupier Tenant 
Grade 0 2.27 1.29 
Grade 1 2.16 1.19 
Grade 2 4.67 3.70 
Grade 3 4.74 3.76 
12.3 DISCUSSION OF KNOWLEDGE OF INHERITANCE IN QUES110NNAIRE 1 
Genetic counsellors often describe their work as a ·communication process that 
deals with the human problems associated with the occurrence, or risk of recurrence, of 
a genetic disorder in the family· (Thomas 1986 p12S). The patient's comprehension of the 
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risk of occurrence of a particular disease is often used as an outcome measure in genetic 
counselling studies as well as an indicator of possible reproductive behaviour (see 
Chapter 2). The fact that the patient may be able to repeat the risks correctly one month 
after counselling does not mean that he or she has comprehended the genetic information 
as it would concern their own situation. For example Evers-Kiebooms (1987) in her study 
of cystic fibrosis found that 3 out of 4 parents interviewed reported correctly that the risk 
of having a child with cystic fibrosis was 25 %. However this author went on to say that 
"the knowledge of the autosomal recessive transmission seemed to be rather superficial 
in keeping with other studies" (P14S). 
It is not surprising that patients have difficulties in comprehending genetic risk. 
The language of genetics is unfamiliar and complicated. Different words such as 'genetic' 
and 'inherited' may be used by counsellors to describe the same concept. The words may 
also be rather randomly interchanged by counsellors and individual counsellors may not 
be consistent in their use of the words. 
The focus in the section on knowledge of inheritance in questionnaire 1 was to 
assess what the respondents understood about the genetics of APKD. Genetic risk is 
discussed in Section 12.9 following the analysis of knowledge of inheritance from 
questionnaire 3. 
The results of the analysis of this section show that there is some confusion 
amongst respondents in their knowledge of the genetics of APKD. While the majority of 
respondents (72%) knew that APKD was 'inherited' only 59% reported that APKD was 
'genetic'. It is possible that the word 'inherited' is more familiar to the respondents than 
the word 'genetic' and this should be considered when giving information about the 
genetics of APKD. There may be a further confusion in the use of the expression 'ran in 
the family'. Although 48 out of 71 or 67% of respondents knew that the disorder ran in 
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the family, this does not mean that these respondents understand that the disease is 
genetically transmitted. It may simply mean that in the case of these patients the illness 
appeared to run in the family. If this assumption is correct then there may be a 
communication gap between the lay language of 'run in the family' and the language of 
the professionals which includes 'genetic'. 
It would not be unreasonable to aSsume that, for those who are not familiar with 
Mendelian patterns of inheritance, it may not be initially obvious that if a disease is 
inherited then there is the possibility that it can be passed on to the next generation. 
However although analysis showed that 80 % of respondents said that APKD could be 
passed on, only a small minority understood correctly how APKD is passed on. In this 
analysis, those respondents with a strong family history had better knowledge of the 
inheritance of APKD. While this result is possibly not surprising it would be important 
that counsellors do not assume that those with a strong family history always understood 
the correct pattern of inheritance. However, unless the pattern of inheritance is explained 
correctly, even in the presence of a strong family history patients are likely to base their 
knowledge on the experience in their own family, which mayor may not be genetically 
correct. 
12.4 KNOWLEDGE OF INHERITANCE OF APKD: QUES110NNAIRE 3, SEC'IlON 5 
12.4.1 Questions and basic results 
In Section S of questionnaire 3 five questions were asked about the patients' 
understanding of the genetics of APKD. These were of 'multiple choice' form, in that the 
respondent was asked to select one from a specified set of answers. 
The first question was: 'how is APKD passed on1'. 34 out of the 47 respondents 
(72 %) stated that APKD is passed from generation to generation (the only correct 
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statement in this question). The misconceptions about transmission were that APKD is 
passed from female to female (2 patients), that it is passed from female to male (1 patient) 
and that it is passed from male to female (2 patient). 
The next two questions were: 'what is the risk of inheriting APKD1' and 'what is 
the risk of passing on APKD1'. To both these questions the greatest number of 
respondents (25 and 22 or S3% and 47% respectively) thought that the risk was a medium 
risk. 12 respondents thought that the risk of inheriting APKD was a big risk and 13 
respondents thought the risk of passing on APKD was a big risk, of whom 9 were female. 
Table 12.3 shows the results for these questions subdivided by severity of disease. 
There was a tendency for patients in severity groups 2 and 3 to say that the risk was a big 
risk. 
Table 12.3 
Third population: subdivided by severity of disease. 
Grade 1 Grade 2 Grade 3 Total 
(a) 'what is the risk of inheriting APKD,]' 
A big risk 2 3 7 12 
A medium risk 9 8 8 2S 
A small risk 3 1 4 
Don't know or no reply 1 1 4 6 
(b) 'what is the risk of passing on APKD1' 
A big risk 2 S 6 13 
A medium risk 8 7 7 22 
A small risk 1 2 2 S 
Don't know or no reply 1 1 S 7 
Total 12 IS 20 47 
Respondents were then asked: 'when does APKD skip generations']'. Slightly more 
patients (21 out of 47 or 4S %) said that APKD never skips a generation compared with 
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19 (40%) who thought that APKD sometimes skips a generation. Autosomal dominant 
disorders such as APKD do not normally 'skip' a generation. Each child of an affected 
parent has a 50-50 chance of inheriting the gene for APKD. A parent may die 
prematurely, for example from an accident, before they have either presented with or 
developed symptoms of APKD and in these circumstances an affected offspring of that 
person may think that the condition has 'skipped' a generation. 
The fmal question in this section was: 'the risk of inheriting APKD is •• ", and 
the possible replies were specific numbers. More than half of the respondents (29 out 47 
or 62 %) gave the answer as 50-50 with another 1 patient who said 1 in 2 and 1 patient 
who gave both these answers. Therefore 31 out of 47 patients (66%) gave the correct 
answer. 
12.4.2 Score for knowledge of Inheritance In questionnaire 3, section 5 
A composite score was constructed from the answers to the questions in this 
Section, denoted KIS2 and described in Appendix F. The maximum score was 4 points. 
The average score was 2.8 points, with 16 respondents (34%) getting the full 4 points, 
and another 16 getting 3 points. 
Analysis of this score using the GUM system and considering all the possible 
explanatory variables described in Section 9.13 showed that the variable that had the most 
significant effect was the factor combining age and number of children, which was 
significant at a 1 % probability level. Once this was taken into account no other factor had 
a significant effect. This factor accounted for 33.7 % of the original variance of the score. 
The mean scores for those in each combination of age and number of children are 
shown in Table 12.4. Those who have a larger number of children (3 or more) had less 
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knowledge of this aspect of genetic inheritance than those with fewer children or none. 
Those under 45 with fewer than 3 children had the best knowledge. 
Table 12.4 
Third population: mean scores for knowledge of inheritance of APKD (KIS2), 
classified by age group and number of children. 
Age group 
up to 44 
45 and over 
Number of children 
0-2 
3.36 
2.14 
3 or more 
1.60 
1.86 
12.5 KNOWLEDGE OF TRANSMISSION OF APKD: QUES110NNAIRE 3, SECI10N 5 
12.5.1 Questions and basic results 
In Section 5 of questionnaire 3 six further questions were asked about the patients' 
understanding of the risks of transmitting APKD, with one question about the presence 
of symptoms. These too were of multiple choice form, in this case asking whether the 
given statements were true or false. 
The first two statements were: 'all children of a person with APKD will develop 
the condition' and 'on average half the children of a person with APKD will develop the 
condition'. 27 out of 47 respondents (57 %) knew that on average half the children of an 
affected parent with APKD will develop the illness. 4 patients (3 females and 1 male) 
thought that all the children of an affected parent would develop APKD. 
The next two statements were: 'on average half the children of a person with 
APKD are at risk of developing the condition' and 'all children of a person with APKD 
are at risk of developing the condition'. Respondents were less sure when asked whether 
on average half the children of an affected person are at risk or all the children of an 
affected person are at risk. 14 respondents thought that on average half the children of an 
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affected parent are at risk of developing the problem and 20 out of 47 (43 %) thought that 
all the children were at risk of developing the problem. 
The next statement gave a choice of three mutually contradictory statements: 'a 
person with APKD sometimes (always/never) has a parent with APKD'. 29 out of 47 
(62 %) gave the correct answer, 'always', whereas 6 said 'sometimes', and 1 said 'never'; 
3 respondents gave two contradictory replies as true. 
The fmal statement in this section gave a choice of two mutually contradictory 
statements: 'APKD always (sometimes) has symptoms'. Replies were evenly divided 
between 'always' and 'sometimes', with 18 (34%) each; 2 respondents gave contradictory 
replies as true. 
12.5.2 Score for knowledge of transmission In questionnaire 3, section 5 
A composite score was constructed from the answers to the questions in this 
Section, as described in Appendix F, and denoted KIS3. The maximum score was 5 
points. The average score was 3.0. 12 respondents (26%) got the full 5 points, 6 (13%) 
got 4, and 13 (28%) got 3 points, so well over half were reasonably well informed by the 
time of this third interview. 
Analysis of this score using the GLIM system showed that the factor that had the 
most significant effect was again that combining age and number of children, which was 
significant at a 1 % probability level. After this was taken into account the only other 
factor that had a significant effect was one of the scores for experience of genetic 
counselling, EGCS2; the correlation coefficient between KIS3 and EGCS2 was 0.44, 
significantly different from zero at a 1 % level. The combined factor accounted for 42.5 % 
of the original variance, and EGCS2 for a further 6.0%, making a total of 48.5%. 
207 
CHAPTER 12: ANALYSIS: KNOWLEDGE OF GENETIC INHERITANCE AND TRANSMISSION 
The components of the mean score for those in each combination of age and 
number of children and for each unit of EGCS2 are shown in Table 12.5. Those who 
were 45 or over had less knowledge of this aspect of genetic inheritance than those who 
were younger. Those under 45 with fewer than 3 children had the best knowledge. 
Table 12.5 
Third population: components of mean scores 
for knowledge of transmission of APKD (KIS3). 
Element 
Age and number of children: 
~44, ~2 
~44, ~3 
~45, ~2 
C!: 45, C!: 3 
Per unit of EGCS2 
Component 
3.28 
2.41 
0.72 
1.43 
+0.16 
12.6 KNOWLEDGE OF INHERITANCE OF APKD: QUESTIONNAIRE 3, SECTION 1 
12.6.1 Questions and basic results 
At the beginning of the third interview respondents were asked a variety of 
questions to ascertain their knowledge of APKD, the rust of which was: 'how did you get 
APKD'1'. The majority of patients (41 out of 47,28 females and 13 males) said that they 
got the condition because it was a hereditary condition. 4 patients (3 females and 1 male) 
replied that they did not know how they got APKD. 1 female patient explained that she 
developed APKD as a result of pregnancy and 1 male patient said that he had become 
affected as a result of pain. 
Respondents were asked how APKD is discovered in patients. The answers reflect 
the different ways in which APKD came to be diagnosed. 16 patients (15 females and 1 
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male) said that it is discovered through the hereditary nature of APKD. It is interesting 
that so many women answered the question in this way. It is possible that because women 
give birth they are more aware than men of hereditary illness. However it is also possible 
that doctors are more likely to give information about inherited illness to women. 5 males 
and 5 female patients gave blood pressure as the reason for discovering about APKD and 
6 married women answered 'during pregnancy'. 
Respondents were asked whether APKD could be caught. Almost all the patients 
(43 out of 47 or 91 %) knew that APKD could not be caught. However 3 patients (2 
married females aged 25-34 and 1 male aged 35-44) said that APKD could be caught and 
1 male patient in the age group 45-54 and in severity group 3, did not know whether or 
not APKD could be caught. 
Patients were asked whether APKD could be prevented. A majority (35 out of 47 
or 74%) thought that APKD could not be prevented. 2 patients (1 female and 1 male) said 
that the condition could be prevented but were unable to specify how this could be done. 
9 patients (3 single females, 3 married females and 3 males) said that APKD could be 
prevented by the affected person having no children. 
12.6.2 Score for knowledge of inheritance In questionnaire J, section 1 
These questions also formed the basis of a composite score, as described in 
Appendix F and denoted KIS4. The maximum score was 3 points, the average was 2.0, 
and 28 out of the 47 (60%) got 2 points, with the rest splitting almost equally between 1 
and 3 points (9 and 10 respectively). 
Analysis of this score with the GLIM system showed not one explanatory variable 
that had any significant effect. 
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12.7 TOTAL SCORES FOR KNOWLEDGE OF GENE'I1C INHERITANCE 
Two further scores were formed as totals: the first, denoted KISS, was formed 
as the total score in questionnaire 3, the sum of the number of points for the three sections 
described above, KIS2, KIS3 and KIS4, combined. The maximum score was 12 points, 
and the average 7.7. The fmal total score, denoted KIS6, was formed as the total score 
in the two questionnaires combined, the sum of the score for questionnaire 1, KIS 1, and 
the total score for questionnaire 3, KISS. The maximum score was 17 points and the 
average was 11.6. 
The average scores for the questionnaire 3 total, KISS, and for the grand total, 
KIS6, subdivided by sex and marital status, by family history and by age and number of 
children, are shown in Tables 12.6, 12.7 and 12.8. 
Table 12.6 
Third population: average scores for questions on knowledge of inheritance of 
APKD (KISS and KIS6), subdivided by sex and marital status. 
Single Married 
females females Males Total 
Total score in 9.1 7.8 6.6 7.7 
questionnaire 3, KISS 
Total score in 12.7 12.1 10.1 11.6 
questionnaires 1 and 3, 
KIS6 
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Table 12.7 
Third population: average scores for questions on knowledge of inheritance of 
APKD (KISS and KIS6), subdivided by family history. 
Total score in 
questionnaire 3, KISS 
Total score in 
questionnaires 1 and 3, 
KIS6 
Grade 1 Grade 2 Grade 3 
5.8 7.3 9.0 
7.0 11.3 13.5 
Table 12.8 . 
Total 
7.7 
11.6 
Third population: average scores for questions on knowledge of inheritance of 
APKD (KISS and KIS6), subdivided by age and number of children. 
Total score in 
questionnaire 3, KISS 
Total score in 
questionnaires 1 and 
3, KIS6 
S44, s2 S44, ~3 ~45, s2 ~45, ~3 Total 
9.2 6.4 5.4 5.1 7.7 
13.1 10.4 9.4 8.7 11.6 
It would be reasonable to expect that a factor that had been relevant in explaining 
the variation in a part of any total score might contribute also to the explanation of the 
total. Analysis of the first total score, KISS, showed that only one factor had a significant 
influence, again that combining age and number of children, which explained 61.5 % of 
the original variance. No other variable made any significant contribution. 
The mean scores are shown in Table 12.9. Again those under age 45 with fewer 
than 3 children have the highest score. 
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Table 12.9 
Third population: mean scores for knowledge of inheritance of APKD in 
questionnaire 3 (KISS), classified by age group and number of children. 
Age group 
up to 44 
4S and over 
Number of children 
0-2 
9.21 
5.43 
3 or more 
6.40 
5.14 
Again it would be reasonable to expect that a factor that had been relevant in 
explaining the variation in a part of the total might contribute also to the total. Analysis 
of the fmal total score, KIS6, showed that the first two candidates were family history and 
the combined factor for age and number of children, both significant at a 1 % probability 
level. No other factor had any significant effect; the experience score EGCS2 was next, 
but not at a 5 % level. 
The mean scores are shown in Table 12.10. (Note that there were no respondents 
with family history grade 0 (unaffected) in this population.) Those in the family history 
grade 3 have the highest mean score, the other grades having significantly lower scores. 
The components for the two explanatory variables, relative to the mean score of 
11.62, are shown in Table 12.10, and the expected scores for the two variables are shown 
in Table 12.11. 
This analysis shows that family history is the strongest single factor overall and 
particularly of the larger first population in explaining variation in knowledge of genetic 
inheritance. Those with a stronger family history have a better appreciation of the 
genetics. Within the third population age and number of children were relevant. Those 
who were aged less than 45 and had fewer then 3 children had the best knowledge. 
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Table 12.10 
Third population: components of mean scores 
for total knowledge of inheritance of APKD (KIS6). 
Element 
Overall mean 
Family history: 
Grade 1 
Grade 2 
Grade 3 
Age and number of children: 
S44, s2 
S44, ~3 
~45, s2 
~45, ~3 
Table 12.11 
Component 
11.62 
-4.00 
-0.11 
+1.34 
+1.20 
-1.69 
-1.73 
-1.89 
Third population: mean scores for total knowledge of inheritance of APKD (KIS6), 
classified by family history and by age and number of children. 
Age and number of children 
Family history S44, s2 S44, ~3 ~45, S2 ~45, ~3 
Grade 1 8.83 5.94 5.89 5.73 
Grade 2 12.71 9.82 9.78 9.62 
Grade 3 14.17 11.28 11.24 11.08 
12.8 CORRELADONS BETWEEN SCORES 
Correlation coefficients were calculated for each of the scores for knowledge of 
inheritance with each other, and with the scores for experience of genetic counselling 
(EGCS 1 and EGCS2) and the scores for knowledge of the symptoms and treatment of 
APKD (KISI to KIS6). There were only small coefficients between many of the scores, 
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but the scores for knowledge, both of symptoms and treatment and of the inheritance of 
APKD, in the third questionnaire, with the exception of KIS4, were reasonably highly 
correlated, as shown in Table 12.12. 
Table 12.12 
Third population: correlation coefficients for scores for knowledge of symptoms 
and treatment (KDS2 and KDS3) and of genetic inheritance (KIS2 to KIS4). 
KDS2 KDS3 KIS2 KIS3 KIS4 
KDS2 
KDS3 
KIS2 
KIS3 
KIS4 
1.00 
0.82-
0.59-
0.67-
0.13 
1.00 
0.52-
0.62-
0.01 
1.00 
0.72- 1.00 
0.17 0.18 1.00 
Note: - indicates that the coefficient is significantly different from zero at a 1 % 
probability level. 
12.9 DISCUSSION OF KNOWLEDGE OF INIIERITANCE IN QUESTIONNAIRE 3 
There are three particular areas of interest in the questions on the knowledge of 
inheritance in the third interview. The first concerns the patient's understanding of whether 
the risk of inheriting APKD is a small, medium or big risk. The second area concerns the 
patient's understanding of the transmission of APKD and specifically whether this means that 
all the children of an affected person are at risk or whether half the children of an affected 
person are at risk. The third area of interest is concerned with the patient's understanding 
of whether APKD can be prevented. 
Researchers have found that the interpretation of statistical probability is highly 
subjective (pearn 1973). What one patient may think of as a high risk may be a medium risk 
for another patient or even a low risk. Wexler (1979), in her study of Huntington's chorea, 
an autosomal dominant illness that the author herself is at 50% risk of inheriting, emphasised 
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that a SO-50 risk of inheriting Huntington '5 chorea always means for an individual person a 
100% certainty that the person will either develop or not develop the illness. The question 
being asked in this study concerned the size of the risk perceived by patients of inheriting 
APKD as I believe that it may be easier for people to understand and make sense of risk 
when described as small, medium or large. 
The majority of respondents thought that both the risk of inheriting APKD as well as 
the risk of transmitting APKD was a medium risk. In addition 66 % of respondents knew that 
the risk of inheriting APKD was 50-50. Within clinical genetics if the risk of transmission 
of a disease is greater than 1 in 10, the risk is generally considered to be a high risk and 
amongst professionals would be described as such. However, it is not illogical for patients 
to believe that a risk of 50-50 of inheriting APKD is a medium risk; the chances each way 
are the same. Patients were not asked in this study what size of risk they would consider a 
big risk. It may be that the risk of inheriting APKD would need to be nearer 100% before 
patients perceived the risk as a big risk. There is a danger that because many of those 
offering genetic counselling may themselves perceive a SO-SO risk as a high risk, they may 
assume that the patients' belief system is the same. 
It can be seen from Table 12.3 that there was a tendency, not statistically significant, 
for the more severely affected patients to consider the risk to be high. It is possible that the 
assessment of probability by an individual patient may vary according to how they were 
feeling and according to their mood. In an optimistic state of mind the risk of transmitting 
APKD to their offspring may seem a medium risk to an affected person. However, when that 
patient is severely affected by APKD, the effect of the illness may make them perceive the 
risk more pessimistically. Wexler (1979) suggests that such perceptions may change 
depending upon the mental state of the patient and the change may be from moment to 
moment, day to day and month to month. 
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It is arguable that the difficulties inherent in the language of genetics are reflected in 
this study in the respondent's understanding of the risks of transmitting APKD, with 
considerable uncertainty about whether on average half the children of an affected person are 
at risk of developing APKD or all the children of an affected person are at risk. The 
questions asked of respondents in this section were quite complicated and it is possible that 
some respondents had become quite ill and had difficulty in concentrating. Older respondents 
had a poorer knowledge of inheritance and they were more likely to be more ill. However, 
if patients are to make informed choices on the basis of information given in genetic 
counselling, then it is essential that patients know that all the children of an affected person 
are at risk of inheriting APKD. These flOdings point to the need for great care to be taken 
by genetic counsellors in their choice of words used to explain genetic transmission. 
Respondents were asked whether they thought that APKD could be prevented. 74 % 
of respondents responded that APKD could not be prevented, with only 9 patients saying that 
APKD could be prevented by affected people not having children. It is perhaps not surprising 
that so few patients appeared to know that APKD can be prevented by the affected person 
not having children. This is a very radical form of prevention of an illness. It is possible that 
many people would consider prevention to include actions such as changing their diet, or 
giving up smoking or following a course of medication. 
Finally, the importance of the strength of family history in patients understanding of 
inheritance and transmission of APKD should be noted. Patients may bring to genetic 
counselling an expertise of knowledge based on the experience in their family. This 
information may be quite correct. However, it is also possible that either because of the lack 
of total information within their family or because of the vagrancies of chance in that, for 
example, the illness had only affected one sex, the information is inaccurate. The task for 
the counsellor is to elicit this information and present it appropriately to the patient. 
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13.1 PERCEP110N OF PROBLEMS: FIRST QUES110NNAIRE 
Respondents to questionnaire 1 were asked to identify from a list of 28 topics 
which of these topics were problematic for the respondents and to indicate on a 6 point 
scale how problematic they were. The grades on the scale were: 
1 Not applicable 
2 Not important 
3 Slight importance . 
4 Quite important 
5 Very important 
6 Extremely jmportant 
Of the 28 problems: 
11 topics (1-11) were associated with the physical symptoms of kidney 
disease and lddney failure. 
4 topics (12-14 and 22) were associated with restriction on the patients 
physical activity. 
6 topics (16-21) related to Job, Income and abllity to remain a 
breadwinner. 
8 topics (15 and 23-29) were related to relationships, marria,e and 
tensions that may be caused by having a chronic and a genetic 
illness. 
The responses were scored by using 'ridit' analysis; according to Agresti (1984), 
ridits were originally suggested by Bross (1958) as appropriate for ordinal scales such as 
these. The methods described by Agresti have been followed for this analysis. The 
advantage of ridit analysis is that it avoids the otherwise arbitrary procedure of assigning 
scores such as 1 to 6 to the different grades of answer, which could imply that the 
respondents thought that, for example, a topic that was seen as 'extremely important' was 
precisely six times as important as one that was 'not applicable'. How ridits are calculated 
and used is explained below. 
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Table 13.1 shows the gradings for each topic for all respondents. Two respondents 
did not complete the questionnaire fully; their answers have been included as far as they 
went; the row totals are therefore variously 71 (topics 1 to 10), 70 (topics 11 to 26) and 
69 (topics 27 and 28). 
The totals of the numbers in each grade from Table 13.1 for all topics have been 
calculated and are shown in Table 13.2. There were 1,968 answers in total, of which 803 
were at grade 1, 'not applicable'. The ridit for grade 1 is calculated by taking half of this 
number (803/2 = 401.5) and by dividing this by the total number of answers (1,968), 
giving a ridit for grade 1 of 0.204. 
There were 625 answers in total in grade 2. The ridit for grade 2 is calculated by 
taking half the number in grade 2 (62512 = 312.5) and adding all the number in grade 1 
(803), giving a total of 1,115.5. This number is divided by the total (1,968) to give the 
rid it for grade 2 of 0.567. 
The ridit for grade 3 is calculated by taking half the number in grade 3 
(243/2 ~ 121.5) together with the total number in grades 1 and 2 (803 + 625 = 1,428), 
giving 1,549.5, and again diving by the grand total of 1,968 to give 0.787. The ridits for 
grades 4, 5 and 6 are calculated similarly. 
The rid it is a measure of the empirical cumulative distribution of answers as at the 
mid-point of each grade. The mean ridit for each topic is then calculated. The average 
ridit for all topics is necessarily 0.5, so any topic with a ridit more than 0.5 is 'above 
average' and any topic with a rid it less than O.S is 'below average'. 
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Table 13.1 
First population: numbers of patients who graded each topic 
in terms of how severe a problem it was. 
Grade 1 2 3 4 5 6 
Not Not Extre-
0 Topic appti- impor- Stiaht Quite Very mely 
cable tant 
1 Lethargy 10 17 19 13 12 
2 Headache 14 25 14 11 4 3 
3 Abdominal pain 23 33 8 4 1 2 
4 Itchiness 25 27 13 2 1 3 
5 Nausea 24 28 10 8 1 
6 Lack of concentration 20 30' 11 5 4 1 
7 Sleepiness 17 26 7 11 9 1 
8 Sickness 28 33 7 3 
9 Moodiness 18 28 11 4 8 2 
10 Back pain 15 17 19 11 8 1 
11 Other physical problems 46 6 6 11 2 
12 Dependence on hospital 34 29 3 2 2 1 
13 Restriction on eating 32 30 4 4 1 
14 Restriction on drinking 35 27 7 2 
15 Feeling different 32 30 7 1 1 
16 Difficulty at work 46 18 5 1 1 
17 Unable to continue job 41 16 5 3 5 1 
18 Remain breadwinner 42 16 5 2 4 2 
19 Loss of job 41 11 9 3 5 2 
20 Loss of income 38 12 11 4 4 2 
21 Reduction in standard of 40 13 9 4 3 2 
living 
22 Restricts physical activity 17 18 17 7 10 2 
23 Puts strain on marriage 34 16 8 8 4 1 
24 Tension in family 30 23 8 6 3 1 
25 Difficult to make plans 29 25 3 5 9 
26 Difficult to keep friends 36 29 5 1 
27 Difficulty with opposite sex 35 20 4 7 4 1 
28 Family1genetic disorder 21 22 8 8 7 5 
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Table 13.2 
First population: total numbers and calculated ridits. 
Grade 1 2 3 4 5 6 Total 
Numbers 803 625 243 148 112 37 1,968 
Ridits 0.204 0.567 0.787 0.887 0.953 0.991 
The Kruskal-Wallis test (Agresti 1984 p182) was used to see whether the grading 
of topics could be assumed to have been picked at random by respondents from the same 
distribution of responses as the total numbers indicate, in which case the mean ridits for 
the topics would not have been significantly different from each other. The Kruskal-Wallis 
test statistic, W, is based on the weighted squares of the deviations of the mean ridits from 
0.5, and it is distributed (asymptotically) as ,( with degrees of freedom equal to one less 
than the number of rows (in this case 27 = 28 - 1). The value of W calculated for this 
table is 193.4, with 27 degrees of freedom, a very significant result. 
Thus not all topics were graded equally by the respondents. The topics have been 
ranked in sequence by their mean ridit and are shown again in Table 13.3 in mean ridit 
sequence with the highest at the top. For each topic the numerical average of the scores 
(1 to 6) was also calculated, and these are also shown in Table 13.3. The ranking! using 
the two measures are similar, but not identical. Most of the differences in ranks occur 
when the mean ridits for the topics and the average scores for the topics are both close 
together. The standard deviations of the scores are also given. These give an indication 
of the 'scatter' of the respondents gradings. 
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Table 13.3 
First population: mean ridit, average score and standard deviation of score 
for each topic which might give problems. 
Ql Mean Average Standard 
seq 0 Topic ridit score deviation 
1 1 Lethargy 0.70 3.00 1.29 
2 10 Back pain 0.65 2.76 1.33 
3 22 Restricts physical activity 0.64 2.76 1.43 
4 2 Headache 0.63 2.65 1.33 
5 7 Sleepiness 0.61 2.61 1.40 
6 28 Family/genetic disorder 0.60 2.67 1.58 
7 9 Moodiness ·0.58 2.46 1.37 
8 6 Lack of concentration 0.55 2.24 1.18 
9 5 Nausea 0.52 2.08 1.07 
10 4 Itchiness 0.51 2.10 1.20 
11 3 Abdominal pain 0.51 2.06 1.11 
12 25 Difficult to make plans 0.50 2.17 1.36 
13 24 Tension in family 0.49 2.06 1.22 
14 23 Puts strain on marriage 0.49 2.10 1.33 
15 27 Difficulty with opposite sex 0.47 2.01 1.30 
16 20 Loss of income 0.46 2.03 1.37 
17 8 Sickness 0.46 1.79 0.79 
18 13 Restriction on eating 0.44 1.77 0.90 
19 19 Loss of job 0.44 1.97 1.40 
20 21 Reduction in standard of 0.44 1.93 1.32 
living 
21 15 Feeling different 0.44 1.73 0.81 
22 12 Dependence on hospital 0.43 1.77 1.03 
23 14 Restriction on drinking 0.42 1.70 0.87 
24 17 Unable to continue job 0.42 1.86 1.29 
25 11 Other physical problems 0.41 1.87 1.34 
26 18 Remain breadwinner 0.41 1.83 1.31 
27 26 Difficult to keep friends 0.41 1.60 0.68 
28 16 Difficulty at work 0.36 1.53 0.92 
Note: column Ql seq gives the sequence in this table; column 0 gives the original 
topic number as in Table 13.1. 
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The difference in level of importance for any two topics can be tested by using the 
Kruskal-Wallis test for the pair of rows, as described by Agresti (1984 pp183-184). For 
two rows this test is a discrete version of the Wilcoxon-Mann-Whitney test, allowing for 
tied ranks. Instead of using the overall ridits which have already been calculated, each pair 
of rows is treated in isolation and pooled ridits are calculated using the numbers in each 
grade for the two rows combined. 
Mean ridits are calculated for each of the two rows, and these necessarily sum to 
unity. The difference of either mean ridit from 0.5 is then compared with the standard 
deviation of this difference, to give a test statistic, z, which has (asymptotically) a unit 
normal distribution. 
Since there is a large number of different pairwise comparisons, Agresti suggests 
that it is appropriate to choose a significance level corresponding to pI d where p is the 
normally desired significance level and d is the number of comparisons. In this case there 
are 378 (= 28 x 27 I 2) different pairwise comparisons. A normal significance level of 
5 % therefore corresponds to one of 0.013 % (= 5 %/378), or to a normally distributed Z 
of about 3.1. A 1 % significance level corresponds to one of 0.0026 % or a z of about 3.8. 
The value of z for the difference between the highest and the lowest mean ridits 
(topics 1 and 16 in the original list) is 6.9, which is very significant. Using a test value 
of z of 3.8 it is observed that topic 1 (lethargy), ranked 1st, is not significantly different 
from any topic down to and including topic 6 (Lack of concentration) ranked 8th; topic 
16 (Difficulty at work), ranked 28th, is not significantly different from any topic up to and 
including topic 4 (Itchiness) ranked 10th; and the middle pair, topics 23 (Puts strain on 
marriage) and 27 (Difficulty with opposite sex), ranked 14th and 15th respectively, are 
not significantly different from any other topic except number 1. The extreme topics are 
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therefore ranked differently by respondents, but many in the middle are ranked at about 
the same level. 
In order to compare the 'concordance' of two topics, i.e. the extent to which 
respondents give similarly ranked grades of importance to the two topics (not necessarily 
at the same overall level), the gamma measure of Goodman and Kruskal (1954) was used, 
following the method described by AgreSti (1984 pl60 for the calculation and p180 for 
the significance test). The gamma measure is defined in terms of C, the number of 
concordant pairs, and D, the number of discordant pairs, taking each pair of respondents 
in the sample and treating them as concordant if one respondent gives higher grades on 
both topics than the other, discordant if the ranking is reversed, and not counting the pair 
if the grades they allocate to either topic are the same. Then: 
gamma = (C - D) I (C + D). 
For large samples the difference (C - D) is nonnally distributed, and the formula 
for the variance is given by Agresti, quoting Kendall (1970). 
The concordance for each pair of topics was calculated, and the value of z, which 
in this case represents the value of the difference (C - D) divided by its standard 
deviation. A significance level for Z of 3.8 was considered interesting, and this 
corresponded in general with a value of gamma of about 0.5. A high level of gamma 
represents close concordance between the gradings given by the respondents. If identical 
grades had been given, the value of gamma would be 1.0. 
The relationship between topics with a high level of concordance can be mapped 
in a diagram, as described for example by Gordon (1981). Figure 13.1 shows such a 
diagram. Each topic is represented by a square box, in which is shown the number of the 
topic as listed in Table 13.1. The outline of the box indicates the mean ridit for the topic, 
those with higher mean ridits having more lines round the box, and those with the lowest 
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mean ridits having dotted lines round the box. The boxes representing pairs of topics that 
have a high concordance are joined by lines, and the value of gamma, multiplied by 100, 
is shown alongside the line. All concordances with a value of gamma at least as great as 
0.5 (lOOgamma ~ 50) are shown, and the strength of the concordance is indicated by the 
heaviness of the line. If a topic, or group of topics, is not sufficiently concordant with any 
other, so that it would remain detached from the other topics, then a dotted line is drawn 
indicating the highest available value of gamma. 
It can be seen that the six topics relating tojob, income and ability to remain a 
breadwinner are all closely concordant with each other, and are detached from the other 
topics except for a medium concordance of 0.44 with topic 7 (Sleepiness). Partly this is 
because respondents divided into those still at work, for whom these topics were 
important, with varying degrees, and those who were not in work and not likely to be, 
for whom these topics were not applicable. 
The topics in the top left part of the diagram, Moodiness, Sleepiness, Lethargy, 
Headache, Back pain and Restricts physical activity, are all physical problems that tend 
to occur in the earlier stages of APKD (but not restricted to the earlier stage). Below them 
is a group of problems that are mainly concerned with the social implications of chronic 
illness. To the bottom right is a group of problems that are concerned with physical 
activity (note that the reference to Drinking means problems with restricting fluid intake, 
not alcohol), and also physical symptoms, Itchiness, Sickness, Nausea, and Abdominal 
pain, that tend to occur in the later stages of APKD. The diagram thus reveals certain 
logical connections between topics. 
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Figure 13.1. Relationships between problems of APKD. 
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13.2 EFFEcr OF EXPLANATORY VARlABLFS 
The effect of different explanatory variables on the gradings given to the topics can 
also be compared. Each topic was assessed first in relation to each of 10 possible 
explanatory variables (sex, age, marital status, number of children, education level, 
occupation, housing, religious affiliation, severity of disease, family history), using a 
Kruskal-Wallis test. This gives 280 comparisons. Using a 2 % probability level, one would 
expect about 6 such comparisons to show apparent. significance, even if the grades had 
been allocated wholly at random. There were in fact 11 comparisons significant at a 2 % 
level, of which 8 were at a 1 % level (denoted * below). There is thus some evidence of 
differences in how certain categories of patient view the problems of APKD, as indicated 
by the explanatory variables, but there is still considerable homogeneity in the population. 
The comparisons which show a significance at a 2 % level arc noted below. 
Age and Moodiness (9): all those over age 44 had lower than 
average rid its for this problem, generally reducing as they got older 
(probability 0.0051*); the younger patients saw Moodiness as a greater 
problem. 
Sex and Abdominal pain (3), Nausea (5) and Sickness (8): Females 
found these three topics much more of a problem than did males. The 
average ridits for females were respectively 0.567, 0.579 and 0.598, 
compared with those for males of 0.390, 0.372 and 0.340. All of these 
were significant at a 1 % level (probabilities respectively 0.0075*,0.0021* 
and 0.0001*). 
Sex and Remain breadwinner (18), Loss of job (19), Loss of income 
(20) and Reduction in standard of living (21): Males found these four 
topics much more of a problem than did females. The average rid its for 
males were respectively 0.614, 0.617, 0.626 and 0.595, compared with 
those for females of 0.429, 0.426, 0.421 and 0.440. Three of these were 
significant at a 1 % level (probabilities respectively 0.0034*, 0.0029*, 
0.0017* and 0.0164). 
Marital status and Puts strain on marriage (23): it is not surprising 
that those who were single found this much less of a problem (average ridit 
0.294) than did those who were married (a.r. 0.573) (probability 0.0007*). 
Number of children and Puts strain on marriage (23): it is also not 
surprising that those who had no children, many of whom were single, 
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found this much less of a problem (average ridit 0.355) than did those who 
had children (probability 0.0149). 
Occupation and Loss of income (20): those who were managers, 
skilled manual, semiskilled manual or agriCUltural workers had mean ridits 
all above 0.6, (probability 0.0164). The significance is not very strong, but 
possibly those who were or had been in these sort of jobs had greater fear 
of redundancy or poorer ill-health pension provision than those in 
professional or clerical jobs who thought this less of a problem. 
Comparisons were also made of the mean ridits for all topics combined within each 
category of the chosen explanatory variables. There were certain interesting tendencies, 
but none that was significant at a 5 % probability level. Each explanatory variable is 
considered below. 
Sex: there was a negligible difference between males and females. 
Age: those 65 and over had a low average ridit (0.335); those 35-54 
had above average ones. 
Marital status: the single (a.r. 0.520) were slightly higher than the 
married (a.r. 0.496). 
Number of children: negligible differences. 
Educational level: those with the highest education level had the 
lowest average ridit (0.435); the others were much the same. 
Occupation: professionals (a.r. 0.327) and farmers (a.r. 0.371) had 
lower figures than others. 
Housing: tenants (a.r. 0.517) had slightly higher figures than owner-
occupiers (a.r. 0.473). 
Church: catholics (a.r. 0.537) were above average; those with no 
church (a.r. 0.472) were below. 
Severity of disease: those with higher severity grades had higher 
average ridits; for grades 0 to 3 they were 0.445,0.486,0.506 and 0.513 
respectively. 
Family history: those with higher family history grades had 
generally higher average ridits; for grades 0 to 3 they were 0.449,0.487, 
0.511 and 0.507 respectively. 
It should be repeated, however, that none of these differences was significant even 
at a 5 % probability level. 
It is perhaps surprising that although those with a higher grade of severity of 
disease had rather higher mean ridits in respect of some topics, and also taking all topics 
into account, none of the differences for individual topics, nor for all topics, was 
significant. The same is true for those with different grades of family history. 
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Each topic was then assessed in relation to each of the 11 independent scores 
described in Chapters 10, 11, 12 and 14, namely EGCSl, EGCS2, KOSI to KOS3, KISI 
to KIS4, ATCS and OGCS, thus omitting the four scores formed as totals. The 
connections between the problems and these scores were compared by using ordinary 
(pearson product-moment) correlation coefficients (as an alternative to the gamma 
measure) and measuring (two-sided) significance by the I-statistic, calculated as the 
correlation coefficient divided by ,,(n-2), where n is the number of observations 
(respondents). Counting all the 11 independent scores and the 28 topics, there are 308 
comparisons. Using a 2% probability level (It I ~2.4), one would expect again about 6 
such comparisons to show apparent significance. There were in fact 6 comparisons 
significant at a 2% level, of which only one was at a 1 % level (III ~2.7, denoted ... 
below). There is thus also some evidence of dependence of how some patients view the 
problems of APKD on the scores, but again there is still considerable homogeneity in the 
population. 
The comparisons which show a significance at a 2 % level are noted below. 
Environment of genetic counselling (EGCS1) and Lethargy (1): 
correlation coefficient (c.c.) = -0.33, I = -2.69; there was thus a 
negative correlation between these factors, those with a better experience 
of genetic counselling fmding Lethargy less of a problem. 
Knowledge of disease (KDSI) and Back pain (10): c.c. = -0.37, 
I = -3.15*; those who knew more about the treatment for APKD in 
questionnaire 1 found Back pain less of a problem. 
Knowledge of disease (KDSl) and Tension in family (24): 
c.c. = 0.32, I = 2.59; those who knew more about the treatment for 
APKD in questionnaire 1 found Tension in family more of a problem. 
Knowledge of symptoms (KDS2) and Moodiness (9): c.c. - 0.37, 
I = 2.52; those who know more about the symptoms of APKD found 
Moodiness more of a problem. 
Knowledge of inheritance (KIS4) and Headache (2): c.c. = 0.35, 
I = 2.43; those who know more about the inheritance of APKD in Section 
1 of questionnaire 3 found Headache more of a problem. 
Attitude to having fewer children (ATCS) and Itchiness (4): 
c.c. = 0.31, t = 2.51; those who would favoured considering fewer 
children found Itchiness more of a problem. 
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It must be said that these correlations look as if they were the result of chance; 
they do not have any great rationale for their existence, and to rationalise them might look 
rather like 'data-mining' after the event. 
13.3 REPEAT IN THIRD QUESllONNAIRE 
In the third questionnaire the same'question was asked with the same list of topics. 
Respondents were asked to complete the questionnaire themselves. Two respondents failed 
to do so. The responses of the 4S respondents who did are shown in Table 13.4. 
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Table 13.4 
Third population: numbers of patients who graded each topic 
in terms of how severe a problem it was. 
Grade 1 2 3 4 S 6 
Not Not Extre-
0 Topic appli- impor- Sli,ht Quite Very mely 
cable tant 
1 Lethargy 8 2 4 10 9 12 
2 Headache 10 15 7 6 4 3 
3 Abdominal pain 12 12 6 5 6 4 
4 Itchiness 14 12 63 3 5 5 
S Nausea 14 9 5 8 8 1 
6 Lack of concentration 13 10 6 7 6 3 
7 Sleepiness 11 8 6 9 7 4 
8 Sickness 16 17 2 4 3 3 
9 Moodiness 11 9 9 6 5 S 
10 Back pain 13 1 10 6 8 7 
11 Other physical problems 29 4 4 4 4 
12 Dependence on hospital 12 16 6 4 4 3 
13 Restriction on eating 26 12 2 2 3 
14 Restriction on drinking 26 12 1 2 1 3 
15 Feeling different 20 12 1 8 2 2 
16 Difficulty at work 30 9 2 2 1 1 
17 Unable to continue job 28 6 1 6 2 2 
18 Remain breadwinner 28 6 1 5 2 3 
19 Loss of job 28 6 1 6 2 2 
20 Loss of income 26 6 1 6 3 3 
21 Reduction in standard of 26 6 1 7 1 4 
living 
22 Restricts physical activity 9 9 8 8 S 6 
23 Puts strain on marriage 22 14 6 3 
24 Tension in family 21 15 2 3 1 3 
25 Difficult to make plans 20 12 7 1 2 3 
26 Difficult to keep friends 26 19 
27 Difficulty with opposite sex 21 17 6 1 
28 Family/genetic disorder 6 13 8 4 6 8 
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The totals of the numbers in each grade from Table 13.4 for all topics were 
calculated and are shown in Table 13.5. There were 1,260 answers in total. The ridits 
were calculated as described above. 
Table 13.5 
Third population: total numbers and calculated ridits. 
Grade 1 2 3 4 5 6 Total 
Numbers 526 289 117 128 99 101 1,260 
Ridits 0.209 0.532 0.693 0.790 0.881 0.960 
The Kruskal-Wallis test was again used to see whether the mean ridits for the 
topics were significantly different from each other. The value of the test statistic, W, for 
this table was In.96, which compared with t with 27 degrees of freedom, is an 
extremely significant result. 
Again not all topics were graded equally by the respondents. The topics have again 
been ranked in sequence by their mean ridit and are shown in Table 13.6 in mean rid it 
(Q3 m.r.) sequence with the highest at the top. Also shown are the averages of the scores 
in questionnaire 3 (Q3 a.s.), the standard deviations of the scores (Q3 s.d.), and the mean 
rid it (Ql m.r.) and sequence (Ql seq) for the responses in questioMaire 1. 
The sequence in this questionnaire is not the same as in questionnaire 1, though 
the same group of topics is at the top and the same group at the bottom. Since many of 
the topics were ranked close together in both questioMaires the shuffling is in general of 
no significance. However, it is worth noting that Dependence on hospital has moved up 
from 22nd to 12th, and Feeling different has moved up from 21st to 15th. It is possible 
that the respondents had progressed further in their illness since the rrrst questionnaire, 
were in fact more dependent on the hospital, and did feel more different by this time. 
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Table 13.6. 
Third population: mean rldit, average score and standard deviation of score 
for each topic which might give problems. 
Q3 Q3 Q3 Q3 Ql Ql 
seq 0 Topic m.r. a.s. s.d. m.r. seq 
1 1 Lethargy 0.73 4.02 1.77 0.70 1 
2 28 Family/genetic disorder 0.66 3.33 1.71 0.60 6 
3 22 Restricts physical activity 0.64 3.20 1.67 0.64 3 
4 10 Back pain 0.64 3.36 1.82 0.65 2 
5 7 Sleepiness 0.62 3.11 1.66 0.61 5 
6 9 Moodiness 0.61 3.00 1.66 0.58 7 
7 3 Abdominal pain 0.58 2.84 1.66 0.51 11 
8 2 Headache 0.58 2.73 1.50 0.63 4 
9 6 Lack of concentration 0.58 2.82 1.62 0.55 8 
10 5 Nausea 0.57 2.78 1.58 0.52 9 
11 4 Itchiness 0.56 2.73 1.72 0.51 10 
12 12 Dependence on hospital 0.55 2.58 1.51 0.43 22 
13 8 Sickness 0.50 2.33 1.52 0.46 17 
14 15 Feeling different 0.47 2.24 1.49 0.44 21 
15 25 Difficult to make plans 0.46 2.16 1.46 0.50 12 
16 24 Tension in family 0.44 2.04 1.43 0.49 13 
17 20 Loss of income 0.44 2.18 1.66 0.46 16 
18 21 Reduction in standard of 0.44 2.18 1.68 0.44 20 
living 
19 23 Puts strain on marriage 0.42 1.91 1.30 0.49 14 
20 27 Difficulty with opposite sex 0.41 1.76 0.95 0.47 15 
21 11 Other physical problems 0.41 2.07 1.72 0.41 25 
22 18 Remain breadwinner 0.41 2.02 1.60 0.41 26 
23 17 Unable to continue job 0.40 1.98 1.51 0.42 24 
24 19 Loss of job 0.40 1.98 1.51 0.44 19 
25 13 Restriction on eating 0.40 1.91 1.49 0.44 18 
26 14 Restriction on drinking 0.40 1.87 1.42 0.42 23 
27 16 Difficulty at work 0.35 1.62 1.14 0.36 28 
28 26 Difficult to keep friends 0.34 1.42 0.49 0.41 27 
Note: column Q3 seq gives the sequence in this table; column Ql seq gives the 
sequence in Table 13.3 relating to questionnaire 1; column 0 gives the original 
sequence as in Table 13.1. 
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13.4 COMPARISON OF FIRST AND 1HIRD QUESTIONNAIRES 
The responses of the 45 patients who replied to questionnaire 3 were compared 
with the responses of the same 45 patients to questionnaire 1. First, the average level of 
assessment of severity of each problem was compared by an analysis of the mean ridits, 
where the ridits were calculated using just the two responses from each respondent for the 
same topic. Secondly, the concordance between the replies of the respondents to each 
topic on the two occasions was compared using the gamma statistic. Table 13.7 lists the 
topics again, in the same order as in Table 13.3, the sequence according to mean ridit on 
the first occasion, and shows the difference (dift) between the individual mean ridits on 
the two occasions (+ for those where the assessment was higher in questionnaire 3, -
for those where the assessment was lower in questionnaire 3), the probability (prob) that 
this difference occurs by chance (using the Kruskal-Wallis test), and the value of gamma 
when the two sets of responses for each topic are compared. 
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Table 13.7. 
First and third populations: comparisons of responses for each topic 
which may be a problem for those with APKD. 
Ql Q3 Ql 
seq seq Topic m.r. diff prob gamma 
1 1 Lethargy 0.70 +0.163 0.0067 0.52 
2 4 Back pain 0.65 +O.on 0.20 0.39 
3 3 Restricts physical activity 0.64 +0.063 0.29 0.53 
4 8 Headache 0.63 +0.000 0.99 0.58 
5 5 Sleepiness 0.61 +0.074 0.22 0.31 
6 2 Family/genetic disorder 0.60 +0.090 0.13 0.19 
7 6 Moodiness 0.58 +0.064 0.28 0.35 
8 9 Lack of concentration 0.55 +0.105 0.076 0.36 
9 10 Nausea 0.52 +0.073 0.22 0.25 
10 11 Itchiness 0.51 +0.061 0.30 0.37 
11 7 Abdominal pain 0.51 +0.115 0.049 0.27 
12 15 Difficult to make plans 0.50 +0.020 0.72 0.40 
13 16 Tension in family 0.49 -0.035 0.54 0.26 
14 19 Puts strain on marriage 0.49 +0.020 0.73 0.69 
15 20 Difficulty with opposite sex 0.47 -0.020 0.72 0.11 
16 17 Loss of income 0.46 +0.007 0.90 0.70 
17 13 Sickness 0.46 +0.054 0.35 0.12 
18 25 Restriction on eating 0.44 -0.034 0.54 0.33 
19 24 Loss of job 0.44 -0.003 0.95 0.50 
20 18 Reduction in standard of 0.44 +0.008 0.88 0.71 
living 
21 14 Feeling different 0.44 +0.054 0.34 0.30 
22 12 Dependence on hospital 0.43 +0.179 0.0019 0.40 
23 26 Restriction on drinking 0.42 -0.024 0.67 -0.03 
24 23 Unable to continue job 0.42 -0.016 0.77 0.74 
25 21 Other physical problems 0.41 -0.034 0.53 0.24 
26 22 Remain breadwinner 0.41 -0.003 0.96 0.78 
27 28 Difficult to keep friends 0.41 -0.068 0.21 0.10 
28 27 Difficulty at work 0.36 -0.015 0.78 0.50 
Note: column Ql seq gives the sequence in Table 13.3, relating to 
questionnaire 1, and column Q3 seq gives the sequence in Table 13.6, relating 
to questionnaire 3. 
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The top 12 topics, those which were the more important ones in questionnaire 1 
and many of which relate to physical problems, have gone up in importance since the first 
interview, and the bottom six, the less important, have gone down. Only Lethargy and 
Dependence on hospital are significantly up, and none is significantly down. Overall, the 
topics have become more problematic for the respondents. 
The concordances between the responses of individuals are surprisingly low. One 
is negative (Restriction on drinking). There is quite strong agreement only among those 
topics relating to employment and income. Although the individual respondents may have 
changed their views, the collective response is remarkably uniform. 
13.5 EFFECT OF EXPLANATORY VARIABLES IN 11IIRD QUES'IlONNAIRE 
As for questionnaire I, comparisons were made between the average ridits for each 
of the categories in the 11 explanatory variables considered. Of the 280 comparisons only 
5 showed differences significant at a 2 % probability level, which is fewer than might 
reasonably have been expected, and 3 of these (denoted - below) were significant at a 1 % 
probability level. The five were: 
Sex and Lethargy (1): males (average ridit 0.668) found lethargy to 
be more of a problem than did females (a.r. 0.432) (probability 0.0117). 
Sex and Remain breadwinner (18): males (a.r. 0.664) found this 
more of a problem than did females (a.r. 0.433) (probability 0.0057*). 
Sex and Restricts physical activity (22): males (a.r. 0.710) found 
this much more of a problem than did females (a.r. 0.415) (probability 
0.0018-). 
Severity of disease and Lethargy (1): those with more severe grades 
of disease found this more of a problem than did those with lower grades 
(a.r. for grades 1, 2 and 3: 0.303, 0.530, 0.602 respectively) (probability 
0.0155). 
Severity of disease and Restricts physical activity (22): the same is 
true for this topic as for the last; those with more severe grades of disease 
found this more of a problem than did those with lower grades (a.r. for 
grades 1, 2 and 3: 0.248,0.585,0.596 respectively) (probability 0.0019*). 
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The connections that were found for the first population had weakened or even 
been reversed in this population. This might suggest that they may really have been the 
result of chance, but it would also be the case that in a smaller total population they are 
less likely to show up as significant. 
Each topic was also assessed in relation to each of the scores as described in 
relation to questionnaire 1, the connections being compared as before by using correlation 
coefficients. Of the 30S comparisons 8 were significant at a (two-sided) 2 % level 
(III ~2.4), of which only one was at a 1 % level (It I ~2.7, denoted • below). There is 
again some evidence of dependence of how some patients view the problems of APKD on 
the scores, but there is still considerable homogeneity in the population. 
The comparisons which show a significance at a 2 % level are noted below. 
Environment of genetic counselling (EGCS2) and Puts strain on 
marriage (23): correlation coefficient c.c. == 0.38, t == 2.S7; those who 
received more content in their genetic counselling found strain on marriage 
more of a problem. 
Knowledge of disease (KDSl) and Puts strain on marriage (23): 
c.c. == 0.37, t == 2.46. 
Knowledge of disease (KDSl) and Difficult to make plans (2S): 
c.c. == 0.37, t == 2.S2. 
Attitude to having fewer children (ATCS) was associated positively 
with five problems: 
Restriction on eating (13): c.c. == 0.37, I == 2.48; 
Restriction on drinking (14): c.c. == 0.37, I == 2.46; 
Restricts physical activity (22): c.c. - 0.37, t - 2.47; 
Puts strain on marriage (23): c.c. == 0.39, t -= 2.62; 
Tension in family (24): c.c. == 0.42, t == 2.7S*; 
this cluster suggests that, at least among those in this population, those who 
favoured considering fewer children found some of the restrictions of 
APKD irksome, found that it caused difficulties in the family, and were 
therefore more in favour of not having children, who might seem more of 
a burden to them. 
None of these relationships showed significant correlations for the responses in the 
first questionnaire, and none of those found significant for the (lIst questionnaire remained 
significant here. This supports the idea that most of these correlations are the result of 
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chance. Only the last cluster, those in relation to the attitudes to having children, seems 
to have a good rationale. 
13.6 COMPARISON OF INDIVIDUAL RESPONSES IN I1RST AND 11IIRD QUES110NNAIRES 
The responses of each individual to the 28 topics in the first and the third 
questionnaires were compared in order to see how consistent was their ranking of the 
problems. This required constructing a 6 by 6 table for each respondent, showing how 
their 28 pairs of responses fell into grades. The concordances between the responses in 
the first and third questionnaires were then calculated, using the gamma measure described 
above. 
The values of gamma theoretically range from -1.0 to 1.0, and the actual range 
observed was indeed from -1.0 (1 case) to + 1.0 (3 cases). The distribution of values of 
gamma for the third population is shown in Table 13.8. There is a considerable number 
of cases with quite high concordance (say gamma~0.6), but a fair number with low 
concordance. 
Table 13.8 
Third population: values of gamma for each individual, 
subdivided by sex and marital status. 
Single Married 
females females Males Total 
Not calculated 2 2 
-1.0 to -0.0 1 2 3 
+0.0 to +0.2 1 1 2 
+0.2 to +0.4 3 1 2 6 
+0.4 to +0.6 4 1 5 
+0.6 to +0.8 4 6 6 16 
+0.8 to +1.0 4 7 2 13 
Total 12 20 15 47 
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Correlation coefficients were calculated for the average ridits for each individual 
in the two questionnaires, the gamma measure of concordance described above, all the 
constructed scores described in Chapters 10, 11, 12 and 14, and also severity of disease 
and family history. The values of the coefficients ranged from -0.23 to +0.24, not 
remotely significant, except for the following: 
the ridits for the first questionnaire and the third questionnaire, 
correlation coefficient 0.52, easily significant at a 1 % level; 
the ridit for the third questionnaire and severity of disease, C.C -
0.36, significant at a (two-sided) 2 % level; 
the concordance measure, gamma, and attitude to having no more 
children (ATCS), c.c. = -0.33, just significant at a (two-sided) 2 % level; 
those with a high score for attitude to having no more children have a low 
concordance between their answers to these parts of the questionnaires. 
The fust of these is not surprising; those with a relatively high assessment of their 
problems at the time of the first interview might well also assess their problems highly by 
the time of the third interview. 
The second is also not surprising, though it did not appear as significant by the 
Kruskal-Wallis test; those more severely affected have more problems overall, 
The third is not readily explained, and may just be a random result; on the other 
hand, those with a strong attitude to having no more children were seen above to have 
problems of an irksome kind, and they may have found it difficult to be consistent in their 
responses to the questions, or may have found them irritating, and so answered them 
without careful consideration. 
13.7 DISCUSSION: ANALYSIS OF PROBLEMS 
The patient's perception of the burden of an illness is often given as an explanation 
for patient's reproductive decisions following genetic counselling, as well as by 
researchers investigating the demand for prenatal diagnosis (Chapter 2). 
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However, in these studies there is very little discussion about what are the factors 
that are used in the development of the patient's concept of the burden of APKD. In this 
study respondents were asked twice, in questionnaires 1 and 3, to rate the importance of 
factors that could influence their perception of the burden of the illness. 
There are two particular results of this analysis that deserve comment. The frrst 
concerns the groupings of the problems and the second concerns the position of certain 
individual problems. 
The four groupings concerned physical symptoms associated with APKD, 
restrictions on activities, questions related to job and income and questions relating to 
personal relationships. 
It is notable that there is very considerable agreement between the two interviews 
in the emphasis that is placed On the different items and on the different groups of topics. 
Patients placed the greatest importance on what could be described as the physical 
symptoms associated with APKD. The next group of questions seen as most problematic 
were those relating to relationships, with those relating to restrictions on activities and 
jobs and income coming third and fourth. There were, however, exceptions: Restricts 
physical activity was rated as a serious problem, as was the fact that APKD is a 
Family/genetic disorder. 
It is interesting that respondents perceive the physical problems associated with 
APKD, rather than the genetic nature of the disease, as the most problematic. It is 
arguable that, as long as the treatments for APKD continue to improve and remain 
available, the burden of the disease will not be perceived as serious. 
Importance is placed by respondents on the social relationships and these become 
more problematic by the time of the third interview when patients had become more ill. 
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The psychological stress caused by chronic renal failure, described by Long (1989), is 
often ignored by medical and nursing staff in renal units. 
Patients may feel that they are no longer sexually attractive, perhaps because of 
the changes in physical appearance due to uraemia. In this study some patients said that 
they did not feel 'a whole person' • 
The importance placed on income-related questions received less importance than 
might have been expected. By the time of the third questionnaire some patients may have 
been too ill to be any more concerned about being able to remain in employment. 
The item Lethargy was seen as the most important problem in both interviews. 
This is interesting as lethargy is not a symptom of APKD that is normally described in 
the medical textbooks. It was included because of the frequency it was mentioned as a 
problem by patients in a small pilot study carried out before the main investigation. 
During the course of the research several patients made another observation about lethargy 
in relation to their as yet untested offspring. These patients commented that a particular 
offspring was 'always tired and lethargic' and that that child 'would possibly be the one 
with APKD'. 
In questionnaire 3 the importance of the physical problems became greater. This 
is possibly because the patients were then more ill. For example in this interview males 
found Lethargy more problematic as did those more severely affected. It is difficult to 
believe that female respondents did not also experience lethargy. Culturally women may 
be more accepting of tiredness as a way of life. Two items, Restrictions on physical 
activities and the Family/genetic nature of the disorder, became more problematic in the 
third questionnaire. A likely explanation for this is that patients were more ill by the third 
questionnaire. Furthermore as the study was about genetic counselling, it is possible that 
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by the time of the third interview there was more awareness of the genetic nature of the 
illness. 
Many of the interactions with explanatory variables appears to be a result of 
chance. However it is worth commenting on some of the results which were significant 
at a 1 % or 2 % level. In the first interview female patients found Abdominal pain, Nausea 
and Sickness significantly more problematic than did male patients. It is not known 
whether there would be a physiological or other medical explanation for this finding. 
Male patients were more concerned than females with Remaining a breadwinner, 
Loss of job, Loss of income and Reduction in standard of living. This finding was also 
significant at the 1 % level in the third interview. This makes sense particularly in a part 
of the world, the west of Scotland, where the man has traditionally been the major 
breadwinner. One of the major problems for patients with another chronic illness, 
haemophilia, is to obtain a job and then hold on to it (Markov a et al 1977), and this 
fmding was confirmed for APKD by Wilkie et al (1985). These authors show that the 
ability of the patients with APKD to remain in employment is affected by their illness and 
they suggest that -patients should be encouraged to seek the appropriate training for non-
manual employment- (P80). It is important that counsellors are aware of the considerable 
concerns that male patients in particular may have about their ability to obtain work and 
remain the breadwinner and the psychological distress and loss of identity that may be 
suffered when patients lose their job. 
In the third interview male patients perceived restriction on their physical activity 
significantly more problematic than female patients. Again this may be relevant 
information for counsellors to give to male patients. The study did not ask what specific 
activities the patient felt restricted in doing although one moderately severely affected 
patient explained that 'he did not even have the energy to go to a football match'. This 
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comments supports the finding also from the third interview that those patients more 
severely affected found Restriction on physical activity more problematic than those more 
mildly affected. 
It is disappointing that so few of the specific problems of APKD were associated 
with the possible explanatory variables or with the composite scores at a significant level. 
There were few comparisons significant at a 1 ~ level and only a few more at a 2" level. 
These are described in Sections 13.2 and 13.S. It is worth commenting in particular on 
the score concerning the attitude to having fewer children. Patients who would consider 
favourably restricting the number of children had found the restrictions concerning diet, 
fluid intake and physical activity caused by APKD very problematic, as well as finding 
that APKD puts a strain on the marriage and causes tension in the family. 
Although so few of the possible associations were 'significant', and many of these 
may have been the results of chance, they are nevertheless indicative of possible 
associations that would be worth investigating in other or larger studies. 
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14.1 INTRODUCJ10N 
In this chapter the results of the following topics of interest in genetic counselling 
are discussed; the detailed results are presented in Appendix G. 
attitudes to having childreri; 
14.2.1 
attitudes to screening and testing at risk relatives; 
attitudes to testing children; 
outcomes of genetic counselling; 
who should do genetic counselling. 
14.2 REsPoNDENTS' ATIllUDES TO HAVING ClIlLDREN 
Numbers or children and influence or APKD thereon 
Respondents were asked how many children they had had, and then how many 
children would like or would have liked to have had; the two answers were compared. 
There were 20 respondents who had two children, 14 who had more than two, and 
31 who had fewer than two. Nevertheless 36 respondents would like to have two children; 
these included 10 single females and 13 married females. 
Only one person would have liked fewer children than she (a married woman) 
already had. 29 respondents (out of 65 or 44 %) were happy with the number of children 
they had, and 33 (out of 65 or 51 %) would have liked more. In a few cases it was not 
appropriate to ask the respondent this question. 
There is no evidence that those with a higher grade of severity of disease either 
have had fewer children, or would like to have fewer children, than those with a lower 
severity. 
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Among the 14 respondents with more than two children, all but one had obtained 
no school qualifications (education level 1). 
Respondents were asked whether their knowledge of APKD had affected their 
views about how many children they would like. 42 out of the 65 (65 %) respondents said 
that knowledge of APKD had not affected their decision about the number of children they 
would like, as opposed to 23 (35 %) who said that it had. 17 out of the 40 female 
respondents (42 %) said that the decision about the number of children they would like had 
been affected by the knowledge of APKD, as opposed to only 6 out of 24 (25 %) among 
the men. However the contrast, although suggestive, is not statistically significant. 
Respondents were asked to describe the effect that their knowledge of APKD had 
had on the number of children they had had or would have liked. Among the 23 who said 
that it had had an effect, 8 had been sterilised (including the wife of one affected male) 
or had had a vasectomy, 3 had had fewer children, 2 had altered the spacing of their 
children, 1 had decided not to have any children, and another not to marry; 7 knew that 
knowledge of APKD would affect their decisions, 4 of these not yet having made any 
plans about children and 3 not having decided what to do. 
14.2.2 Attitudes to voluntary childlessness, sterilisation, vasectomy and A.I.D. 
Respondents were asked whether they would be prepared to consider various forms 
of action to limit their families: 'having no children', sterilisation or vasectomy (of 
themselves or their partner as appropriate), or A. I. D. (strictly appropriate only if the 
male partner is affected). 
The majority of respondents (40 out of 6S or 61 %, comprising 29 females and 11 
males) would not consider or would not have considered having no children. Of the 29 
females in this category 25 were aged under 35. However 18 respondents (9 females and 
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9 males), would consider having no children and 2 respondents would possibly consider 
such a possibility. Six of the females and 4 of the males who said that they would consider 
having no children were under 35. There was a tendency for the more severely affected 
patients to say that they would consider having no children. 
27 respondents (22 females and 5 males) said that they would consider sterilisation. 
10 of the female patients were aged less than 35. In addition 2 female patients said that 
they would consider sterilisation and 1 single female patient aged 19 said that she would 
consider the possibility of sterilisation after she had had a child. 22 patients (14 females 
and 8 males) would not consider sterilisation. 9 of the females and none of the males were 
under the age of 35. The numbers of patients who would consider sterilisation and 
vasectomy increased according to the severity of their disease. 
19 patients (8 females and 11 males), would consider vasectomy, 2 patients (1 
female and 1 male) would think about it and 1 male patient was unsure. 32 patients (21 
female and 11 males) would not consider vasectomy. The 7 female patients who would 
consider vasectomy for their partner were in the age range 25-44 while 13 of the 21 
women who would not consider vasectomy for their partner were under the age of 35. 
The majority of patients (41 out of 65 or 63%) would not consider A. I. D. Only 
three patients were in favour, with an additional 6 patients unsure. One female patient was 
in favour of A. I. D. and one was unsure. Otherwise none of the female patients would 
consider the use of A. I. D. 
In each case there was a clear tendency for the more severely affected patients to 
say that they would consider limiting their family in the way suggested, though in no 
single case is the result statistically significant. 
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14.2.3 Score for attitude to bavin, no more chlldren 
A composite score, denoted ATCS, was fonned to represent each respondent's 
attitude to having no more children, constructed as described in Appendix G. A high score 
represented a favourable attitude to not having more children. The maximum score was 
8 and the mean was 2.3, with 25 respondents getting 0 points. 
Analysis of this score showed that no explanatory variable had any significant 
bearing on this score representing the respondent's attitude to having no children. Nor had 
any of the previously constructed scores, representing experience of genetic counselling 
and knowledge of various aspects of APKD. 
14.3 A1TITtJDE TO SCREENING AND 'JESTING AT RISK RELA11VES 
14.3.1 Attitudes to screening at risk 
Respondents were asked a number of questions that related to their attitude to the 
screening and testing of those at risk of APKD. The frrst question was whether those at 
risk should be told of their situation. The great majority (59 out of 65 or 91 %) thought 
that those at risk should be told. Only one (a male) thought that they should not, though 
I 
S respondents (4 males and one female) were unsure. 
Respondents were asked why they thought that those at risk should be told of their 
risk. There was a variety of answers given being, the most frequent being 'so that they 
can be screened' (24 respondents or 37%), and 'so that they can have choices' (17 or 
26%), and also including 'so that they can plan their lives' (6), 'so that they are prepared' 
(4), 'they have to know' (3), 'because it is sensible' (2), etc. 
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14.3.1 Attitudes to testing at risk 
Respondents were asked whether they thought that those at risk should be tested 
for APKD. Almost all (62 out of 6S or 95 %) thought that they should be tested. One male 
and one married female were unsure and one married female (elt strongly that testing was 
the choice o( the individual concerned and she could herself give an opinion. 
The reasons that respondents gave to explain why they thought that those at risk 
should be tested included 'so that they know' (18 replies), 'so that they can plan their 
lives' (13), 'so that they can be treated' (8), and 'so that they are aware' (6). 
14.4.1 
14.4 ArnnmES TO TES11NG CHILDREN 
Testing children at risk 
Most respondents were asked whether they thought that their children should be 
tested (or APKD; 10 respondents were not asked because they were either younger or 
older and the question was inappropriate. 51 out of the 55 asked (93 %) thought that they 
should be, although for 8 of these the question was inapplicable currently, mainly because 
they were single. The other 4 had views that reflected uncertainty rather than opposition. 
The most frequent reasons given by respondents (or having their own children 
tested were so that the child, i( found to be affected, could be looked after (12 respondents 
or 18%), and so that the child(ren) could plan their lives (10 or 15%). Five respondents 
gave as the reason 'so that the parent would know and could therefore initiate treatment'. 
Respondents were asked whether or not to have their child tested was a difficult 
decision. 11 respondents (17 %) said that it was, but 35 (54 %) said that it was not. The 
more severely affected were rather more likely to respond that this was a difficult 
decision. 
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Infonnlng chUdren at risk 
Respondents were asked at what age they thought that children of an affected 
parent should be told of their risk. The majority of respondents (36 out of 6S or SS %) 
were in favour of children being told between the ages of 16 and 18, with these two ages 
being particularly popular. 
Most respondents (54 out of 65 or 83 %) thought that the at risk child should be 
tested between the ages of 16 and 20; the ages of 16 and 18 were the most favoured. One 
male patient thought that they should be tested prenatally, and another male patient 
thought that they should be tested at birth. 
14.4.3 Dependency on other factors 
It would have been interesting to investigate whether the attitudes of respondents 
to the screening and testing of those at risk and of children differed by any of the possible 
factors that could have been considered. However, when there is almost complete 
unanimity in the responses, almost all being in favour of informing, testing and screening, 
no further analysis is possible. 
14.5 OurCOMES OF GENE11C COUNSELLING 
14.5.1 Consequences of genetic counselling 
Respondents were asked five questions about whether genetic counselling had 
helped them in specific ways, whether it had informed them about risk, helped them to 
decide on their family, informed them about APKD, relieved stress, or informed them 
about treatment. 
A majority of patients (40 out of 65 or 61 %) had received information about the 
risk of inheritance. No other feature of genetic counselling had been noted by more than 
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25% of respondents. 14 patients had found that genetic counselling had helped them in 
deciding whether or not to have a family, 9 patients reported having received information 
about (the symptoms of) APKD, and 5 patients about the treatment available for APKD. 
Five patients (all females) reported that the genetic counselling had helped to 
relieve stress and anxiety; of these 5 who had found that genetic counselling had relieved 
stress 3 were in severity grade 1 and 2 were in severity grade 2, so none of the most 
severely affected patients had found that the genetic counselling they received had relieved 
stress. 
In addition to the responses to questions reported in Appendix 0, respondents 
offered the information that genetic counselling had given them information which helped 
them to consider the number of children they had, whether to get married and whether 
those at risk should be screened. One male patient reported that he had found his 
experience of genetic counselling 'very upsetting' and one female patient said that she had 
'hesitated' about having a family after she had had genetic counselling. 
14.5.2 Score for outcomes or genetic counselling 
A composite score, denoted OOCS, was formed from the questions relating to the 
outcome of genetic counselling, as described in Appendix O. The maximum score was 5 
points. 
Analysis of this score using the GUM system showed that, of the possible 
explanatory variables described in Section 9.13, the only factor with any significance was 
that combining age and number of children, which was significant only at a 5 % 
probability level. However, when the scores for the experience of genetic counselling, 
EGCSI and EGCS2, are introduced as possible factors, each is very significant by itself, 
but adding the other provides little improvement. The correlation coefficients of OGes 
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with these two scores are 0.60 and 0.65 respectively. The higher of the two is that with 
EGCS2, which therefore gives the better fit. The model then takes the form of a simple 
linear regression, accounting for 42.5 % of the original variance. The parameters are 
shown in Table 14.1. 
14.5.3 
Table 14.1 
Parameters for score on outcome of genetic counselling (OGCS). 
Element 
Constant 
Per unit of EGCSI 
Score 
0.09 
+0.34 
Decisions taken as a result or genetic counselling 
Patients were asked whether they had taken decisions as a result of the information 
they had received in genetic counselling. Out of the 49 patients who had received genetic 
counselling, only 16 or 33% had taken decisions as a result of genetic counselling 
information compared with 33 (67%) who had not. Most of those who had taken decisions 
were married women (13 out of 16), or a majority of the married women counselled (13 
out of 22 or 59%). By contrast, only one male (out of 17) and 2 single females (out of 
10) had taken decisions. In a 2 by 2 contingency table, setting single females plus males 
versus married females and 'yes' versus 'no' among those who had taken decisions 
Fisher's exact test shows that the difference is strongly significant (p-0.OOO5). 
Of the 16 patients who had taken decisions following genetic counselling 8 were 
in severity grade 3 (out of 19 who had received genetic counselling); but 2 out of the 4 
unaffected also had taken decisions. 
The decisions taken by patients included the following: 8 had opted for sterilisation 
(including one single female and one male who had had a vasectomy; two had decided to 
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have no more children; one had decided to have no children; and two had decided to have 
a smaller family than they otherwise might have done (including the other single female 
who had taken a decision) (these two were both in the higher education level); one patient 
had told their child; and one patient had suggested that her child should be screened. 
Five of the married women who had been sterilised were in severity grade 3. 
14.6 WHO SHOULD GIVE GENE11C COUNSELLING? 
14.6.1 Who should give genetic counselling? 
Patients were asked what kind (or kinds) of person they would like to see giving 
genetic counselling. The two· most popular were a specialist genetic counsellor (47 out of 
65 or 72%) and doctors in the renal unit (44 out of 65 or 68%). 
17 out of the 65 thought that the GP should give genetic counselling, with single 
women being least in favour of the OP's involvement. 
Two thought that nurses should, and one that a social worker should. The one 
patient in favour of a social worker was a married female, who was severely affected and 
who had had considerable professional help from social workers. 
Nurses in a renal unit are highly specialised. They have considerable responsibility 
in, for example, the running of a haemodialysis unit and in the training of patients for 
dialysis and are therefore in close contact with the patients and are an obvious source of 
information for the patients. Nevertheless only two patients thought that the nurse should 
give genetic counselling. 
Respondents were also asked to name any other person or category of person who 
could give genetic counselling. This question did not yield many suggestions; only 15 out 
of 6S made a suggestion. One patient suggested a parent or cousin, 4 patients suggested 
another affected patient, and 10 patients (8 female and 2 male) suggested 'someone like 
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you', ie like the research worker. 6 of these 10 patients belonged to severity grade 3 and 
may well have seen the research worker more often than those less severely affected; all 
10 patients belonged to the lower educational levels 1 and 2. 
Patients were also asked whether they thought that no genetic counselling should 
be given. Not one patient out of the 6S believed that no genetic counselling should be 
given. 
Respondents were asked about the sort of information that they would like in a 
genetic counselling service if it were to become available, or about the features that should 
characterise it. Respondents were unable to offer suggestions about the precise sort of 
information that they would like in genetic counselling, but comments were offered about 
the need for information (19 responses), the need for quiet (3) and time (1), the use of a 
specialist counsellor (2), or someone non-clinica1 (1) or a good listener (1); 3 patients 
suggested that the GP should be involved, and one suggested a group discussion. 
14.6.2 Who should inform children? 
Almost all the patients (63 out of 6S or 97%) thought that the parents should tell 
their children that they were at risk. One younger female patient thought that the doctor 
and the parents together should tell the child, and one male was not asked this question. 
Respondents were asked how the child should be told. The most frequent response 
was 'in the normal course of conversation'. This was expressed by one patient as 'as an 
opportunity arises at home and certainly always by the parents, as they know the child and 
how to put things over to him'. 
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14.7 DISCUSSION 
In this chapter five topics relating to genetic counselling were analysed. These 
were: attitudes to having children, attitudes to screening and testing at risk relatives, 
attitudes to testing children, what was called the outcomes of genetic counselling, which 
included decisions that patients may have taken as a result of genetic counselling, and 
fmally who should carry out genetic COWlselling. These five topics are discussed below. 
The first comment to make concerns attitudes to having children. It was not 
unreasonable to assume that among the explanatory variables, sex of patient, severity of 
illness, family history and religion might have an influence on the patients' attitudes to 
having children. The GLIM analysis showed that not one of the explanatory variables had 
any bearing at all on the patients' attitudes to having children. Furthermore it is arguable 
that the patients' knowledge of APKD could influence their attitudes to having children, 
on the assumption that the more knowledge that they had about the illness and its wider 
implications the more likely they would be to restrict the number of children they had. 
This was one of the principles within paradigm 2 described in Section 2.4. The focus in 
this paradigm was on prevention. Patients are given information about the illness in the 
hope that they will then have no or no more children. The GUM analysis showed that 
knowledge of the symptoms, treatment and inheritance of APKD had no bearing on the 
patients' attitudes to having children. Furthermore nor had the experience of genetic 
counselling any influence on attitudes to having children. 
There are comments concerning attitudes to having children although not 
statistically significant that are worth discussing. The majority of respondents (61 %) 
would not or would not have considered having no children and that includes 25 females 
under the age of 35 who might still have children or more children. However there were 
I 
18 respondents who would consider having no children and of these 10 patients, 6 females 
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and 4 males were under the age of 35. There was a tendency, but not statistically 
significant, for those patients more severely affected to say that they would consider 
having no children. A feature, however, of APKD is that it is an illness of variable age 
of onset with the result that it is highly likely that patients will have had their children by 
the time they become more ill. 
With regard to the screening and testing of those at risk for APKD, the very great 
majority of respondents thought that those at risk should be told of their risk and that they 
should be tested. As there was such consensus in the responses to this question, no further 
analysis was worth carrying out. 
Almost all respondents also thought that their children should be tested, with the 
majority suggesting that children should be tested between the ages of 16 and 20. 
Respondents were asked why should children be tested. This was an open ended question 
and the answers are those offered by the respondents. Only 5 patients gave the reason 'so 
that they as parents would know'. This was quite surprising, as in discussion with parents 
during the course of the study it became evident that parents would certainly like to be 
reassured that their child did not have APKD and so one reason for agreeing to have a 
child tested would be so that the parent knew. 
There were 11 patients who said that it was a difficult decision whether or not to 
have their child tested. Once again I was surprised that so few patients reported that this 
was a problem as it had appeared from their comments during the course of the research 
that this was an area of concern. One male patient reported that this subject had been a 
source of considerable tension between himself and his wife. His wife had wished that 
their son be told of his risk of inheriting APKD when he was in primary school. His 
father, who had APKD, had disagreed. When the patient eventually got round to 
discussing the illness with his son, by then a student at university, he was surprised to 
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discover that his son already knew, having sought information from a public library some 
years previously. 
There were rather varied answers to how genetic counselling might have helped 
patients. A majority of respondents (61 %) reported that they had received information 
about the inheritance of APKD, but only nine respondents reported that they had received 
information about the symptoms and treatment and yet it was here that patients were really 
quite well informed (see Chapter 11). 
One of the aims of genetic counselling, as described by the Ad Hoc Committee on 
Human Genetics in 1974 (P23), is to relieve stress and anxiety and yet only five patients 
had reported that genetic counselling had helped to relieve stress and anxiety for them. 
None of these patients were the most severely affected although the may have been the 
patients most concerned. 
Approximately one third of the respondents had taken decisions as a result of 
genetic counselling with most of those who had taken decisions being married women. By 
contrast only one male and two single females had taken decisions and this was 
statistically significant (p =0.00(5). It is possible that genetic counselling was aimed at the 
married women. Doctors giving the counselling may also have been concerned for the 
health of female patients should they become pregnant particularly if their renal function 
was impaired. However APKD affects the sexes equally and it would seem important that 
genetic counselling is given to both sexes. 
The majority of decisions taken as a result of genetic counselling were concerned 
with control of fertility and reflect an emphasis on prevention which would appear to have 
been the objective of the genetic counselling given to these patients. 
Finally patients were asked which category of person should give genetic 
counselling. The majority of respondents favoured either a specialist genetic counsellor 
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or a doctor in the renal unit with less than a third of patients favouring the GP. Before 
answering this question patients asked whether a specialist genetic counsellor would be 
like 'the research worker'. Thus the answer to this question and the comment of ten 
respondents who, in answer to the next question, suggested that someone like the research 
worker would be appropriate, are examples of the effect of the research on responses to 
questions. 
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IN GENETIC COUNSELLING 
IS.1 CONI'ENT OF GENE11C COUNSELLING: SECOND QUES'I10NNAIRE 
Respondents to questionnaire 2 were asked to identify from a list of 19 topics 
which of these topics it was important should be included as an element of genetic 
counselling, and to indicate on a 6 point scale how important they thought they were. The 
grades on the scale were: 
1 Not applicable 
2 Not important 
3 Slight importance 
4 Quite important 
5 Very important 
6 Extremely important 
The topics that were included in the list of elements of genetic counselling were 
selected following an extensive literature review as well as from previous experience on 
the Acceptability Study. These topics can be grouped into the following areas: information 
about risk, information about family planning and voluntary childlessness and information 
about the symptoms of and treatment for APKD. Information about the risk of inheriting 
and transmitting a disease is considered by genetic counsellors to be an extremely 
important aspect of genetic counselling (See chapter 2). It can be argued that unless 
patients are also told about the advantages and disadvantages of testing those at risk 
patients may be unable to reach an informed decision. If prevention is seen as an aim of 
genetic counselling, then information about family planning and the possibility of adoption 
or fostering could be included in a counselling session. If patients are to understand what 
are the problems associated with a particular illness they may need to be given information 
about the symptoms of the illness as well as the treatments that are available. 
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The responses of patients obtained in the second interview were scored by using 
ridit analysis as described in Chapter 13 in relation to the perception of problems 
associated with APKD. 
Table 15.1 shows the gradings for each topic for all respondents to questionnaire 
2. All respondents replied to all topics, so the total for each row is 65. 
Table 15.1 
Second population: numbers of patients who graded each topic 
in terms of how important it was for genetic counselling. 
Grade 1 2' 3 4 5 6 
Not Not Extr&-
a Topic appli- impor- Slight Quito Very mely 
cable tant 
1 Risk to you 43 1 1 16 4 
2 Risk to children 2 4 12 33 14 
3 Advantages of testing 8 17 34 6 
4 Disadvantages of testing 1 12 19 28 5 
5 How to tell the at risk 4 15 26 18 2 
6 Screening of sibs, etc 1 15 25 21 2 1 
7 Possibility of adoption 4 4 22 26 8 1 
8 Possibility of fostering 3 11 25 22 4 
9 Voluntary childlessness 8 16 14 15 9 3 
10 Having no more children 6 9 10 23 15 2 
11 Family planning 3 5 14 24 16 3 
12 Sterilisation 7 15 13 18 11 1 
13 Vasectomy 9 14 14 15 12 1 
14 A.I.D. 21 21 13 8 3 
15 Prevention of APKD 10 16 14 13 9 3 
16 Telling boy/girlfriends 5 8 27 14 11 
17 Telling in-laws 7 24 25 S 3 1 
18 Information about symptoms 1 1 1 7 28 27 
of APKD 
19 Information about treatment of 1 2 6 26 30 
APKD 
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The totals of the numbers in each grade from Table 15.1 for all topics were 
calculated and are shown in Table 15.2. There were 1,235 answers in total. The ridits 
were calculated as described in Section 13.1. 
Grade 
Numbers 
Ridits 
Table 15.2 
Second popUlation: total numbers and calculated ridits. 
123 4 S 6 
130 150 249 296 305 105 
0.053 0.166 0.328 0.548 0.791 0.957 
Total 
1,235 
The Kruskal-Wallis test (see Section 13.1) was used to see whether the grading of 
topics could be assumed to have been picked at random by respondents from the same 
distribution of responses as the total numbers indicate, in which case the mean ridits for 
the topics would not have been significantly different from each other. The value of the 
test statistic, W, for this table is 429.7, which compared with X' with 18 degrees of 
freedom (one less than the number of rows) is an extremely significant result. 
Thus not all topics were graded equally by the respondents. The topics have been 
ranked in sequence by their mean ridit and are shown again in Table 15.3 in mean ridit 
sequence with the highest at the top. For each topic the average of the numerical scores 
(1 to 6) was also calculated, and these are also shown in Table 15.3. The rankings using 
the two measures are very close, but not identical. 
The standard deviations of the numerical score were also calaIlated and are shown 
in Table 15.3. They give an indication of the relative scatter of the gradings. One value 
of the standard deviation is particularly high, that for topic 1 (Risk to you). This shows 
a bimodal distribution with 43 in grade 1 (not applicable) and the rest in grades 3 to 6. 
Presumably many of those who knew they were already affected considered that the risk 
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of APKD to themselves was now a certainty and so not relevant to future genetic 
counselling. 
Table 15.3 
Second population: mean ridit, average score and standard deviation of score for 
each topic which may be of importance in genetic counselling. 
Q2 Mean Average Standard 
seq 0 Topic ridit score deviation 
1 19 Information about treatment 0.82 S.25 0.93 
for APKD 
2 18 Information about symptoms 0.81 5.17 0.97 
of APKD 
3 2 Risk to children 0.73 4.78 1.04 
4 3 Advantages of testing 0.69 4.58 0.82 
5 4 Disadvantages of testing 0.64 4.37 0.92 
6 6 Screening of sibs, etc 0.58 4.08 0.93 
7 5 How to tell at risk 0.55 3.98 0.94 
8 11 Family planning 0.53 3.83 1.16 
9 10 Having no more children 0.48 3.58 1.31 
10 7 Possibility of adoption 0.46 3.51 1.04 
11 16 Telling boy/girlfriends 0.41 3.28 1.12 
12 12 Sterilisation 0.41 3.22 1.31 
13 13 Vasectomy 0.40 3.15 1.36 
14 9 Voluntary childlessness 0.40 3.15 1.38 
15 8 Possibility of fostering 0.39 3.20 0.95 
16 15 Prevention of APKD 0.38 3.06 1.42 
17 1 Risk to you 0.30 2.37 1.95 
18 17 Telling in-laws 0.29 2.63 1.03 
19 14 A.I.D. 0.24 2.28 1.16 
Note: column Q2 seq gives the sequence in this table; column 0 gives the original 
topic number as in Table IS.1. 
The difference in level of importance for any two topics can be tested by using the 
Kruskal-Wallis test for the pair of rows, as described in Section 13.1. Since in this case 
there are 171 (= 19 x 18 /2) different pairwise comparisons, it is appropriate to use 
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adjusted significance levels as described in Section 13.1. A normal significance level of 
5% therefore corresponds to one of 0.029% (- 5%/171), or to a normally distributed z 
of about 3.4. A 1 % significance level corresponds to one of 0.0586% or a z of about 3.9. 
The value of z for the difference between the highest and the lowest mean ridits 
(topics 19 and 14 in the original list) is 9.2, which is very significant. Using a test value 
of z of 3.9 it was found that topic 19 (Information about treatment for APKD), ranked 1st, 
is significantly different from the topics ranked 4th and below; topic 14 (A.I.D.), ranked 
19th, is significantly different from the topics ranked 12th and above. The extreme topics 
are therefore ranked very differently by respondents, but many in the middle are ranked 
at about the same level. 
The concordance of each pair of topics was also calculated using the gamma 
measure described in Section 13.1, and the test statistic z. A significance level for z of 3.4 
was considered interesting, and this corresponded in general with a value of gamma of 
about 0.5. A high level of gamma represents close concordance between the grading! 
given by the respondents. If identical grades had been given, the value of gamma would 
be 1.0. 
The relationship between topics with a high level of concordance can be mapped 
in a diagram, as was done for the importance of certain problems of APKD in Chapter 
13. Figure 15.1 shows such a mapping, on the same lines as Figure 13.1. 
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Figure 15.1. Relationships between elements 
that might be included in genetic counselling. 
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It can be seen that Information about symptoms and Information about treatment, 
near the top of the diagram, have a very strong concordance, with a value of gamma of 
0.94. Risk to you and Risk to children are linked with these two, and a number of other 
topics are thinly connected in this region. At the foot of the diagram is a 'spider's web' 
of connections between a group of topics mostly related to Family planning, which itself 
is at the centre of the web. A few topics; such as A.I.D., Fostering and Telling in-laws 
are distributed around the edge of the main part of the diagram. 
15.2 EFFEcT OF EXPLANATORY VAJUABLES 
The effect of different explanatory variables on the gradings given to the topics can 
also be compared with a Kruskal-Wallis test. Each topic was assessed in relation to each 
of 10 possible explanatory variables (sex, age, marital status, number of children, 
education level, occupation, housing, religious afflliation, severity of disease, family 
history). This gives 190 comparisons. Using a 2% probability level, one would expect 
about 4 such comparisons to show apparent significance, even if the grades had been 
allocated wholly at random. There were in fact seven comparisons significant at a 5 % 
level, of which three were at a 1 % level (denoted • below). There is thus evidence of 
remarkable homogeneity in the assessment of the topics of respondents with different 
characteristics, as measured by the explanatory variables. 
The comparisons that show a significance at a 2 % level are noted below. 
Education and Risk to you (1): those with education grade 1 (no 
qualifications) thought this less important (average ridit - a.f. - 0.416) than 
the others (probability 0.0090*). This is mentioned because it is statistically 
significant but this finding is possibly due to chance. 
Education and A.I.D. (14): those with education grade 1 (no 
qualifications) thought this more important (a.r. 0.593) than the others 
(probability 0.0152). 
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Education and Information about treatment for APKD (18): those 
with education grade 1 (no qualifications) thought this less important (a.r. 
0.418) than the others (probability 0.0158). 
Church and Voluntary childlessness (9): those with no church 
thought this more important (a.r. 0.611) than those who had; for catholics 
(a.r. 0.392) this was particularly unimportant (probability 0.0113). 
Church and Family planning (10): for catholics (a.r. 0.315) this was 
particularly unimportant (probability 0.0123). 
Number of children and Risk to children (2): those with no children 
(a.r. 0.518), one child (a.r. 0.653) and those with five or more children 
(a.r. 0.892) thought this more important than those with two, three or four 
children (probability 0.0062·). 
Number of possible future children and Risk to children (2): those 
with no likely future children (a.r. 0.434), thought this less important than 
those with one (a.r. 0.729) or two (a.r. 0.585) future children (probability 
0.0031·); this is of course associated with the preceding factor. 
The three findings above relating to the explanatory variable educationa1level are 
possibly due to chance and is not considered in the discussion at the end of the chapter. 
Each topic was assessed in relation to each of the 11 independent scores described 
in Chapters 10, 11, 12 and 14, namely EGCSl, EGCS2, KDSI to KDS3, KISI to KIS4, 
ATCS and OGCS, thus omitting the four scores formed as totals. The connections 
between the problems and these scores were compared by using ordinary (pearson 
product-moment) correlation coefficients (as an alternative to the gamma measure) and 
measuring (two-sided) significance by the I-statistic, as described in Section 13.2. 
Counting all the 11 independent scores and the 19 topics, there are 209 comparisons. 
Using a 2% probability level (It I ~2.4), one would expect about 4 such comparisons to 
show apparent significance. There were in fact 10 comparisons significant at a 2% level, 
of which 6 were at a 1 % level (It I ~2j, denoted • below). There is thus evidence of 
some dependence of how patients view the importance of various elements of genetic 
counselling on the scores, although there is still considerable homogeneity in the 
population in general. 
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The comparisons which show a significance at a 2 % level are noted below. 
Environment of genetic counselling (EGCS 1) and Risk to children 
(2): correlation coefficient (c. c.) .. 0.48, t - 3.90"'; those who had had 
a better experience of genetic counselling thought it more important that 
Risk to children should be included. 
Content of genetic counselling (EGCS2) and Risk to children (2): 
correlation coefficient (c.c.) .. 0.44, t .. 3.52"'; those who had had more 
content in their genetic counselling also thought it more important that Risk 
to children should be included. 
Knowledge of symptoms (KDS2) and Prevention of APKD (15): 
c.c. = -0.35, t .. -2.41; those who knew more about the symptoms of 
APKD thought it less important that Prevention of APKD should be 
included. 
Knowledge of treatment (KDS3) and Risk to you (1): c.c . .. 0.39, 
t .. 2.66; those who knew' more about the treatments for APKD thought 
it more important that Risk to you should be included. 
Knowledge of inheritance (KlS3) and Risk to children (2): 
c.c. = 0.36, t = 2.45; those who knew more about the transmission of 
APKD thought it more important that Risk to children should be included. 
Attitude to having fewer children (ATCS) was associated positively 
with four elements: 
No more children (10): c.c • .. 0.30, t .. 2.40; 
Sterilisation (12): c.c. = 0.34, t = 2.73"'; 
Vasectomy (13): c.c • .. 0.35, t .. 2.83"'; 
Prevention of APKD (15): c.c • .. 0.45, t .. 3.63"'; 
and a fifth associated element was almost significant: 
Family planning (11): c.c. = 0.29, t .. 2.36; 
it is not surprising that those who favoured considering fewer children 
thought that information about aspects of family planning should be 
included in genetic counselling. 
Consequences of genetic counselling (OOeS) and Risk to children 
(2): c.c. = 0.44, t = 3.52*; those who felt that genetic counselling had 
had a beneficial effect for them thought it important that Risk to children 
should be included. 
Although some of these correlations might be the result of chance, there is a good 
rationale for some of them, and indeed several are statistically very significant. 
15.3 REPEAT IN 11JIRD QUES110NNAIRE 
In questionnaire 3 the same question was asked with the same list of topics. 
Respondents were asked to complete the questionnaire themselves. Two respondents failed 
to do so. The responses of the 45 respondents who did are shown in Table 15.4. 
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Table 15.4 
Third population: numbers of patients who graded each topic 
in terms of how important it was for genetic counselling. 
Grade 1 2 3 4 5 6 
Not Not Extre-
0 Topic appli- impor- Sliaht Quito Very mel)' 
cablo tant 
1 Risk to you 34 1 1 3 6 
2 Risk to children 2 2 5 21 15 
3 Advantages of testing 3 2 4 21 IS 
4 Disadvantages of testing 1 4 3 6 18 13 
5 How to tell the at risk 1 4' 4 10 15 11 
6 Screening of sibs, etc 3 3 8 24 7 
7 Possibility of adoption 5 15 7 10 7 1 
8 Possibility of fostering 6 15 8 10 6 
9 Voluntary childlessness 8 14 3 9 10 1 
10 Having no more children 2 4 7 12 13 7 
11 Family planning 3 6 3 13 14 6 
12 Sterilisation 5 9 4 10 12 5 
13 Vasectomy 6 10 3 10 10 6 
14 A.I.D. 20 19 3 2 1 
15 Prevention of APKD 4 6 6 8 13 8 
16 Telling boy/girlfriends 2 5 6 12 16 4 
17 Telling in-laws 10 22 6 2 3 2 
18 Information about symptoms 1 8 36 
of APKD 
19 Information about treatment of 1 8 36 
APKD 
The totals of the numbers in each grade from Table 15.4 for all topics were 
calculated and are shown in Table 15.5. There were 855 answers in total. The ridits were 
calculated as described above. 
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Table 15.5 
Third population: total numbers and calculated ridits. 
Grade 1 2 3 4 5 6 Total 
Numbers 107 141 73 132 222 180 855 
Ridits 0.063 0.208 0.333 0.453 0.660 0.895 
The Kruskal-Wallis test was again used to see whether the mean ridits for the 
topics were significantly different from each other. The value of the test statistic, W, for 
this table was 360.67, which compared with t with 18 degrees of freedom, is an 
extremely significant result. 
Again not all topics were graded equally by the respondents. The topics have again 
been ranked in sequence by their mean ridit and are shown in Table 15.6 in mean ridit 
(Q3 m.r.) sequence with the highest at the top. Also shown are the averages of the scores 
in questionnaire 3 (Q3 a.s.), the standard deviations of the scores (Q3 s.d.), and the mean 
ridit (Q2 m.r.) and sequence (Q2 seq) for the responses in questionnaire 2. 
As in questionnaire 2, one value of the standard deviation is particularly high, that 
for topic 1 (Risk to you). This again shows a bimodal distribution with 34 in grade 1 (not 
applicable) and the rest in grades 3 to 6. 
The sequence in this questionnaire is almost the same as in questionnaire 2, except 
that Prevention of APKD has moved up from 16th to 10th, and Possibility of adoption has 
moved down from 10th to 15th. 
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Table 15.6 
Third population: mean ridit, average score and standard deviation of score 
for each topic which may be of importance in genetic counselling. 
Q3 Q3 Q3 Q3 Q2 Q2 
seq 0 Topic m.r. a.s. s.d. m.r. seq 
1 19 Information about treatment 0.84 5.76 0.56 0.82 1 
for APKD 
2 18 Information about symptoms 0.84 5.76 0.56 0.81 2 
of APKD 
3 2 Risk to children 0.68 5.00 1.01 0.73 3 
4 3 Advantages of testing 0.68 4.96 1.10 0.69 4 
5 4 Disadvantages of testing 0.62 4.67 1.31 0.64 5 
6 6 Screening of sibs, etc 0.61 4.64 1.04 0.58 6 
7 5 How to tell at risk 0.59 4.49 1.31 0.55 7 
8 10 Having no more children 0.52 4.13 1.34 0.48 9 
9 11 Family planning 0.51 4.04 1.43 0.53 8 
10 15 Prevention of APKD 0.51 3.98 1.57 0.38 16 
11 16 Telling boy/girlfriends 0.50 4.04 1.30 0.41 11 
12 12 Sterilisation 0.45 3.67 1.58 0.41 12 
13 13 Vasectomy 0.44 3.58 1.65 0.40 13 
14 9 Voluntary childlessness 0.36 3.04 1.52 0.40 14 
15 7 Possibility of adoption 0.35 3.04 1.35 0.46 10 
16 8 Possibility of fostering 0.32 2.89 1.27 0.39 15 
17 17 Telling in-laws 0.26 2.38 1.30 0.29 18 
18 1 Risk to you 0.23 2.04 1.90 0.30 17 
19 14 A.I.D. 0.t8 1.80 1.00 0.24 t9 
Note: column Q3 seq gives the sequence in this table; column Q2 seq gives the 
sequence in Table 15.3 relating to questionnaire 2; column 0 gives the original 
sequence as in Table 15.1. 
15.4 COMPARISON OF SECOND AND TBIRD QUES'IlONNAIRES 
The responses of the 45 patients who replied to questionnaire 3 were compared 
with the responses of the same 45 patients to questionnaire 2. First, the average level of 
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assessment of severity of each problem was compared by an analysis of the mean ridits, 
where the ridits were calculated using just the two responses from each respondent for the 
same topic. Secondly, the concordance between the replies from each respondent to each 
topic on the two occasions was compared using the gamma statistic. Table 15.7 lists the 
topics again, in the same order as in Table 15.3, the sequence according to mean ridit on 
the fIrst occasion, and shows the difference (dift) between the mean ridits on the two 
occasions (+ for those where the assessment was higher in questionnaire 3, - for those 
where the assessment was lower in questionnaire· 3), the probability (prob) that this 
difference occurs by chance (using the Kruskal-Wallis test), and the value of gamma when 
the two sets of responses for each topic are compared. 
The top few items, those which were the more important ones on the first 
occasion, have increased in importance, and the bottom few, which were the less 
important, have gone down. Information about treatment, Information about symptoms, 
Screening of sibs, and Telling boy/girlfriends are all significantly up at a 1" probability 
level, and no topic is significantly down. However, the relative positions have polarised. 
It should be noted that the concordances between the responses of patients in 
questionnaire 2 and questionnaire 3 are low; four are negative and the largest is 0.52. 
While individual patients changed their views about the importances of the different 
elements, the view of the collective population remained almost unchanged on the two 
occasions. 
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Table 15.7 
Second and third populations: comparisons of responses for each topic 
which may be of importance in genetic counselling. 
Q2 Q3 Q2 
seq seq m.r. diff prob gamma 
1 1 Information about treatment 0.82 +0.195 0.0002 0.16 
for APKD 
2 2 Information about symptoms 0.81 +0.208 0.0001 0.27 
of APKD 
3 3 Risk to children 0.73 +0.047 0.41 0.52 
4 4 Advantages of testing 0.69 +0.123 0.027 0.41 
5 5 Disadvantages of testing 0.64 +0.090 0.12 0.00 
6 6 Screening of sibs, etc 0.58 +0.161 0.0050 -0.09 
7 7 How to tell at risk 0.55 +0.123 0.036 0.29 
8 9 Family planning 0.53 +0.037 0.53 0.47 
9 8 Having no more children 0.48 +0.066 0.27 0.42 
10 IS Possibility of adoption 0.46 -0.131 0.030 0.25 
11 11 Telling boy/girlfriends 0.41 +0.186 0.0018 -0.05 
12 12 Sterilisation 0.41 +0.060 0.31 0.28 
13 13 Vasectomy 0.40 +0.058 0.33 0.19 
14 14 Voluntary childlessness 0.40 -0.060 0.31 0.25 
15 16 Possibility of fostering 0.39 -0.082 0.16 -0.06 
16 10 Prevention of APKD 0.38 +0.149 0.013 0.44 
17 18 Risk to you 0.30 -0.032 0.52 0.13 
18 17 Telling in-laws 0.29 -0.082 0.15 -0.01 
19 19 A.I.D. 0.24 -0.127 0.027 0.41 
Note: column Q2 seq gives the sequence in Table 15.3, relating to questionnaire 2; 
column Q3 seq gives the sequence in Table 15.6 relating to questionnaire 3. 
15.5 EFFEcr OF EXPLANATORY VARIABLES IN 1mRD QUFSIlONNAIRE 
The effect of the different explanatory variables on the gradings given to the topics 
was examined. Out of 190 independent comparisons made, not one was significant at a 
2 % probability level. The chance of this event occurring if the gradings had been allocated 
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to topics at random is as low as 0.0215, or not much more than 2%. While chance results 
like this do occur sometimes, it is further evidence of the remarkably homogeneity of this 
popUlation in its attitudes. 
Each topic was also assessed in relation to each of the scores as described in 
relation to questionnaire 2, the connections being compared as before by using correlation 
coefficients. Of the 209 comparisons only three were significant at a (two-sided) 2 % level 
(It I ~2.4), and not one at a 1 % level (It I ~2.7). This is further evidence of the 
remarkable homogeneity of these answers from this population. 
The comparisons which do show a significance at a 2 % level are noted below. 
Environment of genetic counselling (EGCS2) and How to tell the 
at risk (5): correlation coefficient c.c. = 0.36, t = 2.44. 
Knowledge ofinheritance (KIS 1) and Having no more children (10): 
c.c. = 0.38, t = 2.54. 
Attitude to having fewer children (ATeS) and Sterilisation (12): 
c.c. = 0.34, t = 2.46. 
Only the last of these relationships, for which there is good rationale, showed 
significant correlation for the responses in the second questionnaire, and no others of those 
found significant for the second questionnaire remained significant here. This supports the 
idea that most of these correlations are the result of chance. 
15.6 CO:MPARISON OF INDIVIDUAL RESPONSES IN SECOND AND l1llRD QUFSIlONNAIRES 
The views of each individual about the 19 topics in the second and the third 
questionnaires were compared in order to see how consistent was their ranking of the 
importance of the topics. This required constructing a 6 by 6 table for each respondent, 
as described in Section 13.6, showing how their 19 pairs of responses fell into grades. 
The concordances between the responses in the second and third questionnaires were then 
calculated, using the gamma measure described previously. 
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The values of gamma theoretically range from -1.0 to 1.0, and the actual range 
observed was from -0.12 (2 cases) to +0.98 (3 cases). The distribution of values of 
gamma for the third population is shown in Table IS.8. It is fairly similar to the 
distribution for the importance of different problems as shown in Table 13.8; a 
considerable number of cases have quite high concordance (say gamma~0.6), but a fair 
number have low concordance. 
Not calculated 
-1.0 to -0.0 
+0.0 to +0.2 
+0.2 to +0.4 
+0.4 to +0.6 
+0.6 to +0.8 
+0.8 to +1.0 
Total 
Table IS.8 
Third population: values of gamma -for each individual, 
subdivided by sex and marital status. 
Single Married 
females females Males Total 
1 
1 
1 
3 
4 
2 
12 
1 
S 
4 
3 
7 
20 
2 
1 
1 
1 
2 
8 
IS 
" 2 
3 
2 
7 
7 
9 
17 
47 
Correlation coefficients were calculated for the average ridits for each individual 
in the two questionnaires, the gamma measure of concordance described above, all the 
constructed scores described in Chapters 10, 11, 12 and 14, severity of disease and family 
history and also the ridits and the gamma measure for the problems discussed in Chapter 
13. The values of the coefficients ranged from -0.21 to +0.30, not significant, except 
for the following: 
the rid its for the importance of elements in the second questionnaire 
and in the third questionnaire, correlation coefficient 0.42, significant at a 
1 % level; 
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the ridit for the second questionnaire and the score for attitudes to 
having further children (ATeS), c.c - 0.38, significant at a 1" level. 
The first of these is not surprising. The second is also not surprising, considering 
the fact that those with a positive attitude to having no further children identified several 
topics that they thought particularly important to have included in genetic counselling. 
15.7 DISaJSSlON OF SECOND QUES110NNAIRE 
In Table 15.3 the mean ridit and average crude score for each topic which may be 
.' 
of importance in genetic counselling is shown. It is quite clear that information about the 
treatment for and symptoms of APKD are perceived by respondents as the two most 
important elements to be included in genetic counselling and are seen as more important 
than giving information about the risk to children of inheriting APKD. This is an 
important finding as there is considerable emphasis in the literature on genetic counselling 
in giving information about the risk of inheritance and transmission of the particular 
disease and little reference to the importance of information about the treatment and the 
symptoms of the illness. It is possible that the patient's perception of the burden of the 
illness is in part based on their knowledge of the symptoms of the illness and the 
treatments available. All respondents had APKD and it could be that this emphasis on the 
importance of information about the treatment and the symptoms also reflects what is a 
common request from patients generally ie the need for more information. 
The next four items in importance all concerned information about testing and 
screening. Presymptomatic diagnosis of APKD by ultrasound was already available and 
while patients agreed in principle with presymptomatic diagnosis of APKD, some patients 
reported to the research worker that it was difficult to know what they should do and say 
when it was suggested that their at risk relatives could be offered presymptomatic testing 
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for APKD. There is evidence in the genetic counselling literature of the reluctance of the 
affected person to inform their at risk relatives of their possibility of inheriting the 
particular illness and this behaviour is frequently attributed to denial (Lynch 1969). While 
not underestimating the importance of denial in this context, it is also possible that patients 
have not had the opportunity to talk about the advantages and the disadvantages of testing 
those at risk and may simply not know what to do about it. 
Eight out of the next 9 items, with mean ridits of 0.53 to 0.38, are concerned with 
the control or prevention of APKD. The exception is information about the telling of 
boyfriends or girlfriends with a mean ridit of 0.40. It would be relevant to consider 
including any of these 8 topics in genetic counselling where prevention of the illness is 
emphasised. It is interesting to note that respondents perceive these elements only of 
moderate importance. 
Artificial Insemination by Donor (A.I.D.) was strongly viewed as an unimportant 
topic. It could be that a population from a different part of the United Kingdom may not 
be so dismissive of A.I.D. Several respondents did not know what this procedure 
involved. When this was explained to them a frequent comment was 'disgusting'. This 
West of Scotland population may not be representative, but on the other hand these views 
may reflect the general population. 
The effect of different explanatory variables on the gradings given to topics in 
genetic counselling is described in Section 15.2. The first comment to be made concerns 
the influence of the explanatory variable of church or religious affiliation. Many authors 
in studies of genetic counselling have sought a link between religious affiliation and 
attitudes to genetic counselling and most studies have reported that they have not found 
an association between religious afflliation and attitudes to genetic counselling. For all 
authors this has appeared a surprising finding. In this analysis there are two statistically 
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significant findings associated with religious affiliation. Catholics did not think either 
voluntary childlessness or family planning were important topics to be included in genetic 
counselling. Respondents in this study may have answered the questions in relation only 
to APKD although they were asked to consider the questions more generally. And for 
these respondents APKD may not be considered sufficiently serious to merit preventing 
the birth of a child who may develop APKD. 
Respondents who had no children, respondents who had one child and those with 
five or more children compared with those who had' two, three and four children thought 
it important to include a discussion about the risk to children. For those who have no 
children or one child, such a discussion may be important as these respondents may 
consider having children or more children in the future. It is likely that those respondents 
who have two, three and four children may have completed their families and therefore 
for them this item is of less importance as it is for those with no likely future children. 
There were not many respondents with five or more children. Although the probability 
of having a child with APKD is SO-50 at each conception, the more children a person has 
the greater the chance there is that there will be an affected offspring. These respondents 
with very large families may simply have thought about the situation very carefully. 
15.8 DISCUSSION OF 1HIRD QUES110NNAIRE 
In questioMaire 3 respondents were asked to complete the same section as in 
questioMaire 2 on the list of topics that could be important in genetic counselling. 
The flI'St observation is to note the very great consistency in answers between the 
two interviews and therefore over a period of time. The time between the second and the 
third interviews was between 6 and 12 months and respondents completed this section of 
the questioMaire themselves so it is very unlikely that there was any collusion. 
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Information about the treatment for and symptoms of APKD remain by far the two most 
important elements and A.I.D. still remains the least important item. Prevention of APKD 
becomes the 10th most important item in this section compared with ISth in the analysis 
of questionnaire 2. This result could be by chance. But between interviews 2 and 3 some 
of the respondents had become ill or more ill and this cOuld influence the priority they 
gave to this topic. 
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16.1 PRENATAL DIAGNOSIS AND A GENE MARKER 
A secondary study was also carried out. The background and methodology of the 
study is described in this chapter. The results of the study are described in Chapter 17. 
The purpose of this study was to explore the views of patients with APKD to 
prenatal diagnosis and termination of pregnancy. The discovery of a gene marker for 
APKD on chromosome 4 in 1986 by Reeders et al before the completion of this study and 
the use of chorion villus sampling in prenatal diagnosis (see Section 2.7.4) meant that it 
could become increasingly possible to offer prenatal diagnosis to some families with 
APKD followed by termination of an affected fetus if they so wished. If the knowledge 
of the gene marker had been available at the beginning of the study, questions about 
prenatal diagnosis would have been included as part of the content of genetic counselling. 
At the time of this study there were no known published investigations into the 
views of APKD patients to prenatal diagnosis for APKD. It was not known whether 
patients would be interested in using prenatal diagnosis for APKD nor whether the timing 
of the procedure in the first or second trimester of pregnancy would influence their views. 
Moreover it was not known what the views of this group of patients would be to 
termination of pregnancy for APKD. 
Because of the delicate nature of this particular question, an interview would 
normally have been required in order to collect data. However, as many of the 
respondents were already well known to the research worker, it was not considered 
, inappropriate to give patients a self-administered questionnaire to complete. This was sent 
to patients between 1986 and 1987. 
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16.2 Srunv POPULATION 
It is likely that a decision about whether or not to take prenatal diagnosis would 
often be taken by both parents. It seemed important therefore to seek the views of the 
partners of the patients for this section of the study. It also seemed relevant to ascertain 
the views of patients with APKD in different stages of the illness from the asymptomatic 
to those with more severe symptoms as well as those at risk for APKD. The main study 
did not include those at risk for APKD. 
It was decided to include subjects of another investigation that was being carried 
out by Dr Keith Simpson and the research worker in conjunction with the Department of 
Human Genetics, Yorkhill Hospital, Glasgow and to seek the views of the subjects of this 
investigation to prenatal diagnosis. This investigation involved following up families with 
members known to have APKD in order to collect blood samples which would be used 
to ascertain the accuracy of a gene marker for APKD. This population included those at 
risk for APKD and their partners and the research worker had already met all the 
proposed sample. 
16.3 METHOD OF INVESIlGAll0N 
It is appreciated that the subject matter under investigation, prenatal diagnosis and 
termination of pregnancy, could be distressing for some people to consider. However as 
all the proposed subjects for this part of the study had already met the researcher worker, 
it was decided that it was not inappropriate for the questionnaire to be sent out by post. 
The main reason for using a postal questionnaire was that there was insufficient time to 
interview all subjects. 
Some of the known disadvantages of postal questionnaires include a possible low 
response rate, acquiring less detailed information than in interview, and the possibility that 
278 
CHAPTER 16: THE SECONDARY STUDY 
the respondent will either omit or misunderstand some of the questions. It was hoped that 
there would be a moderate response rate as many of the respondents particularly those in 
the APKD sample were known to the researcher. The questionnaire was kept as short as 
possible to make it easier for respondents and to encourage a higher response rate. There 
was only one topic per page and no more than 6 questions per topic. The language used 
was clear and unambiguous. 
200 self-administered questionnaires and a prepaid reply envelope were sent to the 
fIrst 200 participants in the gene marker investigation. In the event 194 were returned, an 
exceptionally high response rate of 97%. 
The questionnaires were numbered sequentially and anonymised making it 
impossible to trace respondents. 
16.4 CONTENT OF PRENATAL QUESTIONNAIRE 
In Section A four demographic questions were asked. These were sex, age range, 
marital status and relationship to the disease. 
Section B asked questions about the number of children and grandchildren that the 
respondent had had. 
Section C was concerned with screening for APKD. Four questions were asked 
about the testing of children and grandchildren for APKD and the appropriate age for this 
and whether extended family members should be told of their risk and offered screening 
for APKD. 
Section D was concerned with prenatal screening. Questions were asked about 
whether patients would consider using prenatal diagnosis to diagnose APKD in a fetus and 
whether they would prefer this to be done in the fIrst or second three months of 
pregnancy. There is some evidence that patients prefer termination to be carried out in the 
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first rather than the second trimester of pregnancy (Report of. the Royal College of 
Physicians 1989). It is appreciated that the available technology for prenatal diagnosis of 
APKD in 1986 could not detect APKD in the fetus with 100% accuracy. Therefore, 
questions were phrased 'whether in the future it becomes possible to tell during pregnancy 
whether or not a baby has APKD'. The questions were "appropriate given the state of 
knowledge at the time. 
Section E was concerned with termination of pregnancy. One of the choices that 
becomes open to parents as a result of prenatal diagnosis is termination of an affected 
fetus. Respondents were therefore asked whether they would consider termination of 
pregnancy of a fetus shown to have APKD. Termination of pregnancy is an emotive 
subject. Three questions were asked in this section to assess in what circumstances and 
with which illnesses the respondent would consider termination of pregnancy. 
Sections F and G of the questionnaire were concerned with questions about how 
the respondent ranked APKD in terms of other illnesses. How someone perceives the 
burden of an illness may be one reason why that person would decide to terminate a 
pregnancy. In Section F respondents were asked to rank on a five-point scale the degree 
of impairment likely to be caused to an individual by ten conditions chosen because of the 
frequency with which patients with these conditions were referred to the out-patient clinics 
at GRI. It was assumed that these conditions would be well known to respondents in the 
study. APKD was included in this list of ten conditions. 
In Section G the respondents were asked to answer the same questions as if the 
respondent were the manager of a life insurance company and that the people with the ten 
conditions had applied for insurance. The question was asked in this manner in order to 
explore how the respondent thought that others perceived the seriousness of APKD. 
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16.5 HAEMOPHILIA AND PRENATAL DIAGNOSIS 
It was not known to what extent the views of respondents about prenatal diagnosis 
of APKD would be representative of views of prenatal diagnosis in other illnesses. The 
. research worker was already working in the Haemophilia Unit, GRI, where there was 
considerable staff interest in prenatal diagnosis. Since 1984 it has been possible to detect 
haemophilia A in families with a clear history of haemophilia as well as to identify 
carriers. In families with a clear history of haemophilia A it was also possible to offer 
prenatal diagnosis by chorion villus sampling in the twelfth week of pregnancy. 
Haemophilia is transmitted in a sex linked recessive fashion. Carrier women have 
a 50-50 chance of producing a son with haemophilia. All daughters born to an affected 
male will be carriers but their sons will be unaffected. This is in contrast to the autosomal 
dominant inheritance of APKD where each child, regardless of sex, of an affected person 
has a 50-50 chance of inheriting the gene and subsequently of developing symptoms of the 
disease. In recent years improvements in the treatment for haemophilia had resulted in 
considerable optimism in the haemophilia world. The expectation of life was approaching 
that of normal and a new generation of haemophiliacs were able to anticipate living a 
'normal life' , attending school on a regular basis and obtaining employment appropriate 
to their ability (Wilkie 1992). 
However, in 1982 in the USA a person with haemophilia was diagnosed with what 
was to become known as the human immunodeficiency virus (lIlY) and since then many 
patients worldwide with haemophilia have died of my. Since all blood donors in the 
United Kingdom are now tested for HIV, and since the blood products used in the 
treatment of haemophilia have been heat treated since 1985, there should be no new cases 
of,mY transmitted to people with haemophilia through their treatment by blood products. 
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There are other differences between these two illnesses. APKD is a disease of 
variable age of onset affecting both sexes, whereas haemophilia affects baby boys from 
birth and haemophilia affects only the males. 
It was considered that it would be useful to assess the views on prenatal diagnosis 
of another study group and that it was inappropriate to use a sample from the general 
population because of the complexity of the subject and the lack of involvement of such 
a sample. While there were other groups that could have been sampled, it was considered 
appropriate to use a sample from haemophilia patients, their partners and female carriers 
of haemophilia. This sample were easily accessible, some of the patients were already 
known to the research worker and prenatal diagnosis was a subject of interest to this 
group. 
Permission was sought from the West of Scotland Haemophilia Reference Centre 
Director, Dr Gordon Lowe, to send the prenatal diagnosis questionnaire, adapted for 
haemophilia, to a sample of haemophilia patients, their partners and carrier women. 
Assistance was offered by staff of the haemophilia unit to distribute the questionnaires to 
carrier women when they came to the unit as well as to haemophilia patients and their 
partners. It was hoped that it would be possible to accrue 200 respondents. In the event 
90 questionnaires were returned, but it is not known how many were actually sent out by 
the staff of the Haemophilia Unit. 
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PRENATAL DIAGNOSIS AND TERMINATION OF PREGNANCY 
17.1 IN"rRODuCI1oN 
In this chapter the results of the analysis of the responses to Questionnaire 4, which 
was sent to the two populations described in Chapter 16, are discussed. Section 17.2 
contains an analysis of the results from the APKD respondents. In Section 17.3 the results 
from the haemophilia respondents are examined and compared with the results from the 
APKD population. In Section 17.4 certain results from the two populations are discussed 
together. Section 17.5 contains a general discussion of the results. 
17.2 THE APKD POPULATION 
17.2.1 Characteristics of the popUlation 
Out of the 200 Questionnaires distributed 194 were returned satisfactorily 
completed. This is a response rate of 97 %. One was returned with so little completed that 
it could not be used, and five were not returned. As the Questionnaires were anonymised 
it is not possible to comment on the characteristics of the non-respondents. 
Responses were received from 119 females (61.3%) and 75 males (38.7%). 
Besides their sex, respondents were asked to state their marital status, age (in bands 
mostly of five years) and their 'relationship to the disease', and also the number of 
children and grandchildren that they had. The distribution of the population by each of 
these characteristics, subdivided by sex, is shown in Tables 17.2.1 to 17.2.S. 
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Table 17.2.1 
APKD population: subdivided by marital status and sex. 
Female Male Total % 
Single 31 27 5S 29.9 
Married 6S 40 lOS 55.7 
Widowed 12 2 14 7.2 
Divorced or separated 7 4 11 5.7 
Other 1 2 3 1.5 
Total 119 75 194 100.0 
Table 17.2.2 
APKD population: subdivided by age group and sex. 
Female Male Total % 
15-19 14 12 26 13.4 
20-24 15 9 24 12.4 
25-29 19 S 27 13.9 
30-34 16 11 27 13.9 
35-39 14 12 26 13.4 
40-44 S 4 12 6.2 
45-49 S 7 15 7.7 
50-59 11 S 19 9.S 
60 and over 14 4 IS 9.3 
Total 119 75 194 100.0 
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Table 17.2.3 
APKD population: subdivided by 'relationship to disease' and sex. 
Female Male Total % 
Affected 61 26 87 44.8 
Screened and unaffected 23 14 37 19.1 
At risk (un screened) 13 12 25 12.9 
Unaffected * 3 4 7 3.6 
Spouse of affected 12 12 24 12.4 
Spouse of screened 5 2 7 3.6 
unaffected 
Spouse of at risk 2 3 5 2.6 
Spouse of unaffected 2 2 1.0 
Total 119 75 194 100.0 
Note: * these comprise those who might have been at risk, but are now established 
as unaffected, for example because their at risk parent has been screened and found 
to be unaffected. 
Table 17.2.4 
APKD population: subdivided by number of children and sex. 
Female Male Total % 
None 41 35 76 39.2 
One 24 11 35 18.0 
Two 28 17 45 23.2 
Three 15 7 22 11.3 
Four 6 3 9 4.6 
Five or more 5 2 7 3.6 
Total 119 75 194 100.0 
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Table 17.2.5 
APKD population: subdivided by number of grandchildren and sex. 
Female Male Total % 
None 97 69 166 85.6 
One 5 4 9 4.6 
Two 6 6 3.1 
Three 3 1 4 2.1 
Four 2 2 1.0 
Five or more 6 1 7 3.6 
Total 119 75 194 100.0 
17.2.2 Testing oC children Cor APKD 
Respondents were asked whether they thought that their children (or grandchildren) 
should be tested for APKD. Some 79% of them (154 out of 194) said that they thought 
that their children should be tested for APKD. The percentages among males and females 
were almost the same (94 out of 119 females or 79% and 60 out of 75 males or 80%). 
Only 14 (7%) thought that their children should not be tested; the remainder gave various 
intermediate responses, such as 'children already tested' (9), 'don't know' (11) and 'not 
applicable' (6) (see Table 17.2.6). 
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Table 17.2.6 
APKD population: responses to 'should your children be tested for APKD', 
subdivided by sex. 
Female Male Total % 
Yes 94 60 154 79.4 
No 10 4 14 7.2 
Already tested 7 2 9 4.6 
Not applicable 3 3 6 3.1 
Don't know 5 6 11 5.7 
Total 119 75 194 100.0 
Respondents were asked at what age (of the child) they would like to know 
whether their child had inherited APKD. The responses, subdivided by sex, are shown in 
Table 17.2.7. A majority favoured early testing, 66 (34%) wanting to know prenatally and 
48 (25%) choosing the ages of 0-4. A second group favoured the ages of 15-19 (17) or 
20 and over (14). Rather few favoured the intermediate ages of 5-9 (10) and 10-14 (9), 
while 30 (16%) did not know. 
Table 17.2.7 
APKD population: responses to 'at what age would you like to know whether your 
child had APKD', subdivided by sex. 
Female Male Total % 
Prenatally 39 27 66 34.0 
0-4 years 29 19 48 24.7 
5-9 years 6 4 10 5.2 
10-14 years 7 2 9 4.6 
15-19 years 12 5 17 8.8 
20 years & over 9 5 14 7.2 
Don't know 17 13 30 15.5 
Total 119 75 194 100.0 
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17.2.3 Screening oC relatives Cor APKD 
In answer to the question whether other members of the family (e.g. brothers, 
sisters, cousins) who may be at risk for APKD should be told of their risk, a large 
majority (179 or 92%) were in favour. Only 5 thought that relatives should not be told. 
See Table 17.2.8. 
Table 17.2.8 
APKD population: responses to 'should your relatives be told of their risk of 
APKD', subdivided by sex. 
Yes 
No 
Don't know 
Total 
Female Male 
109 
2 
8 
119 
70 
3 
2 
75 
Total 
179 
5 
10 
194 
92.3 
2.6 
5.2 
100.0 
When asked whether these same relatives should be tested for APKD a few 
changed their answers to 'no'; many replied that their relatives had already been tested, 
and a few that the question was not applicable (perhaps because they had no such 
relatives). See Table 17.2.9. 
Table 17.2.9 
APKD population: responses to 'should your relatives be tested for APKD', 
subdivided by sex. 
Female Male Total % 
Yes 85 48 133 68.6 
Already tested 23 19 42 21.6 
No 4 3 7 3.6 
Not applicable 1 2 3 1.5 
Don't know 6 3 9 4.6 
Total 119 75 194 100.0 
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17.2.4 Prenatal screening and tennlnatIon of pregnancy 
Respondents were asked whether they thought couples should take a test, if such 
a test were to become available, to test for APKD prenatally. A majority (134 or 69%) 
thought that couples should take such a test. See Table 17.2.10. 
Table 17.2.10 
APKD population: responses to 'should couples take a test for APKD during 
pregnancy?', subdivided by sex. 
Yes 
No 
Don't know 
Total 
Female Male Total % 
78 
25 
16 
119 
S6 
11 
8 
7S 
134 
36 
24 
194 
69.1 
18.6 
12.4 
100.0 
Almost the same number (135 or 69%) reported that they personally would take 
such a test to see whether the baby had APKD. See Table 17.2.11. 
Table 17.2.11 
APKD population: responses to 'would you consider taking a test for APKD during 
pregnancy?', subdivided by sex. 
Female Male Total % 
Yes 77 58 135 69.6 
No 32 10 42 2l.6 
Don't know 10 7 17 8.8 
Total 119 75 194 100.0 
Respondents were then asked whether they would take such a test if it were to be followed 
by termination of pregnancy if it were shown that the baby had APKD. A considerable 
majority (120 or 62%) replied that they would not. See Table 17.2.12. The proportion of 
females who would not take such a test (77 out of 119 or 65 %) was rather greater than 
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the proportion of males who took the same view (43 out of 75 or 57%). This is an 
interesting but not statistically significant result. 
Table 17.2.12 
APKD population: responses to 'would you consider taking a test followed by 
termination if the baby had APKD1', subdivided by sex. 
Female Male Total % 
Yes 16 13 29 14.9 
No 77 43 120 61.9 
Don't know 26 19 45 23.2 
Total 119 75 194 100.0 
The last two questions in this part of the questionnaire concerned respondents 
views on prenatal diagnosis followed by termination of pregnancy in the first or the 
second trimester of pregnancy. The responses to these questions were similar to those for 
the previous question, all but 30 (15.5%) giving the same answers to all three questions 
(22 'yes' to all three; 108 'no' to all three; 34 'don't know' to all three). The results, 
subdivided by sex, are shown in Tables 17.2.13 and 17.2.14. Only 25 respondents (13%) 
would consider termination for APKD in the second trimester. A few more (36 or 18%) 
would consider termination of pregnancy for APKD in the first trimester. 
Table 17.2.13 
APKD population: responses to 'would you consider testing followed by 
termination in the second trimester?', subdivided by sex. 
Female Male Total % 
Yes 13 12 25 12.9 
No 80 44 124 63.9 
Don't know 26 19 45 23.2 
Total 119 75 194 100.0 
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Table 17.2.14 
APKD population: responses to 'would you consider testing followed by 
termination in the fust trimester?', subdivided by sex. 
Female Male Total % 
Yes 
No 
Don't know 
Total 
17.2.5 
20 
71 
28 
119 
Termination or pregnancy 
16 
41 
18 
75 
36 
112 
46 
194 
18.6 
57.7 
23.7 
100.0 
Respondents were asked which of three statements best reflected their views on 
termination of pregnancy. The greatest number of respondents (129 or 66%) believed that 
termination should be available sometimes; 36 (19%) believed that termination of 
pregnancy should be available on request; only 28 (14%) said that they were totally 
against termination. See Table 17.2.15. 
Table 17.2.15 
APKD popUlation: responses to 'which best represents your views on termination of 
pregnancy?', subdivided by sex. 
Female Male Total % 
Available on request 18 18 36 18.6 
Available sometimes 83 46 129 66.5 
Totally against 17 11 28 14.4 
Total 119 75 194 100.0 
Respondents were asked under which of seven circumstances, all relating to the situation 
of the parents, they would consider termination of pregnancy. The results are shown in 
Table 17.2.16, in which the circumstances are listed in order of the proportion of 
respondents who replied 'yes'. 
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Table 17.2.16 
APKD population: numbers replying 'yes' to 'would you consider termination of 
pregnancy in the circumstances described'?', subdivided by sex. 
One parent has AIDS 
Mother's physical health 
Mother's mental health 
Mother a young teenager 
Mother over 40 
Family too large 
Mother unmarried 
Maximum 
Female Male Total 
80 46 126 
73 52 125 
54 38 92 
14 11 25 
11 8 19 
4 5 9 
2 4 6 
119 7S 194 
% 
64.9 
64.4 
47.4 
12.9 
9.8 
4.6 
3.1 
100.0 
The third question in this part sought the views of respondents on termination early in 
pregnancy for ten specific conditions from which the baby might suffer. The results are 
shown in Table 17.2.17, in which the conditions are listed in order of the proportion of 
respondents who replied 'yes'. 
o 
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Table 17.2.17 
APKD population: numbers replying 'yes' to 'would you favour termination of 
pregnancy if it could be determined early in the pregnancy that the baby would 
defmitely have the condition described?', subdivided by sex. 
Female Male Total % 
AIDS 84 49 133 68.6 
Severe mental handicap 80 48 128 66.0 
Severe physical handicap 76 41 117 60.3 
Disease likely to cause 43 33 76 39.2 
death before age 5 
Disease likely to cause 38 22 60 30.9 
death aged 6-10 
Disease likely to cause 30 19 49 25.3 
death aged 11-15 
Haemophilia 29 16 45 23.2 
APKD 17 13 30 15.5 
Mild mental handicap 17 8 25 12.9 
Slight physical handicap 9 6 15 7.7 
Maximum 119 75 194 100.0 
17.2.6 Analysis by sub-groups 
So far, 27 questions had been asked about testing, screening and termination. The 
responses to each of these questions were analysed by each of the six possible explanatory 
variables, sex, age, marital status, relationship to the disease, number of children or 
number of grandchildren to see whether there were any significant differences in the 
responses. For this, the categories of both the responses and the explanatory variables 
were grouped somewhat so as to avoid too many cells with too few observations, and then 
the Pearson statistic X2 = E(O-E)2/E was calculated and compared with ,( for the 
appropriate number of degrees of freedom. 
293 
CHAPTER 17: ANALYSIS: PRENATAL DIAGNOSIS AND TERMINATION OF PREGNANCY 
With 162 (27 x 6) tests in all it is reasonable to expect that, by chance, one or two 
of the tests would be apparently significant at a 1 % probability level. In fact six of the 
tests showed probabilities less than 0.01, four of them less than 0.001. These are noted 
below. but the main conclusion to be drawn is that there was little difference in the 
attitude of the respondents to testing, screening or termination, according to any of the 
explanatory variables recorded. 
The six explanatory variables were themselves strongly interconnected in a number 
of obvious ways: for example, older people had more children and grandchildren, widows 
were more likely to be older, and younger people were more likely to be single and to 
have fewer children. There were, however, two groups with a particular relationship to 
the disease worth noting: the older respondents were much more likely to be the spouses 
of those who were affected, some of them being widows; and those who were at risk but 
un screened were much more likely to be younger. 
The significant results were: 
Testing of relatives and relationship to disease: those who were 
affected were much more likely to have relatives that had already been 
tested than were the other groups (probability 0.00(1); but when these are 
combined with those who answered 'yes' to the question about relatives 
being tested the differences disappear. 
All the other significant tests related to the attitudes to termination: 
Age: those aged 20-24 were more likely to favour termination if the 
baby would suffer from mild mental handicap (probability 0.0043); but 
even then only 37.5% (9 out of 24) were in favour, as compared with 
12.9% overall. 
Relationship with disease: those who were at risk but un screened 
were more likely to favour termination if the mother were over 40 
(probability 0.0007), but this still meant that only 32 % (8 out of 25) were 
in favour as compared with 9.8 % overall. The same group were also more 
likely to favour termination if the baby was likely to die at ages 6-10 or 
11-15 (probabilities 0.0010 and 0.00(5), and in each case there was a 
majority in favour of 56% (14 out of 25 in both cases), as compared with 
30.9% and 25.3% overall. 
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Number of grandchildren: those with 4 or more grandchildren were 
more likely to be against termination on the grounds of the mother's 
physical health, 8 out of 9 being against, as compared with 35.6% overall 
(probability 0.0025). 
The fact that so few of the factors analysed show any significance demonstrates 
that the views of respondents on all the topics investigated are extremely consistent across 
all categories of respondents. 
17.2.7 Perception of severity of Ulness 
The final two sets of questions in the questioMaire asked respondents to rate on 
a five point scale firstly how they perceived the degree of impairment that might be 
caused to individuals by ten different conditions including APKD and secondly how 
others, for example the manager of a life insurance company, might view these 
conditions. The descriptions used in the two sets of questions were different, the first 
using: very mild: mild; moderate; severe; very severe, and the second using: normal; 
slight increase; moderate increase; high increase; unacceptable, all with reference to the 
extent to which the hypothetical manager of a life insurance company might increase the 
cost of insurance above the normal level. 
The responses are shown in Tables 17.2.18 and 17.2.19, in the approximate order 
of severity as assessed by the respondents. Further analysis of these results appears in 
Section 17.3, after the results for the haemophilia population have been discussed. 
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Table 17.2.18 
APKD population: numbers assessing each degree of impairment 
for each condition shown. 
Very Very 
mild Mild Moderate Severe severe 
AIDS 1 15 13 165 
Cancer 2 22 63 107 
Previous heart attack 4 14 98 65 13 
Chronic bronchitis 4 22 78 75 15 
APKD 10 23 82 57 22 
Epilepsy 19 27 113 27 8 
Diabetes 17 52 96 25 4 
High blood pressure 19 53 93 26 3 
Stomach ulcer 27 58 92 15 2 
Overweight 50 66 73 4 1 
Total 152 316 762 370 340 
% out of 1,940 7.8 16.3 39.3 19.1 17.5 
Table 17.2.19 
APKD population: numbers assessing how others might assess each degree of 
impairment for each condition shown. 
Unacc-
Normal Slight Moderate High eptable 
AIDS 2 1 9 11 171 
Cancer 3 3 13 65 110 
Previous heart attack 4 26 61 90 13 
Chronic bronchitis 13 37 82 54 8 
APKD 19 38 55 61 21 
Epilepsy 25 49 90 26 4 
Diabetes 50 66 56 20 2 
High blood pressure 46 69 54 20 5 
Stomach ulcer 76 70 44 4 
Overweight 88 66 30 9 1 
Total 326 425 494 360 335 
% out of 1,940 16.8 21.9 25.S 18.6 17.3 
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17.3 THE HAEMOPHILIA POPULAnON 
17.3.1 Characteristics or the population 
Only 90 respondents were accrued to the study in the time available. The questions 
asked were almost the same as those that the APKD population was asked, modified only 
as necessary. There were 51 females (56.7%) and 39 males (43.3%). All but one of the 
males had haemophilia; 32 females were known carriers of haemophilia; 4 females had 
von Willebrand's disease, which is a bleeding disorder similar to haemophilia that can also 
affect women. Tables 17.3.1 to 17.3.5 show the demographic details of the population on 
the same lines as for the APKD population, including, where appropriate, the percentage 
distribution in the APKD population. In most cases the two populations were similar. 
Table 17.3.1 
Haemophilia population: subdivided by marital status and sex. 
Female Male Total % %APKD 
Single 4 24 28 31.1 29.9 
Married 38 13 51 56.7 55.7 
Widowed 2 2 2.2 7.2 
Divorced or separated 7 7 7.8 5.7 
Other 2 2 2.2 1.5 
Total 51 39 90 100.0 100.0 
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Table 17.3.2 
Haemophilia population: subdivided by age group and sex. 
Female Male Total % % APKD 
15-19 1 2 3 3.3 13.4 
20-24 4 11 15 16.7 12.4 
25-29 5 7 12 13.3 13.9 
30-34 13 5 18 20.0 13.9 
35-39 12 3 15 16.7 13.4 
40-44 7 4 11 12.2 6.2 
45-49 4 4 8 8.9 7.7 
50-59 3 3 6 6.7 9.8 
60 and over 2 2 2.2 9.3 
Total 51 39 90 100.0 100.0 
Table 17.3.3 
Haemophilia population: subdivided by 'relationship to disease' and sex. 
Female Male Total % 
Affected male 38 38 42.2 
von Willebrand' s 4 4 4.4 
Female carrier 32 32 35.6 
Female, not carrier 3 3 3.3 
Female, carrier status not 3 3 3.3 
known 
Spouse of affected male 9 9 10.0 
Spouse of female carrier 1 1 1.1 
Total 51 39 90 100.0 
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Table 17.3.4 
Haemophilia population: subdivided by number of children and sex. 
Female Male Total % %APKD 
None 5 26 31 34.4 39.2 
One 11 2 13 14.4 18.0 
Two 21 5 26 28.9 23.2 
Three 8 5 13 14.4 11.3 
Four 3 1 4 4.4 4.6 
Five or more 3 3 3.3 3.6 
Total 51 39 90 100.0 100.0 
Table 17.3.5 
Haemophilia population: subdivided by number of grandchildren and sex. 
Female Male Total % % APKD 
None 48 38 86 95.6 85.6 
One or more 3 1 4 4.4 14.4 
Total 51 39 90 100.0 100.0 
17.3.2 Testing oC children Cor haemophllia 
Respondents were asked whether they thought that their daughters (or 
granddaughters) should be tested for haemophilia carrier status. Over 85 % of them (77 
out of 90 or 86%) said that they thought that their daughters should be tested. The 
proportion is not very different from that in the APKD population (79 %) (see Table 
17.3.6), and the proportions giving other answers were also similar. 
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Table 17.3.6 
Haemophilia population: responses to 'should your daughters be tested for 
haemophilia carrier status', subdivided by sex. 
Female Male Total % %APKD 
Yes 44 33 77 85.5 79.4 
No 2 3 5 5.6 7.2 
Already tested 4 1 5 5.6 4.6 
Not applicable 1 1 1.1 3.1 
Don't know 2 2 2.2 5.7 
Total 51 38 90 100.0 100.0 
Respondents were asked at what age (of the child) they would like to know 
whether their daughter had inherited haemophilia carrier status. The responses, subdivided 
by sex, are shown in Table 17.3.7a. The distribution of responses is similar to that for 
the APKD population, a majority favouring early testing, and a second group favouring 
higher ages, but starting in the 10-14 group rather than in the 15-19 group. 
Table 17.3.7a 
Haemophilia population: responses to 'at what age would you like to know whether 
your daughter had haemophilia carrier status', subdivided by sex. 
Female Male Total % % APKD 
Prenatally 18 14 32 35.6 34.0 
0-4 years 12 13 25 27.8 24.7 
5-9 years 2 2 4 4.4 5.2 
10-14 years 8 4 12 13.3 4.6 
15-19 years 6 4 10 11.1 8.8 
20 years & over 2 2 2.2 7.2 
Don't know 3 2 5 5.6 15.5 
Total 51 39 90 100.0 100.0 
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Respondents were asked at what age they would like to know whether their son had 
haemophilia. The answers are given in Table 17.3. 7b. The choice is really between 
prenatal and postnatal knowledge; a haemophiliac male is usually identified at quite an 
early age. Rather more than half (57%) favoured prenatal knowledge. 
Table 17.3.7b 
Haemophilia population: responses to 'at what age would you like to know whether 
your son had haemophilia t, subdivided by sex. 
Prenatally 
0-4 years 
5-9 years 
Total 
17.3.3 
Female Male Total % 
31 
20 
51 
20 
18 
1 
39 
Screening of relatives for haemophilia 
51 
38 
1 
90 
56.7 
42.2 
1.1 
100.0 
In answer to the question whether other members of the family (e.g. aunts, sisters, 
cousins) who may be at risk for haemophilia carrier status should be told of their risk, a 
large majority (80 or 89%) were in favour, just as for APKD. See Table 17.3.8. 
Table 17.3.8 
Haemophilia population: responses to 'should your relatives be told of their risk of 
haemophilia carrier status', subdivided by sex. 
Female Male Total % % APKD 
Yes 46 34 80 88.9 92.3 
No 2 3 5 5.6 2.6 
Don't know 3 2 5 5.6 5.2 
Total 51 39 90 100.0 100.0 
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When asked whether these same relatives should be tested for haemophilia a few 
changed their answers to 'no', again just as for APKD. Fewer than among the APKD 
population replied that their relatives had already been tested. See Table 17.3.9. 
Table 17.3.9 
Haemophilia population: responses to 'should your relatives be tested for 
haemophilia carrier status'?', subdivided by sex. 
Female Male Total % 
Yes 40 27 67 74.4 
Already tested 3 6 9 10.0 
No 1 3 4 4.4 
Not applicable 2 2 2.2 
Don't know 5 3 8 8.9 
Total 51 39 90 100.0 
%APKD 
68.6 
21.6 
3.6 
1.5 
4.6 
100.0 
17.3.4 Prenatal screenin& and termination of pre&nancy 
Respondents were asked whether they thought couples should take a test, if such 
a test were to become available, to test a male fetus for haemophilia prenatally. As for the 
APKD population a majority (72 %) thought that couples should take such a test. See 
Table 17.3.10. 
Table 17.3.10 
Haemophilia population: responses to 'should couples take a test for haemophilia 
during pregnancy'?', subdivided by sex. 
Yes 
No 
Don't know 
Total 
Female Male Total % % APKD 
39 
7 
5 
51 
26 
7 
6 
39 
302 
65 
14 
11 
90 
72.2 69.1 
15.6 18.6 
12.2 12.4 
100.0 100.0 
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One more respondent thought that they personally would take such a test to see 
whether the baby had haemophilia. See Table 17.3.11. 
Table 17.3.11 
Haemophilia population: responses to 'would you consider taking a test for 
haemophilia during pregnancy'l', subdivided by sex. 
Female Male Total % % APKD 
Yes 39 27 66 73.3 69.6 
No 
Don't know 
Total 
11 
1 
51 
12 
39 
23 
1 
90 
25.6 
1.1 
100.0 
21.6 
8.8 
100.0 
When respondents were asked whether they would take such a test if it were to followed 
by termination of pregnancy if it were shown that the baby had haemophilia, a 
considerable majority (70%) replied that they would not, just as for the APKD population. 
See Table 17.3.12. 
Table 17.3.12 
Haemophilia population: responses to 'would you consider taking a test followed by 
termination if the baby had haemophilia'l', subdivided by sex. 
Female Male Total % % APKD 
Yes 11 4 15 16.7 14.9 
No 35 28 63 70.0 61.9 
Don't know 5 7 12 13.3 23.2 
Total 51 39 90 100.0 100.0 
The responses to the questions about prenatal diagnosis followed by termination 
of pregnancy in the flIst or the second trimester of pregnancy were very similar to those 
for the previous question, and similar to those for APKD. All but IS (16.7%) gave the 
same answers to all three questions (8 'yes' to all three; 61 'no' to all three; 6 'don't 
know' to all three), very similar to the APKD responses. It made little difference to the 
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responses whether termination of an affected fetus could be carried out in the second or 
the first trimester of pregnancy. See Tables 11.3.13 and 11.3.14. 
Table 11.3.13 
Haemophilia population: responses to 'would you consider testing followed by 
termination in the second trimester?', subdivided by sex. 
Female Male Total % % APKD 
Yes 6 2 8 8.9 12.9 
No 39 28 61 14.4 63.9 
Don't know 6 9 IS 16.1 23.2 
Total 51 39 90 100.0 100.0 
Table 11.3.14 
Haemophilia population: responses to 'would you consider testing followed by 
termination in the frrst trimester?', subdivided by sex. 
Female Male Total % % APKD 
Yes 
No 
Don't know 
Total 
17.3.5 
12 
35 
4 
51 
Termination of pregnancy 
5 
21 
1 
39 
11 
62 
11 
90 
18.9 
68.9 
12.2 
100.0 
18.6 
51.1 
23.1 
100.0 
The views of respondents when asked which of three statements best reflected their 
views on termination of pregnancy are shown in Table 11.3.15. The proportions are quite 
similar to those for the APKD population, with a majority considering that it should be 
available sometimes. 
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Table 17.3.1S 
Haemophilia population: responses to 'which best represents your views on 
termination of pregnancy?', subdivided by sex. 
Female Male Total % % APKD 
Available on request 4 10 14 15.6 18.6 
Available sometimes 40 23 63 70.0 66.S 
Totally against 7 6 13 14.4 14.4 
Total 51 39 90 100.0 100.0 
The responses to the question about which of the seven circumstances, relating to the 
situation of the mother, could justify termination of pregnancy are shown in Table 
17.3.16. The proportions saying 'yes' are similar to those in the APKD population, and 
the sequence of proportions is identical. 
Table 17.3.16 
Haemophilia population: numbers replying 'yes' to 'would you consider termination 
of pregnancy in the circumstances described']', subdivided by sex. 
Female Male Total % % APKD 
One parent has AIDS 30 28 58 64.4 64.9 
Mother's physical 32 26 58 64.4 64.4 
health 
Mother's mental 28 18 46 51.1 47.4 
health 
Mother a young 9 8 17 18.9 12.9 
teenager 
Mother over 40 6 4 11 11.1 9.8 
Family too large 7 7 7.8 4.6 
Mother unmarried 5 2 7 7.8 3.1 
Maximum 51 39 90 100.0 100.0 
The same is true for the question relating to the views of respondents on termination early 
in pregnancy for ten specific conditions from which the baby might suffer, as shown in 
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Table 17.3.17. The proportions are similar to those for APKD and the sequence is 
identical. 
Table 17.3.17 
Haemophilia population: numbers replying 'yes' to 'would you favour termination 
of pregnancy if it could be determined early in the pregnancy that the baby would 
defInitely have the condition described?', subdivided by sex. 
Female Male Total % %APKD 
AIDS 34 29 63 70.0 68.6 
Severe mental 32 27 59 65.6 66.0 
handicap 
Severe physical 29 27 56 62.2 60.3 
handicap 
Disease likely to cause 16 22 38 42.2 39.2 
death before age 5 
Disease likely to cause 13 18 31 34.4 30.9 
death aged 6-10 
Disease likely to cause 12 16 28 31.1 25.3 
death aged 11-15 
Haemophilia 9 5 14 15.6 23.2 
Mild mental handicap 8 6 14 15.6 12.9 
Slight physical S 3 8 8.9 7.7 
handicap 
Maximum 51 39 90 100.0 100.0 
.. 
17.3.6 Analysis by sub-groups 
As for the APKD population, the responses to the 27 questions asked so far about 
testing, screening and termination were analysed by each of the six possible explanatory 
variables, to see whether there were any significant differences in the responses according 
to sex, age, marital status, relationship to the disease, number of children or number of 
grandchildren. The same Pearson statistic was calculated and compared with X' for the 
appropriate number of degrees of freedom. 
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Only two of the 162 tests showed probabilities of"; that were less than 0.01. The 
apparently significant results noted below might therefore be the result of chance. Both 
relate to attitudes to termination for specific reasons. 
17.3.7 
Marital status: those who were single and also those who were 
divorced, separated or 'other' were more likely to favour termination if the 
baby was likely to die before the age of 5. While overall only 42.2 % were 
in favour, 57.1 % of the single (16 out of 28) and 77.8% of the divorced 
(7 out of 9) were in favour (probability 0.(070). 
Number of children: those with only one child were less likely to 
favour termination for a baby that might have AIDS. While overall 64.4% 
were in favour, among those with one child only 30.8% (4 out of 13) were 
in favour (probability 0.0046). 
Perception of severity of illness 
The final two questions, as for the APKD population, asked respondents to rate 
on a five point scale firstly how they perceived the degree of impairment that might be 
caused to individuals by ten different conditions including haemophilia and secondly how 
others, for example the manager of a life insurance company, might view these 
conditions. 
The responses are shown in Tables 17.3.18 and 17.3.19, in the approximate order 
of severity as assessed by the respondents. Further discussion of these results, in 
conjunction with those for the APKD population, follows in Section 17.4. 
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Table 17.3.18 
Haemophilia population: numbers assessing each degree of impairment 
for each condition shown. 
Not Very Mode- Very 
given mild Mild rate Severe severe 
AIDS 5 1 3 9 72 
Cancer 8 2 4 10 25 41 
Previous heart attack 7 5 8 47 19 4 
Haemophilia 8 6 10 33 26 7 
Chronic bronchitis 6 2 7 27 39 9 
Epilepsy 6 6 16 43 17 2 
Diabetes 6 7 27 32 18 
High blood pressure 5 7 26 40 10 2 
Stomach ulcer 5 9 29 41 6 
Overweight 5 25 31 24 2 3 
Total 61 70 158 300 171 140 
% of 839 8.3 18.8 35.8 20.4 16.7 
Table 17.3.19 
Haemophilia population: numbers assessing how others might assess each degree 
of impairment for each condition shown. 
Not. Mode- Unacc-
given Normal Slight rate High eptable 
AIDS 7 1 1 7 74 
Cancer 8 2 1 6 29 44 
Previous heart attack 8 3 10 27 38 4 
Haemophilia 8 5 15 25 21 16 
Chronic bronchitis 7 6 11 33 27 6 
Epilepsy 8 6 18 36 17 5 
Diabetes 7 11 31 33 7 1 
High blood pressure 7 13 35 27 6 2 
Stomach ulcer 7 28 32 17 S 1 
Overweight 7 24 38 15 4 2 
Total 74 99 191 220 161 15S 
% of 826 12.0 23.1 26.6 19.5 18.8 
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17.4 ANALYSIS OF THE PERCEPTIONS OF THE SEVERITY OF ILLNESS 
Tables 17.2.18, 17.2.19, 17.3.18 and 17.3.19 show the numbers of respondents 
in the APKD and the haemophilia populations who rated eleven conditions (ten each, 
including APKD for the APKD population and haemophilia for the haemophilia 
population, but not vice versa), first in order of severity as perceived by themselves, and 
secondly in order of severity as the condition might be perceived by others. In this section 
the two sets of results are compared. 
For these comparisons the ridits for all questions were used. All four sets of 
answers for all eleven questions were combined, and aggregate ridits were calculated. 
Table 17.4.1 shows the calculation. 
Table 17.4.1 
Combined populations: calculation of ridits for degree of impairment 
for ten conditions. 
Very Mode- Very 
Self-assessment: mild Mild rate Severe severe 
Mode- Unacc- Total 
Others: Normal Slight rate High eptable 
APKD self 152 316 762 370 340 1,940 
APKD others 326 425 494 360 335 1,940 
Haemophilia 70 158 300 171 140 839 
self 
Haemophilia 99 191 220 161 155 826 
others 
Total 647 1,090 1,776 1,062 970 5,545 
Ridits 0.0583 0.2150 0.4734 0.7293 0.9125 
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The ridit for the first column is calculated as the average cumulative proportion 
in that cell or Ih X 647/5,545 = 0.0583; that for the second as (647 + Ih X 1,090)/5,545 
= 0.2150; and so on. The average ridit for all cases is necessarily 0.5. 
The average ridit for each condition, for each population, and the average ridit for 
all conditions were then calculated, and the results are shown in Table 17.4.2, with the 
conditions being ranked in order of overall average rid it. Although there were some 
differences in the average ridits, the ranking of the impairments was similar for each of 
the populations, and for both self-assessment and assessment by others. Thus AIDS came 
first in every list, followed by cancer. The next four, previous heart attack, haemophilia, 
chronic bronchitis and APKD, changed sequence among themselves but always came after 
cancer and before epilepsy, which always came next. High blood pressure and diabetes 
filled the next two positions, in either order, and stomach ulcer and overweight always 
filled the last two places, in either order. 
There is no doubt that the respondents had a clear order of severity among the 
different conditions, which are not ranked all equal in any of the four sets of results. A 
Kruskal-WaIlis test (Agresti 1984 p182) on the average ridits shows that the average levels 
of the four sets are not the same, although they are fairly close. The APKD self-
assessment has a significantly higher overall average ridit (0.5245), and the APKD 
assessment by others has a significantly lower overall average ridit (0.4703) than either 
of the haemophilia sets, which do not themselves differ significantly from one another. 
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Table 17.4.2 
Both populations: average ridits for each of eleven conditions for APKD and 
haemophilia populations, for self-assessment and for assessment by others. 
Haemo- Haemo-
APKD APKD philia philia 
self others self others Total 
1 AIDS 0.8627 0.8693 0.8676 0.8815 0.8686 
2 Cancer 0.7944 0.79n 0.7482 0.7862 0.7875 
3 Previous heart attack 0.5614 0.5784 0.5032 0.5667 0.5594 
4 Haemophilia 0.5301 0.5520 0.5410 
5 Chronic bronchitis 0.5684 0.4856 0.6078 0.5241 0.5388 
6 APKD 0.5463 0.5101 0.5282 
7 Epilepsy 0.4505 0.3980 0.4568 0.4661 0.4354 
8 Diabetes 0.4098 0.3094 0.4106 0.3487 0.3657 
9 High blood pressure 0.4032 0.3208 0.4006 0.3285 0.3629 
10 Stomach ulcer 0.3627 0.2228 0.3594 0.2544 0.2972 
11 Overweight 0.2860 0.2113 0.2786 0.2580 0.2546 
Total 0.5245 0.4703 0.5155 0.4962 0.5000 
The Kruskal-Wallis test can be used to show whether any of the differences 
between mean ridits for the four sets for any of the individual conditions are significant. 
In the two populations there were 24 such overall comparisons, of which two in each 
population showed probabilities less than 0.02. 
For the APKD population, in the assessment of others, those who 
were 15-19 or in the 35-39, 40-44 or 45-49 age groups ranked the 
conditions more seriously overall than those in the intermediate (20 to 34) 
and higher (over 50) age groups. The average ridit for the 45-49 age group 
(0.584) was the highest (probability 0.(011). 
For the APKD population, in the assessment of others, those who 
had no grandchildren ranked the conditions more seriously overall than 
those with some grandchildren, particularly those with four or more 
(average rid it 0.422) (probability 0.0016). This may be associated with the 
previous result, because naturally those with grandchildren are older and 
all of those with four or more grandchildren were over 50. 
For the haemophilia population, in the self-assessment, males 
(average ridit 0.467) ranked the condition less severely than females 
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(average ridit 0.527) (probability 0.020). 'This is particularly influenced by 
the low ranking given by males to haemophilia, as noted below. 
For the haemophilia population, in the self-assessment, those who 
are affected (and therefore all males) ranked the condition less seriously 
than the others, all but one of whom were females (probability 0.0188). 
This is the same point as the preceding one. 
'The Kruskal-Wallis test can also be used to compare the rankings for sub-sets of 
the population for anyone condition or for all conditions combined. 'There are six possible 
explanatory variables: sex, age, marital status, relationship to disease, number of children 
and number of grandchildren, and tests of each variable with each of the ten conditions, 
for both self-assessment and assessment by others, within each population were carried 
out. This gives 120 tests within each population. It is only reasonable to look at those 
which gave a probability level of less than 1 in 100 or 0.01, and even then one should 
expect one or two tests to show significance in such a number. 
Four of the tests in the APKD population showed probability levels of less than 
0.01, and two in the haemophilia population. While some of these appear to have little 
logic, others are, however, of interest. 
In the APKD population the following tests showed probabilities less than 0.01: 
Sex and other's assessment of chronic bronchitis: males assess this 
condition more seriously than females (average rid it 0.575 against 0.453, 
probability 0.0024). Although the average ridit for males for the 
haemophilia population is also greater than that for females, the difference 
is far from significant (probability 0.4454), and the average ridits for self-
assessment for both populations are quite close. 
Age and overweight for self-assessment: those in the 15-19 and 
20-24 age groups assess this condition as less serious than older people 
(probability 0.0057); there seems little reason for this, and little supporting 
evidence in the other population. 
Age and APKD for self-assessment: those in the 15-19, 20-24 and 
25-29 age groups assess this as more serious than those who are older 
(probability 0.0075); however, this is best explained by consideration of the 
next significant test. 
Relationship to disease and APKD for self-assessment: those who 
are affected and the spouses of those who may be affected or at risk assess 
this condition much less severely (average ridits 0.452 and 0.420 
respectively) than those have been screened and been found unaffected 
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(average ridit 0.594) and those who are at risk but unscreened (average 
ridit 0.625) (probability 0.(010). The connections with age (see the 
previous test) are that spouses are substantially older than average and 
those at risk but unscreened are substantially younger than average. The 
same tendency can be seen in the assessment of others, but not to a 
significant extent. 
This last significant result is of importance, and is corroborated by the two results 
from the haemophilia population that show probabilities less than 0.01: 
Sex and haemophilia for self-assessment: males (who are almost all 
affected) assess this condition as much less serious than do females 
(average ridit 0.414 against 0.574, probability 0.(089). 
Sex and haemophilia for assessment by others: the same is true as 
in the previous test; males expect others to assess this condition as less 
serious than do females (average rid it 0.407 versus 0.576, probability 
0.(068). 
17.S DISCUSSION 
The first observation to make about these results is the high degree of agreement 
between the results of the APKD and the haemophilia populations. The majority of 
respondents in both populations would like to know at a young age whether or not their 
child had APKD or their daughter was a carrier of haemophilia or their son had 
haemophilia, with a slightly greater number in both populations favouring knowing about 
the situation prenatally than at age 0-4. An even greater proportion (98 %) would wish to 
know at an early age that their son had haemophilia; this may be explained by the fact that 
the sooner there is an accurate diagnosis of haemophilia the sooner appropriate treatment 
can be given. 
The great majority of respondents in both populations (APKD 92 %, haemophilia 
89 %) thought that relatives should be told of their risk with a slightly smaller but still 
considerable majority believing that relatives should be tested for APKD or haemophilia 
carrier status. This finding could be interpreted in a variety of ways. If both APKD and 
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haemophilia respondents perceived the respective illnesses as very serious then they 
themselves may cope by denying the genetic nature of the illness as some people with 
Huntington's chorea have been reported to do (Phillips 1982). However the evidence from 
the findings of this study suggests that respondents may simply think that such genetic 
information is important for relatives to have and that there are unlikely to be any 
problems for the relatives in receiving such information or in getting such information to 
the relative. These respondents do not deny the presence of the illness. 
The majority of both populations (70% APKD and 73% haemophilia) would 
consider having prenatal diagnosis for APKD and haemophilia. This is consistent with 
their desire to know at an early age whether or not their child is affected. 
Although the majority of both sets of respondents would consider prenatal 
diagnosis, the majority (62 % APKD and 70% haemophilia) would not consider prenatal 
diagnosis to be followed by termination of pregnancy. The availability of termination in 
the first trimester of pregnancy marginally increased the percentage of those who would 
favour termination of fetus affected by APKD or haemophilia to 18 % in both populations. 
These findings are in contrast with those of Hodgkinson et al (1990) where only 
a minority of the APKD population studied said that they would be interested in prenatal 
diagnosis for APKD. It is not known from the Hodgkinson study whether respondents 
assumed that termination of a fetus with APKD would normally follow prenatal diagnosis. 
Prenatal diagnosis is usually offered with the intention that if a serious abnormality is 
detected then the woman may have her pregnancy terminated (Henderson 1987) and 
indeed some obstetricians restrict prenatal diagnosis only to patients who will make a prior 
decision to terminate the pregnancy in the event of a positive diagnosis (Richards 1987). 
In the current study, respondents were asked their views of prenatal diagnosis, not 
associated with termination. Respondents had also made it clear that they favoured early 
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knowledge of APKD or haemophilia in their child, either prenatally or from birth to 4 
years. A possible explanation is that the interests of those considering having prenatal 
diagnosis on one hand and the obstetricians on the other may be different. Farrant (1985) 
points to a significant difference in the perspective of the professionals, the obstetricians, 
and the laity, the parents, considering prenatal diagnosis and suggests that for the majority 
of women the prime goal of fetal diagnosis is to obtain reassurance about the good health 
of their fetus while obstetricians place priority on the diagnosis and termination of an 
affected fetus. 
Neither the APKD nor the haemophilia population is against, in principle, 
termination of pregnancy, with considerable agreement demonstrated between the 
populations. The majority of both populations believe that termination of pregnancy should 
be available sometimes and both populations display consistent and identical discriminatory 
views as to the circumstances in which they consider it appropriate for termination of 
pregnancy to be carried out. If one parent has AIDS and for reasons of the mother's 
physical health are seen as the two most important reasons with respondents expressing 
less certainty about reasons of the mother's mental health. There is little support for 
termination of pregnancy for reasons of the mother's age, for the size of the family or for 
the marital status of the mother. 
Over 60% of respondents in both populations were in favour of termination early 
in pregnancy if it could definitely be shown that the fetus would have AIDS, severe 
mental handicap or severe physical handicap. Respondents were also quite consistent in 
their views on termination of pregnancy for illnesses where the child would die before 5 
years old, between 6-10 and between 11-15 with more support for termination when the 
child might die younger. Only 15% of the APKD population would consider termination 
of pregnancy for a fetus with APKD and 15.6% of the haemophilia population would 
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consider termination of pregnancy for haemophilia. This part of the study was carried out 
in 198617 when media coverage ofmV and AIDS was high and this may help explain the 
emphasis on the severity of AIDS by both populations. 
It is clear that while both populations are in favour of termination of pregnancy for 
specific 'serious conditions' neither population views "their respective disorders as 
sufficiently serious to merit termination. 
When the results of patients' perceptions of serious illness are examined, an 
interesting finding is that respondents affected by APKD perceive APKD much less 
severely than the screened unaffected and the at risk but unscreened. A similar finding 
was found in the haemophilia population where male respondents, who were almost all 
affected by haemophilia, perceived haemophilia to be much less serious than did female 
respondents. In a parallel study in which the researcher was involved, HIV positive and 
mv negative haemophiliacs were asked the same rating questions to assess the perception 
of mv. An examination of the self ratings of HIV antibody positive patients on the 
seriousness of HIV showed that this sub-group of patients did not consider HIV to be such 
a serious condition as did other sub-groups in the study, all of whom were HIV antibody 
negative (Markova et al1990). These authors offered explanations for their findings (P78): 
"One possibility is that their coping strategy was to deny the seriousness 
of HIV •.• Another possible reason for diminishing the seriousness of HIV 
infection is that the severely affected patients who were mv antibody 
positive had overcome many of the life threatening problems of 
haemophilia and for these patients HIV infection was yet another problem 
to cope with and therefore relatively of a smaller importance than for those 
with mild/moderate haemophilia". 
In the above example the HIV antibody positive haemophiliacs may be 'distracted' 
from mv by the problems created by their severe haemophilia. However that argument 
does not apply to the APKD population. Another possible explanation is that the HIV 
antibody haemophiliacs have spent their life overcoming the problems of haemophilia and 
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mv is merely a continuation of that. This explanation would apply to the APKD 
population where many of the affected respondents have experienced some of the 
symptoms and treatments for APKD. 
The medical defmition of ill-health is largely based on objectively demonstrable 
physical changes in the structure of the body or function of the body. These changes can 
be quantified by reference to 'normal' physiological measurements and according to 
Fabrega and Silver (1973) it is often assumed that these changes are the same regardless 
of the society or culture in which they appear. This medical model of ill health does not 
include factors which clarify the meaning of the illness for the patient. It is likely that 
many doctors would define APKD as a serious illness. It is also likely that insurance 
underwriters would also view APKD as serious. As Brackenridge (1977 p383) states: 
"It is obvious that applicants who are known to suffer from familial 
polycystic disease of the kidneys cannot be offered terms for ordinary life 
assurance. II 
If our society is able to continue to offer the same or improved standard of 
treatment and care for people with APKD then it is unlikely that the perceptions of 
patients to APKD will change. However if more stringent rationing of health resources 
is introduced and dialysis and transplant facilities are reduced, then the perceptions of 
people with APKD to this illness may change. 
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This thesis was concerned with knowledge, perceptions and understanding of 
genetic counselling amongst patients with APKD. 
18.1 EXPERIENCE OF GENE11C COUNSELLING 
The information for this study was collected retrospectively from patients attending 
the Renal Unit of Glasgow Royal Infirmary. There had been no particular policy in the 
Renal Unit to give genetic counselling to patients with APKD. Yet at the time of the first 
interview 75 % of patients remembered receiving some genetic counselling and this had 
in the great majority of cases been given by doctors in the Renal Unit. So some genetic 
counselling was being included in the management of the patients. 
18.2 KNOWLEDGE OF SYMPTOMS AND TREATMENT 
The majority of respondents at the time of the first interview knew about anti-
hypertensive therapy, transplant and haemodialysis as treatments. In addition two-thirds 
of respondents recollect being told about cysts. 
Patients were not asked in the study what they understood by 'cysts', and it is not 
known what patients think a cyst is. Is a cyst a growth which may be cancerous, or do 
cysts simply go away? Furthermore, it is doubtful whether the meaning attached to renal 
cysts by renal physicians would be the same as the meaning for the patients. The cysts of 
APKD resemble blisters. But blisters burst and go away, with the skin usually healing 
afterwards. So there is a potential knowledge gap between the professional and the lay, 
in that patients may not be told of the implications of the presence of renal cysts in APKD 
for normal renal function. 
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By the third interview patients were generally knowledgeable about the symptoms 
and treatment of APKD. However, information about the symptoms of and treatments for 
APKD were perceived by patients in both the first and third interviews as the two most 
important elements to be included in genetic counselling. This fmding supports the 
suggestion by Gerhardt (1990) that, as new and more effective treatments become 
available for chronic illnesses, the expectation of what medicine has to offer can lead 
patients into searching for more information that makes more sense to them. It is also 
possible that this search by patients for information gives them a sense of security, as 
suggested by Moscovici and Hewstone (1983). A sense of security could be particularly 
important for patients suffering from a chronic illness such as APKD which by the very 
variability of the illness may create considerable uncertainty for the patient. Knowledge 
may also give the patient a feeling of control over an illness over which there is actually 
no control. 
Lay organisations can be a very helpful source of information for patients. Such 
organisations often produce useful literature about the disease as well as providing 
opportunities for members to meet. Very few patients in this study were members of the 
local Kidney Patients Association (see Appendix B.IO). At the time of the study there was 
no specific APKD organisation. 
In view of the finding of the importance of knowledge of the symptoms and 
treatment of APKD for patients and, considering how complicated renal medicine is as 
well as how many and varied are the functions of the kidneys, I would recommend that 
in genetic counselling patients with APKD be given some written information about renal 
function, and the symptoms of and treatments for APKD. In addition some patients may 
find references such as Gabriel's A Patient's Guide to Dialysis and Transplantation (1981) 
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or Mills's The Gift 0/ a Kidney (1992) helpful. Patients should also be told about the 
Kidney Patients Association and be given a contact address. 
18.3 PREvENTION IN GENETIC COUNSELLING 
The topics most frequently remembered by respondents as having been included 
in genetic counselling were the risk to children, having no more children, sterilisation and 
prevention of APKD, and so this model of genetic counselling falls firmly into the second 
paradigm of genetic counselling described in Chapter 2. 
It is not surprising that renal physicians in giving genetic counselling should be 
concerned with prevention. Renal physicians are likely to be aware of the extent of the 
medical and social problems associated with APKD. Some may be concerned about the 
costs of treating renal patients including those with APKD. In 1983, Gabriel and also 
Pincherle and Mancini, in a symposium on renal medicine, discussed the problems of 
scarce resources and escalating costs of the treatment for patients in ESRF. And in 1992 
Sibbald et aI and Wilkie et ai, in their study on prescribing at the hospital-general 
practitioner interface, demonstrated that hospitals in England and Wales were cutting back 
on the prescribing of drugs such as erythropoietin used in the treatment of anaemia in 
patients with ESRF. APKD can be an expensive illness. It is therefore not surprising that 
doctors concentrate on the prevention of future cases of APKD. 
18.4 WHO SHOULD GIVE GENETIC COUNSELLING? 
A majority of respondents were in favour of genetic counselling being given by 
doctors in the renal unit, although a rather larger number of patients preferred a specialist 
genetic counsellor. The possibility of research bias in this last result has already been 
referred to in Section 14.7. Nevertheless this finding would suggest the usefulness of 
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having a specialist non-medical counsellor as part of the team, who could give genetic 
counselling and could evaluate the results. In the United Kingdom, genetic counselling has 
traditionally been given by doctors. However, gradually other professionals including 
specialist nurse counsellors, psychologists and other social scientists are becoming 
involved. 
Patients were not asked whether they would be prepared to go to another hospital 
or place for genetic counselling, but it was evident from comments made by patients that 
they did not wish to have to make a journey to another hospital for genetic counselling. 
In some hospitals it is possible that the genetic department and the renal unit are in the 
same building, and genetic counselling could then be offered by the genetic department. 
However, in the foreseeable future it is likely that genetic counselling will be given to 
patients with APKD by renal unit staff. 
18.5 THE ORGANISATION OF GENETIC COUNSEUJNG 
Most patients remembered having received genetic counselling on one occasion 
only, during a routine medical consultation, and on their own. A genetic illness has 
implications not only for the person with the illness but also for other family members. 
In this study there was seldom a record kept of the information that had been given to 
patients. The information in genetic counselling is complex and the patient may find it 
difficult to remember, particularly if he or she becomes distressed. I would, therefore, 
recommend that when genetic counselling for APKD is given by doctors in a renal unit: 
(a) a separate appointment be made especially for genetic counselling; 
(b) the patient be invited and encouraged to bring their partner, other 
family member or friend; and 
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(C) a record of the discussion, which may be in the form of a letter to 
the patient detailing the discussion, be kept in the patient's notes. 
18.6 KNOWLEDGE OF INHERITANCE AND TRANSMISSION 
The concept of genetic information must include information both about the 
inheritance of the illness and about the pattern of transmission. It is a misconception to 
assume that if a person understands that they have inherited APKD then they also 
understand that they have the ability to pass the illness on to the next generation. The 
objective assessment of risk may be described as the probability of some unwanted 
outcome multiplied by the severity of that outcome. But Pearn (1973) suggests that the 
subjective interpretation of risks by patients in genetic counselling is much more complex 
than this. 
There is another possible explanation why patients may have difficulty in 
understanding genetic inheritance and transmission. In Chapter 5 different ways used by 
lay persons to explain their illness were described. BIaxter (1983), in her study of the 
attitudes of Scottish women to health and disease, found that the most commonly cited 
cause of illness was family susceptibility and heredity. However, these family 
susceptibilities were often seen as inherited weaknesses. This attitude was also found 
amongst some of the respondents in Herzlich's (1973) study, who restricted the meaning 
of heredity to abnormality and social weakness. It is not surprising that such views of 
heredity associated with abnormality and social weakness should be held by some lay 
people, since these were the views of the 'professionals' in paradigm 1 described in 
Section 2.3. 
Furthermore, the gene is 'inside the body' and therefore difficult to fight, thus 
discouraging patients from accepting heredity as the cause of their illness. It is also 
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arguable that, apart from the speciality of clinical genetics, the medical profession appears 
to have been relatively slow to accept heredity as the cause of illness, although this may 
change in the future with the mapping of the human genome. Doctors may then be more 
ready to attribute the cause of illness as genetic and this may then influence lay ideas 
about the cause of illness. 
18.7 LANGUAGE OF GENETICS 
In this study patients showed some confusion in their understanding of the genetics 
of APKD. In the first interview while 72 % of respondents knew that APKD was 
'inherited' only 59% reported that APKD was 'genetic'., Furthermore 67% knew that 
APKD 'ran in the family'. 
While 80% of respondents said that APKD could be passed on, only a small 
minority understood how APKD is passed on. This finding was confmned in the third 
interview with respondents showing considerable uncertainty about whether on average 
half the children of an affected person are at risk of developing APKD or all the children 
are at risk. These fmdings suggest that some of this group of patients found it difficult to 
understand that all the children of an affected person are at risk of inheriting APKD but 
on average only half of these children will become affected. This is a difficult concept to 
understand. It is also a difficult concept to explain, and it is possible that some of the 
doctors themselves were unsure about this principle. However, if patients are to make 
informed choices based on the information they receive in genetic counselling then it is 
important that this information be clearly explained to them. I would, therefore, 
recommend that patients be given some written information about the genetic inheritance 
and transmission of APKD in their family. This information can then be kept by the 
patient for reference. 
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18.8 PERCEFI10N OF THE SIZE OF RISK OF APKD 
Within the field of clinical genetics, if the risk of transmission of a disease is 
greater than 1 in 10, then the risk is generally considered to be a high risk and amongst 
. professionals it would be described as such. In this study the majority of respondents 
thought that the risk of inheriting APKD and the risk of transmitting APKD were both 
medium risks. Furthermore 65 % of respondents knew that the risk of inheriting APKD 
was 50-50. This is an interesting finding and possibly worthy of further study. It is not 
illogical for patients to consider a 50-50 risk as a medium risk; the chances each way are 
equal. However, there may be a problem for those offering genetic counselling, since they 
may perceive a risk of 50-50 as a high risk and may assume that the patient also thinks 
this way. 
18.9 PERCEFI10N OF PROBLEMS ASSOCIATED WITH APKD 
In this study patients perceived certain physical problems associated with APKD 
as more problematic than social problems that may be associated with the illness. In 
particular Lethargy was seen as the most important problem in both the first and the third 
interviews. Lethargy is not a symptom normally referred to in articles about APKD, and 
it is not known whether there is any physiological explanation for this finding. Lethargy 
is certainly perceived by patients as a very problematic symptom of APKD. This finding 
may be of interest to renal physicians, and may also be useful when explaining the nature 
of the illness to patients. 
There are two other findings of interest concerning the problems associated with 
APKD. The first is that female patients found abdominal pain, nausea and sickness much 
more problematic than did male patients. No reference to this difference in symptoms 
according to sex has been found in the literature. 
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The second fmding is that male patients found the possible loss of job and 
reduction in standard of living particularly problematic. Patients with APKD, regardless 
of the nature of their employment, may fmd that, as the illness progresses, they have to 
give up work. However, this is much more likely if they are involved in manual work. 
Bury (1991) argues that the meaning of chronic illness for the indivjdual is to be found 
not only in the symptoms of the illness but also in the effect of these symptoms on 
everyday life at home and at work and that these effects could influence how that patient 
regards himself. 
In order to minimise feelings of worthlessness because the patient no longer has 
a job, I would recommend that patients with APKD, and particularly male patients, be 
advised and encouraged to seek employment appropriate to their illness. 
IS.10 ATTI1lJDES TO SCREENING AND TESTING OF AT-RISK RELATIVES AND CIlILDREN 
In this study the very great majority of patients thought that those relatives at risk 
for APKD should be told of their risk and that they should be tested. It is however 
important that the interests of individual relatives are considered (Harding 1990). Some 
relatives may neither wish to know of their risk nor be tested. The confidentiality of all 
relatives, who are not necessarily patients, must be protected. 
Almost all the respondents also thought that their children should be tested, with 
the majority suggesting that the most appropriate age for children to be tested was between 
16 and 20. This finding was also supported by the results from the secondary study on 
prenatal diagnosis, with the very great majority of both the APKD and the haemophilia 
populations reporting that their relatives should be told of their risk and should be tested. 
The availability of ultrasound had made presymptomatic diagnosis of APKD easy, 
and the non-invasive nature of ultrasound made it an acceptable procedure for patients. 
However DNA linkage analysis has possibly made early presymptomatic diagnosis of 
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APKD even more accurate than ultrasound. The availability of the technology and the 
desire of patients for genetic information raise questions that have not necessarily been 
considered previously. 
One particular question concerns the possibility of discrimination as a consequence 
of the diagnosis of a genetic disease and in particular of presymptomatic diagnosis. 
Authors such as Nelkin and Tancredi (1989) describe the early diagnosis of a 
presymptomatic illness as 'diagnostic labelling' and, once diagnosed, the way is open to 
discrimination; similar comments are made by Natowicz et al (1992). 
Another form of discrimination concerns life insurance. In this study relatively few 
patients had experienced difficulties with life insurance (see Appendix B.14). However, 
it is likely that, if an individual has been presymptomatically diagnosed as having APKD, 
should that individual apply for insurance, the application would be rejected. A principle 
of insurance is 'uberrima fides', good faith on both sides. When an applicant knows that 
there may be a problem that could affect the risk on the policy they must disclose this 
information otherwise the insurance company may declare the policy void (Wilkie 1987). 
Billings et al (1992) found that, because of the fear of discrimination, several 
respondents in their study either withheld or 'forgot to mention' potentially important 
medical or family history information to insurers, and some respondents reported that their 
insurance agents had suggested that they give incomplete or dishonest information on 
insurance application forms. In the case of APKD it may be many years before symptoms 
appear by which time the policy may have matured, so there is less risk of any dishonesty 
being discovered. 
Respondents in the study of Billings et al (1992) also experienced discrimination 
in employment, a problem also faced by some of those who are mv asymptomatic 
antibody positive (Anderson and Wilkie 1992). Indeed those working in HN have been 
very sensitive to the problems of discrimination in employment that may be faced by those 
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who are HIV antibody positive and asymptomatic, and such potential difficulties may be 
included in mv pretest counselling (Anderson and Wilkie 1992). 
The past history of eugenics and the current evidence of genetic discrimination are 
reminders also of the use of scapegoats, which can be acute in times of economic hardship 
(Holtzman and Rothstein 1992). Avoiding the birth of a fetus prenatally diagnosed as 
having a genetic disease is likely to be less expensive to the health services in society than 
clinical management of the disease. 
The findings described above clearly have implications for renal physicians. Should 
they consider establishing a screening and counselling service to ensure that relatives at 
risk for APKD can be informed of their risk and offered testing? I would recommend that 
the concerns about genetic discrimination referred to above and described more fully in 
Chapter 5 are taken into consideration and included in the information given to any patient 
considering pre symptomatic diagnosis of APKD. 
18.11 PERCEPTION OF PRENATAL DIAGNOSIS 
The majority of respondents in the secondary study favoured knowing prenatally 
whether or not their child had APKD and in the parallel haemophilia group the majority 
of respondents also wanted to know whether or not their daughter was a carrier or their 
son had haemophilia. Whilst the majority of both these populations would consider 
prenatal diagnosis, they would not consider prenatal diagnosis followed by termination of 
pregnancy of a fetus affected by APKD or Haemophilia. It was clear from this secondary 
investigation into prenatal diagnosis that respondents would like to know the genetic status 
of their child prenatally. However, the risks of miscarriage from the diagnostic procedures 
were not discussed with the respondents in this study, since they were given self-
administered questionnaires. Nor were the prenatal diagnostic procedures described to the 
patients. 
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One possible explanation for this finding, that patients would like to know the 
genetic status of their child prenatally but would not consider termination of pregnancy 
either for APKD or for haemophilia, is that all parents have a strong desire to have a 
'normal' baby. Parents may also assume that parental love is unconditional. It is also 
possible that more people stated that they would consider prenatal diagnosis than would 
actually be prepared to use it. 
18.12 ATIl1UDES TO TERMINATION OF PREGNANCY 
Neither the APKD nor the haemophilia population were in principle against 
termination of pregnancy, with both populations agreeing that termination should be 
available sometimes. Over 60% of respondents in both populations were in favour of 
termination early in pregnancy if it could certainly be shown that the fetus would have 
AIDS, severe mental handicap or severe physical handicap. In comparison only 15 % of 
the APKD population and 16 % of the haemophilia population would consider termination 
of pregnancy for their respective illnesses. 
These findings suggest that neither APKD nor haemophilia is viewed as sufficiently 
serious by respondents for them to consider termination of pregnancy if it could certainly 
be shown that the fetus had APKD or haemophilia. I believe that this area deserves further 
research, and I would recommend that there be very careful discussion about what the 
patients want with those for whom these procedures would be appropriate. 
18.13 PERCEmON OF SERIOUSNESS OF APKD 
Respondents had a very clear idea of the order of severity of several well known 
illnesses, with AIDS and cancer consistently being perceived as the most serious. APKD, 
like haemophilia, was ranked as an illness of medium severity. If patients' perception of 
the burden of the illness is important in their decision about whether to have termination 
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of pregnancy of a fetus with APKD then it is not surprising that patients with APKD or 
. with haemophilia, who viewed the severity of their respective illnesses as medium, would 
not consider termination of a fetus affected by these illnesses. 
An additional fInding was that respondents affected by APKD perceived APKD 
much less severely than those who had been tested and were unaffected, and less severely 
than those who were at risk but had not yet been tested. It is not known what proportion 
of the population at risk for APKD would decline to be tested if testing were offered to 
them on a systematic basis. It would be relevant to establish whether there were particular 
characteristics of those who declined testing and in particular whether those who declined 
to be tested viewed APKD as a serious illness. 
18.14 EnncAL ISSUES 
In the fInal fourth paradigm of genetic counselling, which was discussed in Section 
2.6, I suggested that new technologies in clinical genetics created ethical issues that had 
previously not been addressed. There are three ethical issues that need to be considered: 
presymptomatic testing; prenatal testing not followed by termination; and the 
confidentiality of data. 
In this study there are two almost contradictory fIndings. Patients in the main study 
thought that children should be tested between the ages of 16 and 20; but this was before 
the gene marker technology was available. Then, when the possibility of prenatal 
diagnosis of APKD was introduced, respondents in the secondary study were in favour 
of learning prenatally whether or not their child had APKD. There may be diffIculties for 
any parent about telling their child of that child's risk of having APKD. But if respondents 
do not discuss this with their child until he or she is older, as the majority of respondents 
in the main study suggested, then the child can be brought up 'ignorant' of their risk. 
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To confirm prenatally that the fetus has the gene for an illness where the symptoms 
do not normally appear until adulthood may raise other difficulties. The parents have still 
to decide when to tell the child. In addition it is not known whether the fact that the child 
has the gene for APKD and is very likely to develop symptoms in the future will affect 
the way that the parents bring up the child. Will this child face discrimination within the 
family, at school, in employment and with life insurance, because he or she is the carrier 
of a gene? Will any medical problem that the child develops be attributed to the fact that 
he or she carries this gene even though' the problem is not obviously associated with 
APKD? 
It is not known what are the long term implications of presymptomatic diagnosis 
of APKD both for the patient and for their parents. These are new problems created by 
the new technologies and they are worthy of further investigation. 
Respondents in the secondary study wished prenatal diagnosis but did not wish this 
to be followed by termination of an affected fetus. There is an ethical question in whether 
patients should be offered prenatal diagnosis when they state that they will not consider 
termination. Prenatal diagnosis itself is not without a small risk and it is a labour-intensive 
procedure. It is often assumed that prenatal diagnosis would usually be followed by 
termination of an affected fetus. However, it is interesting to note that more than half the 
medical geneticists in the study by Wertz (1990) stated that "performance of prenatal 
diagnosis should not depend on the use that patients intend to make of the information" 
(p 1210). If the technologies are available and the patients want these tests, who will 
decide what they can have? 
The third ethical issue concerns the confidentiality of data. This topic has already 
b(~n referred to in Chapter 2. The fmdings of this study suggest that genetic counselling 
should be part of the management or care given to patients with APKD attending a renal 
unit. It is essential that genetic data be confidential. This becomes critical when details of 
330 
CHAPTER 18: DISCUSSION OF FINDINGS AND CONCLUSIONS 
at risk relatives who are not patients are included in the records. It is not appropriate to 
hold information about the at risk relatives in the notes of an index patient, since many 
people have access to patients' notes. Renal physicians considering offering 
presymptomatic diagnosis of those at risk for APKD will need to consider (a) who has 
access to the genetic information and (b) how and where this information will be stored. 
Those offering genetic counselling also need to consider on one hand their duty to 
protect the confidentiality of their patient and on the other hand a perceived obligation to 
offer the genetic information to at risk relatives. When blood samples are required for 
genetic linkage analysis, it is important that there is an awareness that family pressures 
on relatives to participate can result in harm to those relatives and to family relationships 
(Nolan and Swenson 1988). 
18.1S FuRTHER S1lJDIES 
The study described in this thesis was of an exploratory nature, but I believe that 
it raises some very critical issues for genetic counselling, issues that are worthy of further 
investigation, which have been indicated above. 
In this thesis a statistical approach to the analysis of the data has been used. 
Inevitably qualitative data is lost thereby. The study of genetic counselling requires 
sensitive treatment of the respondent by the interviewer. An alternative and possibly more 
sympathetic approach to the research would have been to emphasise and use direct 
quotations from the respondents to highlight particular points. This would have added a 
richness to the study that is missing in the tabulated numbers. Yet another approach would 
have been to use video recordings of the interviews, and to analyse body language, 
hesitations an~ expressions of the patients. But such methodology would have added length 
to a thesis that is already long. I would recommend, however, that these alternative 
approaches should be considered in future by those working in this field. 
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